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Abstract 
 
 The bulk of the work presented in this thesis represents an evolution of 
copper-mediated atom transfer radical cyclisation.  Chapter 1 provides introduction 
to radical cyclisation methods and applications and is followed by the shortest results 
chapter that discusses the outcome of 1,4-dimethylpiperazine mediated radical 
cyclisation of monobromoacetamides.  Cyclisation was possible but competing 
reduction and elimination pathways are prevalent when less reactive substrates are 
used. 
 Chapters 3 and 4 focus on the evolution of copper-mediated atom transfer 
radical cyclisation.  A number of additives were screened in the hope of achieving 
catalyst regeneration which would allow catalyst loadings to be reduced without loss 
of efficiency and negate the need for an inert atmosphere throughout the reaction.  In 
chapter 3, AIBN was found to be the optimum additive and efficient cyclisation was 
possible using copper (I) (Cu(TPA)Br) and copper (II) (Cu(TPA)Br2) complexes (1 
mol%) in DCM and toluene (at 50 and 110 
o
C respectively) suggesting AIBN could 
activate and reactivate the catalyst in situ. 
 In chapter 4 an alternative, highly efficient process was developed using 
copper (II) in the presence of potassium borohydride in MeOH.  Reaction times were 
significantly reduced (10-30 min) and reactions were performed at room temperature 
even at decreased catalyst loadings (0.1 mol%).  The mechanism for the process is 
likely to differ from that of conventional atom transfer radical cyclisation.  UV 
analysis of the catalyst complex and the reactions progress, compared to literature 
data, suggest the active catalyst could be a copper borohydride (CuBH4) complex. 
  
x 
 
 Finally chapter 5 compiles a structural analysis of a variety of enamides to 
determine the feasibility of chiral induction during 5-endo trig radical cyclisation.  A 
number of N-cycloalkenyl and N-cyclohexenyl enamides, which share an axis of 
chirality about the N-C(cycloalkenyl) bond, were analysed by variable temperature 
NMR to determine the rate and barrier of rotation of the chiral axis.  Although none 
of the enamides studied had barriers great enough to achieve chiral induction it was 
recognised that the barrier to rotation could be significantly increased if 
tetrasubstituted enamides were accessible.  Tetrasubstituted enamides were prepared 
and their barriers were determined by chiral HPLC, with barriers predicted to be 
great enough for chiral induction.  Cyclisation was attempted but to no avail with 
unexpected oxidation products being obtained.  Despite this, a more comprehensive 
understanding of the enamide structure has paved the way for potential chiral 
induction in 5-endo trig radical cyclisation.  
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1.0 Introduction 
 
1.1 TRADITIONAL RADICAL CYCLISATION 
 
Traditionally, radical cyclisation reactions are achieved using organostannane 
and organosilane reagents (Bu3SnH or (SiMe3)3SiH)
1,2,3
 in the presence of radical 
initiators (peroxides, AIBN) in refluxing benzene or toluene to generate tin or silicon 
centered radicals.  These radicals take advantage of weak ζ-C-X (X = halogen) 
bonds in the precursor 1 to produce radical 2 that cyclises onto a radical sink (alkene 
or alkyne) to form a third radical 3, which abstracts a hydrogen atom from the 
organostannane or organosilane reagent to furnish the cyclised product 4 and another 
reactive radical to continue the radical chain (Scheme 1.1). 
 
 
Scheme 1.1: Reductive Radical Cyclisation Mechanism 
 
Chapter 1: Introduction 
2 
 
Although this has been shown to be a synthetically useful transformation, 
there are a number of disadvantages associated with organostannane and 
organosilane reagents.  The principal drawback for both methods is that they are 
reductive in nature.  On a laboratory scale this is not always a problem, but 
quenching the cyclised radicals 3 with hydrogen atoms can be limiting as it leads to 
the loss of two functional groups in the product 4.  Additional disadvantages include 
the need for stoichiometric amounts (high cost), and organostannane reagents and 
their byproducts are particularly toxic, which cause problems and complicate the 
purification process.  All of these issues are magnified on scale-up, making such 
reactions industrially unattractive. 
A non-reductive, non-stoichiometric, alternative organostannane mediated 
radical cyclisation was developed in the late 80’s and early 90’s by Curran.4,5  The 
possibility of reductive termination was removed by replacing Bu3SnH with 
hexabutylditin (Bu3SnSnBu3), which also allowed the loading of the organostannane 
reagent to be reduced to the catalytic level of 10 mol% (Scheme 1.2).   
 
 
Scheme 1.2: Hexabutylditin Mediated ATRC 
 
 The reaction was initiated by photolysis of the Sn-Sn bond and the reaction 
was found to be terminated by iodine atom transfer from the substrate 5.  Radical 
cyclisations of this sort are commonly known as atom transfer radical cyclisation 
reactions (ATRC).  The preservation of functionality and the catalytic nature of the 
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ditin reagent represented significant improvements in organostannane mediated 
radical cyclisation.  However, the toxicity of the tin reagents and byproducts 
remained a major drawback of these radical cyclisation protocols. 
 
1.2 ORIGINS OF ATOM TRANSFER RADICAL CYCLISATION 
 
In 1945-46,
6,7,8
 Kharasch performed a number experiments resulting in the 
addition of carbon tetrahalides and haloforms across alkenes.  When the halogens 
present were chlorine atoms, a catalytic amount of diacyl peroxide was required to 
afford addition.  However, when the halogens present were bromine atoms, addition 
was observed in the absence of peroxides, but in the presence of visible light. 
 
 
Scheme 1.3: Kharasch Addition of CBr4 to Terminal Alkenes 
 
 Mechanistically, Kharasch proposed that addition proceeded through a 
radical chain reaction, initiated by homolysis of a C-X (halogen) bond to form a 
carbon centered radical 8, and a halogen radical 9.  Addition of the carbon radical 8 
to the less substituted end of the alkene 10 then formed a second radical 11.  This 
could then react with another molecule of CX4 to form the addition product 12, and 
another carbon centered radical that could react with another alkene molecule.  
Initiation of this transformation can be achieved chemically or photolytically 
depending on the nature of the initiator, and propagation relies on the preservation of 
a reactive radical upon product formation. 
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Scheme 1.4: Radical Chain Mechanism 
 
 In order for the radical chain to propagate, termination pathways must be 
avoided.  Kharasch addition (Scheme 1.4) can be identified as the first example of 
intermolecular atom transfer radical addition (ATRA).  Substrate and reagent 
concentrations dictate the relative propensities of propagation and termination.  
Altering the reactivity of the radicals present during reaction can dictate the product 
identity, as telomers and polymers, as well as monoadduct products, can be obtained.  
This is discussed in more detail in section 3.1.     
   A less toxic, oxidative route to cyclisation (18 → 19, Scheme 1.5b) has been 
developed.  The intermolecular version of this reaction, namely addition of 16 to 
ethyl acrylate 15 to give functionalized monoadduct products 17 (Scheme 1.5a), is 
also known.
9
  These reactions were mediated using transition metal catalysis, in 
particular cuprous (CuCl) and cupric chloride (CuCl2).  The authors predicted that 
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the transition metal catalysed process was unlikely to follow the radical chain 
mechanism of Kharasch addition, with an alternative catalytic redox mechanism 
thought to be more likely (Scheme 1.6).   
 
 
 
Scheme 1.5: a) Copper Mediated Intermolecular Addition  
b) Copper Mediated Intramolecular Addition 
 
The copper-mediated intramolecular addition reaction was achieved by 
Nagashima in 1983 when they heated activated trichloroacetate 21, in the presence 
of CuCl in MeCN (140 
o
C) in a pressurized bottle for 1 hour to give lactone 24 in 
72% yield.
10
  With greater confidence they proposed that the reaction followed a 
catalytic redox mechanism in which CuCl interacted with the substrate 21 to furnish 
a tertiary radical 22.  This then cyclised to give a more reactive primary radical 23 
which could react with CuCl2 to furnish a functionalised lactone 24 and regenerate 
the CuCl catalyst (Scheme 1.6).   
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Scheme 1.6: Intramolecular Radical Addition Mechanism (ATRC) 
 
 The redox mechanism allows the reaction to be oxidatively quenched, 
preserving a degree of functionality in the cyclised products for additional chemistry.  
Furthermore, the transition metal reagents are relatively cheap, easily handled and 
purified (via filtration through a silica plug) and most importantly the process is 
catalytic as sub-stoichiometric amounts of copper salts are used.  It should also be 
noted that mechanistically 24 could also be formed from atom transfer from the 
reaction substrate 21 (23 + 21 → 24).  If the desired product 24 is furnished in this 
way, the failure of the final redox process (CuCl2 → CuCl) would lead to an 
accumulation of CuCl2, and this would lead to the retardation of reaction initiation; 
however, in the hands of Nagashima and at 30 mol% catalyst loading this potential 
problem was not evident.   
 
Chapter 1: Introduction 
7 
 
1.3 COPPER MEDIATED ATOM TRANSFER RADICAL CYCLISATION 
 
The cyclisation of trichloroacetate 21 is an example of copper (I) mediated 5-
exo trig ATRC, which is the most facile and abundantly studied mode of radical 
cyclisation.  A number of factors that influence the rate and outcome of copper (I) 
mediated ATRC must be considered.  Firstly, cyclisation is initiated by homolysis of 
the C-X (halogen) bond, the rate of which is dependent upon the bond dissociation 
energy of the bond in question.
11,12,13
  Stronger bonds are more difficult to homolyse 
than weaker ones and as a result the ease of C-X bond homolysis follows the order 
C-F < C-Cl < C-Br < C-I.  In addition, adjacent halogen substituents weaken the 
bond dissociation energy further so for homolysis CCl3 > CHCl2 > CH2Cl. 
Once the radical is formed the rate and outcome of cyclisation is determined 
by the radical stability, stereoelectronic effects of ring formation and the radical 
conformation.  Like their ionic counterparts (carbocations R3C
+
), carbon-centered 
radicals are stabilized by adjacent electron donating substituents.  Therefore carbon-
centered radicals show the following order of stability R3C
.
 > R2HC
.
 > RH2C
.
.  
Additionally, and unlike carbocations, radicals can also be stabilized by electron 
withdrawing groups such as halogens and carbonyl groups. 
Some radical precursors are not predisposed for cyclisation, existing in 
conformations that prevent the required orbital overlap between the radical and the 
unsaturated carbon of the radical sink.  Trichloroacetamides and the radicals derived 
from them, such as 25 and 26, can exist as two amide conformers due to slow 
rotation about the amide (N-CO) bond.  When unprotected (R = H) the least 
sterically hindered syn amide conformer is preferred which cannot cyclise.  However 
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addition of bulky or electron withdrawing R groups pushes the equilibrium towards 
the anti conformer which can undergo cyclisation (Scheme 1.7).
14
   
 
 
Scheme 1.7: Amide Bond Rotation Giving Rise to Syn and Anti Acetamide Rotamers 
 
 Two other factors that affect the outcome of the radical cyclisation are the 
nature of the reaction solvent and the addition of additives.  Hydrogen donating 
solvents, such as THF,
 15
 can intercept intermediate radicals (e.g. 22 or 23, Scheme 
1.6) leading to reduction and as a result poor donor solvents tend to be used for 
ATRC (toluene, DCM).  The addition of amine and pyridine based ligands to the 
reaction mixture has been shown to significantly accelerate the rate of cyclisation by 
improving the solubility of the copper salts and/or altering the redox potential of the 
catalyst system.
 16,17
  
 
1.3.1 5-Exo Trig ATRC 
  
The development of copper-mediated ATRC during the end of the last 
century and the beginning of this one has been summarized in a comprehensive 
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review by Clark.
18
  Initial reactions of trichloroacetamides such as 28a/b utilized 
CuCl as a catalyst in MeCN to afford γ-lactams19,20 such as 29a/b via 5-exo trig 
cyclisation.  However, in order to achieve synthetically useful yields, high reaction 
temperatures, and in some cases long reaction times, were required to overcome 
unfavourable conformer populations (Scheme 1.8).    
 
 
Scheme 1.8: CuCl Catalysed ATRC 
 
 Reactions were improved following the discovery of ligand-accelerated 
ATRC.  Originally, nitrogen containing bidentate ligands including bipyridine (bipy, 
30),
16,17
 pyridine-imine ligands (NPMI’s, 31) 15,21,22,23,24,25 and tetramethylethylene-
diamine (TMEDA, 32)
26,27,28,29
 were shown to significantly improve the efficiency of 
copper-mediated ATRC.   
 
 
Figure 1.1: Bidentate Ligands Used in Copper Mediated ATRC 
 
It was proposed that these ligands accelerated the atom transfer process by 
either improving the solubility of the copper salt (CuCl), by altering the redox 
potential of catalyst system, or by both.
16,17
  For example, the addition of bipy 
reduced both the reaction time and temperature of the cyclisation of acetamides 
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33a/b/c. In addition, the formation of such a copper complex allowed the reaction to 
be carried out in a variety of solvents such as DCM, in which CuCl alone is insoluble 
(Table 1.1).
17
  
 
 
Entry Substrate Catalyst (30 mol%) Temp 
o
C Time h  Yield 
1 33a CuCl 80 18 68% 
2 33a
a 
Cu(30)Cl rt 1 98% 
3 33b CuCl rt 24 97% 
4 33b
a 
Cu(30)Cl rt 0.2 91% 
5 33c CuCl 80 4 80% 
6 33c
a
 Cu(30)Cl rt 2 78% 
a
 Reactions performed in DCM 
 
Table 1.1: The Effect of Bipy and Protecting Group (R) on Copper Catalysed ATRC 
  
The use of TMEDA (32) as a ligand was found to furnish a more reactive 
catalyst complex (Cu(TMEDA)2Cl) than the bipy (30) and NPMI (31) ligands, 
improving reaction yields even at reduced catalyst loadings.  Cyclisation of 
dichloroacetamide 35 was unsuccessful using Cu(bipy)Cl, however in the presence 
of 10 mol% Cu(TMEDA)2Cl cyclisation was observed to afford an 88% yield of 36 
as a single diastereomer (Scheme 1.9).
26
  
 
 
Scheme 1.9 Cu(TMEDA)2Cl Mediated ATRC 
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 More recently, TMEDA (32) has been used as the ligand for the copper-
catalysed formation of benzospiro-indolizidinepyrrolidinones 39.
30
  These 
compounds occur as a result of sequential carbon-carbon bond forming reaction via 
5-exo (37 → 38) then 6-endo trig (38 → 39) cyclisations.  For optimal conversions, 
the substrate was refluxed in acetonitrile with a 1 : 2 mixture of CuCl (40 mol%) and 
TMEDA (80 mol%), resulting in formation of the desired product 39 in 40% yield as 
a mixture of diastereomers (Scheme 1.10). 
 
 
Scheme 1.10: Tandem Copper Mediated ATRC as a Route to Spiro-Cyclised Indoles 
 
 Ghelfi and coworkers reported that the optimum TMEDA (32) to copper ratio 
was 2 : 1, stipulating that 2 equivalents of the bidentate ligand were required to form 
an active complex.
26
  As a result alternative ligands N,N,N’,N’,N’’-
pentamethyldiethylenetriamine (PMDETA 40),
31
 N,N,N’,N’,N’’,N’’-hexamethyltri-
ethylenetetramine (Me6-Tren 41),
 15,21,25, 32
 and tetradentate pyridine ligand tri-
pyridylamine (TPA 42),
33
 have been developed to form complexes with a 1 : 1 
copper/ligand ratio (Figure 1.2). 
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Figure 1.2: Amine and Pyridine Based Ligands That Form Highly Active Complexes 
  
   The Cu(Me6-Tren)X and Cu(TPA)X complexes were found to be 
significantly more active than any of the bidentate ligand complexes.  The more 
activated nature of the Cu(Me6-Tren)Cl catalyst allowed the cyclisation of activated 
dichloroacetamide 43 with a catalyst loading as low as 5 mol% in good yield 
(Scheme 1.11a).
21,32
  Similarly, Cu(TPA)Br efficiently catalysed the cyclisation of 
relatively deactivated monobromoacetamide 45 (Scheme 1.11b).
33 
 
 
 
Scheme 1.11: a) Cu(Me6-Tren)Cl Mediated ATRC  
b) Cu(TPA)Br Mediated ATRC 
 
 In a recent study by Ghelfi and co-workers, a related dichlorohemiacetal 
acetate 47 was shown to undergo facile Ueno-Stork ATRC using Cu(PMDETA)Cl, 
in a one pot, multi step reaction (Scheme 1.12).
31
  The cyclic product 48 was 
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obtained in 84% yield, and the lactone product 49 was easily obtained via subsequent 
oxidation processes. 
 
 
 
Scheme 1.12: Cu(PMDETA)Cl Mediated Ueno-Stork ATRC 
 
1.3.2 5-Exo Dig ATRC 
 
5-Exo dig ATRC reactions of propargylic acetates and acetamides leading to 
the formation of highly reactive vinyl radicals have been found to be more difficult 
than the corresponding 5-exo trig reactions.
 15
  In some cases where bidentate ligands 
such as NPMI’s (31) and TMEDA (32) are used, reactions can be complicated by 
facile oxidative dimerisation.
15
   
 
 
 
Scheme 1.13: Oxidative Coupling of Terminal Alkynes 
 
 
Consequently, the successful 5-exo dig radical cyclisation of acetamides has 
been shown to be dependent on the nature of the protecting group.  For example, N-
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benzyl propargylic acetamides (49) tend to undergo dimerisation
15
 to give 52 
(Scheme 1.13), whereas bulky or electron-withdrawing groups such as N-Boc (53a/b) 
or N-Ts acetamides can undergo ATRC (54a/b) (Scheme 1.14).
15
 
 
 
 
Scheme 1.14: 5-Exo Dig ATRC 
 
Cyclisation of less activated monobromide acetamides 56a/b has also been 
achieved.
 15,21
  Stereoisomeric products 57a/b are obtained in addition to a third 
product characterized as the reduced compound 58a/b.  The product distribution and 
stereochemistry (57a/b) have been shown to be dependent upon the R group, ligand 
and solvent used (Table 1.2).     
 
 
Entry Ligand Solvent R Ratio 
57:58 
Yield 57 E:Z 
1 (56a)  50 CH2Cl2 Ts 25 : 1 96% 2 : 5 
2 (56a) 50 Benzene Ts 74 : 1 94% 1 : 4 
3 (56a) 42 THF Ts 1 : 20 95% 1 : 4 
4 (56b) 50 CH2Cl2 Boc 10 : 1 96% 1 : 2 
 
Table 1.2: Ligand and Solvent Effects on 5-Exo Dig ATRC 
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Conducting the reactions in a poor hydrogen donor solvent such as benzene 
(entry 2) gave a greater proportion of the atom transfer products (57).  Conversely, 
when the reaction was repeated using Cu(Me6-Tren)Br and with a good hydrogen 
donor solvent such as THF (entry 3), the ratio of the reduced product 58 significantly 
increased.   
 
1.3.3 4-Exo and 5-Endo Trig Radical Cyclisation 
 
The more active catalyst complexes, containing tetradentate ligands Me6-
Tren 41 and TPA 42, have also been shown to facilitate 4-exo and 5-endo trig radical 
cyclisations of enamides.
34,35
  For substituted enamides, the two reaction pathways 
are competitive.  4-Exo trig ATRC is often quicker, but reversible, forming the 
kinetic product, while 5-endo trig cyclisation produces a less strained 
thermodynamic product.  Enamides substituted at the β-position of the enamide 
alkene functional group (e.g. 59) tend to undergo 4-exo trig ATRC furnishing the β-
lactam product 60
35
 (Scheme 1.).  This has also been shown to be the case when 
intermediate radicals are stabilized,
25
 for example by conjugation, as demonstrated 
by the benzylic radical 62 formed from radical cyclisation of enamide 61 leading to 
formation of β-lactam 63 (Scheme 1.15b). 
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Scheme 1.15: a) Cu(TPA)Br Mediated 4-Exo Trig ATRC  
b) Cu(Me6-Tren)Br Mediated 4-Exo Trig ATRC via Stabilised Benzyl Radical 
 
Conversely, if the α-position of the enamide alkene is substituted then 5-endo 
trig radical cyclisation prevails.  However, rather than atom transfer products, 
unsaturated products such as 64a/b are obtained under copper-mediated ATRC 
conditions.
25
  This implies that the mechanism differs from that established for 4- 
and 5-exo trig ATRC.  Radical cyclisation of enamides such as 63 have been 
proposed to form tertiary radicals that are stabilised by the adjacent nitrogen atom 66.  
Cu(L)X2 mediated oxidation can convert the stabilised radical into a cation via a 
radical-polar cross over reaction to form a N-acyliminium ion 67.  Subsequent 
elimination of a proton furnishes the unsaturated cyclised products (Scheme 1.16).  
This reaction has been found to be general for a variety of ring sizes and 
substitutions.
25,36,37
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Scheme 1.16: 5-Endo Trig Radical Cyclisation via an N-Acyliminium Ion 
 
 Upon 5-endo trig radical cyclisation α-tetralone enamide 69 forms an 
extremely stable tertiary radical stabilised by adjacent nitrogen and aromatic groups.  
Consequently, this reaction is highly efficient occurring at room temperature to give 
70 in quantitative yield. 
 
 
Scheme 1.17: Cu(Me6-Tren)Br Mediated 5-Endo Trig Radical Cyclisation 
 
 The regiochemistry of competing 5-exo and 6-endo trig, and 4-exo and 5-
endo trig radical cyclisation reactions of dienamides, catalysed by a Cu(TPA)X 
complex, has been investigated by Clark and co-workers.
38
  2-Substituted di-
enamides were found to undergo 5-exo or 6-endo trig ATRC depending on the 
nature of the initiating group.  Dienamide 71, containing the trichloro initiating 
functionality was expected to undergo 5-endo trig radical cyclisation so it was 
surprising that the relatively rare mode of 6-endo trig cyclistion was observed.  
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Cyclic products 72 and 73 (50% combined yield) were identified as the major 
products, with the minor product being characterised as the 5-exo trig product 74 
(Scheme 1.18).   
 
 
Scheme 1.18: Regiochemistry of Dienamide ATRC 
 
 Alternatively, dienamide 75, containing the less reactive monobromide 
initiating group exclusively underwent 5-exo trig radical ATRC to furnish 
spirocyclic products 76a/b in a combined yield of 72% (Scheme 1.19).  Again, no 5-
endo trig cyclisation was observed. 
 
 
Scheme 1.19:  Regiochemistry of Dienamide ATRC 
 
 3-Substituted dienamides were found to undergo exclusive 4-exo trig ATRC 
which could be terminated via a variety of pathways to produce β-lactam products.  
The termination pathway was found to be dependent upon the nature of the diene.  
Substrate 77 furnished the atom transfer terminated β-lactam product 78 in 60% 
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yield in 2 hours.  Alternatively, dienes 79 and 83, both substituted at the terminal 
carbon of the diene functional group, required longer reaction times (19 hours) and 
led to an array of products arising from atom transfer 80, elimination 81, 84, 
oxidation 82 or dimeriation 85 (Scheme 1.20). 
 
 
 
Scheme 1.20: Regiochemistry of Dienamide ATRC 
 
 
1.3.4 Other Ring Sizes by ATRC 
 
Tetradentate ligand complexes have also been used to facilitate 
macrolactonisation of trichloroacetates, such as 86.  For example, Verlhac et al. 
discovered that the highly active complex, Cu(TPA)Cl, could catalyse 8-, 9- and 10-
endo trig ATRC reactions, to form macrocyclic lactones (Scheme 1.21a).
39
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Furthermore, with respect to synthetic application, radical macrocyclisation by 
ATRC has been utilized in the synthesis of synthetically useful crown ethers such as 
89 (Scheme 1.21b).
40
 
 
 
Scheme 1.21: a) Macrocyclisation by Copper-Mediated ATRC  
b) Crown Ether Synthesis by ATRC 
 
Ram et al. have used the copper-bipy complex (Cu(bipy)Cl) for the formation 
of benzannulated compound 92 via an 8-endo trig ATRC intermediate 91.
41
  
However, one equivalent of the copper complex was required and yields were poor 
as the reaction is complicated by the formation of two other products 93 and 94 
(Scheme 1.22).  
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Scheme 1.22: Cu(Bipy)Cl Mediated Benzannulation via an 8-endo trig Intermediate 
 
N-Heterocyclic carbenes (NHC)
42
 have emerged as potential ligands for 
copper-catalysed processes.  These substrates have been identified as phosphane 
surrogates in transition metal catalysis with potentially greater stability and reactivity.  
Buchwald
43
 and Nolan
44
 have shown that stable copper-NHC complexes can 
efficiently catalyse hydrosilylation,
44
 C-H activation
45
 and Huisgen cycloaddition 
(‘click’) reactions.46  Subsequently, Quayle et al. have reported that copper-NHC 
complexes such as 92 (5 mol%) can catalyse a regiospecific benzannulation reaction 
that proceeds via the initial 8-endo trig ATRC of aryl trichloroacetate 93 (Scheme 
1.23).
47
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Scheme 1.23: NHC Mediated Benzannulation via 8-endo trig Intermediate 
  
Quayle has had success in constructing a number of benzannulated products 
using 92 and related complexes.  Additionally, the use of microwave radiation has 
allowed the catalyst system to be extended to the familiar ATRC of 
trichloroacetamide 96 to form 97 in 80% yield (Scheme 1.24). 
 
 
Scheme 1.24: NHC Mediated ATRC 
 
1.3.5 Rearrangement Reactions 
   
 Under ATRC conditions (Cu(L)X, 30 mol%) the synthesis of larger ring 
lactams from acetamides and enamides has been met with limited success.  δ-
Lactams such as 99, are accessible using more activated copper complexes 
(Cu(TPA)Cl) via 6-exo trig ATRC (Scheme 1.25).
21
  However, attempts to mediate 
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8-endo trig ATRC of tricholoracetamides like 100 have been unsuccessful, leading 
to the isolation of rearranged products such as 101 (Scheme 1.26).
21
  
 
 
Scheme 1.25: 6-Exo Trig ATRC of Acetamides 
 
 
Scheme 1.26: 5-Exo Ipso Substitution of Acetamides 
 
 It has been postulated that this reaction occurs via a 5-exo ipso aromatic 
radical substitution
48,49,50,51
 via the radical intermediate 102 to give cyclised radical 
103.  The rearrangement is then driven by re-aromatisation (rather than atom transfer) 
which produces sulphur radical 104.  Observed loss of SO2 from 104 and subsequent 
reduction of the resulting amide radical gives 101.  This rearrangement reaction has 
been investigated by the Clark group for a number of N-alkyl sulfonamides which 
have been shown to follow this reaction pathway (Scheme 1.27).
52,53 
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Scheme 1.27: 5-Exo Ipso Substitution of Monobromide Acetamides 
 
 
1.4 RECENT DEVELOPMENTS IN TRANSITION METAL 
MEDIATED ATRC 
 
1.4.1 Di-tin Derivatives 
 
The Clark review
18
 comprehensively establishes copper-mediated radical 
cyclisation as a synthetically useful process, and since its publication numerous 
advances and applications have been achieved.  The principal drawback of the 
copper-mediated ATRC reaction is that despite being a catalytic process, relatively 
large amounts (30 mol%) of catalyst are often required.  Consequently, it is often 
difficult to ensure complete removal of the copper complexes from the cyclised 
products and on scale-up the process could become expensive.  As a result 
heterogeneous methods, and methods designed to improve catalyst efficiency have 
been developed.
 54,55,56,57
   
In homogeneous reactions, hexabutylditin-mediated cyclisations are known to 
furnish atom transfer products.  The use of solid-supported hexabutylditin has 
recently been shown to facilitate efficient radical cyclisations, with the expected 
preservation of functionality.
54
  For example, resin-bound hexabutylditin has been 
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shown to catalyse the iodine ATRC reaction of 5 to give γ-lactam 6 in excellent yield 
(Scheme 1.28).   
 
 
Scheme 1.28: Solid-Supported Tin Mediated ATRC 
 
1.4.2 Solid Supported Copper Catalysed ATRC 
 
A range of desirable solid-supported copper catalysts, which are oxidative in 
nature and preserve functionality, have also been developed.
55
  These are prepared 
by immobilizing amine and pyridine based ligands onto various solid supports and 
then stirring them, under an inert atmosphere, with the relevant copper salt (Scheme 
1.29).  The prime advantage of solid-supported catalysis is that following reaction 
and product separation, the catalyst can be isolated and re-used. 
 
 
Scheme 1.29: Preparation of Solid-Supported Copper/Pyridine-Imine Catalyst 
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Applying the heterogeneous catalysts 110 and 111 to ATRC reactions of a 
variety of activated and relatively deactivated acetamides successfully furnishes 
cyclised products between 75-96%.
55
  Activated trichloroacetamides such as 33b 
undergo facile cyclisation at room temperature within 1 hour, whereas deactivated 
monobromoacetamides like 45 require higher temperatures (80 
o
C) and longer 
reaction times (24 h) (Scheme 1.30).  Heterogeneous NPMI complexes are less 
active than their homogeneous counterparts but this is compensated for by the ease 
in which the heterogeneous catalysts can be separated from the cyclised products 
(filtration) and re-used. 
 
 
Scheme 1.30: Solid-Supported Copper Mediated ATRC 
 
 The concept of catalyst recycling was examined for the cyclisation of 
activated trichloroacetamide 33b.  The result displayed in Scheme 1.30 represents 
the yield for the first cyclisation attempt.  The catalyst was then isolated by filtration 
and used under identical conditions with a fresh batch of 33b.  Cyclisation was 
observed in 18-24 hours and a comparable yield (90%) of 34b was obtained.  After 
filtration the catalyst was recycled a third time and in order to obtain a comparable 
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yield (86%) a reaction time of 24-36 hours was required.  The longer reaction times 
and gradual reduction in the yields of this reaction reflects a steady deactivation of 
the catalyst complex.  It was recognized that the catalyst could be deactivated either 
by leeching of the copper from the solid support or by accumulation of deactivated 
CuX2.  In a later publication
56
 5-exo trig and dig, as well as disfavoured 5-endo trig 
and 4-exo trig radical cyclisations were achieved using a range of solid supported 
NPMI’s and polyamines.  In all examples, the heterogeneous method was found to 
be slower than the homogeneous counterpart and catalyst recycling was possible but 
with gradual loss of activity.   
 In 2010, Nagashima applied a novel polysiloxane gel-encapsulated 
Cu(bipy)Cl species as a reusable catalyst system for the ATRC of α-halogenated 
acetamide derivatives.
57
  Trichloroacetamide 96 was cyclised in quantitative yield 
within 4 hours using a substrate/catalyst ratio of 220.  Upon recycling, identical 
conversion was obtained but a longer reaction time was required.  Less activated 
monobromoacetamide 45 could also be cyclised in quantitative yield using the 
polysiloxane gel encapsulated Cu(bipy)Cl catalyst, in 16 hours (Scheme 1.31). 
 
 
Scheme 1.31: Polysiloxane Gel-Encapsulated Cu(Bipy)X Mediated ATRC 
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 The principal advantage of this novel catalyst system is that there is little 
evidence to suggest that any metal, ligand and/or metal-ligand complex is leaking 
from the polysiloxane gel supports.  Consequently, quantitative conversions to the 
cyclic products allow facile purification by simple filtration to separate the catalyst 
from the desired product.  
 
1.4.3 ATRC Using Perfluorous Catalysts 
 
Perfluorous catalysts have found application in a number of organic 
transformations.
58,59,60
  In principle, these reactions consist of two phases, an organic 
phase that contains a reaction substrate, and a perfluorous phase that contains the 
catalyst.  At elevated temperatures the phases are miscible and catalysis is possible.  
However, when the reaction is complete and the temperature is reduced (to ambient 
temperature) the phases separate again and the catalyst can be easily removed from 
the reaction product by decanting off the perfluorous phase. 
In the field of ATRC, Verlhac et al. have employed a perfluorous analogue 
112 of Me6-Tren 41, generally soluble in perfluorous alkanes, to catalyse the 8-endo 
trig ATRC of trichloroacetate 113.
61
  With a catalyst loading of 5 mol% and a 
solvent system of perfluoroheptane, trifluorotoluene and dichloroethane (1 : 2 : 1), 8-
membered lactone 114 was obtained in 97% yield (Scheme 1.36). 
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Scheme 1.32: ATRC Using Perfluorous Catalysis 
 
 As with the solid-supported heterogenous reactions, perfluorous catalysed 
ATRC was found to be slower than the analagous homogeneous reaction.  However 
this is compensated for by the recyclability of the catalyst, which is isolated after 
reaction by decantation and subsequently reused with little loss of efficiency (97%, 
95%, 93%, 91% in successive cycles) at the cost of a slight decrease in rate.      
 
1.4.4 Reducing Catalyst Loadings in Atom Transfer Radical Reactions 
 
The first examples of reduced catalyst loadings were reported in the field of 
atom transfer radical polymerisation (ATRP),
62,63
 which is discussed in more detail 
in chapter 3.  Perhaps the most common and successful processes are the activator 
generation/regeneration methods that utilize common additives, reductive in nature, 
to continuously regenerate the active catalyst (Cu(L)X) from the deactivator 
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(Cu(L)X2).  Common reducing agents include phenols,
64
 monosaccarides,
65 , 66
 
ascorbic acid,
67,68
 hydrazine,
64
 tin(II) 2-ethylhexanoate
66,67 
and diazo compounds.
64
  
The principal benefit of the inclusion of such additives is the ability to perform 
efficient polymerizations in the presence of as little as 5 ppm copper. 
Application of similar processes to ATRA reactions has been met with 
similar success as monoadduct products were accessible with impressive turnover 
numbers using both ruthenium
69
 and copper catalysts.
 70,71,72
  Significantly, the most 
impressive results were obtained using Cu(TPA)Br2 from which the active catalyst 
(Cu(TPA)Br) was formed in situ in the presence of diazo initiators.
70,71,72
  The 
concept of copper-mediated ATRP and ATRA at reduced catalyst loadings has been 
recently reviewed by Matyjaszewski and Pintauer.
73
    
Given the compatibility of the Cu(TPA)Br catalyst and its previous success 
in ATRC reactions, the concept of reducing loadings by catalyst regeneration was 
contemplated.  For ATRC the advantage of catalyst regeneration is thought to be 
two-fold.  The amount of metal catalyst could be significantly reduced and as a 
consequence the rate of radical trapping by the deactivator would decrease relative to 
the rate of ring closure.   
Subsequent research into this field has been fruitful.  The success of the Clark 
group at copper-mediated ATRC in the presence of reduced catalyst loadings
33
 is 
discussed in chapters 3 and 4, and similar success has been achieved in ATRA and 
ATRC cascade reactions by Pintauer and co-workers (Scheme 1.33).
74
  Sequential 
addition and cyclisation mediated by Cu(TPA)Cl2 and facilitated by diazo initiators 
has provided an efficient route to functional carbo- and heterocyclic systems from a 
range of 1,6-dienes.   
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Scheme 1.33: Possible Reaction Pathways of Radical Addition to 1,6-Dienes 
 
  Initially, diazo- initiators AIBN and V70 (2,2’-azobis-(4-methoxy-2,4-
dimethyl valeronitrile)) were used to initiate ATRA of CCl4 to 1,6-hexadiene 115 in 
the absence of any catalyst (20% yield), but no cyclisation was observed.  However, 
upon addition of Cu(TPA)Cl2 in conjunction with the diazo initiator, carbocycle 121 
was obtained in excellent yield (96%) via an addition, cyclisation cascade catalysed 
by as little as 0.02 mol% catalyst (Scheme 1.34). 
 
 
Scheme 1.34: Cu(TPA)Cl2 Mediated Cascade Radical Addition and Cyclisation 
 
 Additionally, functionalized tetrahydrofuran derivative 123 and pyrrolidine 
125 were efficiently prepared under similar conditions (Scheme 1.35).  This 
represents a significant increase in the efficiency of radical cyclisation, and if it 
could be coupled with the solid support protocol it would result in an industrially 
amenable process. 
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Scheme 1.35: Heterocycles From Cascade ATRA/ATRC Reactions 
 
 In the ATRA literature there are examples of efficient monoadduct formation 
at reduced catalyst loading in the absence of any additional reducing agents.
75
  
Efficient copper catalysts for ATRA containing trispyrazolylborate ligands (Tp
x
Cu) 
have been reported,
76
 with Tp
tBu, Me
Cu(NCMe) giving the best results.  Both carbon 
tetrachloride and carbon tetrabromide can be efficiently added to a variety of alkenes 
in the presence of 500 ppm catalyst (Scheme 1.36). 
 
 
Scheme 1.36: ATRC at Reduced Catalyst Loadings Using Trispyrazolylborate Ligands 
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1.4.5 Alternative Transition Metal Mediated ATRC 
 
A range of other transition metals have been shown to mediate radical 
cyclisation reactions.  Early research in the 80’s and 90’s utilized cobalt salen 
complexes
77,78,79,80
 and functional products were obtainable using radical traps.  The 
emergence of the ATRC process inspired the development of transition metal 
mediators and catalysts including Ni metal,
81
 RuCl2(PPh3)3,
82
 and FeCl2(P(OEt)3)3.
82
  
It is feasible to predict that any transition metal with easily accessible oxidation 
states could mediate redox-initiated ATRC reactions.  In more recent years, a 
number of efficient methods using ruthenium, titanium and zinc complexes have 
emerged as alternative catalysts or mediators for ATRC.
83,84,89,90
   
 
1.4.5.1 Ruthenium 
 
 The efficiency of ruthenium complexes closely rival those of copper.  Two of 
the most efficient and recently applied complexes are a ruthenium methoxide 
complex ([Cp*Ru(OMe)]2)
83
 129 and a ruthenium chloride complex 
([RuCl2Cp
*
(PPh3)])
84
 130.  These complexes can efficiently catalyse ATRC 
reactions in the presence of reductive additives that enhance the catalyst lifetime and 
activity.  The ruthenium methoxide complex (10 mol%), in the presence of 2-
electron donor pyridine (5 mol%), has been shown to exhibit excellent catalytic 
activity for the cyclisation of N-allyl and N-vinyl acetamides (43) to furnish γ- and β-
lactams respectively with good control of diastereoselectivity (44a/b) (Scheme 
1.37).
83
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Scheme 1.37: Ruthenium Catalysed 5-Exo Trig ATRC 
 
 Cyclisation of less activated N-vinyl acetamide 131, which undergoes 4-exo 
trig radical cyclisation was also possible using 129 (30 mol%) and pyridine (15 
mol%) (Scheme 1.38), providing an efficient route to functionalized β-lactams such 
as 132.
83
 
 
 
Scheme 1.38: Ruthenium Catalysed 4-Exo Trig ATRC 
 
 Following this work, Severin and co-workers developed a catalytic procedure 
using 130 ([RuCl2Cp
*
(PPh3)]) in the presence of activated magnesium powder to 
mediate ATRA and ATRC under mild conditions with high efficiency.
84
  The same 
dicholoroacetamide 54 underwent cyclisation with as little as 5 mol% 130 and 
tetrahydrofuran derivative 134 was accessible using only 0.5 mol%.  In both cases 
good diastereoselectivity was observed (Scheme 1.39).   
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Scheme 1.39: Magnesium-Mediated Ruthenium ATRC  
a) Trichloroacetamides b) Trichloroacetates 
 
 The magnesium present activates 130, which is a Ru(III) precatalyst complex, 
to give catalytic Ru(II) in situ.  The main advantage of this technique was the ability 
to perform the reaction open to air, as the pre-catalyst was a stable complex.  In 
addition, the magnesium powder could be easily separated from the products by 
filtration.  5-Endo trig radical cyclisation of monobromoacetamide 135 was also 
possible furnishing regioisomeric products 136a/b using only 0.05 mol% 130 
(Scheme 1.40).
84
   
 
 
Scheme 1.40: Magnesium Mediated Ruthenium Catalysed 5-Endo Trig Radical Cyclisation 
 
 Finally for ruthenium complexes, Quayle and co-workers have developed a 
method that utilizes Grubbs metathesis catalyst 137 to catalyse ATRC reactions.  It 
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was shown to catalyse ATRC directly
85
 (Scheme 1.41), and sequentially,
86 , 87
 
following metathesis (Scheme 1.42). 
 
 
Scheme 1.41: ATRC Using Grubbs Metathesis Catalyst 
 
The ATRC activity of this complex is remarkable considering species of this 
kind are primarily responsible for catalysing ring-closing metathesis (RCM) 
reactions and analogous decomposition species show activity in alkene isomerisation, 
redox isomerisation of allylic alcohols and transfer hydrogenation reactions.
88
  For 
the sequential reactions (Scheme 1.42), it was suggested that 137 acted as a 
precatalyst for ATRC cyclisation and required denaturation, generating a new 
ruthenium complex 138 (structure unknown) in which metathesis activity was lost. 
 
 
 
Scheme 1.42: Sequential Metathesis and ATRC Using Grubbs Metathesis Catalyst 
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1.4.5.2 Titanium 
 
 The combination of a p-methoxybenzene diazonium salt and TiCl3 has been 
shown to mediate a range of efficient atom transfer radical addition and cyclisation 
reactions in aqueous solutions.
89
  Initially, the reaction was optimized by screening a 
number of diazonium and transition metal salts for the addition of iodide 139 to 
alkene 140.  p-Methoxybenzene diazonium and TiCl3 were found to be the best 
reagents to initiate the transformation to 141 at catalytic loadings (Scheme 1.43).  
 
 
Scheme 1.43: TiCl3/ArN2
+
BF4
-
 Mediated ATRA 
 
 Mechanistically, it is proposed that TiCl3 acts as a reductant to facilitate the 
decomposition of the diazonium salt to produce aryl radicals.  These then selectively 
initiate cyclisation by abstraction of a halogen radical, forming a carbon-centred 
radical equipped for addition or cyclisation.  The catalytic nature of the reaction 
suggests that termination occurs via radical abstraction from the starting material 139, 
which would re-initiate the reaction.  However it is possible that termination could 
occur from radical abstraction from an aryl halide byproduct.  If this was the case, 
this would reform aryl radicals which could also re-iniate cyclisation. 
The reaction conditions were applied to the cyclisation of primary iodide 142 
which was found to undergo cyclisation within 3 hours at room temperature to give 
lactam 143 in 96% yield (Scheme 1.44).   
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Scheme 1.44: TiCl3/ArN2
+
BF4
-
 Mediated ATRC 
 
This reaction represents an alternative, efficient method of ATRC which 
allows reactions to be performed at room temperature in aqueous solution, as 
opposed to the organic solvents required for copper mediated ATRC. 
 
1.4.5.3 Zinc 
 
Dialkyl zinc reagents have been used as initiators for sequential radical 
addition and cyclisation reactions under aerobic conditions.
90
   
 
 
Scheme 1.45: Zinc Mediated Sequential ATRA/ATRC 
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 The substrates used to demonstrate this method were 1,6-enynes such as N,N-
diallylpropiolamide 144, which furnished lactam product 145 (Scheme 1.45).  
Mechanistically, the reaction was said to be initiated by iodine atom transfer from 
t
BuI to the dialkyl zinc derived ethyl radical.  The 
t
Bu radical could then undergo 
addition to the activated triple-bond followed by 5-exo trig radical cyclisation of the 
high reactive vinyl radical 146 leading to primary radical 147 which could undergo 
iodine atom transfer to give the product 145. 
 No competitive reductive zincation was observed when 
t
BuI was used.  
However, when 
i
PrI was used instead, a degree of reduction was observed, as 148 
was isolated as well as atom transfer product 145 (Scheme 1.46).  Despite this, under 
the reaction conditions, atom transfer was found to predominate in all examples 
reported. 
 
 
Scheme 1.46: Zinc Mediated Sequential ATRA/ATRC 
 
1.5 SYNTHETIC APPLICATIONS OF RADICAL CYCLISATION 
 
Radical cyclisation has proved to be a useful step in a number of total 
syntheses of biologically interesting compounds.  The use of organosilane- and 
organostannane-mediated radical cyclisation has been extensively reviewed.
91
  Most 
recently, natural products (±)-Melinonine-E 149,
 92
 (±)-Strychnoxanthine 150,
92 
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antibacterial natural toxin (±)-Botryodiplodin 151,
 93
 and (+)-Lactacystin 152
94,95,96
  
have been synthesised using these protocols.   
 
 
Figure 1.3: Natural Products Recently Synthesised Incorporating 
Radical Cyclisation as a Key Step 
 
 Comparatively, there are fewer examples of total syntheses published 
utilizing ATRC methodology.  However in recent years, to coincide with the 
development of the ATRC protocol, examples of natural product syntheses using 
ATRC have started to steadily increase.
97,106,107,108,110
 
 
1.5.1 Natural Product Synthesis Using Di-tin Reagents 
 
 Hexabutylditin has been used in key steps of the total syntheses of 
sesquiterenoids (±)-Axamide-1 153 and (±)-Axisonitrile-1
97
 154 that possess a 
modest number of biological activities.
98,99 
 
 
Figure 1.4: Natural Products Obtained Applying ATRC as Key Reaction Step 
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 Previously, Piers et al. employed a novel annulation sequence in the 
construction of the key perhydroindane intermediate
100,101
 157b, whilst Hart and co-
workers employed intramolecular conjugate additions to reach the same 
intermediate.
102,103,104,105
  Most recently, Kuo et al. have employed hexabutylditin-
mediated 6-exo dig ATRC of iodo-intermediate 156 to construct the key 
perhydroindane intermediate 157b in 66% yield, which can be transformed to 153 
and 154 in 5 and 6 additional steps with total yields of 16% and 14% respectively 
(Scheme 1.47).
97
 
 
 
 
Scheme 1.47: ATRC as a Key Reaction on Route to the Perhydroindane Intermediate 
 
1.5.2 Natural Product Synthesis Using Copper-Mediated ATRC 
 
 As an alternative to the radical protocols mediated by organostannane and 
organosilane reagents, copper-catalysed ATRC has also found application in 
synthesis of biologically interesting natural products.  Felluga et al. have applied a 
Cu(bipy)Cl catalyst system to the chemoenzymatic synthesis of Quercus lactones 
(164 and 165),
106
 naturally found in different types of wood and responsible for the 
sensory characteristics of wine and other alcoholic beverages.  Starting from racemic 
1-hepten-3-ol 158 and 1-octen-3-ol 159, the (+)-trans whisky lactone 164 and (+)-
trans cognac lactone 165 were prepared via lipase-catalysed kinetic resolution of 
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dichloroacetates 160 and 161.  This was followed by Cu(bipy)Cl-mediated ATRC to 
give intermediates 162 and 163, which were converted to 164 and 165 by reduction 
(Scheme 1.48). 
 
 
Scheme 1.48: (±) trans whiskey (164) and cognac (165) lactones via 
 Cu(Bipy)Cl-Mediated ATRC 
 
 The same catalyst complex (Cu(bipy)Cl) has also been applied to tandem 
ATRC reactions providing rapid access to 2-oxabicyclo-[4.3.0]-nonane ring systems 
that are present biologically in terpenes such as Eunicellin
107
 166.  The cyclisation 
precursor 168 was obtained by trichloroacetylation of geraniol 167.  Subsequent 
treatment with Cu(bipy)Cl (5 mol%) gave the desired products 169a/b, which are 
key intermediates to the formation 2-oxabicyclo-[4.3.0]-nonane ring systems.  
However, purification gave alkenes 170a/b due to elimination of HCl on the 
chromatography column (Scheme 1.49). 
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Scheme 1.49: Cu(Bipy)Cl-Mediated ATRC as a Key Step to the Synthesis of Eunicellin 
   
 Roncaglia and co-workers have made use of the Cu(TMEDA)Cl complex for 
a key step in the synthesis of Tyromycin A
108
 171, which has shown potential as a 
immunomodulating drug target,
109
 and can be obtained from 10-undecanoic acid 172, 
a renewable starting material obtained in ample quantities from castor oil.  In a key 
step of the synthesis, Cu(TMEDA)2Cl (1 : 2 CuCl, TMEDA) was applied for the 
cyclisation of diamide 173 to give intermediate 174 in 86% yield and good 
diastereoselectivity (cis, cis 86%).  The natural product 171 was then obtained via 2-
step functional rearrangements (Scheme 1.50).   
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Scheme 1.50: Cu(TMEDA)2Cl-Mediated ATRC as a Key Reaction in the  
Synthesis of Tyromycin 
 
 Ghelfi and co-workers have used the same catalyst system for the synthesis 
of chaetomellic anhydride A
110
 175 from 2,2-dichloropalmitic acid 177.  The 
anhydride 175 can be easily hydrolysed to give the diacid 176
111
 which is known to 
inhibit recombinant human FTPase with an IC50 value of 55 nM.
112
 
 
 
Scheme 1.51: Biologically Active Chaetomellic Diacid 176 from Chaetomellic Anhydride 175 
 
 Again a key step in the synthesis was the copper-catalysed ATRC of 
intermediate 179 using a 1 : 2 ratio of CuCl (10 mol%) and TMEDA (20 mol%).  
This furnished the cyclised product 180 in 93% yield as a 9 : 1 ratio of cis and trans 
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diastereomers.  The synthesis was completed by a 2-step functional rearrangement to 
give the desired product 175 in 68% overall total yield (Scheme 1.56). 
 
 
Scheme 1.52: Cu(TMEDA)2Cl-Mediated ATRC as a Key Reaction Towards  
Chaetomellic Anhydride 
 
1.6 SUMMARY 
 
Atom transfer radical cyclisation reactions are attractive due to the catalytic 
nature of the mediators involved, the ease of work up and preservation of 
functionality in the cyclised products.  This methodology is constantly evolving and 
efficient lab scale cyclisation is now possible using either solid-supported 
reagents
54,55,56,57
 or using low catalyst loadings in solution.
33
  For industrial 
application, these two methods require to be combined into a single process for 
solid-supported ATRC at low catalyst loadings.  Herein, we report a contribution to 
the field of copper-mediated ATRC in which we investigate the effect of the 
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presence of additives as a move towards reducing catalyst loadings even further, and 
for mediating radical cyclisations under aerobic conditions. 
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2.0 Radical Cyclisation Reactions Using 1,4-Dimethylpiperazine 
 
2.1 INTRODUCTION 
 
Organic amines are known to act as electron donors in single electron transfer 
(SET) reactions, and have gained utility as reagents for reductive dehalogenation of 
α-halo carbonyl compounds.113 ,114 ,115 ,116   Common amines used for this process 
include N,N-dimethylaniline, morpholine and 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU).  It is believed to occur via a radical mechanism, which involves single 
electron transfer from the nitrogen atom of an amine to the α-halo carbonyl 
compound.  Subsequent loss of a halogen anion to leave a radical which is 
reductively quenched, furnishes a reduced product.  However, until recently the only 
examples of organic amines being utilised as reagents for radical cyclisations have 
involved photoirradiation of alkyl bromides in the presence of triethylamine.
117
  
Ishibashi recognised the potential for organic amine mediated radical cyclisation and 
screened a variety of amines during a study of the cyclisation of N-allylic α,α,α-
trichloroacetamide 181.
118
 
 
 
Scheme 2.1: Amine-Mediated Radical Cyclisation 
 
 Ishibashi’s initial experiments involved heating 181 in simple amines with 
sequentially greater boiling points.  In triethylamine (89 
o
C), no reaction was 
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observed (Table 2.3, entry 1) but when amines with higher boiling points were used 
cyclisation was evident.  Tripropylamine (156 
o
C) gave 182 in 2% yield (entry 2) 
whereas dibutylamine (159 
o
C) provided 182 in 44% yield (entry 3).  Encouraged by 
these results he decided to focus on reactions in cyclic and acyclic, secondary and 
tertiary amines with boiling points > 100 
o
C. 
 
Entry Amine Bpt (
o
C) Time (min) Yield X
a 
1 Et3N 89 30 0 (97) 
2 Pr3N 156 30 2 (82) 
3 Bu2NH 159 30 44 (32) 
4 
 
106 20 34
b
 (0) 
5 
 
106 90 18 (77) 
6 
 
116 90 46 (33) 
7 
 
133 
100 
65 
2 
15 
120 
75 (0) 
77 (0) 
81 (0) 
8 
 
162 90 2 (0) 
9 
 
122 30 17 (32) 
10 
 
145 30 26 (58) 
a
 Numbers in parentheses correspond to the yield of starting material 181. 
b
 Yield of compound 183. 
 
Table 2.1: Attempted Cyclisations Using a Variety of Amines 
 
 The only cyclic secondary amine investigated was piperidine (entry 4) which 
provided a 34% yield of the unexpected cyclised product 183 (Scheme 2.2).  It was 
speculated that 183 was actually formed from the compound 182 under the reaction 
conditions.  This was confirmed as 183 was formed in 79% yield when cyclised 
product 182 was treated with boiling piperidine for 30 minutes.   
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Scheme 2.2: Cyclised Product Obtained From Piperidine-Mediated Radical Cyclisation 
 
 The tertiary cyclic amines (entries 5-8) provided the most promising results.  
Cyclic tertiary diamine 1,4-dimethylpiperazine (1,4-DMP, entry 7), gave solely the 
desired cyclised product 182 in 75% yield after only 2 minutes.  Acyclic diamines 
tetramethylethylenediamine (TMEDA, entry 9) and tetramethylpropanediamine 
(entry 10) did furnish 182 but yields were not as impressive as when 1,4-DMP was 
used.  Given the results obtained for 1,4-DMP, the effect of reaction temperature was 
examined.  It was found that the yield steadily increased as the reaction temperature 
was reduced to 100 
o
C (77%) and then 65 
o
C (81%).  The increase in yield was 
compromised by longer reaction times but the results suggested cyclisation probably 
took place at lower temperatures than initially thought.  Unfortunately, cyclisation 
was not observed at room temperature.       
 The scope of the reaction was shown to extend to efficient 5-exo trig 
cyclisation of substituted N-allylic α,α,α-trichloroacetamide 184, and N-(cyclohex-2-
enyl-1-yl)-α,α,α-trichloroacetamides 187 and 188, and to the disfavoured 5-endo trig 
cyclisation of enamide 191 (Scheme 2.3). 
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Scheme 2.3: 1,4-DMP Mediated Radical Cyclisation 
 
 Ishibashi recently applied this methodology to a key cyclisation step in the 
synthesis of pyrrolizidine alkaloid (-)-trachelanthamide 196.
119
  The cyclisation 
precursor 194 was prepared in 6 steps from (S)-(+)-pyrrolidinemethanol 193 and 
sequential catalytic hydrogenolysis and reduction of the cyclised product 195 
furnished (-)-trachelanthamide 196.  The key cyclisation step, mediated by 1,4-DMP, 
was efficient (15 min, 133 
o
C) and provided 195 in 52% yield. 
 
 
 
Scheme 2.4: 1,4-DMP Mediated Radical Cyclisation Applied to the  
Synthesis of Trachelanthamide 196 
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 There are numerous advantages with the single electron transfer methodology 
mediated by organic amines.  Existing radical cyclisation protocols require either the 
presence of toxic reagents, such as organostannanes (Bu3SnH), or transition metal 
catalysts (ATRC).  The presence of such reagents can complicate the purification 
procedure following cyclisation and add to the cost of running reactions, particularly 
on scale up.  However, in the presence of 1,4-DMP Ishibashi has shown that radical 
cyclisation can be performed efficiently and cleanly for activated α,α,α-
trichloroacetamides, in the absence of other reagents.   
 
2.2 RESULTS AND DISCUSSION 
 
The work of Ishibashi inspired a brief investigation into the scope of the 1,4-
DMP mediated single electron transfer radical cyclisation methodology.  It would be 
interesting to discover whether 1,4-DMP could mediate the cyclisations of less 
activated acetamides that possessed competing reaction pathways.  
Monobromoacetamides undergo efficient 5-exo trig radical cyclisations in the 
presence of ligand-bound copper complexes.
24
  However, catalyst loadings are not 
ideal (30 mol%), so cyclisation in the absence of a catalyst would be an attractive 
prospect.  Additionally, as these acetamides contain tertiary bromides, they would 
also be susceptible to base-catalysed elimination in the presence of a suitable amine, 
providing a competitive reaction pathway (Scheme 2.5).  The success of the 
relatively slow 5-endo trig radical cyclisation (Scheme 2.3) suggested that 5-exo dig 
radical cyclisation onto alkynes, which are known to be slower than 5-exo trig 
cyclisations, may also be possible using 1,4-DMP.  
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Scheme 2.5: Possible Reaction Pathways Using 1, 4-DMP 
 
In transition metal-mediated ATRC the nature of the N-protecting group is 
known to have an effect on the efficiency of cyclisation,
18
 with larger and electron-
withdrawing substituents forming the most efficient substrates.  As a result, both N-
tosyl and N-benzyl acetamides were prepared.  The N-tosyl acetamides 202 and 203 
were synthesised from allylamine 197 and propargylamine 198, with the key step 
being the acetylation of intermediates 199 and 200 using 2-bromoisobutyryl bromide 
201 (Scheme 2.6). 
 
 
Scheme 2.6: Synthesis of 5-Exo Trig and Dig Substrates for Radical Cyclisation 
 
 The N-benzyl analogues were synthesised via alternative routes.  Acetamide 
206 was prepared from allylamine 197 and benzyl bromide 204, and acetamides 210 
and 215 were prepared from benzylamine 208 using dimethylallyl bromide 207 and 
propargyl bromides 211 respectively.  Again the key step in these reactions was the 
acetylation reaction using 2-bromoisobutyryl bromide 201.  To complete the reaction 
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set of three 5-exo trig and three 5-exo dig precursors, the internal alkyne 216 was 
prepared from benzylamine 208, using 1-bromo-2-butyne 212 (Scheme 2.7).  
 
 
Scheme 2.7: Synthesis of Substrates for 5-Exo Trig and Dig Radical Cyclisation 
 
2.2.1 1,4-DMP Mediated Radical Cyclisation 
 
Under transition metal catalysed, atom transfer conditions, cyclisation of N-
tosyl acetamide 202 has been shown to be facile,
23,32
 and as a result initial attempts at 
1,4-DMP mediated cyclisation were approached with confidence.  Disappointingly, 
at reflux (133 
o
C) and at the previously reported optimum temperature (65 
o
C), 
cyclisation was not observed.  Alternatively, the only product isolated was 217 
which arose from the elimination of HBr from the tertiary bromide present in 202.  
The formation of 217 was not unexpected as the acetamides chosen for the 
Chapter 2: Radical Cyclisation Reactions Using 1,4-Dimethylpiperazine 
54 
 
investigation were prepared with the competing elimination pathway in mind.  Thus, 
from the initial results it was concluded that between 65-133 
o
C, base-mediated 
elimination occurred faster than the initiation of the radical chain.  The reaction was 
therefore repeated at room temperature in the hope of slowing the rate of elimination.  
Unfortunately, after 5 days no reaction had occurred (Scheme 2.8). 
 
 
Scheme 2.8: Initial Attempts at 1,4-DMP Mediated Radical Cyclisation 
 
 In order to accelerate the rate of initiation, a copper catalyst was added to the 
reaction mixture at 65 
o
C.  To ensure that the reaction could proceed in 1,4-DMP, the 
solvent remained the same and the effect of copper bromide (CuBr, 30 mol%) 
addition was examined.  Tertiary amines can chelate copper salts and form active 
copper complexes for ATRC by assisting in the dissolution of the CuX salt and 
stabilizing the low oxidation state (Chapter 1).  However, this was not observed for 
1,4-DMP as the solubility of CuBr was poor and the eliminated product 217 
prevailed (Scheme 2.9).  Tetradentate nitrogen ligand TPA 53, is known to form one 
of the most active copper complexes (Cu(TPA)Br) for ATRC,
33
 and upon addition of 
this complex (Cu(TPA)Br, 30 mol%) to the N-tosyl acetamide 202 in 1,4-DMP, 
cyclisation was achieved.  Under conventional ATRC conditions (DCM, rt), atom 
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transfer product 218 is obtained exclusively in almost quanitative yields (98%), 
though this was not the case in 1,4-DMP at 65
 o
C.  Atom transfer product 218 was 
obtained along with a second cyclised product that was characterized as reduced 
cyclic product 219.  Crude NMR identified the two products as a 3 : 2 (218 : 219) 
mixture which was purified to give a combined yield of  86% (Scheme 2.9). 
 
 
Scheme 2.9: 1,4-DMP Mediated 5-Exo Trig Radical Cyclisation in the Presence of Cu(TPA)Br 
 
 Addition of the catalyst (Cu(TPA)Br) is unlikely to enhance the rate of single 
electron transfer from 1,4-DMP to the substrate.  It is more probable that cyclisation 
is mediated by the copper complex and that the rate of ATRC is faster than the rate 
of elimination.  Furthermore, the reduced product 219 can arise from the competitive 
reduction of the reactive primary radical formed upon cyclisation by the 1,4-DMP 
solvent. 
 The sequence of reactions performed to accomplish the 5-exo trig radical 
cyclisation of N-tosyl acetamide 202 was repeated, using N-tosyl acetamide 203 
(alkyne), to determine the likelihood of 5-exo dig radical cyclisation in 1,4-DMP.  
Unsurprisingly, attempted cyclisation in 1,4-DMP at 65 
o
C was unsuccessful with 
elimination occurring to form 220 (78%).  However, in the presence of CuBr and 
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1,4-DMP, cyclisation was observed in reasonable yield (58%), and this was 
improved in the presence of the complex Cu(TPA)Br (83%).  The 5-exo dig cyclised 
product was not the expected atom transfer compound 222, but the reduced 
compound 221 and no atom transfer was detected at all.  The vinyl radicals formed 
during 5-exo dig radical cyclisation, are more reactive than the primary radicals 
formed during 5-exo trig cyclisation, and presumably are reduced by 1,4-DMP at a 
much faster rate than potential atom transfer (Scheme 2.12). 
 
 
Scheme 2.10: 1,4-DMP Mediated 5-Exo Dig Radical Cyclisation 
 
 Despite being satisfied with observing 5-exo trig and dig cyclisations in 1,4-
DMP, the need for a catalyst to initiate cyslisation was disappointing, as this had 
previously been avoided by Ishibashi.
118
  However, the initial results of this study 
indicated that the rate of elimination of HBr from the starting material was greater 
than the rate of single electron transfer radical chain initiation.  This conclusion was 
drawn from reactions performed using 1,4-DMP that was 6-12 months old and open 
to the atmosphere.  Therefore it was highly likely that the reagent had collected a 
degree of moisture which could have facilitated the elimination reaction.  
Consequently the decision was taken to purchase a fresh batch of 1,4-DMP, dry it 
over molecular sieves (4 Å), degas it through the freeze-pump-thaw technique and 
store it under nitrogen to eliminate any moisture present. 
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 The 5-exo trig cyclisation of 202 and 5-exo dig cyclisation of 203 was then 
attempted using the dried 1,4-DMP at 65 
o
C, and under inert conditions cyclisation 
was observed.  For 5-exo trig cyclisation of 202 the major product was identified as 
the reduced compound 219, as a 3 : 1 mixture with the atom transfer compound 218, 
giving a combined yield of 77%.  A single product was isolated for the 5-exo dig 
cyclisation of alkyne 203, and it was characterised as the reduced compound 221 
(82%). 
 
 
Scheme 2.11: 1,4-DMP Mediated 5-Exo Trig and Dig Radical Cyclisation  
in the Absence of Cu(TPA)Br 
 
These results suggest that, in the absence of moisture, the rate of single 
electron transfer from 1,4-DMP to 202 and 203 is faster than the rate of elimination 
(ki > kelim).  At this point the exact mechanism of 1,4-DMP mediated cyclisation is 
unknown and requires investigation.  Ishibashi has suggested that initiation is likely 
to occur via single electron transfer
118
 to the substrates from the nitrogen of 1,4-DMP, 
followed by  elimination of a bromine anion.  This would furnish the familiar radical 
intermediates 223 and 224 (Scheme 2.12), which could undergo cyclisation to give 
radicals 227 and 228.  At this point, the results obtained suggest that the vinyl radical 
228 is reductively quenched by 1,4-DMP to give 221 (kred
ii
 >>> ki(AT)), whereas 
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although primary radical 227 is preferentially reductively quenched by 1,4-DMP 
(219), some atom transfer to give 218 does occur, presumably by abstraction of a 
bromine radical from the substrate 202 to reinitiate the radical chain (kred
ii
 > ki(AT)).  
As reductions of cylised radicals 227 and 228 are observed, potential reductions of 
radicals 223 and 224 are also possible.  However, the isolation of cyclised products 
strongly implies that cylisation is the much faster process for these substrates 
(kcyc > > > kred
i
) (Scheme 2.12). 
 
 
 
Scheme 2.12: Possible Reaction Pathways Followed 1,4-DMP Mediated Radical Formation 
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 The cyclisation of 202 was examined further to determine the effects of 
temperature and addition of catalyst on the proportions of reduced 219 and atom 
transfer 218 products obtained (Table 2.3).   
 
 
Entry Solvent Temp 
o
C 
Catalyst  
(30 mol%) 
Product(s) Yield 218 : 219 
1 
2 
3 
1,4-DMP 50 - 217 75% x 
CuBr  217 40% x 
CuBr, TPA  218/219 46% 3:2 
4 
5 
6 
1,4-DMP 60 - 218/219 50% 1:3 
CuBr  218/219 72% 1:3 
CuBr, TPA  218/219 61% 1:1 
7 
8 
9 
1,4-DMP 70 - 218/219 60% 1:8 
CuBr  218/219 60% 1:3 
CuBr, TPA  218/219 73% 1.5:1 
10 
11 
12 
1,4-DMP 65 - 218/219 77% 1:3 
CuBr 218/219 65% 1:3 
CuBr, TPA  218/219 86% 3:2 
 
Table 2.2: 1,4-DMP Mediated 5-Exo Trig Radical Cyclisation 
 
 Ishibashi reported that the cyclisation of α,α,α-trichloroacetamides could not 
be realized in 1,4-DMP at room temperature, so the lowest temperature considered 
was 50
 o
C.  In the presence of dried 1,4-DMP at this temperature, cyclisation was not 
observed and the eliminated product 217 prevailed (Table 2.3 entry 1).  Increasing 
the temperature to 60 
o
C afforded cyclisation to 218 and 219 in a 1 : 3 ratio with a 
combined yield of 50% (entry 4).  Both the yield (60%) and the preference for 
reduced product (218 : 219 1 : 8) increased when the temperature was increased to 
70 
o
C (entry 7).  The introduction of CuBr (30 mol%) could not initiate cyclisation at 
50 
o
C (entry 2), but at 60 
o
C cyclisation was observed in 72% overall yield, with no 
Chapter 2: Radical Cyclisation Reactions Using 1,4-Dimethylpiperazine 
60 
 
change in the product ratio (entry 5).  At 70 
o
C, the preference for the reduced 
product 219 decreased when CuBr was added (entry 8).  Finally, addition of the 
ATRC complex (Cu(TPA)Br) provided cyclisation at all temperatures, generally 
favouring the atom transfer product 218 (entries 3, 6, 9).  Cyclisation in the presence 
of the copper complex (Cu(TPA)Br) at 50 
o
C implied that the rate of initiation of the 
ATRC reaction, was greater than the rate of single electron transfer (ki, Scheme 2.12).  
At all temperatures 1,4-DMP was found to contribute to the quenching of the 
reaction leading to the formation of 219.   
 The most favorable results for 1,4-DMP mediated cyclisation occurred at a 
temperature of 65 
o
C (entries 10, 11, 12).  Consequently, the N-benzyl acetamides 
that are known to be harder to cyclise than the N-tosyl analogues were next 
considered under these conditions.  These substrates were expected to have a slower 
rate of cyclisation (kcyc), as in the ground state an unfavourable population of the 
syn-amide rotamer exists which cannot cyclise upon initiation, due to the radical 
being held too far away from the acceptor (Scheme 2.13).
14
   
 
 
Scheme 2.13: Amide Rotomers of Monobromide Acetamide 206 
 
 Cyclisations of N-benzyl acetamides 206, 210, 215 and 216 in 1,4-DMP at 
65
o
C were unsuccessful.  Conversions were low, even after 72 hours, and in the 
event of any conversion, the eliminated products 229-232 were exclusively obtained, 
except in the case of the 5-exo trig cyclisation of 206 which furnished atom transfer 
product 233 in a meager 1% yield (Table 2.3). 
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Entry Solvent Temp 
o
C Products Yield 
1 (206) 1,4-DMP 65 206 (SM) 
229 
233 
73% 
6% 
1% 
2 (210) 1,4-DMP 65 210 (SM) 
230 
63% 
13% 
3 (215) 1,4-DMP 65 231 69% 
4 (216) 1,4-DMP 65 232 70% 
 
Table 2.3: Reaction Products of Attempted 1,4-DMP Mediated  
5-Exo Trig and Dig Radical Cyclisations 
 
 The results suggested that cyclisation was indeed much slower than the N-
tosyl acetamides 202 and 203, but evidence of atom transfer product 233 indicated 
that formation of cyclised products was possible.  Consequently, the reactions of 206 
and 215 were repeated in a microwave (Scheme 2.14) to determine whether the rate 
of cyclisation could become comparable to those observed for related N-tosyl 
acetamides 202 and 203.   
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Scheme 2.14: Microwave Assisted 1,4-DMP Mediated 5-Exo Trig and Dig Radical Cyclisation 
 
 For both substrates the reaction time was set at 1 hr with a temperature of 130 
o
C, just below the boiling point of 1,4-DMP.  Compound 215 gave significantly 
improved results providing a 1 : 1 mixture of the eliminated 231 and cyclised 235 
products in a combined yield of 94%, while 206 gave a four-fold increase in 
conversion improving the yield of 229 to 20% and 233 to 4%.  Thus, use of 
microwave heating improved the situation markedly, but the overall transformation 
was still not synthetically useful for N-benzyl acetamides.  Consequently, 1,4-DMP 
mediated radical cyclisation (at the present time) is limited to activated trichloro- 
precursors with fast rates of cyclisation.  
   
2.2.2 Radical Trapping 
 
In the late 1980’s/early 1990’s Pattenden at Nottingham was using 
alkylcobalt complexes in the formation of carbo- and heterocyclic compounds.
80,120
  
During this time, Pattenden proposed the combination of transition metal mediated 
radical cyclisation and radical trapping methodologies.
80
  The result of this 
amalgamation was a synthetic route to heterocycles, through intramolecular carbon-
to-carbon bond formation, followed by immediate trapping of the radical 
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intermediate to introduce new functionality (Scheme 2.15).  For example, cobalt(I) 
mediated cyclisation of the allyl ether 236 followed by radical trapping using 
TEMPO
121
 237, furnished 238 which on reaction with zinc and acetic acid 
underwent reductive cleavage to yield a primary alcohol.  
 
 
Scheme 2.15: Cobalt Mediated Radical Cyclisation 
 
The cyclisation of N-tosyl acetamide 202 in 1,4-DMP led to the formation of 
an atom transfer 218 and reduced 219 products, the ratios of which were shown to be 
temperature-dependent (Table 2.2).  The possibility of trapping the radical 
intermediate (227, Scheme 2.12) was briefly considered as this would furnish 
products with new functional groups where further chemistry could take place.  The 
concept of radical trapping has found considerable application in synthetic chemistry, 
and consequently a number of radical traps exist.
122,123,124,125,126
  In this investigation, 
stable radicals TEMPO 237, and diphenylpicryl hydrazyl radical 239 were 
considered, as reductive cleavage of the trapped intermediates would yield the 
respective primary alcohol and amine. 
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Scheme 2.16: Attempted Radical Trapping During 1,4-DMP Mediated Radical Cyclisation 
 
 Unfortunately, under the reaction conditions (1,4-DMP, 65 
o
C), addition of 
the radical traps did not furnish any trapped product 240, and their inclusion retarded 
that rate of cyclisation as only starting material 202 was recovered after 24 hours 
(Scheme 2.16).  The functionalized trapping of intermediate 227 was abandoned at 
this point and an attempt to exclusively obtain the reduced cyclised compound 219 
was pursued.  Cyclisation of 202 was repeated (1,4-DMP, 65 
o
C) with addition of an 
excess of diethyl phosphite 241 (with its labile P-H bond), which was expected to 
yield an increased proportion of 219 by trapping the primary radical 227 with a 
hydrogen atom.  However, the lability of the P-H bond was exploited prior to 
cyclisation by the radical intermediate 223, to give 225 in 41 % yield (Scheme 2.17). 
 
 
Scheme 2.17: Attempted 1,4-DMP Mediated Radical Cyclisation in the Presence  
of Hydrogen Donor Diethyl Phosphite as a route to 219 
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 This implied that the rate of cyclisation (kcyc) of 202 was now slower than the 
rate of reduction (kred
i
) in the presence of diethyl phosphite.  For comparison, the 
cyclisation of 202 was attempted under conventional transition metal-mediated 
ATRC conditions (30 mol%, rt), in the presence of the same excess of diethyl 
phosphite 241.  Reduction of the intermediate 223 was not observed, alternatively 
cyclisation followed by atom transfer to intermediate 227 produced cyclised product 
218 (Scheme 2.18).  Increasing the concentration of diethyl phosphite to 10 
equivalents had little effect and ATRC was able to proceed to furnish 218.   
 
 
Scheme 2.18: Copper-Mediated ATRC in the Presence of Hydrogen Donor Diethyl Phosphite 
 
 Significantly, this implies a superior rate of cyclisation (kcyc) for the ATRC 
mechanism compared to the single electron transfer mechanism.  Thus, this could 
mean that the mechanism and intermediates involved in the two pathways are not 
identical as first thought.  To fully comprehend the results presented in this chapter a 
more definite idea of the mechanism for 1,4-DMP and Cu(TPA)Br mediated radical 
cyclisation is required.   
   
Chapter 2: Radical Cyclisation Reactions Using 1,4-Dimethylpiperazine 
66 
 
 
2.2.3 Conclusion 
 
A novel method for radical cyclisation, utilizing tertiary amine 1,4-DMP, has 
been applied to the radical cyclisations of N-tosyl acetamides 202 and 203.  
Acetamides possessing the tertiary bromide acyl group can also undergo base-
mediated elimination.  However, under anhydrous and anaerobic conditions, the rate 
of cyclisation (kcyc) was found to be greater than the rate of elimination (kelim).  
Conversely, for less reactive N-benzyl intermediates, kcyc was found to be slower 
than kelim, and cyclisation was not observed in synthetically useful yields.  
Cyclisation of acetamide 202 furnished two products (218 and 219) with yields that 
were tentatively shown to be temperature-dependent.  Attempts to trap cyclised 
radical 227 to furnish functionalized products were unsuccessful and addition of 
diethyl phosphite, with a labile P-H bond, led to trapping of the intermediate radical 
223 prior to cyclisation (kred
i
 > kcyc).  However, the extent of the lability of the P-H 
bond was not sufficient enough to trap the same intermediate under ATRC (30 mol% 
Cu(TPA)Br) conditions.  In order to fully understand these results a comprehensive 
mechanistic investigation is required.   
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3.0 Copper-Mediated Atom Transfer Radical Cyclisation Using  
AIBN and Other Additives 
 
3.1 INTRODUCTION 
 
3.1.1 The Use of Additives in Atom Transfer Radical Addition and 
Polymerisation 
 
Transition metal-catalysed radical additions and cyclisations have been well 
studied and have proved to be useful synthetic tools (Chapter 1).  However, a 
common drawback for these reactions was the need for high catalyst loadings (up to 
30 mol%) to achieve the desired products, often causing difficulties in product 
separation and purification, and in catalyst regeneration.  Taken together these 
obstacles made these processes, although very useful, environmentally unfriendly 
and expensive.  Consequently, recent academic research has focused on reducing 
catalyst loadings to make these processes more attractive. 
In the 1990’s atom transfer radical polymerisation (ATRP)73 was born out of 
the fundamental concepts of atom transfer radical addition (ATRA)
73
 and cyclisation 
(ATRC),
18
 opening a new field of research led by the groups of Matyjaszewski,
62
 
Sawamoto
63
 and Haddleton.
127,128
  The mechanism of ATRP
129,130,131
 is thought to be 
similar to that of ATRA,
6,7,8,73
 differing only due to the reaction conditions applied, 
to favour single or multiple additions forming monoadducts (ATRA) or polymers 
(ATRP) (Scheme 3.1).  In order to selectively obtain a monoadduct, initial radical 
concentrations (from an alkyl halide, R-X) should be low (to avoid termination 
reactions R-R), activation of the monoadduct should be avoided and the rate of 
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propagation (polymer formation) should be suppressed.  Conversely, to observe 
polymerisation the reactivity of the initial radical (from R-X) and radical formed 
from addition should be similar and the rate of propagation should not be suppressed.  
If this is the case the activation-addition-deactivation cycle can continue until all of 
the monomer has been completely consumed, forming a polymer product.   
 
 
Scheme 3.1: Mechanisms of ATRA and ATRP 
 
A number of transition metals have been shown to catalyse both the addition 
(Cu, Fe, Ru, Ni)
73,82,132,133
 and polymerisation (Ti, Mo, Re, Fr, Ru, Os, Rh, Co, Ni, 
Pd, Cu)
129
 reactions.  However, particularly for the polymerisation reaction, copper 
complexes have been found to be the most efficient, allowing a range of monomers 
to be polymerised under a variety of conditions depending on the nature of the 
complex (Cu
I
LX).    
It was in the field of ATRP that the origin of a solution to high catalyst 
loadings was developed.
73
  High monomer conversions relied on an equilibrium 
between the activator (Cu
I
LX) and deactivator (Cu
II
LX2), in favour of the activator 
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(Scheme 3.2).  The deactivator (Cu
II
LX2) tends to accumulate during these reactions 
due to unavoidable termination reactions (forming R-R, Scheme 3.1) which results in 
slower polymerisation rates and lower monomer conversions.  This is known as the 
persistent radical effect.
134,135 ,136
  Although high catalyst loadings alleviated this 
problem, it also caused leaching of the catalyst into the polymer product, 
complicating the purification process, particularly when scaled up.  Consequently, a 
method was developed in which the activator for polymerisation (Cu
I
LX) was 
continuously regenerated from the deactivator (Cu
II
LX2) by additives (Scheme 3.2) 
such as phenols,
64
 monosaccharides,
65,66
 ascorbic acid,
67,68
 hydrazine,
65
 tertiary 
amines
137,138
 and diazo compounds such as AIBN.
65
   
 
 
Scheme 3.2: Proposed Activator Regeneration of Copper(I) Complexes 
 
This method is commonly known as ‘activators regenerated by electron 
transfer’ atom transfer radical polymerisation (ARGET-ATRP).  The method can 
also be applied to polymerisations in which there is no activator (Cu
I
LX) present to 
begin with and the deactivator (Cu
II
LX2) is reduced in situ to give the active complex 
(Cu
I
LX).  This is known as ‘activators generated by electron transfer’ (AGET-
ATRP).  Indeed these new methods have allowed for efficient, well controlled 
polymerisations of n-butyl acrylate, methyl methacrylate and styrene (amongst 
others) with catalyst concentrations as low as 50 ppm.
66,139140
  Furthermore, the 
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antioxidant nature of the additives (phenols, glucose, ascorbic acid) allowed the 
reactions to be performed in the presence of air.
141
 
 If the reaction conditions are such that formation of a monoadduct is 
favoured (ATRA), the mechanism still relies on the equilibrium between activator 
(Cu
I
LX) and deactivator (Cu
II
LX2), and under the same rationale the unavoidable 
accumulation of (Cu
II
LX2) has an adverse effect upon conversion.  Recently, copper 
catalysed ATRA has focussed on the complex formed from tetradentate nitrogen 
ligand TPA (53) as both Cu
I
X and Cu
II
X2 complexes are highly active.
70,71
  Using 
these catalysts, Pintauer has shown that polychlorinated and polybrominated 
substrates can add to simple alkenes, such as 1-hexene and 1-octene, and more 
complex alkenes, styrene and methyl acrylate (MA) to selectively form monoadduct 
products (Table 3.1).   
 
 
Entry Alkene R-Cl [Alk]:[Cu
I
] Yield R-Br [Alk]:[Cu
I
] Yield 
1 1-Hexene CCl4 5000:1 98% - - - 
2 1-Octene CCl4 5000:1 87% - - - 
3 Styrene CCl4 250:1 85% CBr4 200000:1 95% 
4 MA CCl4 1000:1 60% CBr4 200000:1 81% 
5 1-Hexene CHCl3 1000:1 56% CHBr3 10000:1 61% 
6 1-Octene CHCl3 500:1 49% CHBr3 10000:1 69% 
7 Styrene CHCl3 1000:1 58% CHBr3 10000:1 70% 
8 MA CHCl3 1000:1 63% CHBr3 1000:1 57% 
 
Table 3.1: Copper-Mediated ATRA in the Presence of AIBN 
 
 Using AIBN as an additive, and the Cu(TPA)Cl complex as catalyst, allowed 
for excellent conversions to the monoadduct when 1-hexene (Table 3.1, entry 1) and 
1-octene (entry 2) were used with only 200 ppm catalyst (Cu(TPA)Cl).  Experiments 
conducted using the Cu(TPA)Cl2 complex as catalyst also yielded similar results in 
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the presence of AIBN suggesting the additive was capable of generating and 
regenerating the active complex.  The results for the polybrominated substrates were 
achieved using only the Cu(TPA)Br2 complex which would require in situ activation.  
Remarkably, excellent yields of monoadduct products were obtained for previously 
difficult alkenes, such as styrene (entry 3) and methyl acrylate (MA) (entry 4) with 
as little as 5 ppm catalyst.  The improved efficiency, compared to the 
polychlorinated results, was not unexpected as C-Br and Cu-Br bonds are much 
weaker than the corresponding choride analogues.  However, the extent of the 
improvement was significant, indicating that the addition of AIBN vastly improved 
the efficiency of additions of polybrominated compounds, including less active 
bromoform compounds (entries 5-8) using as little as 5-100 ppm catalyst. 
 The mechanism for ATRC (Chapter 1, Scheme 1.6) has been identified as an 
intramolecular version of ATRA, where the radical initiator (halogenated group) and 
radical sink (alkene) are within the same compound and in close proximity.  
Consequently, it was recognised that catalyst loadings could possibly be reduced by 
the introduction of additives with the purpose of activator regeneration.  The 
principal advantages of activator regeneration for the cyclisation methodology would 
be reduced catalyst loadings and the ability to perform reactions under aerobic 
conditions, which up to now has not been possible for copper-catalysed ATRC due 
to the deactivation of the catalyst by adventitious oxygen present in reaction 
mixtures.    
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3.2 RESULTS AND DISCUSSION 
 
3.2.1 Screening Potential Additives for Copper Mediated ATRC 
 
The applicability of activator regeneration in ATRC was assessed by the 
investigation of the 5-exo trig radical cyclisation of tertiary bromide 206 (Scheme 
3.3).  Under conventional ATRC conditions (30 mol% Cu(TPA)Br, DCM) a 98% 
yield of cyclised product 233 is obtained within 2 hours. 
 
 
Scheme 3.3: Established Conditions for Copper-Mediated 5-Exo Trig ATRC 
 
Given the results obtained by Pintauer for copper-catalysed ATRA using 
AIBN,
70,71
 attention was turned to reducing the catalyst loading for ATRC using the 
same additive.  A 30-fold decrease in catalyst (1 mol%, Table 3.2, entry 2) afforded 
only 5% conversion, in the absence of AIBN, in 24 hours at room temperature.  
Repeating the reaction at reflux caused the conversion to increase but only to 14% 
(entry 3).  At such low catalyst loadings, conversions are likely to be limited due to 
the equilibrium of activator and deactivator (Scheme 3.2) favouring the deactivator, 
which limits the C-Br bond homolysis required to initiate cyclisation.   
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Entry Time Temp 
o
C 
Solvent AIBN CuBr/TPA Conv MB 
1 2 RT CH2Cl2 - 30 mol% 100% 98% 
2 24 RT CH2Cl2 - 1 mol% 5% 98% 
3 24 50 CH2Cl2 - 1 mol% 14% 99% 
4 24 50 CH2Cl2 10 mol% 1 mol% 100% 84% 
5 24 50 CH2Cl2 10 mol% -  - 98% 
6 24 50 CH2Cl2 5 mol% 1 mol% 95% 99% 
7 24 50 CH2Cl2 10 mol% 0.1 mol% 40% 89% 
8 24 110 toluene 10 mol% 1 mol% 100% 87% 
9 24 50 CH2Cl2 10 mol% 1 mol% 100% 97% 
 
Table 3.2: Establishing AIBN as a Useful Additive for Copper-Mediated ATRC 
 
 Upon addition of 10 mol% AIBN (entry 4), complete conversion was 
observed and after work-up the cyclised product 233 was isolated in 84% yield.  The 
reaction was also found to proceed in toluene at reflux (110 
o
C, entry 8).  To ensure 
that AIBN was not homolysing the C-Br bond and initiating the radical chain itself 
the reaction was repeated in the absence of the catalyst Cu(TPA)Br (entry 5).  Under 
these conditions no conversion to 233 was observed which indicated that AIBN was 
acting to regenerate Cu(TPA)Br, and not mediating the reaction.  The amount of 
AIBN added could be reduced (5 mol%) with little effect on conversion, to afford 
233 in 94% yield (entry 6).  However, when the copper catalyst loading was reduced 
further (0.1 mol%) conversions and yields decreased (entry 7) even in the presence 
of AIBN.  Finally, in situ generation of the activator (Cu(TPA)Br) from the 
deactivator (Cu(TPA)Br2) (AGET-ATRC) was investigated by changing the 
oxidation state of the copper catalyst (Cu(TPA)Br2), which afforded cyclised product 
233 in the greatest yield (97%, entry 9).  Addition of AIBN to the reaction mixture 
was therefore shown to facilitate the regeneration and generation of the activator 
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(Cu(TPA)Br) from (Cu(TPA)Br2).  Purification techniques were not complicated by 
the addition of AIBN as the proposed by-products would be volatile and facilitate 
work-up.  A revised mechanism is shown in Scheme 3.4, showing the expected 
redox mechanism (red) and the proposed role of AIBN (blue). 
 
 
Scheme 3.4: Proposed Mechanism for Copper-Mediated ATRC in the Presence of AIBN 
 
 Traditionally the mechanism for ATRC is believed to be initiated and 
terminated via a copper(I)-copper(II) redox process that continually regenerates the 
copper(I) catalyst (Chapter 1, Scheme 1.6).  However, the catalyst efficiency can be 
compromised by accumulation of non-catalytic copper(II) which is possible if 
radicals such as 243 are quenched by radical precursors such as 206.  This limits the 
amount of copper(I) available to re-initiate the reaction when catalyst loadings are 
reduced.  In our reaction (Scheme 3.4) it is proposed that the addition of AIBN 
reduces non-catalytic Cu(TPA)Br2 back to Cu(TPA)Br for further initiation of 206.  
Furthermore the likely pathways for quenching radical 243 include the traditional 
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route (red), by Cu(TPA)Br2, which is unlikely given its constant reduction to 
Cu(TPA)Br, as well as quenching via the precursor 206 and cyano-intermediate 244 
which are both consumed during the reaction and/or the work-up processes.   
 In light of the results obtained using AIBN as an additive, a number of other 
compounds were investigated based upon their application in ARGET-ATRP as 
activator regenerators.
65,66,67,68
  To compare the efficiencies of these additives with 
AIBN, the AIBN reaction was repeated at a reaction time of 5 hours at reflux (Table 
3.3, entry 1).  Pleasingly, complete conversion was obtained to provide 233 in 87% 
yield.  AIBN requires elevated temperatures in order to split into its radical 
constituents, required to regenerate the activator (Cu(TPA)Br).  However, this is not 
necessarily the case for other additives, so as well as being carried out at reflux, 
reactions were also carried out at room temperature for 24 hours (Table 3.3).  
Initially, a range of phenols were investigated including electron-withdrawing and 
donating phenols. 
 
 
Entry Time Temp 
o
C Additive Conv MB 
1 5 h 50 AIBN 100% 87% 
2 24 h RT AIBN 5% 98% 
3 5 h 50 Phenol 91% 91% 
4 24 h RT Phenol - 97% 
5 5 h 50 4-Methoxyphenol 18% 87% 
6 24 h RT 4-Methoxyphenol - 99% 
7 5 h 50 4-Nitrophenol 13% 45% 
8 24 h RT 4-Nitrophenol - 99% 
9 5 h 50 4-Trifluoromethylphenol 100% 51% 
10 24 h RT 4-Trifluoromethylphenol trace 99% 
 
Table 3.3: Effect of AIBN and Other Additives on Copper-Mediated ATRC 
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 At reflux, phenol (entry 3) and 4-trifluoromethylphenol (entry 9) provided 
cyclised product 233 in 91% and 100% conversion with yields of 83% and 51% 
respectively.  When 4-methoxyphenol was used as an additive (entry 5) no 
improvement on conversion, relative to the reaction in the absence of an additive 
(Table 3.2, entry 3), was observed.  The reaction using a second electron-
withdrawing phenol, 4-nitrophenol (entry 5), also offered no improvement.  
Experiments at room temperature offered only disappointing results.  Unsurprisingly, 
at room temperature only 5% conversion was achieved in the presence of AIBN after 
24 hours (entry 2).  As the half-life of AIBN decomposition
142,143,144,145,146
 is 10 
hours at 65 
o
C access to its radical constituents required to regenerate Cu(TPA)Br 
would be limited at room temperature.  Unfortunately, only little, or no conversion at 
all was observed at room temperature after 24 hours with the phenol derivatives 
(entries 4, 6, 8, 10).   
 Next, due to their antioxidant nature, L-ascorbic acid and D-glucose were 
investigated, and to complete the investigation hydrazine, which has been used in 
ARGET-ATRP,
65
 was also considered (Table 3.4).  The reactions were again carried 
out at both reflux and room temperature for 5 hours and 24 hours respectively for 
direct comparison with the AIBN results.   
 
Entry Time Temp 
o
C Additive Conv MB 
1 5 h 50 D-Glucose 27% 38% 
2 24 h RT D-Glucose - 96% 
3 5 h 50 L-Ascorbic Acid 55% 16% 
4 24 h RT L-Ascorbic Acid - 94% 
5 5 h 50 Hydrazine 54% 10% 
6 24 h RT Hydrazine - 86% 
 
Table 3.4: Effect of Additives on Copper-Mediated ATRC 
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At room temperature no conversion to 233 was observed in either case (Table 
3.4, entries 2, 4, 6).  At reflux, d-glucose furnished 27% conversion but when the 
mass balance was considered this only equated to a 10% yield (entry 1).  Similarly, 
despite L-ascorbic acid and hydrazine leading to 55% (entry 3) and 54% (entry 5) 
conversions, when the mass balances were taken into account this translated to 
disappointing yields of 9% and 5% respectively.  It was recognized that d-glucose 
and L-ascorbic acid were only sparingly soluble in DCM under the reaction 
conditions, so the experiments for all additives, including AIBN, were repeated in 
methanol at 50 
o
C (Table 3.5). 
 
 
Entry Additive Conv
* 
MB 
1 AIBN 50% (100) 87% 
2 Phenol 10% (91) 99% 
3 4-Methoxyphenol 5% (18) 75% 
4 4-Nitrophenol 3% (13) 89% 
5 4-Trifluoromethylphenol 19% (100) 99% 
6 D-Glucose 23% (27) 73% 
7 L-Ascorbic Acid 95% (55) 86% 
8 Hydrazine 14% (54) 82% 
*
Numbers in parentheses are yields obtained in DCM at 50 
o
C after 5 h. 
Table 3.5: Effect of Additives on Copper-Mediated ATRC in Methanol 
 
 Interestingly, AIBN was not as efficient when methanol was used as solvent 
(Table 3.5, entry 1).  Likewise, the phenols examined also lost efficiency in 
methanol (entries 2-5).  With respect to the yield of 233 obtained, D-glucose (17%), 
L-ascorbic acid (82%) and hydrazine (11%) all performed better in methanol (entries 
6-8).  The improvement observed for l-ascorbic acid was significant as simply 
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changing the solvent saw the yield of 233 rise from 9% to 82%.  The performance of 
L-ascorbic acid in methanol was a promising result, but in terms of reproducibility, 
reliability and the ease of work up, it was obvious from this investigation that AIBN 
would be the ideal additive for reactions carried out in DCM.  
 Under the conventional reaction conditions (30 mol% catalyst) it has been 
shown that different ligand complexes can mediate the same cyclisation reaction 
with differing efficiencies.  The cyclisation of tertiary bromide 206 proceeds with 30 
mol% CuBr and ligands in the following order, TPA (42) > Me6-Tren (41) > 
PMDETA (40) > Bipy (30).
21,24,25,32
  In order to determine whether this reactivity 
order would be translated to the reaction carried out at lower loadings in the presence 
of AIBN (Table 3.2, entry 4), the substrate 206 was heated at reflux in the presence 
of each complex (Table 3.6).       
 
 
Entry Ligand Time Conv 
1 TPA (42) 24 h  100% 
2 Me6-Tren (41) 24 h  100% 
3 PMDETA (40) 24 h 85% 
4 Bipy (30) 24 h 5% 
5 TPA (42) 6 h 100% 
6 Me6-Tren (41) 6 h 100% 
7 TPA (42) 2 h 15% 
8 Me6-Tren (41) 2 h 5% 
 
Table 3.6: The Effect of Ligand on Complex Efficiency for Copper-Mediated  
ATRC in the Presence of AIBN 
 
When the reaction was allowed to run for 24 hours it became evident the 
TPA (42) and Me6-Tren (52) (Table 3.6, entries 1 and 2) were more efficient than 
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PMDETA (40) (entry 3), which in turn was more efficient than Bipy (30) (entry 4).  
In order to distinguish between TPA (41) and Me6-Tren (42) the reaction time was 
reduced to 6 hours.  Again complete conversion was observed for both complexes 
(entries 5 and 6), so both reactions were repeated and stopped after 2 hours.  After 
this time TPA (42) was found to provide 15% conversion (entry 7) whilst Me6-Tren 
(41) could only provide 5% conversion.  Consequently, the order of reactivity 
(Figure 3.1) was not compromised by the reduction in the catalyst loading and the 
addition of AIBN. 
 
 
 
Figure 3.1: Reactivity Scheme for Complexes Formed From Chelating Ligands 
 
3.2.2 Scope of Copper-Mediated ATRC Using AIBN 
 
To investigate the scope and limitation of the reaction conditions developed 
in section 3.2.1 (1 mol% Cu(TPA)Br, 10 mol% AIBN, DCM, reflux) a number of 5-
exo trig  and dig substrates were prepared.  The preparation of substrates 202, 203, 
210 and 215 was detailed in chapter 2.  The remaining substrates 249-251 were all 
prepared by a similar route in which allylic halides 245-247 were reacted with 
tosylsulfonamide 248 then acetylated using 2-bromoisobutyryl bromide 201 
(Scheme 3.5). 
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Figure 3.2: Substrates Selected to Demonstrate the Scope of Copper Mediated  
ATRC in the Presence of AIBN 
 
 
 
Scheme 3.5: Synthesis of 5-Exo Trig ATRC Substrates 
 
Finally, a secondary bromide 252 was also prepared to see if the reaction 
conditions could extend to facilitate more difficult 5-exo trig cyclisations. 
 
 
Scheme 3.6: Synthesis of Secondary Bromide Acetamide for 5-Exo Trig ATRC 
 
3.2.2.1 5-exo trig ARGET-ATRC 
 
Substrates 202 and 249-251, were investigated first.  The cyclisation of 202 
would offer a direct comparison with the N-benzyl acetamide 206, extensively 
studied in sections 3.2.1 and 3.2.2.  It has been reported that the N-protecting group 
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can have a significant effect on the efficiency of cyclisations of acetamides such as 
206 by dictating the amide conformation.  Acetamides can exist as two possible 
amide rotamers and only the anti rotamer is predisposed for cyclisation (Scheme 3.7).  
It is known that increasing the size of the N-protecting group, or making the group 
electron-withdrawing favours the anti rotamer.
 14
  Conveniently, the sulfur atom (N-
tosyl) bound to the amide nitrogen can make an extra contribution to bonding 
through its empty, low level d-orbitals, which would also favour the anti rotomer and 
consequently, changing from an N-benzyl to N-tosyl protected nitrogen was expected 
to result in more efficient cyclisations.   
 
 
Scheme 3.7: Allowed and Disallowed Conformations for ATRC 
 
 As expected, following the reactions of the N-tosyl acetamides (202 and 249-
251) by TLC revealed that these reactions were complete within 1 hour furnishing 
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the atom transfer products (218 and 253-255) in excellent yields (95-100%) (Table 
3.7).  
 
 
Entry Substrate R
1
 R
2
 Conv MB 
1 202 H H 95% 97% 
2 249 Me Me 99% 100% 
3 250 Me H 100% 100% 
4 251 Ph H 99% 100% 
 
Table 3.7: Scope of Copper-Mediated 5-Exo Trig ATRC in the Presence of AIBN 
 
 The atom transfer products 254 and 255 of the cyclisations of 250 and 251 
were obtained as a 3.5 : 1.0 and 6.0 : 1.0 mixture of diastereomers respectively.  It 
was possible to isolate a single crystal of the major diastereomer of 255 and its 
crystal structure was solved (Figure 3.3).  The efficiency of the N-tosyl acetamide 
cyclisation was exemplified by the cyclisation of 250 which could be mediated at a 
catalyst loading of 0.1 mol% in the presence of AIBN (10 mol%) with no adverse 
effects upon the yield, or change in the diastereoselectivity (3.5 : 1.0) (Scheme 3.8).  
Conversely, reducing the catalyst loading to 0.1 mol% for the 5-exo trig cyclisation 
of N-benzyl acetamide 206 caused the conversion to fall to 40% with an overall yield 
of 36% (Table 3.2, entry 7).  Changing the copper source to (Cu(TPA)Br2) had little 
effect on the reaction yields and diastereoselectivities, suggesting both efficient 
activator generation and regeneration under the chosen conditions. 
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Figure 3.3: Crystal Structure of Cyclised Product 254 
 
 
Scheme 3.8: 5-Exo Trig ATRC of Crotyl Acetamide 250 
 
 The reaction of the N-benzyl acetamide 210 was expected to be accompanied 
by a reduction in reaction efficiency relative to its N-tosyl analogue 249.  Indeed, 
even after 24 hours at 50
 o
C in DCM only 14% conversion was obtained (Table 3.8, 
entry 1), and changing the copper source (Cu(TPA)Br2) did little to improve the rate 
of cyclisation (entry 3).  During the initial investigation into using AIBN as an 
additive for these reactions, the cyclisation of 206 was shown to proceed in toluene 
at 110 
o
C (Table 3.2, entry 8), as well as in DCM at 50 
o
C (Table 3.2, entry 4).  
Consequently, the cyclisation of acetamide 210 was repeated at 110 
o
C in toluene in 
the hope of obtaining an acceptable rate of cyclisation (Table 3.8, entries 2 and 4).   
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Entry Temp 
o
C Solvent CuX Conv MB 
1 50 CH2Cl2 CuBr 15% 90% 
2 110 Toluene CuBr 100% 75% 
3 50 CH2Cl2 CuBr2 15% 86% 
4 110 Toluene CuBr2 100% 75% 
 
Table 3.8: Conversion of Less Activated Monobromide Acetamide 210 
 
 After 24 hours complete conversion was observed to afford a 1 : 2 mixture of 
alkene regioisomers 256a/b in quantitative yields, presumably from the elimination 
of HBr from the tertiary bromide atom transfer product under the reaction conditions.  
Identical results were obtained when the reaction was repeated under the AGET-
ATRC conditions using Cu(TPA)Br2 in place of Cu(TPA)Br.   
The final 5-exo trig cyclisation attempted utilised secondary bromide 252.  
Secondary bromides are known to be more difficult to cyclise than tertiary bromides, 
so it was no surprise that no conversion was observed under the reaction conditions 
which were successful for the tertiary bromide analogue 202 (DCM, 50
 o
C, 1 mol% 
Cu(TPA)Br, 10 mol% AIBN).  However, when the temperature was increased to 110
 
o
C in toluene, cyclisation was achieved to furnish 257a/b as a 4 : 1 mixture of 
diastereomers (de 60%) and the major diastereomer was assigned as 257a from 
comparison with authentic samples (Scheme 3.9).
21
  The diasteroselectivity was 
found to have decreased relative to when the cyclisation was performed under the 
conventional conditions (30 mol% catalyst, DCM, rt, de 76%). 
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Scheme 3.9: Copper-Mediated 5-Exo Trig ATRC of Secondary Bromide 252 
in the Presence of AIBN 
 
3.2.2.2 5-exo dig ARGET-ATRC 
 
Cyclisations onto alkynes have been studied previously,
15
 and under 
conventional conditions (30 mol%, DCM, rt) they have been found to be up to 100 
times slower than 5-exo trig cyclisations, and the products obtained are solvent-, 
ligand- and N-protecting group-dependent.  For instance, terminal alkynes are known 
to undergo facile oxidative dimerisations in the presence of copper halide/pyridine 
complexes (Chapter 1, Scheme 1.13).  It is also known that the nature of the N-
substituent has an effect on the cyclisation efficiency.
14
  Nagashima and co-workers 
have reported that substrates with bulky or electron-withdrawing groups, such as N-
tosyl and N-Boc, cyclise more efficiently than the N-benzyl substrates (Chapter 1).   
Given the success of the 5-exo trig reactions in the presence of AIBN 
discussed earlier in this chapter, the extent to which this could apply to 5-exo dig 
cyclisations was investigated using previously studied N-tosyl acetamide 203 and 
less activated N-benzyl acetamide 215. 
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Entry Temp 
o
C Solvent R CuX Ratio 
222 : 221 
Conv MB 
1  50 CH2Cl2 Ts CuBr 1 : 2 33% 99% 
2 50 CH2Cl2 Ts CuBr2 2 : 3 10% 95% 
3 110 toluene Ts CuBr 1 : 1 67% 99% 
4 110 toluene Ts CuBr2 1 : 1 80% 99% 
 
Table 3.10: Copper-Mediated 5-Exo Dig ATRC of 203 in the Presence of AIBN 
 
 Firstly, N-tosyl acetamide 203 was investigated, and the reaction conditions 
previously applied to 5-exo trig cyclisations of tertiary bromides (1 mol% catalyst, 
10 mol% AIBN, DCM, 50 
o
C), were found to be inadequate in the presence of either 
Cu(TPA)Br or Cu(TPA)Br2.  Conversions were limited to 33% (Table 3.10, entry 1) 
and 10% (entry 2) respectively.  In the hope of obtaining a more acceptable rate of 5-
exo dig cyclisation, the reactions were repeated using Cu(TPA)Br and Cu(TPA)Br2 
in toluene at 110 
o
C.  Pleasingly, under these reaction conditions, more acceptable 
conversions were obtained.  Cu(TPA)Br (1 mol%) afforded a 67% conversion to a 1 : 
1 mixture of atom transfer 222 and reduced 221 products (entry 3), and when 
Cu(TPA)Br2 was used as catalyst this increased to 80% conversion to the same 
products (entry 4).  Under the conventional conditions (30 mol%, rt, DCM, 48 h) the 
atom transfer product 222 was preferentially formed (25 : 1), but this bias was not 
observed during these reactions as the reduced product 221 was the major product in 
DCM, and a 1 : 1 mixture was observed in toluene.   
 As the N-benzyl acetamide 215 was thought to be less efficient than the N-
tosyl acetamide 203, it came as no surprise that attempts to perform the 5-exo dig 
cyclisation using the 5-exo trig conditions (1 mol% catalyst, 10 mol% AIBN, DCM, 
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50
 o
C), were again unsuccessful (Table 3.11).  Both Cu(TPA)Br (Table 3.11, entry 1) 
and Cu(TPA)Br2 (entry 3) gave 33% conversion to the atom transfer 258 and reduced 
235 products in a 3 : 2 and 1 : 1 ratio respectively.  Repeating the reaction using 
Cu(TPA)Br and heating it at reflux for 72 hours provided 74% conversion to 258 
and 235 in a 2 : 1 ratio (entry 2), suggesting the rate of 5-exo dig cyclisation was 
particularly slow and would require harsher reaction conditions to observe an 
acceptable rate.      
 
 
Entry Temp 
o
C Solvent R CuX Ratio 
258 : 235 
Conv MB 
1 50 CH2Cl2 Bn CuBr 3 : 2 33% 90% 
2 50
a
 CH2Cl2 Bn CuBr 2 : 1 74% 90% 
3 50 CH2Cl2 Bn CuBr2 1 : 1 33% 86% 
4 110 toluene Bn CuBr 1 : 1 75% 68% 
5 110 toluene Bn CuBr2 2 : 1 82% 76% 
6 110 toluene Bn CuBr2
b 
1 : 1 84% 74% 
7 110 toluene Bn CuBr2
c 
1 : 1 100% 70% 
8 75 THF Bn CuBr 1 : 10 30% 98% 
a
 72 hour reflux 
b
 2.5 mol% Cu(TPA)Br2 
c
 5.0 mol% Cu(TPA)Br2 
 
Table 3.11: Effects of Solvent and Temperature on Copper-Mediated 5-Exo Dig  
ATRC of 215 in the Presence of AIBN 
 
 The reactions of 215 using Cu(TPA)Br and Cu(TPA)Br2 were repeated using 
toluene at 110
 o
C.  After 24 hours the results obtained were comparable with those 
obtained for the N-tosyl acetamide 203.  Cu(TPA)Br afforded 75% conversion to 
258 and 235 in a 1 : 1 ratio (entry 4), whilst Cu(TPA)Br2 gave 82% conversion to 
258 and 235 in a 2 : 1 ratio (entry 5).  As Cu(TPA)Br2 provided better conversions 
than Cu(TPA)Br for both the N-tosyl 203 and N-benzyl 215 acetamides, the loading 
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of Cu(TPA)Br2 was increased in the hope of achieving complete conversion of the 
N-benzyl acetamide 215.  Increasing the loading to 2.5 mol% (entry 6) had little 
effect, furnishing an 84% conversion to 258 and 235 in a 1 : 1 ratio.  However, when 
the loading was increased further to 5 mol% Cu(TPA)Br2 complete conversion was 
obtained within 24 hours to afford 258 and reduced 235 products in a 1 : 1 ratio.  In 
comparison with the N-tosyl acetamide 203 the bias for the atom transfer product, 
observed when reactions were carried out under conventional conditions (30 mol%), 
was not observed for the N-benzyl acetamide 215.  However, when the 5-exo dig 
cyclisation of 215 was attempted using Cu(TPA)Br in THF at reflux, the reduced 
product 235 was preferentially formed (258 : 235, 1 : 10), though conversions were 
low (entry 8).  Interestingly, in all cases where the atom transfer products 222 or 258 
were observed, the E : Z ratio was constant (1 : 9), with the Z isomer formed in 
favour of the E isomer.  The isomers were assigned by comparison with authentic 
samples prepared during previous research.
15,21
    
 
3.2.3 Conclusion 
 
It was possible to mediate a range of relatively slow 5-exo trig and 5-exo dig 
atom transfer radical cyclisations of tertiary and secondary bromoacetamides using 
Cu(TPA)Br at a reduced catalyst loading of 1 mol% in the presence of AIBN (10 
mol%).  Compared to the conventional conditions for ATRC (30 mol%), this equates 
to a 30 fold reduction in the amount of catalyst required to mediate such reactions.  It 
is proposed that AIBN acts to regenerate the activator (Cu(TPA)Br), reducing the 
potential build up of deactivator (Cu(TPA)Br2), which is known to hinder ATRC and 
related reactions (ATRA, ATRP).  It was also possible to perform the cyclisation 
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reactions in the absence of the activator (Cu(TPA)Br), as the AIBN can generate it 
from the oxidatively stable deactivator (Cu(TPA)Br2) in situ, which allowed the 
reactions to be carried out under aerobic conditions (AGET-ATRC).  The cyclisation 
of more reactive N-tosyl acetamides were mediated at a catalyst loading of 0.1 mol% 
in the presence of AIBN (10 mol%).  This suggests that if the substrate and catalyst 
reactivity can be adequately tuned, applying the AIBN protocol in conjunction with 
solid supported catalyst systems, could lead to an industrially attractive ATRC 
methodology. 
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4.0  Copper-Mediated Radical Cyclisation in the Presence of 
Borohydrides 
 
4.1 INTRODUCTION 
 
Chapters 1-3 have discussed the origins, and recent developments of radical 
cyclisation reactions, in particular copper-mediated atom transfer radical cyclisations, 
and their synthetic utility in the formation of lactone and lactam products, which are 
prevalent in natural products and synthetic drug candidates.  Initially, the high 
temperatures (50-110
 o
C) and high catalyst loadings (30 mol%) required to drive 
these reactions made them industrially unattractive.  Chapter 3 discusses how this 
can be alleviated by the addition of additives, notably AIBN, which allows the 
catalyst loading to be reduced up to 300 fold for reactive substrates and 30 fold for 
less reactive substrates.
33
  However these cyclisation reactions require temperatures 
above room temperature (50-110
o
C), and some are sluggish offering moderate yields 
after 24 hrs.   
The inspiration for the work in this chapter came from literature scrutinised 
during research for Chapter 3, and from numerous discussions with both the project 
supervisor and Dr David Fox, a fellow academic within the department.  The 
literature for radical cyclisations, specifically copper-mediated radical cyclisations is 
sparse concerning the use of additives to reduce catalyst loadings.  However, the 
literature for related ATRP and ATRA offers numerous publications, reviewed in 
2008 by Matyjaszewski and Pintauer,
73
 detailing the use of additives to reduce 
catalyst loadings for desirable polymerisation and addition reactions.  These 
additives tend to be reductive or anti-oxidant in nature, and their principal role is to 
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reduce Cu(L)Br2, which can build-up under the reaction conditions and in the 
presence of adventitious oxygen, to the active Cu(L)Br.  To our knowledge there is 
no such evidence for the use of borohydrides of any kind, to facilitate ATRC, ATRA 
or ATRP.   
Herein we report an investigation designed to improve the reaction conditions 
of copper mediated radical cyclisations, focussing on reducing catalyst loadings 
further, and the potential to perform reactions under aerobic conditions, making the 
methodology more industrially amenable.   
 
4.1.1 Classical Borohydride Chemistry
147
 
 
 
 
Scheme 4.1: Carbonyl Reductions Using Sodium Borohydride 
 
In classical organic chemistry, the borohydride anion, usually present as a 
Na
+
BH4
-
 salt, is used for selective reductions of carbonyl compounds.  Borohydrides 
act as a nucleophilic source of hydrogen reducing aldehydes and ketones selectively 
via a ‘hydride transfer.’  Although there is no detectable hydride ion (H-) present 
during the reaction, reduction is achieved by a hydrogen atom and an attached pair of 
electrons.  Reactive carbonyls such as aldehydes and ketones can be reduced to the 
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corresponding alcohols, whereas less active carbonyls such as esters and amides are 
inert (Scheme 4.1).  A variety of other functional groups are also tolerant to reaction 
conditions, including nitro groups and, significantly, alkyl halides such as 261. 
 The reactivity of borohydrides can be tuned by inclusion of electron-
withdrawing anions such as cyano groups to give sodium cyanoborohydride 
(NaCNBH3), and acetates to give sodium triacetoxyborohydride (NaB(OAc)3H).  In 
both these cases the reactivity of the borohydride is reduced as the electron-
withdrawing substituents decrease the ease in which hydrogen, and a pair of 
electrons, can be transferred.  Consequently, at pH 6 unprotonated ketones are not 
reduced by these reagents, but the analogous reaction of imines, which are 
protonated and fully polarized at pH 6 is successfully.  As a result these reagents find 
application in a number of reductive amination methods (Scheme 4.2).  
 
 
Scheme 4.2: Organic Reductions Using Less Reactive Borohydride Reagents 
 
4.1.2 Radical Reactions Involving Sodium Borohydride 
 
Perhaps a less common, but extremely relevant application of sodium 
borohydride is its participation in radical chain mechanisms leading to reductive 
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dehalogenation or radical cyclisation, depending on the nature of the substrates and 
conditions used. 
Having demonstrated that lithium aluminium hydride, in the presence of di-
tert-butyl peroxide (DTBP)
148,149
 could facilitate reductive dehalogenation of aryl 
halides, Beckwith investigated the use of sodium borohydride (NaBH4), which had 
previously been shown to reduce a variety of alkyl halides in polar aprotic solvents, 
in such reactions.  
 
 
Scheme 4.3: NaBH4 Mediated Reductive Dehalogenation and Cyclisation 
 
 The NaBH4 mediated process relied on photolytic homolysis of the C(aryl)-X 
bond, induced by a medium pressure Hg lamp (λ = 254 nm), and was efficient for a 
range of aryl iodides and reactive bromides, such as 1-bromonaphthalene.
150
  The 
radical nature of the reaction was confirmed by the diagnostic ring-closure of o-
allyloxyiodobenzene 263 which was transformed to reduced and cyclised products 
264a and 264b depending on the reaction conditions (Scheme 4.3).
150,151,152 
 More recently, Liu and Yu were able to selectively produce the cyclic 
product 264b from o-allylxoyiodobenzene via a photo-induced radical cyclisation 
using NaBH4.
153
  It was found the inclusion of DTBP was unnecessary if the 
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substrates were directly excited by UV radiation in the presence of excess NaBH4.  
Effiecient 5-exo trig and dig cyclisations were achieved and a degree of 6-endo trig 
cyclisation was observed from o-but-3-enyloxy-halobenzenes subtrates.  However, 
due to the slow progress of the 6-endo cyclisations competitive dehalogenation was 
also observed.   
 Considering NaBH4 mediated reductive dehalogenation had previously been 
attributed to a radical chain process,
154,155
 Liu and Yu proposed a similar mechanism 
for their cyclisation reactions (Scheme 4.4).  The mechanism is initiated by UV light 
(Hg lamp 254 nm) and the key propagating species is thought to be the borane 
radical anion (BH3
.-
). 
 
 
Scheme 4.4: Proposed Mechanism for NaBH4 Mediated Radical Cyclisation 
 
4.1.3 Copper Borohydride (CuBH4) 
 
The chemistry of borohydrides has been widely researched leading to many 
sophisticated methods of reduction.  Of particular interest to the Clark group was 
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evidence in the literature in which borohydrides were shown to be compatible with 
copper complexes, in particular those stabilised by nitrogen containing ligands. 
Copper(I) borohydride (CuBH4) was first reported by Wiberg and Henle in 
1952
156
 as a thermally unstable compound arising from the reaction of ethereal 
LiBH4 at -20
 o
C with CuCl suspended in THF.  However, as the temperature 
approached 0 
o
C decomposition was observed to copper hydride (CuH) and diborane.  
This was supported by the work of Klingen who reported the precipitation of 
thermally unstable CuBH4 from a mixture of LiBH4 and CuCl in ether at -45 
o
C, 
supporting his observations with reliable analytic data.
157
  The stoichiometries of the 
reactions between LiBH4 and CuCl at room temperature and -45 
o
C, as determined 
by Klingen are shown in schemes 4.5 and 4.6.   
 
CuCl2   +   2LiBH4  → Cu   +   2LiCl   +   B2H6   +   H2 
 
Scheme 4.5 
 
CuCl2   +   2LiBH4  →       CuBH4   +   2LiCl  +  1/2B2H6  +  1/2H2 
 
Scheme 4.6 
 
Where decomposition was previously reported at 0 
o
C, the CuBH4 prepared 
by Klingen decomposed at -12 
o
C to give copper(0), diborane and hydrogen as 
shown in scheme 4.7. 
 
CuBH4        →     Cu   +   1/2B2H6   +   1/2H2 
 
Scheme 4.7 
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Recently, in order to understand and apply copper borohydrides, thermally 
stable complexes containing phosphine ligands such as bis(triphenylphosphine)-
copper(I) borohydride ((Ph3P)2CuBH4) 265 have been developed (Figure 4.1).
158
  
This complex is commercially available through Aldrich for the selective reduction 
of carbonyl compounds.
159
  Additionally, it has been reported to form adducts with 
aldehydes and ketones though the nature of these structures is not clear.
160
  Another 
ligand associated with copper borohydride complexes is the substituted 
phenanthroline ligand.  This closely resembles the complexes of pyridyl and pyridyl-
imine ligands with copper(I), used previously for ATRC reactions (chapter 1) and 
has been used to form a stable CuBH4 complex 266 (Figure 4.1),
161
    
 
 
Figure 4.1: Copper Borohydride Stabilised by Phosphine 265 and Phenanthroline 266 Ligands 
 
 Typically, phosphine complexes of CuBH4, such as 265 are much more 
stable than their imine/pyridine counterparts, but given its similarity to ATRC 
copper complexes, the 2,9-dimethyl-1,10-phenanthroline complex 266 was of 
particular interest.  Research has shown that not only can free and coordinated 
borohydride act as a versatile reductant, but it can also take part in charge transfer 
reactions.  For example, Volger and co-workers have demonstrated the formation of 
donor-acceptor adducts between phosphine complex 265 and phenanthroquinone via 
an outer-sphere charge transfer (OSCT).
162
  Interestingly, the borohydride 
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coordinated to this adduct can then reduce the quinone to a hydroquinone via charge 
transfer.  Consequently, the same group proposed that the ligand-to-ligand charge 
transfer from CuBH4 to the phenanthroline ligand (stabilised by steric hindrance due 
to the 2,9-dimethyl arrangement) would allow formation of complex 266.  This was 
the case as indicated by long wavelength absorption at λmax 465 nm which was 
assigned as the BH4
-
 → phenanthroline charge transfer transition.  
  
4.2 RESULTS AND DISCUSSION 
 
4.2.1 The Effect of Borohydride Addition 
 
The reaction chosen to investigate the effects of borohydride addition was the 
5-exo trig cyclisation of 206 (Scheme 4.8).  The monobromide substrate was 
identical to that used in Chapter 3, and crucially the amide carbonyl would be inert to 
reduction by the borohydrides used.  All conversions were determined by 
1
H NMR 
of the crude reaction mixture, and in instances where only partial conversion was 
observed, the only other product present in the crude NMR was the starting material.   
 
 
Scheme 4.8: General Reaction Scheme for Investigating the Effect of 
Borohydride Addition on ATRC in Methanol 
 
In Chapter 3, optimum results for the cyclisation of 206 were observed using 
AIBN as an additive, in DCM at 50 
o
C.
33
  Immediately it was recognised that, rather 
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than simply changing a single variable, namely the additive, the insolubility of 
borohydride salts in DCM enforced a change of solvent too.  Selecting an alternative 
solvent was not a difficult choice.  Generally organic reductions using borohydride 
salts are carried out in methanol or ethanol, and in the literature there are examples 
of methanol being employed as a solvent for radical polymerisations.
163
  The use of 
methanol allowed full dissolution of substrate, catalyst and borohydride salt. 
The first reaction performed in methanol used sodium borohydride (NaBH4) 
as an additive, with the same catalyst, loadings, time and temperature used in 
Chapter 3.  Pleasingly this provided the desired cyclised product 233 in 98% yield in 
5 hrs at 50 
o
C (Scheme 4.9). 
 
 
Scheme 4.9: Copper Catalysed ATRC in the Presence of Sodium Borohydride 
 
When AIBN was employed as an additive, the primary reason for using 
elevated temperatures, even for reactive substrates, was to facilitate the 
decomposition of AIBN into its radical constituents.  As this was not necessary for 
NaBH4, the reaction shown in scheme 4.7 was repeated at room temperature.  To our 
delight after 1 hour at room temperature, 100% conversion was observed (Table 4.1, 
entry 1).  Additional experiments (Table 4.1) under these conditions ensured that the 
combination of Cu(TPA)Br and NaBH4 was in fact having an effect on the reaction, 
and dispelled any thoughts that NaBH4 may be catalysing the reaction on its own.  
This is truly remarkable because previously the N-benzyl derivative had required 
high temperatures to undergo efficient cyclisation in order to obtain the correct 
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rotamer populations.  Consequently, the success of this room temperature reaction 
may suggest an alternative reaction mechanism, possibly through a CuBH4 species. 
 
 
Entry Time Temp 
o
C Solvent CuBr/TPA Additive  
(10 mol%) 
Conv MB 
1 1 h RT MeOH 1 mol% NaBH4  100% 82% 
2 1 h RT MeOH 1 mol% - Trace 90% 
3 1 h RT MeOH - NaBH4 - 82% 
 
Table 4.1: Establishing NaBH4 as a Useful Addition for Copper Catalysed ATRC of 206 
 
Under the conditions described above, 100% conversion is observed furnishing 233 
in 82% yield (Table 4.1, entry 1).  However when the additive or the catalyst was 
removed only trace amounts of 233 were observed at best (entry 2, 3), confirming 
the synergistic role of both NaBH4 and Cu(TPA)Br.   
Having shown that NaBH4 could mediate this transformation, attention was 
turned to screening a range of commercially available borohydrides (Table 4.2). 
 
Entry Time Temp 
o
C 
Solvent CuBr/
TPA 
Additive  
(10 mol%) 
Conv MB 
1 1 h RT MeOH 1 mol% LiBH4 24% 73% 
2 10 min RT MeOH 1 mol% NaBH4 100% 89% 
3 10 min RT MeOH 1 mol% KBH4 100% 68% 
4 10 min RT MeOH 1 mol% NaB(OAc)3H 100% 84% 
 
Table 4.2: Effect of Commercially Available Borohydrides on Copper Catalysed ATRC of 206 
 
When the conditions outlined above were used with lithium borohydride 
(LiBH4, Table 4.2, entry 1), only 24% conversion was achieved.  When the mass 
balance was taken into account, a disappointing yield of 18% was the result.  With 
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sodium borohydride (NaBH4), potassium borohydride (KBH4) and sodium 
triacetoxyborohydride (NaB(OAc)3H), complete conversion to the cyclised product 
was achieved within 10 mins (entries 2-4).  The general procedure involved 
dissolving the substrate 206 in dry MeOH at room temperature at a concentration of 
0.12 M.  When fully dissolved, the desired amount of Cu(TPA)Br as the complex in 
a solution of MeOH (0.01 M) was added.  This produced a faint blue solution, 
indicative of Cu
II
.  Finally the borohydride was added, and the reaction was allowed 
to stir at room temperature.  Within the time of the reaction (10 min), the colour of 
the reaction medium changed from blue, to brown (almost immediately upon 
addition of borohydride), then finally over time changed again to a faint green colour.  
These colour changes were indicative of the reaction’s progress, as once all colour 
changes ceased the reaction was invariably complete, and in the case of 206 this was 
always within 10 mins.  If the borohydride was added before the catalyst complex, 
conversions did not always reach 100%. 
To distinguish between the reactive borohydrides (entries 2 and 3), the 
reactions were repeated at lower loadings (Table 4.3). 
 
 
Entry Time Additive  Conv MB 
1 10 min NaBH4 (5 mol%) 67% 67% 
2 10 min KBH4 (5 mol%) 100% 74% 
3 10 min NaB(OAc)3H (5 mol%) 100% 72% 
4 10 min KBH4 (2.5 mol%) 50% 82% 
5 10 min NaB(OAc)3H (2.5 mol%) - 78% 
 
Table 4.3: Establishing the Most Efficient Borohydride Additive 
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When the loading was reduced to 5 mol% it became clear that KBH4 and 
NaB(OAc)3H were better additives than NaBH4.  Thus, while KBH4 and 
NaB(OAc)3H gave complete conversion to 233 (Table 4.3, entries 1-2), 5 mol% 
NaBH4 only provided 67% conversion furnishing 233 in 45% yield (entry 3).  
Decreasing the loading further to 2.5 mol% led to the conclusion that KBH4 was the 
optimum reagent providing a 50% conversion to 233 in 41% yield (entry 4), whereas 
NaB(OAc)3H gave no conversion at all.  Considering this, for all future reactions 
KBH4 was the reagent of choice. 
 
4.2.2 The Effects of the Copper Salt and Ligand 
 
As stated in chapter 3 there is a general order of reactivity in ATRC observed 
for copper complexes formed using different nitrogen-containing ligands, and for 5-
exo cyclisations the order of reactivity for these ligands is TPA (42) > Me6-Tren 
(41) > PMDETA (40) > Bipy (30).
21,24,25,32,33
  A set of reactions was performed using 
substrate 206 to determine if this order of reactivity was also observed in the 
presence of KBH4 (Table 4.4). 
 
 
Entry Ligand Time Conv 
1 Bipy (30) 10 min - 
2 PMDETA (40) 10 min - 
3 Me6-Tren (41) 10 min 77% 
4 TPA (42) 10 min 100% 
 
Table 4.4: The Ligand Reactivity Series as Observed for Copper Catalysed  
ATRC of 206 in the Presence of KBH4 
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Unsurprisingly, the efficiencies of the complexes formed mirrored those 
reported previously, and under these reaction conditions, for this substrate, it was 
ascertained that TPA > Me6-Tren > PMDETA > Bipy.  Consequently, TPA was the 
ligand of choice for all future reactions, along with KBH4 chosen as the reagent of 
choice.  The final variable that would require investigation was the identity of the 
copper salt.  Up to this point all reactions had been carried out using CuBr, but a 
number of copper salts and other transition metal salts, were identified as potential 
alternative sources of catalyst. 
To identify whether any of the alternative sources of catalyst were more 
efficient than CuBr, all other variables, including time and temperature were kept 
constant.  Initially a range of transition metal salts were investigated (Table 4.5). 
 
 
Entry Time MX Conv 
1 10 min CuBr 100% 
2 10 min CuBr2 100% 
3 10 min FeBr2 - 
4 10 min NiBr2.H2O 5% 
5 10 min CrBr3.6H2O - 
6 10 min AgBr 7% 
7 10 min CoBr2.H2O 7% 
 
Table 4.5: The Effect of Alternative Transition Metal Salts 
 
Complete conversion was observed with CuBr, and CuBr2 (Table 4.5, entries 
1-2), however, when the investigation was extended into the d-block, results were 
less impressive.  Complexes formed containing Fe(II) (entry 3) and Cr(III) (entry 5) 
gave no conversion at all.  A degree of conversion was observed, however, for 
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complexes containing Ni(II) (entry 4), Ag(I) (entry 6) and Co(II) (entry 7), but 
unfortunately yields were low, 5-7%.  Consequently the decision was made to persist 
with copper catalysts, and in order to optimise the reaction conditions a number of 
different Cu(I) and Cu(II) salts were investigated.  To compare the degree of 
conversion for each copper salt the catalyst loading was further reduced to 0.1 mol%, 
and the KBH4 loading was reduced to 5 mol%, under the assumption the conversions 
would not reach 100%.  The results are displayed in Table 4.6. 
 
 
Entry X Conv MB 
1 Br 23% 94% 
2 Br2 Trace 89% 
3 OAc 16% 79% 
4 (OAc)2.H2O 16% 88% 
5 OC(O)CF3.H2O Trace 92% 
6 (acac)2 100% 83% 
7 (trifluoro acac)2 43% 76% 
8 (OTf)2 100% 85% 
9 OTf 92% 90% 
10 (OCC(CH3)3CHCOCF2CF2CF3)2 100% 97% 
11 SO4.5H2O 100% 97% 
12 (ClO4)2.6H2O 100% 85% 
13 (NO3)2.H2O 32% 85% 
 
Table 4.6: An Investigation into the Effect of Copper Salt 
 
Initially, reducing the catalyst and KBH4 loading revealed that CuBr, was a 
better source of catalyst than CuBr2 (Table 4.6, entries 1-2), providing 23% 
conversion to 233 in 22% yield.  This result was also better than those observed for 
the acetate salts of copper, which gave only between 1-14% yields (entry 3-5).  The 
other Cu(II) salts investigated offered significantly improved results.  Even at the 
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reduced loadings of catalyst (0.1 mol%) and KBH4 (5 mol%), in a number of cases 
100% conversion was observed (entries 6, 8, 10-12) with excellent yields (83-97%).  
In order to distinguish between the reactivity of these copper salts the loading of 
catalyst (0.05 mol%) and KBH4
 
(2.5 mol%) was reduced further (Table 4.7). 
 
 
Entry X Conv MB 
1 (acac)2 49% 86% 
2 (OTf)2 47% 86% 
3 (OCC(CH3)3CHCOCF2CF2CF3)2 37% 88% 
4 SO4.5H2O 40% 88% 
5 (ClO4)2.6H2O 54% 94% 
 
Table 4.7: Investigating the Effect of Copper Salt 
 
Even at these considerably lower loadings, conversions between 37-54% 
were observed in 10 mins at RT, and yields also ranged between 33-50%.  The most 
satisfying result of this investigation was achieved using CuSO4 (Table 4.7, entry 4).  
Although the overall conversion and yield in this instance was not the highest, when 
considering the cost CuSO4.5H2O, which can be bought on the kilo scale for £20-30, 
possible scale up of this reaction would be attractive, certainly cost-wise, in industry.  
Consequently for the remaining attempted cyclisations, CuSO4 was selected as the 
copper salt of choice.   
 
 
 
 
Chapter 4: Copper-Mediated Radical Cyclisation in the Presence of Borohydrides 
 
105 
 
4.2.3 UV Experiments 
 
In all the experiments discussed in this section, the colour change alluded to 
in section 4.2.1., was observed.  When alternative copper salts and ligands were used 
the colour and/or the intensity was variable, but the standard blue, brown, green shift 
was observed within the reaction time.  Accordingly, a number of reactions were 
followed by UV-vis spectroscopy in the hope of gaining an insight into the 
mechanism and identity of the species involved.  Firstly CuBr, CuBr2 and CuSO4 
were all dissolved in methanol and their absorbance was measured (Figure 4.2)  
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Figure 4.2: UV Traces of Selected Copper Salts and Complexes 
 
Then TPA was added (Figure 4.2) to determine the effect of complex 
formation.  A characteristic absorbance for Cu
II
(TPA)X was observed at 900-950 nm 
for all three copper sources.
163, 164
  Cu(TPA)Br is known to undergo 
4,   
r 
, TP  
2,   
 
CuBr2 
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disproportionation forming Cu(0) metal and Cu(TPA)Br2 in polar solvents such as 
methanol and DMSO, and this is what is observed in this case.
165,166,167
  In polymer 
chemistry this dissociation mechanism leads to reaction via a single electron transfer 
living radical polymerisation (SET-LRP) where the actual catalytic species is 
Cu(0).
168
  Thus, this potential alternative mechanism involving a Cu(0) species 
initiating the cyclisation reaction with CuBr/TPA in methanol is possible.  However, 
under these reaction conditions (Cu(TPA)Br 1.0 mol%) only trace amounts of 
conversion of 206 to 233 were observed in the absence of KBH4.  As a result the 
effect of KBH4 addition was examined for one of the copper salts, namely 
Cu(TPA)SO4
 
(Figure 4.3).   
 
 
Figure 4.3: UV Traces Following the Progress of the Reaction 
 
Addition of KBH4 to the reaction mixture had a profound effect on the 
absorption profile.  The characteristic Cu
II
(TPA)X absorbance between 900-950 nm 
was replaced by an absorbance at approximately 450 nm.  However, after 30 mins 
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the Cu
II
(TPA)X peak was seen to return.  In order to monitor the change in 
absorbance for the reaction, against time, a second sample was prepared containing 
Cu(TPA)SO4 and substrate, and the effect of KBH4 addition was monitored at 2.5 
minute intervals (Figure 4.4).      
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Figure 4.4: UV Traces Tracking the Progress of CuSO4 Mediated ATRC 
 
As seen in figure 4.3, the scan at t = 0 lacked an absorbance peak at 900-950 
nm, (indicative of Cu
II
(TPA)X) but contained the alternative peak, reaching 
maximum at approximately 450 nm.  This absorbance profile was consistent up to 10 
minutes after which time the Cu
II
(TPA)X peak began to return and the peak at 450 
nm was found to gradually decrease.  The scans between 10-45 minutes show an 
increase in absorbance at 900 nm, providing evidence for the accumulation of 
Cu
II
(TPA)X, and further decrease in the 450 nm absorbance.   
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As previously alluded to (section 4.1.3) Kunkely and Volger
161,162
 have been 
able to prepare CuBH4 complexes stabilised by phosphine 265 and phenanthroline 
266 ligands (Figure 4.5), and through UV-vis spectroscopy identify charge transfer 
processes between coordinated ligands.  Significantly, one of these processes was a 
ligand-to-ligand charge transfer (LLCT) between coordinated borohydride and 
phenanthroline ligands in complex 266.  This process gave a UV absorbance at λmax 
465 nm, which is not too dissimilar to the absorbance we observed when tracing our 
reaction (~ 450 nm).  Given the structural similarities of the ligands (phenanthroline 
267, TPA 53, Figure 4.5) it would not be unreasonable to tentatively assign the 
observed absorbance to a borohydride-TPA ligand-to-ligand charge transfer.  For the 
conversion of 206 to 233 it was observed that the reaction was complete within 10 
minutes.  Consequently from figure 4.3 the catalytic species that is involved in this 
process is predicted to be that responsible for the absorbance at ~ 450 nm, which is 
not a Cu
II
(TPA)X species, but could in fact be a CuBH4 complex, proceeding via an 
as yet unknown mechanism. 
 
 
Figure 4.5: Known Borohydride Complexes and Nitrogen Containing Ligands 
Phenanthroline 267 and TPA 53 
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To investigate the catalytic species in the absence of substrate a second time 
experiment was performed (Figure 4.6).  As predicted, upon addition of KBH4, at t = 
0 there is no evidence of Cu
II
(TPA)X species and the peak at ~ 450 nm prevails.  
Over time, as observed previously, this peak diminishes and the Cu
II
(TPA)X 
absorbance at 900 nm returns.  This suggested that the catalytic species itself is 
highly reactive as even in the absence of substrate its lifetime suggested by UV-vis is 
of the order of minutes.  
 
 
Figure 4.6: UV Traces in the Absence of Substrate 
 
This observation was supported by the result of an attempted cyclisation of 
206 using the aged UV sample (t = 45 min) as the source of catalyst.  Hence, 
reaction of 206 with the aged UV sample provided no reaction with only starting 
material being recovered (Scheme 4.10).   
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Scheme 4.10: Attempted Cyclisation of 206 Using an Aged Catalyst Solution 
 
4.3 SCOPE AND LIMITATION of Cu(TPA)SO4/KBH4 MEDIATED 
CYCLISATION 
 
5-exo trig 
 
5-exo dig 
 
 
4-exo trig   5-endo trig 
 
Figure 4.7: Substrates Selected to Investigate the Scope of Copper Catalysed 
ATRC in the Presence of KBH4 
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Having determined model conditions for the conversion 206 to 233 in 
methanol (Cu(TPA)SO4, 0.1 mol %, KBH4 10 mol %), the scope of the cyclisation 
methodology was investigated.  A number of 5-exo trig and dig substrates were 
investigated for comparison with previously reported methods, and more recent 
methods reported in chapter 3.
33
  In addition, 4-exo and 5-endo trig cyclisations, 
which are ‘disfavoured’, were investigated to determine if the scope of the reaction 
could extend to more difficult cyclisations. 
The synthesis of 5-exo trig and dig substrates was discussed in chapters 2 and 
3.  However, the 4-exo 270-272 and 5-endo 273-275 substrates were prepared 
differently.  They were prepared by acetylating the corresponding imines, prepared 
in situ, from the corresponding aldehydes (276-278) and ketones (279-281) (Scheme 
4.11).    
 
 
Scheme 4.11: Preparation of 4-Exo and 5-Endo Trig Radical Cyclisation 
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4.3.1 5-Exo trig AGET-ATRC 
 
Initially the cyclisation of tertiary bromide 202 with Cu(TPA)SO4 (0.1 mol%) 
and KBH4 (10 mol%) was attempted.   
 
 
Scheme 4.12: Copper Mediated 5-Exo Trig ATRC of Activated N-Tosyl Acetamide 202 
 
Under these conditions conversions were much lower than anticipated (33%) 
considering the results obtained in chapter 3, where the N-tosyl substrates were 
shown to be more reactive than their N-benzyl counterparts.  It was observed that 
202 was only sparingly soluble in methanol, which could have caused the conversion 
rates and yields to decrease.  Two solutions were identified to overcome this problem.  
While the sulfonamide was found to be soluble in methanol at elevated temperatures, 
this had previously been avoided, so alternatively a few drops of DCM were added 
as a co-solvent as assist dissolution of 202 (Table 4.8). 
 
      
Entry Time KBH4 Conv MB 
1 10 min 10 mol% 33% 84% 
2 10 min 20 mol% 57% 87% 
3 10 min 50 mol% 94% 79% 
4 10 min 100 mol% 100%
 
90% 
 
Table 4.8: Effect of Increasing KBH4 Loading on the Conversion of 202 to 218 
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Addition of DCM as a co-solvent did result in full dissolution of 202 but had 
little effect on the conversion when 10 mol% KBH4 was used (Table 4.8, entry 1).  
Consequently, rather than increasing the catalyst loading (0.1 mol%), the amount of 
KBH4 was gradually increased.  At 20 mol% the conversion was still disappointing 
(54%, 50 % yield), so the loading was increased further to 50 mol%.  Conversions 
were more acceptable at this loading (94%, 74% yield) but it was not until the 
loading was increased to 100 mol% (1 equivalent) that complete conversion (100%, 
90% yield) was obtained on a reliable, reproducible basis. 
For the remaining sulfonamide substrates 1 equivalent of KBH4 was used 
along with Cu(TPA)SO4 (0.1 mol%) in methanol, spiked with a few drops of DCM 
(Table 4.9).  
 
 
Entry Substrate Time CuSO4/TPA R
1
 R
2
 R
3
 R
4
 Conv MB 
1 268 10 min 0.1 mol% Ts
 
Me H H 100% 84%
a 
2 249 10 min 0.1 mol% Ts
 
H Me Me 100% 76% 
3 250 10 min 0.1 mol% Ts
 
H Me H 100%
b 
90% 
4 251 10 min 0.1 mol% Ts
 
H Ph H 100%
c
 81% 
5 210 20 min 1.0 mol% Bn H Me Me 100%
d 
72% 
a
 Cyclised product 282 was isolated in 80% yield. 
b
 3.8 : 1.0 mixture of diastereomers.  
c
 5.0 : 1.0 mixture of diastereomers. 
d
 Isolated as a 10 : 1 mixture of 256a : 256b, in a combined yield of 98%. 
Table 4.9: CuSO4 Mediated 5-Exo Trig ATRC 
 
In the case of substrates 249-251 (Table 4.9, entries 2-4) only the 5-exo trig 
cyclised products were produced.  However, for substrate 268, 4% of non-cyclised 
compounds were also produced.  Although not fully characterised (due to the 
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inability to isolate compounds during chromatography), tentative structures were 
assigned as 283a and 283b. 
 
 
Figure 4.8: Minor Products Obtained From the Cyclisation of 268 as Identified by 
1
H NMR 
 
Evidence for these structures was seen in the crude NMR.  A septet (1H) at δ 
2.98 ppm, coupling to doublet (6H) at δ 1.02 ppm was indicative of 283a whilst 
additional terminal alkene protons at δ 5.27 ppm and δ 5.15 ppm coupling to an 
additional methyl group at δ 1.91 ppm indicated the presence of the eliminated 
product compound 283b. 
 Substrates 250 and 251 underwent complete conversion to the cyclised 
products 254 and 255 in 90% and 81% yield respectively.  Cyclic product 254 was 
isolated as a 3.8 : 1.0 mixture of diastereomers, whilst 255 was isolated as a 5.0 : 1.0 
mixture.  In previous work, using AIBN mediation (chapter 3), 254 and 255 were 
isolated as 3.5 : 1.0 and 6.0 : 1.0 mixtures of diastereomers respectively.
33
   
 
 
Figure 4.9: Products of CuSO4 Mediated 5-Exo Trig ATRC of 
Crotyl 250 and Cinnamyl 251 Substrates 
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For reactions involving AIBN mediation (chapter 3), substrate 210 (entry 6) 
required significantly longer reactions times and temperatures (24 h, 110 
o
C) than its 
sulfonamide counterparts to achieve comparable yields.  Thus, the reaction of 210 
using Cu(TPA)SO4 (0.1 mol%) and KBH4 (10 mol%) produced only a trace amount 
of cyclisation.  However, when the catalyst loading was comparable to those used in 
chapter 3 (1.0 mol%), in the presence of 1 equivalent KBH4, complete conversion 
was achieved within 20 minutes at room temperature to give a 15 : 14 : 1 mixture of 
atom transfer product 284 and alkene regioisomers 256a/b in a combined yield of 
98% (Figure 4.10).  Purification by column chromatography led to the elimination of 
HBr from the tertiary bromide 284, and a subsequent 10 : 1 mixture of alkene 
regiosomers 256a/b was isolated.  The ratio of alkene regiosomers obtained was 
significantly different to that reported when AIBN was used in chapter 3 (1 : 2).      
 
 
Figure 4.10: Atom-Transfer and Subsequent Elimination Products Formed 
Under the Reaction Conditions 
 
Unfortunately, when more challenging 5-exo trig cyclisations of secondary 
and primary bromides were attempted under these conditions only hydrolysed or 
reduced products were obtained.  The rates of these cyclisations are slower than 
those of tertiary bromides, and this allows unwanted side reactions, potentially 
hydrolysis or reduction of the sulfonamides to produce 199 (Scheme 4.13). 
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Scheme 4.13: Failed Attempted Cyclisations of Secondary 252 and Primary 285 Bromides 
 
4.3.2 5-Exo dig AGET-ATRC 
 
In chapter 3, 5-exo dig cyclisations onto alkynes were more difficult to 
mediate than related 5-exo trig cyclisations.  For this investigation, initial attempts at 
the cyclisation of substrates 203 and 215 employed Cu(TPA)SO4
 
(0.1 mol%) and 
KBH4 (1 equivalent) in methanol (Table 4.10). 
 
 
Entry Substrate Time CuSO4/TPA R Ratio  Conv MB 
1 203 10 min 0.1 mol% Ts
a
 1.0 : 2.8 
(222 : 221) 
100% 70%
b
 
2 215 10 min 1.0 mol% Bn 1 : 2 
(258 : 235) 
100% 67%
c
 
a
 A few drops of DCM were added to help dissolve the sulphonamide fully. 
b 
Yield of 222, 18% (as a 1 : 12 mixture of E:Z isomers). Yield of 221, 66%. 
c
 Yield of 258, 22% (as a 8 : 1 mixture of E:Z isomers). Yield of 235, 61%. 
Table 4.10: CuSO4 Mediated 5-Exo Dig ATRC in the Presence of KBH4 
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Complete conversion of the sulfonamide substrate 203 (Table 4.10, entry 1) 
was afforded in 10 minutes at room temperature using 0.1 mol% catalyst and 1 
equivalent KBH4 to give a 1.0 : 2.8 ratio of 222 and 221, with 222 obtained as a 1 : 
12 mixture of E : Z regioisomers, in a combined yield 84%.  Alkyne 215 required a 
greater catalyst loading to observe comparable conversions (entry 2).  Using 
Cu(TPA)SO4 (1.0 mol%) and KBH4 a 1 : 2 ratio of 258 and 235 was obtained, with 
258 isolated as a 8 : 1 mixture of E : Z regioisomers, in 83% total yield.   
The ratio of atom transfer to reduced products has been shown to be solvent- 
and ligand-dependent (Chapter 1), and in the presence of methanol a higher 
proportion of the reduced products (221 and 235) was obtained.  These results 
present a significant improvement in the efficiency of 5-exo dig cyclisation even 
compared to the results presented in chapter 3.  Conversions comparable to those of 
5-exo trig cyclisations are possible without the need for more severe reaction 
conditions.  
Despite the lack of success in attempting to perform a 5-exo trig cyclisation 
using a secondary bromide, partial success was observed for the secondary bromide 
269 undergoing 5-exo dig cyclisation to give 286 in 45% yield (Scheme 4.14). 
 
 
a
 A few drops of DCM were added to help dissolve the sulphonamide fully. 
Scheme 4.14: CuSO4 Mediated 5-Exo Dig ATRC of Secondary Bromide 269 
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4.3.3 4-Exo trig AGET-ATRC 
 
The 4-exo trig substrates were examined to determine whether the 
Cu(TPA)SO4/KBH4 procedure could be applied to β-lactam synthesis.  Previously, 
efficient synthesis of β-lactams was achieved using catalytic CuBr (30 mol%) and 
TPA (53) (30 mol%) at room temperature in 1 hr.
35
  Using the new conditions, the 
aim was achieve comparable results with a 30-fold reduction in catalyst (1.0 mol% 
Cu(TPA)SO4) within 10 minutes. 
Examination of the crude NMR spectra obtained during this investigation 
indicated the atom-transfer products 287-289 were the major products for all 3 
substrates 270-272.  However, during chromatography elimination of HBr from the 
tertiary bromide functional groups partially occurred, which led to the isolation of 
alkene regioisomers 290a/b-291a/b in addition to the atom transfer products 287-
289 (Table 4.11).  
 
 
Entry Substrate Time R
1
 R
2
 Ratio
a
  Conv Yield 
1 270 10 min H H 3 : 1 : 0 
(287 : 290a : 290b) 
100% 81% 
2 271 10 min CH3 H 1.7 : 3.7 : 1.0 
(288 : 291a : 291b) 
100% 89% 
3 272 10 min -(CH2)3- 1 : 1 : 0 
(289 : 292a : 292b) 
100% 80%
b 
a
 Ratio for cyclised products after purification. 
b
 Compounds 293 and 294 were also isolated in 12% and 8% yields respectively. 
 
Table 4.11: CuSO4 Mediated 4-Exo Trig ATRC in the Presence of KBH4 
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Reaction of 272 proceeded to give two further, isolable, compounds formed 
from direct reduction of 272 to give 293, and elimination of HBr from 272 to give 
294, in 12% and 8% yield respectively (Scheme 4.15).   
 
 
Scheme 4.15: Minor Byproducts Obtained From the Cyclisation of 272 as Identified by 
1
H NMR 
 
The yields obtained for substrates 270 and 271 were comparable.  Substrate 
270 provided a 3.0 : 1.0 ratio in favour of the atom transfer product, with a total yield 
of 81% (Table 4.11, entry 1) whereas 271 gave a 1.7 : 3.7 : 1.0 ratio in favour of the 
alkene regioisomers, with a total yield of 89% (entry 2).  The atom transfer product 
288 was obtained as a 3.0 : 1.0 mixture of diastereomers, and the major alkene 
regioisomer was the internal alkene 291a which was obtained as a 3.0 : 1.0 mixture 
of E and Z isomers.  Again, the reactions of 270 and 271 proceeded to give two 
further compounds (Scheme 4.16).  Although it was not possible to purify these 
minor components, they were tentatively assigned as 295-298 from crude NMR.  
Evidence for 295 and 297 was present in the form of enamide protons at δ 5.72 and 
5.81 ppm respectively, along with septets at δ 2.76 and 2.78 ppm respectively.  
Eliminated substrates 296 and 298 also displayed enamide protons at δ 5.69 (296) 
and 5.68 ppm (298), as well as terminal alkene protons at δ 5.18 (296) and 5.15 ppm 
(298). 
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Scheme 4.16: Minor Byproducts Obtained From the Cyclisation of 270 and 271  
as Identified by 
1
H NMR 
 
4.3.4 5-Endo trig Radical Cyclisations 
 
Having shown it was possible to mediate 4-exo trig cyclisation, the 5-endo 
trig cyclisations of 273-275 were investigated.  As discussed previously, the 
mechanism of CuBr/TPA mediated 5-endo radical cyclisation of enamides differs to 
that of the related 5-exo ATRC, proceeding through a radical-polar crossover 
mechanism via an N-acyliminium ion 300 (Scheme 4.17).
25
   
 
 
Scheme 4.17: Pathway to the Alkene Regioisomeric Products Obtained From 
5-Endo Trig Radical Cyclisation 
 
This N-acyliminium ion (300) can undergo elimination of a proton to furnish 
two alkene regioisomers 301a/b.  Using Cu(TPA)SO4 (1.0 mol%) and KBH4 (1.0 
equivalent) in methanol, further evidence for the intermediacy of an N-acyliminium 
ion was investigated under these reductive conditions (Table 4.12). 
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Substrate Time n Ratio  Conv Yield 
273 30 min 1 2 : 4 :1
a 
a : b : c 
100% 83% 
274 30 min 3 1 : 12 : 2
b 
a : b : c 
100% 86% 
275 30 min 7 0 : 1 : 0
c 
a : b : c 
100% 55% 
a
 Corresponding yields are 24%:47%:12%. 
b
 Corresponding yields are 6%:69%:11%. 
c
 Only trace, unisolable amounts of 303a and 303c observed in crude NMR. 
 
Table 4.12: CuSO4 Mediated 5-Endo Trig Radical Cyclisation in the Presence of KBH4 
 
The reaction of substrate 275 yielded only cyclised product 303b in 55%.  
However, reaction of 273 and 274 with Cu(TPA)SO4 (1.0 mol%) and KBH4 (1.0 
equivalent) led not only to the alkene regioisomers (301/302 a and b), but also to 
reduced products (301c/302c).  Due to the presence of an equivalent of KBH4 in the 
reaction mixture it is likely that the N-acyliminium ion intermediates (300) were 
reduced to furnish these products.  It was a surprise that, due to the reaction 
conditions and nucleophilic nature of the solvent (methanol), compound 304 was not 
isolated.
169,170 
 
 
Figure 4.11: Product Anticipated From 5-Endo trig Radical Cyclisation 
Followed by Nucleophilic Substitution 
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4.3.5 Tetralone Enamides 
 
At this point it was decided to investigate the cyclisations of two tetralone 
enamides 305 and 306.  These were synthesised using the method outlined in section 
4.3 from α-tetralone and β-tetralone in 58% and 84% yield respectively. 
 
 
Figure 4.12: β-Tetralone 305 and α-Tetralone 306 
 
The reaction of the β-tetralone enamide 305 using Cu(TPA)SO4 (1.0 mol%) 
and KBH4 (1.0 equivalent), was expected to furnish the 4-exo trig atom transfer 
product 307.
25
 However this product was not observed, instead the only product 
identified was 308 in a disappointing 23% yield (Scheme 4.18).  It could be possible 
to arrive at 308 via two pathways.  Firstly, hydride (H
-
) reduction of the reactive 
atom transfer product 307, could yield 308.  Secondly, due to the stability of the 
benzylic radical 309 formed, an oxidation by Cu(II), could yield a cation 310 that 
could also undergo hydride reduction to yield 308 (Scheme 4.19). 
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Scheme 4.18: CuSO4 Mediated 4-Exo Trig ATRC of β-Tetralone 305 
 
 
Scheme 4.19: Possible Reaction Pathways to Reduced Product 308 
 
The cyclisation of α-tetralone enamide 306 using Cu(TPA)SO4 (1.0 mol%) 
and KBH4 (1.0 equivalent) was expected to yield 311.
25
 However this was not 
observed, instead, naphthalene 312 and reduced product 313 were observed in a 
combined yield of 69% (Scheme 4.20). 
 
 
 
Scheme 4.20: CuSO4 Mediated Radical Cyclisation of α-Tetralone 306 
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Product 313 arises from the reduction of N-acyliminium ion, whilst 312 
presumably arises from the oxidation of 311 to form the fully conjugated 
naphthalene derivative.  Oxidations of tetralone derivatives are not uncommon in the 
literature, but it is not known how 312 is formed under these reductive reaction 
conditions.  Due to the similarities in the yields obtained for 312 and 313 one 
possible explanation could involve a radical disproportionation from 311, which 
would also explain why 311 is not isolated from the reaction mixture. 
 
4.4 CONCLUSIONS 
 
It has been shown that efficient copper mediated 5-exo trig and dig as well as 
4-exo and 5-endo trig radical cyclisation of tertiary bromides can be achieved at 
room temperature, in methanol, by CuSO4/TPA (0.1-1.0 mol%), in the presence of 
KBH4 (10-100 mol%) in 10-30 minutes.  This corresponds to a significant 
improvement in the catalytic efficiency of these reactions, and moreover the use of 
Cu
II
 salts negates the previous need for an inert atmosphere.  Additionally UV-vis 
analysis of this reaction has discounted the possibility of the mechanism being 
similar to that of SET-LRP in polar solvents, and indicates that the catalytic species 
is a Cu
I
 species, the true identity of which unfortunately remains unknown at this 
time.  A drawback identified when using these conditions was identified when 
investigating the 4-exo and 5-endo trig radical cyclisations.  Although, in the main, 
conversions and yields were comparable to those reported previously, there was very 
little control over product distributions.  For example, where under conventional 
ATRC conditions (30 mol%), enamides 270 and 273 gave exclusively atom transfer 
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products 287 and 289, the revised conditions (Cu(TPA)SO4 1mol%, KBH4 1 eq) 
gave a mixture of atom transfer 287 and 289, and eliminated products 290a and 292a. 
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5.0 Atropisomeric Enamides. A Route to Asymmetric 5-Endo 
Radical Cyclisation? 
 
5.1 INTRODUCTION 
 
5.1.1 Early Evidence of Atropisomerism 
 
There are qualitative and quantitative definitions for atropisomerism.  
Qualitatively it is defined as ‘the phenomenon of chirality as a result of restricted 
rotation about a single bond.’  Quantitatively this was translated by Ōki who defined 
an atropisomer as a conformer which can retain its axial chirality with a half life for 
racemisation of t1/2 ≥ 1000 seconds.
171
   
 Unlike stereoisomers, atropisomers do not necessarily contain a stereogenic 
centre, however chirality arises from two possible spatial arrangements about a given 
axis, an axis of chirality, giving rise to enantiomers.  It is these ‘spatial enantiomers’ 
that are commonly known as atropisomers.  Consequently, atropisomers are also 
identified using the Cahn-Ingold-Prelog notation, but unlike R and S, used for 
stereoisomers, atropisomers are identified using M and P.
172
  Considering the 
definitions of an atropisomer, another point of interest is that, as chirality arises 
through restricted rotation about a single bond, racemisation occurs thermally, rather 
than chemically.  Therefore rather than performing a chemical reaction, breaking and 
forming bonds, the energy required for racemisation is simply the energy needed to 
overcome the barrier to rotation for a single bond to rotate 180
o
.   
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Scheme 5.1: First Isolated Atropisomers Isolated by Christie and Kenner 
 
The first stable atropisomer was isolated in 1922 by Christie and Kenner.
173
  
The 6,6’-dinitro-2,2’-diphenic acid was resolved by co-crystallisation with a chiral 
amine.  Subsequent research has shown that biaryl structures with ortho substitution 
tend to exhibit axial chirality about the single bond between the two aryl rings.  
 
 
Scheme 5.2: BINAP Catalysed Synthesis of Menthol 
 
As the understanding of axial chirality has expanded it has become a major 
area of synthetic research.  Perhaps the most notable example of the synthetic utility 
of axial chirality and atropisomers has come in the field of ligand design for 
transition metal catalysed asymmetric synthesis.  The impact of such research has 
not gone unrecognized and in 2001, Noyori shared the Nobel Prize in Chemistry for 
his work on asymmetric catalysis, with the use of axial chiral ligands, having 
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contributed significantly to his unquestionable success.  The industrial impact of his 
work has been far reaching.  For example, axially chiral diphosphine ligand BINAP 
is industrially applied for the production of menthol (Scheme 5.2).  Specifically, (S)-
BINAP is used as the ligand for a ruthenium-catalysed olefin isomerisation to 
produce a crucial intermediate during the synthesis of menthol in 96-99% ee on a 
multi-ton scale.
174
    
 Axial chirality and atropisomerism are not phenomena confined to synthetic 
chemistry.  A number of natural products contain biaryl systems and as a result have 
been shown to possess axial chirality.  These include the potent, gram positive 
antibiotic vancomycin,
175
 and the protein kinase inhibitor michellamine B,
176
 the 
structures and chiral axes of which are shown in (Figure 5.1). 
 
 
Figure 5.1: Natural Products Containing Axes of Chirality 
 
In more recent years, research into axial chirality has expanded to include 
alternative synthetic systems.  Work by Prof Dennis Curran in Pittsburgh, has shown 
that axial chirality is also prevalent in the chemistry of acetanilides,
177,178,179,180,181
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and even enamides,
182
 which have been used previously in the Clark group for 5-
endo trig radical cyclisation.
25
 
 Conformational studies
183,184,185,186,187,188,189,190,191,192
 on a number of related 
substrates containing amide bonds have been conducted by Johnathan Clayden at 
Manchester.  Particular interest has been focused on the stereodynamics of bond 
rotations in tertiary aromatic amides, such as ortho substituted 
benzamides
184,187,189, 193 , 194
 316 that tend to exhibit atropisomerism through slow 
rotation about the Ar-CO bond (Figure 5.2).  Related structures include anilides
195,196
 
317 and benzanilides
191
 318.  These are also often ortho substituted at the aryl 
groups and exhibit atropismerism through slow N-aryl bond rotation.  Benzanilides 
316 have an added degree of complexity with possible atropisomersim through slow 
rotation of the Ar-CO bond.  However, the stereogenic amide axes have been shown 
to exhibit a degree of conformational communication and conformational control in 
solution.
191
 
 
 
Figure 5.2: Synthetic Compounds Containing Axes of Chirality 
       
 In the case of acetanilides and enamides there are two rotational elements that 
require consideration.  Amide rotation about the N-CO bond gives rise to E and Z 
amide rotomers,
196 ,197
 while restricted rotation about an N-aryl bond (anilides) can 
give rise to atropisomerism (Scheme 5.3).  In the case of acetanilides ortho 
substitution of the aryl ring is a pre-requisite for atropisomerism.
178,179,180,198
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Scheme 5.3: Rotational Processes Present in Anilides 
  
Rotational barriers for both processes must be considered.  Amide rotation 
has been well studied and is well understood.
196
  Unsymmetrical N,N-disubstituted 
amides can interconvert between E and Z rotamers by a single rotation of the N-CO 
bond, and in the case of tertiary amides the Z rotamer is preferred at equilibrium 
placing bulkier groups cis to the  carbonyl (Scheme 5.4a).
196
   
 
 
Scheme 5.4: a) Amide Bond Rotation b) Amide Bond Resonance 
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Generally N,N-disubstituted amides have rotational barriers between 15-20 
kcal mol
-1
.
197
  The precise values are dictated by steric and electronic effects of the 
substituents.
199,200
  In the ground state the N-CO bond exhibits partial double bond 
character (Scheme 5.4b).  As a result neighbouring substituents are co-planar and the 
greatest steric interactions occur between them.  Increasing the steric bulk of R
2
 and 
R
3
 has a destabilizing effect on the partial double-bond character causing the barrier 
of rotation to decrease.
199,200
  Conversely, if R
1
 is electron-withdrawing, for example 
if there is multiple α-halogen substitution, then the barrier is raised due to electron 
density being withdrawn from the carbonyl group, stabilizing the ground state.
199
 
 
 
Figure 5.3: The Steric and Electronic Effects on the Barrier to Amide Rotation 
 
The second, more subtle rotation present in acetanilides is the rotation about 
the N-aryl bond.  Aryl groups bonded to the amide nitrogen tend to break the 
planarity observed in tertiary amides by twisting into an almost orthogonal plane 
relative to the amide plane.
201
  This minimizes steric interactions with neighbouring 
groups and consequently, in contrast to tertiary amides, tertiary anilides prefer the E-
configuration in solution.
178
  Atropisomerism occurs in tertiary anilides when the 
aryl group is ortho substituted, leading to a barrier to rotation great enough to install 
an axis of chirality about the N-aryl bond (Scheme 5.5b).
178,179,180,198
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Scheme 5.5: a) Amide Bond Rotation b) N-Aryl Bond Rotation (Atropisomerism) 
 
If the substituent X is sufficiently bulky, the atropisomers can be resolved by 
laboratory means, such as chiral HPLC.
178,179,180,181,198,202,203
  The magnitude of the 
rotational barrier is dependent upon the degree of substitution present in the anilide. 
Increasing the degree of substitution around the aryl ring, the bulk of either the X 
substituent or the bulk at the α-position of the carbonyl (R1), increases the barrier to 
rotation (Figure 5.4).  However the barrier to rotation decreases for both benzoyl and 
acrylanilides, where R
1
 is an aryl ring and vinyl group respectively.  This is because, 
unlike simple alkyl groups, these conjugated groups can twist out of planarity with 
the carbonyl group, minimizing steric clashes with the substituted N-aryl group in 
the rotation transition state.
178
 
 
 
Figure 5.4: Effects of Substitution on Barrier to N-Aryl Bond Rotation 
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A barrier to rotation large enough for resolution at room temperature is 
afforded when X = I, and Curran et al. have shown that acrylanilides can be 
manipulated to perform 5-exo trig radical cyclisation reactions with impressive 
chirality transfer (Section 5.1.2).  
 
5.1.2 Chiral Induction in Radical Cyclisation 
 
 Transfer of chirality requires an element of chirality present in the starting 
material to be preserved throughout a reaction, to yield a chiral product with the 
same stereochemistry.
204,205,206
  Acrylanilides, designed for 5-exo trig radical cyclis-
ation, have an axis of chirality about the N-aryl bond.
198
  However the barrier to 
rotation of the starting materials, which are ortho substituted, are much greater than 
configurationally labile radical intermediates 319a-b.  
 
 
Scheme 5.6: If kc > krot Acrylanilide Chiral Induction is Possible 
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 Consequently, in order for the stereochemistry of the starting atropisomer to 
be transferred to the cyclised product (319a → 320a) the rate of cyclisation kc must 
be greater than the rate of rotation krot (319a → 319b) of the radical intermediate 
(Scheme 5.6).
203
  Furthermore the cyclisation must proceed with facial selectivity to 
avoid racemisation.  
 Prior to the identification of atropisomerism in acrylanilides, chirality transfer 
in rapid 5-exo trig cyclisations was investigated using chiral inducing groups 
incorporated into the substrates producing acrylanilides such as 321.  However under 
the reaction conditions applied a 1 : 1 mixture of diastereomers was obtained with no 
selectivity (Scheme 5.7).
207
 
 
 
Scheme 5.7: Unsuccessful Attempted Chirality Transfer Using a Chiral Inducing Group 
 
It was unclear at the time why this was the case.  Curran then recognized that 
due to slow rotation about the N-aryl bond an axis of chirality was present in 321, as 
well as the chiral inducing group.  Consequently the starting material 321 was a 
mixture of diastereomers, and despite a fast rate of cyclisation (~10
8
 s
-1
) a mixture of 
diastereomers was obtained due to the formation of diastereomeric radical 
intermediates.  Curran then predicted that resolution of diastereomers of the related 
iodide 323 would lead to chiral induction.
203
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Scheme 5.8: Resolved Diastereomeric Acrylanilides Undergo Cyclisation 
 With Excellent Chiral Induction 
 
Resolution of 323 by chiral HPLC gave a 91/9 mixture of diastereomers 
which delivered excellent chirality transfer, producing 322 as a 95/5 mixture of 
diastereomers (Scheme 5.8).
203
  Curran recognized that if the barrier to rotation about 
the N-aryl bond was great enough,
179,180,198, 208
 individual atropisomers could be 
resolved by chiral HPLC, negating the need for a chiral auxiliary present in the 
substrate.  Acrylanilide 324 was found to have a barrier to rotation of ~ 29 kcal mol
-1
.  
This allowed resolution of the atropisomers by chiral HPLC and room temperature 5-
exo trig radical cyclisation afforded ~ 90% chirality transfer to give 325 (Scheme 
5.9).
179,198
 
  
 
Scheme 5.9: Chiral Induction Imposed by Restricted Rotation About the N-Aryl Bond 
 
 The ability to resolve acrylanilide atropisomers using laboratory techniques 
led to excellent chirality transfer for acrylanilides.  Given that high chirality transfer 
relies on the rate of cyclisation (kc) being faster than the rate of rotation (krot), 
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cyclisations of this sort (Scheme 5.9) suggest that this is the case.  The rates of 
cyclisation for radicals formed from 324 have been measured and are in the order of 
3 x 10
9
 s
-1
.
179
    
  
5.1.3 Atropisomerism in Enamides 
 
 Enamides are related to anilides through a N-C(alkenyl) bond.  A common 
reaction of enamides is the tin-mediated 5-endo trig radical cyclisation of α-
haloenamides.
25,34,209,210,211,212,213
  Only the E-rotamer of enamide radicals such as 
326 can undergo cyclisation, as in the Z-rotamer, the radical formed is too far away 
from the alkene to attack.  Comprehensive mechanistic studies
212,214
 have led to the 
determination of rates of cyclisation (kc) and Chatgilialoglu was able to 
experimentally determine kc for the cyclisation of α-amide radical of enamide 326 
(Scheme 5.10). 
 
 
Scheme 5.10: Representative Rates of Rotation and Cyclisation for Acyl Radicals 
 
Subsequently, Curran performed kinetic investigations to calculate kc for N-
benzyl α-haloenamides 328-330213 and his results were in good agreement with 
Chatgilialoglu’s experimental findings for the N-methyl enamide 326 at 110 oC 
regardless of the nature of the halogen.  For example, α-chloroenamide 328 was 
found to have a rate of cyclisation of 1.3 x 10
5
 s
-1
.   
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Scheme 5.11: Rate Cyclisation Acyl Radicals Derived From α-Haloenamides 
 
These values are of the order of 10
4
 slower than those reported for the aryl 5-
exo trig radical cyclisations for acrylanilides (324, 3 x 10
9
 s
-1
).
179
  Consequently 
chirality transfer in 5-endo trig cyclisations is expected to be more difficult to 
achieve than the related 5-exo trig cyclisations.  To determine whether chirality 
transfer could be possible for 5-endo trig cyclisations of enamides, a greater 
conformational understanding of these substrates is required (Scheme 5.12).   
 
 
Scheme 5.12: Rotational Processes Present in Enamides 
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 The most recent conformational analysis of α-haloenamides 328 and 330, 
performed by Curran and co-workers was designed in order to establish the syn/anti 
amide geometry of these substrates, using 
1
H NMR techniques.
213
  Variable 
temperature NMR showed a single peak for both the benzyl and α-protons at room 
temperature.  It was concluded that this was indicative of either the existence of a 
single rotamer
215
 in solution or an unusually low barrier to rotation about the N-CO 
amide bond giving rise to sharp, coalesced rotamer signals (Figure 5.5).
216,217
   
 
 
 
Figure 5.5
217
: Room Temperature NMR of α-Iodoenamide 330 
 
As the sample was cooled the benzyl and α-proton singlets decoalesced into 
mutually coupled doublets.  Spectroscopically this behaviour was not thought to be 
the result of slowing down and locking out the E/Z amide rotamers
218
 as this would 
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have resulted in the doubling up of all signals near the amide bond.  Additionally, as 
there was no element of chirality present in 330 the benzyl- and α-protons were 
expected to be homotopic, but at lower temperatures they were found to be 
diastereotopic (Figure 5.5). 
 
 
Scheme 5.13: Diastereotopic benzyl- and α-Haloenamides Used as a Handle for VTNMR 
 
 The diastereotopicity of the benzyl and α-protons suggested that at low 
temperatures an element of asymmetry was present in substrates of this structure.  It 
was proposed that this was due to the slowing down of rotation about the N-
C(cycloalkenyl) bond, to produce an axis of chirality, analogous to the one present in 
acetanilides,
198
 visible on the NMR timescale.  It had been shown previously, by 
Mannschreck and coworkers,
219
 that the barriers to rotation for enamides could be 
determined spectroscopically from the coalescence temperature of diastereotopic 
protons.
220
  Consequently, Curran and coworkers set about determining the rate of 
rotation (krot) and the barrier to rotation (ΔG
‡
) for their α-haloenamides.  Line shape 
analysis of variable temperature NMR spectra
221,222
 allowed values for krot to be 
determined at each temperature, which factored into the Arrhenius equation 
(Equation 5.1), allowed determination of ΔG‡ at each temperature. 
 
 
Equation 5.1 
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Equation 5.2 was used to produce an Eyring plot, allowing access to important 
kinetic and thermodynamic parameters for the N-C(cycloalkenyl) bond rotations.
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Equation 5.4
  
Curran and coworkers determined that N-cycloalkenyl
 
bond rotations in 328 
and 330 had krot values of 8.49 x 10
3
 and 1.12 x 10
4 
s
-1
 at 298 K (Equation 5.3) and 
when these values were factored into equation 5.1 to give equation 5.4, ΔG‡298 was 
found to be 12.1 kcal mol
-1
 and 11.9 kcal mol
-1
 respectively.
182
  These values are 
lower than those reported for related amide bond rotations (15-17 kcal mol
-1
).  
Additionally in an overlay, the Eyring plots for 328 and 330 were shown to almost 
coincide (Figure 5.6)
217
 which suggested the dynamics in each substrate were similar. 
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Figure 5.6: Coinciding Eyring Plots of α-Chloroenamide 328 and α-Iodoenamide 330 
 
 Overall the spectroscopic analysis of 328 and 330 strongly suggested that the 
α-haloenamides exist as single rotamers in solution and that the N-C(cycloalkenyl) 
bond rotation was the major conformational process occurring in these compounds.  
Further evidence for this was elucidated from the X-ray crystal structure obtained for 
328 (Figure 5.7).
217
   
 
 
 
Figure 5.7
217
: X-Ray Crystal Structure of α-Chloroenamide 328 
 
330 
328 
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This showed the N-cyclohexenyl bond preferred to lie orthogonal to the plane 
of the N-CO amide bond and that the torsional angle was 74
o
.  Finally the amide 
bond was shown to possess the E-conformation and to exhibit the anticipated sp
2
 
character in the ground state, and the sum of the bond angles around the nitrogen was 
found to be 359.9
o
 dismissing any suspicion of pyramidalisation. 
 Given the conformation of enamides such as 328 and 330, and the rate of 
cyclisation (~ 10
4
 s
-1
),
212
  it has been postulated that transfer of chirality could be 
observed during 5-endo trig cyclisations providing cyclisation occurs faster than N-
cycloalkenyl bond rotation.  In order to better contemplate the prospects of chirality 
transfer during these reactions, a basic investigation of the rotational dynamics of a 
number of enamides has been performed using variable temperature NMR.  Albrecht 
and co-workers reported on the rotational dynamics of acyclic enamides and related 
compounds in 1979.
220
  In our work, the effect of the cycloalkenyl group
182
 and 
substitution in the α-position of the carbonyl have been examined.  Furthermore 
tetrasubstituted enamides have been synthesised, towards the preparation of 
enamides with kc > krot.  
 
5.2 RESULTS AND DISCUSSION 
 
The cycloalkenyl enamides discussed in sections 5.2.1 and 5.2.2 were all 
synthesised by the same technique outlined in section 4.2.2.  Acetylation of the 
imines formed from the corresponding ketones, in situ, produced enamides 273-275, 
305-306 and 331-333 (Figure 5.8).   
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Figure 5.8: Enamides Selected to Investigate N-Cycloalkenyl Bond Rotation 
 
In order to investigate the effect of α-substitution at the carbonyl group on the 
rate of rotation, the acetylating group (acid halide) was also changed to produce 
cyclohexenyl enamides 334-344 (Figure 5.9). 
 
 
Figure 5.9: Enamides Selected to Investigate N-Cyclohexenyl Bond Rotation 
 
5.2.1 Barriers to Rotation for Cycloalkenyl Enamides – Effect of α-Halogen 
 
In the last section we reported the work initiated by Curran and co-workers 
who performed a conformational analysis on α-chloro- and α-iodoenamides 328 and 
330 (section 5.1.2).  For completion, we synthesised the α-bromoenamide 338 and 
analysed it by variable temperature NMR.  Bromide 338 was dissolved in CDCl3, 
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containing tetramethylsilane for use as a line width and internal standard. 
1
H NMR 
was recorded at temperature intervals in the range of 213-298 K.  Portions of these 
spectra are displayed in (Figure 5.9, x marks an impurity). 
 
 
ppm (t1) 4.505.00  
 
Figure 5.9: Stack Plot of a-Bromoenamide 338 
 
The results were consistent with those expected from the analysis of 328 and 
330, suggesting that 338 existed in solution as mainly the E-amide rotamer.  At 298 
K two singlets were observed for the benzyl and α-protons and upon cooling both 
decoalesced to give mutually coupled doublets (213 K).  As discussed previously 
(section 5.1.2) this is not consistent with N-CO bond rotation as this would lead to a 
doubling up of all peaks and would not result in the emergence of diastereotopic 
geminal protons.  Consequently, the major rotational process was assigned as the N-
cyclohexenyl rotation, which was slow enough at lower temperatures to generate a 
chiral axis.  This was confirmed by overlaying the Eyring plot of 338 with those 
213 K 
233 K 
247 K 
251 K 
263 K 
283 K 
298 K 
x 
x 
x 
x 
x 
x 
x 
x 
x 
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determined previously by Curran and co-workers to produce Figure 5.11 which 
suggested the rotational dynamics of the α-haloenamides were all similar.  
 
 
 
Figure 5.11: Coinciding Eyring Plots of α-Haloenamides 
 
 Using the program WINDNMR
221
 the krot for α-bromoenamide 338 was 
determined at each temperature.  From this plot it was possible to calculate the rate 
of rotation about the N-cylcohexenyl bond at 298 K (k298) using equation 5.3, which 
could then be factored into the Arrhenius equation (equation 5.1) to determine the 
barrier to rotation at 298 K (ΔG‡298). 
 
 
338 
330 
328 
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Substrate X k298 ΔG
‡
298  
328 Cl 8.49 x 10
3
 s
-1
 12.1 kcal mol
-1
 
338 Br 1.59 x 10
4
 s
-1
 11.7 kcal mol
-1
 
330 I 1.12 x 10
4
 s
-1
 11.9 kcal mol
-1
 
 
Table 5.1: Rates and Barriers to Rotation for α-Haloenamides Determined by VTNMR 
 
The coincidence of the Eyring plots is replicated in the values obtained for 
k298 and ΔG
‡
298 (Table 5.1).  Using the Eyring plots, it was also possible to determine 
the entropy and enthalpy for the N-cyclohexenyl bond rotation using equations 5.5 
and 5.6.  These figures have been omitted from table 5.1 but can be seen later in 
table 5.2. 
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Equation 5.6
 
 
5.2.2 General Appearance of 
1
H NMR of Enamide Substrates  
 
The study was then extended to a series of α-bromoisobutyryl enamides182 
that could undergo either 5-endo trig or 4-exo trig radical cyclisations.  The 
1
H NMR 
spectra of α-haloenamides (328, 330, 338) were relatively simple at room 
temperature and peak broadening and decoalescence was only observed upon 
β’ β β β’ 
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cooling.  However, the 
1
H NMR of the α-bromoisobutyryl enamides 273-275, 305-
306, 331-333 at room temperature, exhibited a range of behaviours depending on the 
nature of the cycloalkenyl group.    For the cyclopentenyl enamide 331, the benzyl 
protons were a sharp singlet at room temperature (Figure 5.12), and as a result, like 
α-halonenamides (328, 338, 330), only cooling of the sample would be required to 
observe decoalescence in order to determine k298 and ΔG
‡
298.  Conversely, for the α-
tetralone-derived enamide 306 the benzyl protons were resolved, mutually coupled 
doublets at room temperature (Figure 5.13), and consequently heating of the sample 
would be required.   
 
 
Figure 5.12: α-Bromoisobutyryl Enamides for NMR Analysis 
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Figure 5.13a: Room Temperature NMR of Cyclopentenyl Enamide 331 Showing  
a Sharp Signal for Benzyl Protons 
 
  
 
Figure 5.13b: Room Temperature NMR of α-Tetralone Enamide 306 Showing  
Diastereotopic Benzyl Protons 
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5.2.3 Effect of Ring Size 
 
Figures 5.13a and 5.13b display the two extremes observed and the 
remaining α-bromoisobutyryl enamides exhibited behaviour between them, often 
displaying broad resonances.  In the case of 275 and 332 the resonances were so 
broad that they disappeared in to the baseline.  Accordingly, these samples were both 
heated and cooled to in order to determine k298 and ΔG
‡
298.  As the need to heat the 
samples during variable temperature NMR was now apparent, δ8-toluene was 
selected as the solvent for this set of experiments to extend the range for data 
collection (183-373 K).   
 
 
ppm (t1) 3.504.004.505.005.50  
Figure 5.14: Stack Plot of α-Bromoisobutenamide 273 
 
As the α-position of the carbonyl was now substituted, and the appearance of 
benzyl protons was well resolved in every case, the benzyl protons were made the 
focal points of the line shape analyses.
221,222
  Figure 5.14 shows a portion of the 
183 K 
253 K 
283 K 
303 K 
343 K 
373 K 
x 
x 
x 
x 
x 
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variable temperature NMR spectra obtained for α-bromoisobutyryl enamide 273.  An 
impurity arising from the reaction of the acid bromide with unreacted benzylamine 
has been marked x. 
At low temperature (183 K) mutually coupled doublets were observed, due to 
slow N-cyclohexenyl bond rotation.  Increasing the temperature increased the rate of 
rotation, causing the doublets to broaden (283 K), and eventually complete 
coalescence was observed (303 K).  At high temperatures (373 K) rotation about the 
N-cyclohexenyl bond was so rapid, a sharp singlet was observed.  Line shape 
analysis of 273 found a rate of N-cyclohexenyl bond rotatio of 1.06 x 10
3
 and a 
barrier to rotation of 13.3 kcal mol
-1
 (Table 5.2), calculated from the Eyring plot 
(Figure 5.15).  
 
 
Figure 5.15: Eyring Plot for N-Cyclohexenyl Bond Rotation of α-Bromoisobutenamide 273 
273 
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This analysis was performed on all the α-bromoisobutyryl enamides (Eyring 
plots can be found in appendix A) and the resulting rate constants (k298) and 
activation parameters are displayed in table 5.2. 
 
Entry Substrate Temp 
Range (K) 
k298 (s
-1
)  ΔH‡  
(kcal mol
-1
) 
ΔS‡  
(cal mol
-1
 K
-1
) 
ΔG‡298 
(kcal mol
-1
) 
1 328
 a
 297-215
 
8.49 x 10
3 
8.9 -10.6 12.1 
2 338
 a
 323-213
 
1.58 x 10
4
 8.5 -10.6 11.7 
3 330
 a
 270-216
 
1.12 x 10
4
 9.2 -9.0 11.9 
4 338 323-193 4.54 x 10
4
 8.1 -10.0 11.1 
5 331 290-186 3.11 x 10
5
 8.0 -6.6 10.0 
6 273 311-233 1.06 x 10
3
 11.3 -6.6 13.3 
7 332 350-250 7.35 x 10
2 
11.8 -5.7 13.5 
8 275 341-230 3.09 x 10
3
 11.4 -4.3 12.7 
9 275 341-230 4.88 x 10
3
 11.4 -3.5 12.4 
10 305 313-203 1.77 x 10
4
 9.8 -6.3 11.7 
11 306 379-341 4.08 x 10
-1
 11.9 -20.4 18.0 
12 333
b 
350-271 1.83 x 10
2
 
3.64 x 10
2
 
12.7 
12.7 
-5.4 
-4.0 
14.4 
14.0 
a
 CDCl3 was the solvent. 
b
 Additional stereocentre gives rise to diastereomers with an equilibrium constant of 2. 
 
Table 5.2: Kinetic and Thermodynamic Parameters for α-Bromoisobutenamides 
 Derived From VTNMR 
 
 
Figure 5.16: α-Bromoisobutenamides Used to Investigate Barriers to Rotation 
 
For comparison, the results obtained for the α-haloenamides (328, 338, 330) 
have been included and 338 was resubmitted for analysis in δ8-toluene.  The 
presence of quaternary carbon on the acyl group furnishes a barrier to rotation of 
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13.3 kcal mol
-1
 for enamide 273 (Table 5.2, entry 6).  This was over 1 kcal mol
-1
 
greater than the barrier observed for α-haloenamides 328, 338, 330 (entries 1-3) in 
CDCl3, and when 338 was analysed in δ8-toluene (entry 4) the rotational barrier of 
273 was found to be ~ 2 kcal mol
-1
 greater.  Varying the ring size of the cycloalkenyl 
group (entries 6-9) had little effect on the barrier to rotation (12.4-13.3 kcal mol
-1
) 
except when the ring size was small for cyclopentenamide 331 (entry 5) which had a 
barrier to rotation of 10.0 kcal mol
-1
.   
Enamide 333 has an additional stereocentre and, as a result, slow rotation 
about the N-cyclohexenyl bond gives rise to diastereomers, not enantiomers.  Upon 
cooling the diastereomers were resolved as a 2 : 1 mixture, but no attempt to identify 
the major diastereomer was made.  As the rotamers were diastereomers, forward and 
reverse rates were measured (entry 12), and the presence of the phenethyl group 
increased to the barrier to rotation by ~ 1 kcal mol
-1
. 
 
5.2.4 Tetralone Enamides 
   
 
Figure 5.17: α-Tetralone and β-Tetralone Enamides 
 
The tetralone enamides 305 and 306 have different β’ (Figure 5.17) 
substitutions and as a result give remarkably different results.  β-Tetralone enamide 
305, is unsubstituted at the β’ position, which is a sp3 hybridised CH2 group.  In that 
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respect it was expected to resemble the cyclohexenamide 273.  However, the barrier 
to rotation was calculated at 11.7 kcal mol
-1
 (entry 10) which was 1.6 kcal mol
-1
 
lower than 273 (entry 6).  In contrast, the α-tetralone enamide 306 is sp2 hybridised 
at β’ due to the aromatic portion of the tetralone unit.  Consequently, 306 better 
resembles an anilide than cyclohexenamide 273, and this is reflected in the barrier to 
rotation which was found to be 18.0 kcal mol
-1
 (entry 11).  Even at the highest 
possible temperatures for the solvent in question (δ8-toluene) only the beginnings of 
coalescence was observed for 306 and as a result values obtained may not be as 
accurate as the others. 
A crystal of 305 was grown in the hope of gaining an indication as to why a 
lower than expected barrier to rotation was observed (Figure 5.18).   
 
   
Figure 5.18: X-ray Crystal Structure of β-Tetralone Enamide 305 
 
 The N-alkenyl bond torsional angle was found to be 56
o
 which was lower 
than that previously found for related anilides (70-90
o
), and α-haloenamide 328 
(74
o
).
213,217
  It is possible that additional overlap of the nitrogen lone pair through the 
alkene to the phenyl ring reduces the twist angle and subsequently the rotation 
barrier compared to anilides and α-haloenamides.  Furthermore the sum of the angles 
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around nitrogen was found to 356.9
o
 indicating a deviation away from planarity
223
 
(360
o
) and the torsion angle for N-CO amide bond, relative to the cycloalkene was 
found to be 152
o
 and not 180
o
 as expected for an sp
2
 hybridised nitrogen.  
Consequently these values suggest a partial rehybridisation of the amide nitrogen 
from sp
2
 to sp
3
, which could also reduce the barrier to rotation. 
 
5.2.5 Effect of Solvent 
 
The effect of solvent
224 , 225
 on rate constants and rotational barriers was 
briefly explored for α-haloenamide 338 and α-bromoisobutyryl enamide 273 (Table 
5.3).  5-Endo trig cyclisations of enamides can be mediated by organostannane 
reagents and with copper complexes under ATRC conditions.  The former tend be 
carried out in non-polar solvents such as toluene, while for ATRC, more polar 
solvents are required (DCM, methanol).   Generally, it was found that more polar 
solvents decreased the rate of rotation and increased the rotation barrier, although the 
difference was not significant (0.5-0.9 kcal mol
-1
 ± 0.2 kcal mol
-1
).  Unfortunately, 
there did not seem to be an obvious correlation between the rotation barrier and 
dielectric constant (ε), dipole moment (μ) or the viscosity (η) of the solvents studied.  
The solvents used for organostannane (toluene) and ATRC (chlorinated, methanol) 
reactions exhibited identical trends with the ΔG‡298 increasing for the more polar 
solvents (toluene < methanol ~ CDCl3), for both 273 and 338 which also corresponds 
to a decrease in the rate of N-cyclohexenyl bond rotation. 
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Substrate Solvent k298 ΔG
‡
298  
338 δ8-toluene 4.54 x 10
3
 11.1 kcal mol
-1
 
338 δ4-methanol 1.96 x10
3 
11.6 kcal mol
-1
 
338 CDCl3 1.58 x 10
3 
11.7 kcal mol
-1
 
273 δ8-toluene 1.06 x 10
3
 s
-1
 13.3 kcal mol
-1
 
273 CD3CN 371.4 13.9 kcal mol
-1
 
273 δ4-methanol 326.1 s
-1
 14.0 kcal mol
-1
 
273 CDCl3 251.4 s
-1
 14.2 kcal mol
-1
 
273 CD3NO2 245.3 s
-1
 13.9 kcal mol
-1
 
 
Table 5.3: Effect of Solvent on the Rate and Barrier to Rotation 
 
 None of the enamides in this investigation had N-cycloalkenyl rotation 
barriers high enough for atropisomer resolution at room temperature.  However, 
when taken with previous results, enamides show a number of parallels with the 
related anilides which have been well studied.  From enamide 306 (Table 5.2, entry 
11) it was recognised that substitution at β and β
’
 positions could lead to resolvable 
enamides at room temperature.  Precedence for this in the literature has been 
reported by Albrecht and co-workers
220
 who have shown that it is possible to 
partially resolve tetrasubstituted enamide 345, and its rotational barrier has been 
measured (~ 25 kcal mol
-1
).  Tetrasubstituted enamides will be discussed in section 
5.2.3.  
 
 
Figure 5.19: Tetrasubstituted Enamide 
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5.2.6 Barriers to Rotation for Cyclohexenyl Enamides, Varying the Acyl 
Group and Modelling the Barrier to Rotation in Related Radicals 
 
 Transfer of chirality requires the rate of cyclisation (kc) of the radical 
enamide (e.g. E,P-346) to be greater than the rate of N-alkenyl bond rotation (krot) 
(e.g. E,P-346 → E,M-346) (Scheme 5.20).  For α-haloenamides the kc has been 
determined (~10
4
 s
-1
),
212
 and is approximately equal to the krot for the enamides 328, 
330, 338 (~10
4 
s
-1
).
213
  The rate and barrier to rotation for α-bromoisobutyryl 
enamides (273-275, 305-306, 331-333) have also been determined
182
 (Table 5.2, 
section 5.2.1), but up to now little is known of the rotation of the radical 
intermediates (e.g. E,P-346 → E,M-346). 
 
 
Scheme 5.20: Potential Chirality Transfer in Enamides 
 
 To better contemplate the prospects of chirality transfer in the 5-endo trig 
cyclisations of enamides, and to complement previous work, a series of N-
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cyclohexenyl enamides 334-344, in which the size of the acyl group is varied, have 
been investigated.  These experiments were designed to better estimate the barrier to 
rotation for the reactive radicals (346-349) produced by replacing the halogen (Br) 
with a hydrogen atom (334-337).  Aryl and vinyl groups (342 and 343), furnishing a 
sp
2
 hybridised acyl substituent have also been considered. 
 
 
Figure 5.20: Enamides For Study 
 
 
Figure 5.21: Designing Substrates as Models for Radical Intermediates  
Present During Cyclisation 
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 The experiments were initiated by the preparation of 339, completing the 
bromoenamide series 338 → 339 → 273, to determine the effect of sequential 
replacement of hydrogen atoms with methyl groups.  Additionally enamides 334-336 
were also prepared to determine the same effect in instances where the bromine had 
been replaced by a hydrogen atom to provide potential models for the reactive 
radicals 346-348.  The di- and trichloro enamides 340 and 341 were also prepared as 
these have also be shown to undergo 5-endo trig cyclisations, with the additional 
halogens facilitating reaction.  Conveniently, 340 could also act as a model for the 
radical 349. 
 For analysis all samples were dissolved in d8-toluene, spiked with 
tetramethylsilane for use as an internal and line width standard and NMR were 
recorded at temperature intervals in the range of 183-373 K.  For enamide 337 a 
portion of these spectra is shown in figure 5.22 (x marks an impurity). 
 
 
ppm (t1)
4.004.505.005.50
 
Figure 5.22: Stack Plot of Enamide 337 
 
353 K 
313 K 
298 K 
283 K 
263 K 
243 K 
223 K 
203 K 
183 K 
x 
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 Consistent with previous observations, as the samples were cooled 
decoalescence of the benzyl protons was observed to afford mutually coupled, 
geminal, doublets, indicative of largely a single E-rotamer in solution and slowing 
down of the N-cyclohexenyl bond rotation.  Enamide 339 has an additional 
stereocentre so, like 333 in section 5.2.1, its rotamers are diastereomers.  During this 
experiment, the equilibrium constant for the two diastereomers was measured at low 
temperature and found to be 1.  Rotational rate constants (krot) were determined at 
each temperature and activation parameters and k298 were determined (Table 5.4) 
from the subsequent Eyring plots (appendix A).  Standard Eyring plots for the 
enamide 334 (radical model) and fully substituted enamide 337 are shown in figure 
5.23. 
 
 
Figure 5.23: Eyring Plots of Unsubstituted and Fully Substituted Enamides 334 and 337 
334 
337 
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Entry 
(Substrate) 
R krot 298 K 
(s
-1
) 
ΔH‡  
(kcal mol
-1
) 
ΔS‡  
(cal mol
-1
 K
-1
) 
ΔG‡298  
(kcal mol
-1
) 
1 (338) CH2Br 4.54 x 10
4
 8.1 -10.0 11.1 
2 (339)
a 
CH(CH3)Br 9.00 x 10
3
 
9.00 x 10
3
 
7.9 
7.9 
-13.8 
-13.8 
12.0 
12.0 
3 (273) C(CH3)2Br 1.06 x 10
3
 11.3 -6.6 13.3 
4 (341) CCl3 2.53 x 10
2 
14.8 2.0 14.2 
5 (334) Me 2.51 x 10
5
 9.2 -2.9 10.1 
6 (335) Et 7.46 x 10
4
 6.4 -14.7 10.9 
7 (336) 
i
Pr 1.80 x 10
4
 9.3 -7.7 11.7 
8 (340) CCl2 6.66 x 10
3
 10.0 -7.4 12.2 
9 (337) 
t
Bu 6.43 x 10
3
 12.5 0.9 12.3 
10 (343) CH=CH2 7.45 x 10
4
 7.5 -11.1 10.8 
11 (342) C6H5 4.88 x 10
5
 6.0 -12.2 9.7 
12 (344) CH2Ph 2.29 x 10
4
 7.8 -12.4 11.5 
a
 Addition stereocentre gives rise to diastereomers with an equilibrium constant of 1. 
 
Table 5.4: Kinetic and Thermodynamic Parameters Obtained for  
N-Cyclohexenyl Enamides  
 
 
Figure 5.24: N-Cyclohexenyl Enamides Selected to Investigate Barriers to Rotation 
 
Sequential addition of methyl groups was unsurprisingly found to steadily 
increase the rotation barrier.  Adding  a methyl group to transform 334 → 335 was 
seen to increase the barrier 0.8 kcal mol
-1
 (Table 5.4, entry 5 → 6) and this increase 
was repeated upon addition of second methyl, converting 335 → 336 (entry 6 → 7).  
A third addition afforded 336 → 337 and fit the pattern increasing the ΔG‡298 by 0.6 
kcal mol
-1
 (entry 7 → 9).  This steady increase in ΔG‡298 was also observed upon 
substitution of bromoenamide 338.  Sequential addition of methyl groups to 338 → 
339 → 273 increaseg the barrier by 0.9 kcal mol-1 (entry 2) and 1.3 kcal mol-1 (entry 
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3) respectively.  A more significant comparison is between the radical precursors 
(338, 339, 273) and their ‘radical models’ (334-336), where the bromine atoms have 
been replaced by hydrogen atoms.  Substituting bromine for hydrogen was found to 
decrease ΔG‡298 by 1-1.6 kcal mol
-1
 (entries 1, 2, 3 → 5, 6, 7).  An even greater 
decrease of 2.0 kcal mol
-1
 (entry 4 → 9) was observed between the trichloroenamide 
341 and its dichloroenamide ‘radical model’ 340.  Thus, ΔG‡298 was found to 
decrease between 1.0-2.0 kcal mol
-1
 for the radical precursors and their ‘radical 
models’ and this constitutes to a 5-26 fold increase in rate (k298) for N-cycloalkenyl 
rotation in the radical models.   
As the reactive radicals (346-348) would be sp
2
 hybridised in the α-acyl 
position, aryl 342 and vinyl 343 substituted enamides were thought to be more 
appropriate ‘radical models.’  For radical 347 the sp2 and sp3 ‘models’ are in 
reasonable agreement (10.8, 10.9 kcal mol
-1
 respectively).  However, the same 
cannot be said for the sp
2
 and sp
3
 ‘models’ of radical 348, where the sp2 ‘model’ 
barrier (342, entry 11) was found to be significantly lower (2 kcal mol
-1
) than the sp
3
 
‘model’ (335, entry 6).  This trend is consistent with observations made for benzoyl 
anilides and occurs due to the aryl ring twisting out of the plane of the N-
cyclohexenyl rotation.
201
  Acrylanilides analogous to 342 tend to manifest a similar 
decrease which was not observed here.  Presumably this is because, compared to 
acrylanilides, the enamide 343 exhibits a degree of both the s-cis 343 and s-trans 343 
conformers,
226
 and the s-trans conformer, can lie in the plane of the N-cyclohexenyl 
bond rotation (Scheme 5.21).   
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Scheme 5.21: Rotation of the Acrylate Bond giving Rise to s-cis and s-trans Isomers 
 
 Finally the benzylic derivative (344, entry 12) was analysed and gave a 
barrier of 11.5 kcal mol
-1
, which was greater than the primary bromide (338, entry 1), 
but similar to the isopropyl enamide (336, entry 7). 
 
 
Figure 5.25: Enamides Representing the Radical Precursor and Models 
 
The structure of one of the diastereomers of 339 was solved be X-ray 
crystallography (Figure 5.26), and resembled the previously solved anilides, and α-
haloenamide 328.
213,217
  The torsion angle of the N-alkenyl bond was found to be 84
o
, 
and unlike the tetralone enamide (305, figure 5.18) there was little evidence to 
suggest partial rehybridisation of the nitrogen to sp
3
.  The sum of the angles around 
nitrogen was found to be 359.9
o
 (356.9
o
 for 305), and the torsion angle of the N-CO 
amide bond was found to be 179.1
o
 (152.0 for 305), which is indicative of sp
2
 
hybridisation.  
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Figure 5.26: X-Ray Crystal Structure of Cyclohexenamide 339 
 
 The analysis of enamides in which the acyl group has been varied has 
allowed an estimation of possible rates of rotation about the N-alkenyl and for 
reactive radical species involved in 5-endo trig radical cyclisation reactions.  It was 
estimated that the rate of rotation would increase by 5-26 times for reactive radicals 
compared to their radical precursors.  Unfortunately, considering the rates of rotation 
and cyclisation, this makes chiral transfer unlikely for enamides 273-275, 305-306, 
331-333.  However taken with the results from section 5.2.1 it has become evident 
that the rates of rotation need to be decreased and that this may be possible by 
changing the substitution pattern of the enamides.  Consequently a number of 
tetrasubstituted enamides were prepared to determine if they could offer a route to 
chiral transfer in 5-endo trig radical cyclisations. 
 
5.2.7 Tetrasubstituted Enamides 
 
 In section 5.2.1 it was recognised that α-tetralone enamide 306, substituted in 
the β’ position, gave rise to the greatest barrier to rotation about the N-alkenyl 
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bond.
182
  Consequently, a range of enamides, with both β and β’ substitution were 
pursued in order to determine the magnitude of their rotation barriers and assess their 
potential utility as substrates able to undergo chiral transfer during 5-endo trig 
radical cyclisation. 
 
 
Figure 5.27: Trisubstituted α-Tetralone Enamide 306 
 
 Attempts to synthesise tetrasubstituted enamides using the existing synthetic 
route, involving acetylation of corresponding imines was unsuccessful.  As a result, 
an alternative synthesis of enamides
227,228,229,230,231
 from the corresponding ketones 
via oxime imtermediates was pursued. Hence oxime formation, followed by iron-
mediated rearrangement then alkylation
232
 gave the N-benzyl enamides 360-364 
(Scheme 5.22).   
 
β 
β’ 
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Scheme 5.22: Synthesis of Tetrasubstituted Enamides 
 
Although the yields obtained were not impressive, they were ample for the 
purpose of the investigation.  α-Tetralone enamide 363 was analysed by variable 
temperature NMR (appendix A) and a barrier (ΔG‡298) of 17.7 kcal mol
-1
 was 
determined which equated to a rate of rotation of the N-alkenyl bond (krot) of 0.7 s
-1
.  
This was not as low as would have been predicted given the results obtained for α-
tetralone 306 in section 5.2.1, and the effect of acyl substitution as determined in 
section 5.2.2.  The tetrasubstituted enamides were all thought to have rotation 
barriers significantly larger than α-tetralone enamide 306 (18.0 kcal mol-1), and 
consequently were not analysed by variable temperature NMR.  Instead they were 
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sent to Pittsburgh for HPLC analysis and separation by Prof Dennis Curran co-
workers.   
Pleasingly, separation of enamides 360-362 and 364 was possible by chiral 
HPLC using a Whelk-O
®
 column.  A degree of separation was observed for 361 
(appendix B), but given that the other substrates were benzylated and provided much 
better separation, this was not analysed any further, or considered for possible chiral 
transfer in this investigation.  Substrates 360 (Figure 5.28) and 364 (Figure 5.29) 
gave particularly good separation.  Their atropisomers were resolved and their 
barriers to rotation were determined.  Enamide 360 had been partially resolved 
previously and its barrier to rotation had been measured (~24 kcal mol
-1
).
220
  For this 
study, in which the barrier was determined from the rate of racemisation using chiral 
HPLC, it was calculated as 25.7 kcal mol
-1
.  Likewise the barrier for 364 was found 
to be 27.5 kcalmol
-1
.   
 
 
Figure 5.28: HPLC Trace of Tetrasubstituted Enamide 360 Showing Two Atropisomers 
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Figure 5.29: HPLC Trace of Tetrasubstituted Enamide 364 Showing Two Atropisomers 
 
The barrier for 362 (appendix B) was not determined, but due to the 
structural similarity with 360 it is presumably ~25 kcal mol
-1
.  A crystal structure of 
364 was solved (Figure 5.30), and it resembled the anilide structure rather than that 
observed for the β-tetralone 305.  The N-alkenyl bond torsion angle was found to be 
74.3
o
, the N-CO angle was 175.1
o
 and finally the sum of the angle around nitrogen 
was 359.9, suggesting the nitrogen was sp
2
 hybridised. 
  
Figure 5.30: X-Ray Crystal Structure of Tetrasubstituted Enamide 364 
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 Unfortunately, despite the tetrasubstituted enamides being resolvable by 
chiral HPLC, there was no radical source (halogen) present to initiate cyclisation by 
either organstannane- or copper-mediated processes.  Therefore, bromination at the 
α-carbon of the acyl group of 360 was attempted.  Given the results obtained in 
section 5.2.2 these α-bromoenamides would be expected to have barriers > 25.7 
kcalmol
-1
 and therefore would also be resolvable. 
 Two methods of bromination were attempted
233,234
  Acid-catalysed bromin-
ation using Br2 in acetic acid was unsuccessful, as was base-mediated bromination, 
using sec-BuLi and Br2 (Scheme 5.23).  For base-mediated bromination, both normal 
and inverse addition of the anion formed was unsuccessful.  The acid catalysed 
reaction led to the isolation of only starting material 360 even after prolonged 
periods of heating (3 days), whereas the base-catalysed reaction led to hydrolysis of 
the amide bond, presumably due to the acceleration of the haloform reaction. 
 
 
Scheme 5.23: Unsuccessful Attempts at Bromination of Tetrasubstituted Enamide 360 
 
 Alternative approaches to halogen introduction were attempted. The Fe 
mediated rearrangement
231
 of oximes (Scheme 5.24) to give enamides (366 → 359) 
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has been only been reported using simple anhydrides (acetic anhydride) as acylating 
agents.  
 
 
Scheme 5.24: Fe Mediated Synthesis of Tetrasubstituted Enamides 
 
The ability to use trichloroacetyl chloride and chloroacetyl chloride in place 
of acetic anhyride in this reaction has not been investigated previously.  These 
acetylating agents were applied to the rearragement reaction and although the 
reactions were unoptimised, halogen-containing enamides 367-371 (Figure 5.31) 
were prepared.  In addition 359 was alkylated using o-bromobenzyl bromide to give 
372 as an alternative radical cyclisation substrate. 
 
 
Figure 5.31: Tetrasubstituted Enamides Synthesised by Iron Mediated Acetylation 
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At this stage attentions were focused to the attempted (racemic) cyclisation of 
375 formed from the benzylation of enamide 370 with benzyl bromide.  As the 
product of this benzylation reaction was a 5 : 1 mixture of α-choloro and α-
bromoenamides 373 and 374, a literature procedure
209
 of the Finkelstein reaction 
using sodium iodide (NaI) in acetone was performed to convert the mixture to the α-
iodoenamide 375. 
 
 
Scheme 5.25: Procedure for the Alkylation of Tetrasubstituted Enamides 
 
Mechanistic studies of the cyclisations of α-haloenamides performed by 
Curran and co-workers have shown that the rate for cyclisation (kc) depends on the 
nature of the halogen present in the radical precursor, despite the reactions going 
through identical intermediates.
 213
   Unfortunately, it was determined in their studies 
that α-iodoenamides were the poorest cyclisation substrates, leading to the highest 
proportion of direct halogen reduction. Cyclisation was observed at low tin 
concentrations, but diminished as the concentration was increased.  Consequently it 
was hoped that some cyclisation of 375 would be observed at low tin concentrations. 
 Enamide 375 was chosen for cyclisation due to its significantly larger barrier 
to rotation (>27.5 kcal mol
-1
).  Considering the substitution pattern of the alkenyl 
bonds it was difficult to predict whether 4-exo or 5-endo trig cyclisation would 
predominate (Scheme 5.26).  However, either outcome would result in an 
asymmetric centre to which chiral information could be transferred from 375. 
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Scheme 5.26: Possible Products From the Cyclisation of 375. 
   
Copper mediated cyclisations are generally unsuccessful for primary α-halo 
precursors, and consequently the standard tin reaction was attempted using AIBN, in 
toluene at reflux, using a syringe pump to maintain the tin concentration at ~10 mM.  
To ensure the absence of moisture and air, both the reaction and reagent mixtures (in 
toluene) were thoroughly degassed prior to the reaction.  Despite this, no cyclisation 
was observed and a mixture of interesting, seemingly oxidized, products 376 and 
377 were obtained (Scheme 5.27).   
 
 
Scheme 5.27: Attempted Tin-Mediated Radical Cyclisation of Tetrasubstituted Enamide 375 
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 It was initally unclear how these oxidized products could be formed under 
reductive conditions.  A second sample of 375 was heated in toluene with AIBN (1 
equivalent), in the absence of Bu3SnH and open to the atmosphere.  Under these 
conditions the naphthalene 376 was obtained in 53% yield along with unreacted 
starting material.  This indicated that the AIBN mediated rate of the oxidation, to 
form the naphthalene, was likely to have been quicker than initiation of the radical 
chain leading to the homolysis of the C-I bond.  The greatest confusion came from 
the formation of 377, which could only be identified after HRMS, IR and exhaustive 
NMR analysis.  Standard 
13
C NMR (75 MHz) indicated the existence of three 
carbonyl groups (208.2, 167.3, 166.1 ppm), and this was confirmed by three 
distinguishable bands in the IR (1731, 1701, 1665 cm
-1
).  The HRMS revealed a 
molecular formula of C20H21NNaO4, which indicated that there must have been 
adventitious oxygen (at least 2 molecules) present in the reaction mixture.  
Mechanistically it is unclear how 377 was formed but we can speculate that cleavage 
of the enamide bond may have taken place after the addition of oxygen to the radical 
intermediate 378 (Scheme 5.28). 
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Scheme 5.28: Proposed Mechanism for the Formation of 377 
 
 Hence, 6-exo cyclisation of the peroxy radical 379, followed by trapping with 
another molecule of oxygen would furnish 381 which, after a ‘SH2’-like reaction and 
molozonide rearrangement would furnish imide 383.  Given this rationale, it was 
initially thought that the compound isolated could have been intermediate 383.  
However the actual structure 377 was confirmed after a HMBC experiment was 
performed.  This showed the amide C=O (167 ppm) coupling with both the adjacent 
CH2 and the benzyl CH2 (through the amide bond).  Additionally it confirmed the 
position of the ester functional group as its C=O (166 ppm) was seen to couple with 
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both the aryl ring and the CH2 adjacent to the ester bond.  Thus, if this mechanistic 
pathway was followed intermediate 383 must have undergone a further acyl transfer 
during the course of the reaction.  The failure to isolate a racemic cyclised product 
was disappointing.  The production of 377 was particularly intriguing and 
confirmation of the ‘pseudo-ozonolysis’ mechanism would require a number of 
reactions designed to trap out the radical intermediates for characterization and was 
beyond the scope of this investigation. 
 Finally, in the hope of observing a cyclisation reaction for the tetrasubstituted 
enamides, an aryl bromide analogue of 364 was synthesized using o-bromobenzyl 
bromide as the alkylating agent to produce 372. 
  
 
Scheme 5.29: Synthesis of an Alternative Precursor for Tetrasubstituted 
 Enamide Radical Cyclisation 
 
It was predicted that cyclisation may be more favourable for the aryl bromide 
372 as the reactive aryl radical could undergo 5-exo trig cyclisation attacking the α-
carbon of the enamide.  Support for this hypothesis comes from the rates of 
cyclisation obtained for the 5-exo trig cyclisation of aryl radicals formed from 
acrylanilides.
179
  Indeed the first reaction attempted borrowed the conditions from 
such reactions utilising Et3B as an initiator at room temperature, open to the 
atmosphere.  Unfortunately, after 24 hours only starting material was recovered 
(Scheme 5.30).   
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Scheme 5.30: Unsuccessful Protocols Attempted to Observe Cyclisation of 372 
 
Repeating the reaction using the standard tin conditions was equally 
disappointing.  Again no cyclisation was observed and, similar to the reaction of α-
iodoenamide 375, a naphthalene derivative 384 was obtained, as indicatated by 
additional aromatic doublets at 7.81 and 7.75 ppm in the crude NMR, suggesting an 
oxidation was taking place under reductive reaction conditions.  Subsequently, a 2 : 
1 mixture of 372 and 384 was heated at reflux in the presence of AIBN and absence 
of Bu3SnH.  This caused the ratio of the naphthalene to increase and a 1 : 2 ratio of 
372 and 384 was re-isolated, suggesting that, like the α-iodoenamide 375, the AIBN 
was responsible for the oxidation.  A third and final attempt was made to cyclise 372, 
using the samarium iodide (SmI2),
235
 hexamethylphosphoramide (HMPA) technique.  
This too was unsuccessful, leading to the recovery of only starting material.   
 It was surprising that, given that no cyclisation was observed, no directly 
reduced product (364) was obtained.  The structure of 372 was solved by x-ray 
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crystallography in order to determine how hindered the aryl bromide was (Figure 
5.32). 
 
  
Figure 5.32: X-Ray Crystal Structure of Tetrasubstituted Cyclisation Precursor 372 
 
The structure was comparable to the previously solved structures (339 and 
364) and with anilides, and the relevant torsion angles were found to be 81
o
 (N-
alkenyl bond) and 179
o 
(N-CO bond).  Furthermore the sum of the bond angles 
around nitrogen was found to be 359.6
o
 indicative of sp
2
 hybridisation.  The bromine 
did not appear to be particularly hindered but there was a degree of disorder 
associated with a rotation around the C-C(aryl) bond, which placed the bromine 
away from the alkenyl bond in the minor rotamer.  On closer examination it was 
clear that cyclisation would be difficult for either rotamer as the aryl radicals 
produced would not be in close proximity to the alkenyl group for 5-exo trig 
cyclisation.  
 
5.2.8 Conclusions 
 
 A number of enamides have been prepared in order to gain an insight into 
their potential as possible reagents for chiral transfer in 4-exo and 5-endo trig radical 
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cyclisation reactions.  Variable temperature NMR was used to determine the rate of 
rotation and barrier to rotation about the N-alkenyl bond.  The size of the 
cycloalkenyl group had little effect on the barrier to rotation.  However, when the 
enamide is substituted at the β’-position, particularly if it is sp2 hybridised 
(resembling an anilide) then the barrier was seen to significantly increase (306, 18.0 
kcal mol
-1
).  Substitution at the acyl group also allowed for a crude estimation of the 
rotation barrier for the reactive radicals, which up to now have been unknown, but 
are crucial in establishing the potential for chiral transfer.  Using sp
3
 and sp
2
 
hybridised ‘radical models’ the barrier to rotation was found to decrease by 1-2 kcal 
mol
-1
 compared to the radical precursors, which equates to a 5-26 fold increase in 
rate of rotation about the N-alkenyl bond.  Finally, tetrasubstituted enamides have 
been prepared, substituted at the β and β’-positions.  These have been resolved by 
chiral HPLC and the barriers for two examples (360 and 364) have been found to be 
significantly higher (25.7-27.5 kcal mol
-1
) than any other enamide synthesised 
during this investigation.  Halogens were incorporated to prepare an enamide 
suitable for cyclisation.  The barrier to rotation was not measured for this enamide 
but it is safe to assume that it would be >27.5 kcal mol
-1
, and therefore resolvable 
and suitable for chiral transfer.  However, attempts to racemically cyclise the 
tetrasubstituted enamides 375 and 372 were unsuccessful.    
 
5.3 FUTURE WORK 
 
 It was possible to prepare resolvable enamides, however, attempts to cyclise 
them were unsuccessful.  A common problem associated with the cyclisations of 
tetralone derived enamides 372 and 375 was AIBN initiated aromatisation, forming a 
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naphthalene product.  To alleviate this problem a number of alternative substrates 
could be prepared.  Indanone enamides 385-387, would have a lower barrier to 
rotation than the tetralone enamide (up to 3.3 kcal mol
-1
 lower based on the 
comparison between cyclopentenyl and cyclohexenyl enamides in section 5.2.1), but 
aromatisation would not be possible.  Furthermore, the potential 5-exo trig 
cyclisation of these enamides could be investigated using more flexible groups 386. 
 
 
Figure 5.33: Alternative Tetrasubstituted Enamides 
 
Other commercially available ketones such as 388 and 389 could also provide access 
to enamides 390 and 391 that may have barriers to rotation great enough to be 
resolved by chiral HPLC (based on results for other tetrasubstituted enamides 360-
364) and would also avoid the problem of possible aromatisation.   
 
 
 
Scheme 5.31: Alternative Tetrasubstituted Enamides 
 
Chapter 6: Experimental 
 
179 
 
6.0 Experimental 
 
6.1 GENERAL INFORMATION AND PROCEDURES 
 
 All reactions were performed using oven dried glassware and heat transfer 
was achieved using either an oil bath (chapter 2) or drysyn
©
 apparatus.  All reactions 
were performed using commercially available anhydrous solvents, and exhaustive 
deoxygenation was not required except for the case of 1,4-DMP which required 
thorough degassing and an inert atmosphere.  Degassing was achieved using the 
freeze-pump-thaw technique and reactions were performed on a Schlenk line under a 
nitrogen atmosphere.  With the exception of 1,4-DMP, all chemicals were used as 
received without any further purification. 
 Reactions were followed by TLC, performed on silica coated aluminium 
plates (Merck Kieselgel 60F254 230-400 mesh) developed either from UV 
fluorescence (254 nm) or potassium permanganate.  Flash chromatography was 
carried out using Merck 9385 Keiselgel 60 SiO2 (230-400 mesh).   
IR was achieved using a Perkin-Elmer 1720X Fourier transform spectrometer.  
Solids were compressed into a thin tablet and oils/non-volatile liquids were analysed 
as films over a diamond sensor. 
 
1
H and 
13
C NMR spectroscopy was performed on Bruker DPX300 and 
DPX400 machines at either 300 or 400 MHz and 75 or 100 MHz respectively.  
Chemical shifts are quoted in ppm relative to the internal standard tetramethylsilane 
(δ = 0) and reference to the residual solvent.  All coupling constants are quoted in 
hertz (Hz).  For variable temperature NMR samples were submitted to the NMR 
service and analysis on a Bruker DPX500 spectrometer.  Spectra obtained were 
Chapter 6: Experimental 
 
180 
 
analysed using Mestrec
©
 and NUTS
©
 software prior to lineshape analysis using 
WINDNMR.
221
  
 Mass Spectroscopy was achieved using either electron, chemical or 
electrospray ionisation techniques.  The bulk of low resolution analyses were 
performed on a Bruker Esquire 200 machine.  Accurate mass spectroscopy was 
available through the in house mass spec service using either Bruker HCT or Bruker 
HCT Ultra machines to perform accurate mass ESI analysis.  Elemental analysis was 
performed by Warwick Analytical Service using a CE440 Elemental Analyser. 
 Analytical chiral HPLC was performed by the Curran group in Pittsburgh and 
was conducted using either an (S,S)-Whelk-O 1 column (Pirkle, 250 mm x 4.6 mm 
ID) or a Chiralcel OD column (Daicel, 250 mm x 4.6 mm ID). 
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6.2 GENERAL PROCEDURES 
 
6.2.1 General Procedure for Substrates Synthesised in Chapter 2 
   
6.2.1.1  N-Allyl-4-methyl-benzenesulfonamide 199
236 
 
Allylamine (4.50 ml, 60.0 mmol) was dissolved in 
dichloromethane (70 cm
3
) and cooled to 0
o
C.  Triethylamine 
(8.36 ml, 60.0 mmol) was added followed by p-
toluenesulfonyl chloride (11.40 g, 60.0 mmol) in dichloromethane (70 cm
3
), which 
was added via a dropping funnel over 5 minutes.  The reaction was allowed to reach 
room temperature overnight.  After 18 hrs the reaction was quenched with 1 M HCl 
(150 cm
3
) and the aqueous layer was extracted using dichloromethane (3 x 150 cm
3
).  
The combined organic extracts were washed with brine (150 cm
3
), dried using 
MgSO4, filtered and concentrated in vacuo to yield 199 as a pale yellow solid (11.72 
g, 55.5 mmol, 93%);  Rf (3:1 petrol:EtOAc) 0.56; mpt 64-65 
o
C, lit
236
 64-65 
o
C; max 
(cm
–1
) 3245, 2852, 1595, 1493, 1422, 1317, 1289, 1156, 1061, 810; δH (300 MHz, 
CDCl3) 7.75 (2H, d, JHH 8.1, Ar), 7.31 (2H, d, JHH 8.1, Ar), 5.71 (1H, ddt, JHH 17.1, 
10.2, 5.7 Hz, CH=CH2), 5.19 (1H, dd, JHH 17.1, 1.5 Hz, CH=CH2), 5.10 (1H, dd, JHH 
10.2, 1.5 Hz, CH=CH2), 4.70 (1H, br t, JHH 6 Hz, NH), 3.57 (2H, ddd, JHH 6.0, 5.7, 
1.5 Hz, N-CH2), 2.42 (3H, s, CH3); δC (75.5 MHz, CDCl3) 142.9 (Ar quaternary), 
136.3 (Ar quaternary), 132.4 (CH=CH2), 129.1, 126.5 (Ar), 117.1 (CH=CH2), 45.2 
(N-CH2), 20.9 (CH3); m/z (EI) 211 [M]
+
; [Found: C, 56.7; H, 6.2; N, 6.6; 
C10H13NO2S requires: C, 56.9; H, 6.3; N, 6.6]. 
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6.2.1.2  4-Methyl-N-prop-2-ynyl-benzenesulfonamide 200
237
 
 
Using the same procedure as 6.2.1.1, propagylamine (1.00 g, 
18.2 mmol), triethylamine (5.60 ml, 40.0 mmol) and p-
toluenesulfonyl chloride (3.47 g, 18.2 mmol) in 
dichloromethane (30 cm
3
) yielded 200 as an off-white solid (3.43 g, 16.4 mmol, 
90%). Rf (3:1 petrol:EtOAc) 0.31; mpt 77-78
 o
C, lit
237
 77-78 
o
C; max (cm
–1
) 3267, 
2858, 2596, 1436, 1320, 1156, 1091, 1066, 869, 813, 698; δH (300 MHz, CDCl3) 
7.71 (2H, d, JHH 8.1 Hz, Ar), 7.24 (2H, d, JHH 8.1 Hz, Ar), 4.74 (1H, br t, JHH 5.7, 
NH), 3.76 (2H, dd, JHH 5.7, 2.4 Hz, N-CH2), 2.36 (3H, s, CH3), 2.04 (1H, t, JHH 2.4 
Hz, CH); δC (75.5 MHz, CDCl3) 143.9 (Ar quaternary), 136.5 (Ar quaternary), 129.7, 
127.4 (Ar), 73.0 (CH), 32.9 (N-CH2), 21.6 (CH3);  m/z (EI) 209 [M]
+
; [Found: C, 
57.1; H, 5.3; N, 6.6; C10H11NO2S requires: C, 57.4; H, 5.3; N, 6.7]. 
 
6.2.1.3 N-Allyl-N-(2-bromo-2-methyl-propionyl)-4-methyl-
benzenesulfonamide 202
238
 
 
N-Allyl-4-methyl-benzenesulfonamide (2.11 g, 10.0 mmol) 
was dissolved in dry THF (100 cm
3
) and cooled to -78
o
C at 
which point n-BuLi (2.5 M in hexanes, 4.40 ml, 11.0 mmol) 
was added dropwise via syringe.  The reaction was allowed to proceed for 30 mins, 
2-bromoisobutyryl bromide (1.48 ml, 12.0 mmol) was added and the reaction was 
allowed to reach room temperature overnight.  The reaction was quenched with 
NH4Cl (10 cm
3
) and partitioned between NaHCO3 (200 cm
3
) and dichloromethane 
(200 cm
3
). The aqueous layer was extracted using dichloromethane (2 x 200 cm
3
).  
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The combined organic extracts were washed with brine (200 cm
3
), dried with 
MgSO4, filtered and concentrated in vacuo to yield a crude yellow oil as product.  
Purification was achieved via flash chromatography, eluting with 5:1 pet 
ether:EtOAc, monitored by TLC eluting with 3:1 hexane:EtOAc, to afford 202 as a 
pale yellow solid (1.80 g, 5.0 mmol, 50%); Rf (3:1 petrol:EtOAc) 0.73; mpt 82-84
 o
C, 
lit
238
 83-84 
o
C; max (cm
–1
) 2961, 2935, 2873, 1672, 1593, 1458, 1350, 1315, 1287, 
1187, 1117, 1086, 925, 717;  δH (300 MHz, CDCl3) 7.86 (2H, d, JHH 8.1 Hz, Ar), 
7.30 (2H, d, JHH 8.1 Hz, Ar), 5.98 (1H, ddt, JHH 17.1, 10.5, 4.8 Hz, CH=CH2), 5.39 
(1H, br d, JHH 17.1 Hz, CH=CH2), 5.38 (1H, br d, JHH 10.5 Hz, CH=CH2), 4.95 (2H, 
dt, JHH 4.8, 1.8 Hz, N-CH2), 2.43 (3H, s, CH3), 1.88 (6H, s, C(CH3)2); δC (75.5 MHz, 
CDCl3) 170.4 (C=O), 144.7 (Ar quaternary), 136.1 (Ar quaternary), 133.6 
(CH=CH2), 129.2, 128.9 (Ar), 118.2 (CH=CH2), 57.0 (C(CH3)2), 50.6 (N-CH2), 32.0 
(C(CH3)2), 21.7 (Ar-CH3); m/z (ESI) 361 ([M]
+
H); [Found: C, 46.8; H, 5.0; N, 3.9; 
C14H18BrNO3S requires: C, 46.6; H, 5.0; N, 3.9]. 
 
6.2.1.4  N-(2-bromo-2-methyl-propionyl)-4-methyl-N-prop-2-ynyl-
benzenesulfonamide 203
238
 
 
Using the same procedure as 6.2.1.3 4-methyl-N-prop-2-
ynyl-benzenesulfonamide (1.05 g, 5 mmol) dissolved in dry 
THF (50 cm
3
), n-BuLi (2.5M in hexanes, 2.20 ml, 5.5 mmol), 
and 2-bromoisobutyryl bromide (0.75 ml, 6.0 mmol) yielded a crude pale yellow oil.  
Purification was achieved via flash chromatography eluting with 5:1 pet ether: 
EtOAc, monitored by TLC eluting with 3:1 hexane:EtOAc, to afford 203 as a white 
solid (1.47 g, 4.1 mmol, 82%); Rf (3:1 petrol:EtOAc) 0.7; mpt 90-92 
o
C, lit
238
 92-93 
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o
C;  max (cm
–1
)  3293, 2934, 1678, 1594, 1457, 1350, 1170, 1084, 820; δH (300 MHz, 
CDCl3) 7.97 (2H, d, JHH 8.1 Hz, Ar), 7.31 (2H, d, JHH 8.1 Hz, Ar), 5.13 (2H, d, JHH 
2.4 Hz, N-CH2), 2.46 (1H, t, JHH 2.4 Hz, CH), 2.43 (3H, s, Ar-CH3), 1.94 (6H, s, 
C(CH3)2); δC (75.5 MHz, CDCl3) 169.7 (C=O), 145.0 (Ar quaternary), 135.6 (Ar 
quaternary), 129.3, 129.1 (Ar), 78.8 (CCH), 74.0 (CH), 56.7 (C(CH3)2), 37.8 (N-
CH2), 31.7 (C(CH3)2), 21.7 (Ar-CH3); m/z (EI) 359 ([M]
+
H); [Found: C, 47.2; H, 4.5; 
N, 3.9; C14H16BrNO3S requires: C, 46.9; H, 4.5; N, 3.9]. 
 
6.2.1.5  N-Allyl-N-benzylamine 205
239
 
 
Benzyl bromide (2.00 ml, 16.5 mmol) was added dropwise to a 
mixture of allylamine (6.18 ml, 80.7 mmol) and K2CO3 (2.70 g, 
19.4 mmol) forming a yellow suspension.  Reaction was allowed to proceed 
overnight.  The reaction mixture was filtered through a silica plug and washed with 
DCM (2 x 50 cm
3
), and the resulting organic filtrate was concentrated in vacuo.  The 
crude orange liquid was purified by gradient chromatography, eluting in 0-10% 
EtOAc in pet ether to yield 205 as a yellow liquid (1.00 g, 6.79 mmol, 41%).  Rf 
(50% EtOAc/petrol) 0.92; max (cm
–1
)
 
3254, 3027, 2809, 1495, 1453, 1359, 1105, 
1028, 993, 915, 732;  δH (300 MHz, CDCl3) 7.35-7.28 (5H, m, Ar), 5.96 (1H, ddt, 
JHH 17.1, 10.2, 6.0 Hz, CH=CH2), 5.22 (1H, ddt, JHH 17.1, 1.5, 1.2 Hz, CH=CH2), 
5.14 (1H, ddt, JHH 10.2, 1.5, 1.2 Hz, CHCH2), 3.82, (2H, s, ArCH2), 3.31 (2H, dt, JHH 
6.0, 6.0, 1.2 Hz, N-CH2), 1.46 (1H, br s, NH); δC (75 MHz, CDCl3) 139.7 
(quartenrary), 136.0 (CH=CH2) 128.8, 128.2, 126.9 (Ar), 117.4 (CH=CH2), 57.8 (N-
CH2), 56.4 (Ar-CH2); m/z (EI) 147 [M
+
]; [Found: [M
+
] 147.1052; C10H13N requires 
147.1048]. 
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6.2.1.6  N-(3-methyl-2-butenyl)-N-benzylamine 209
240
 
 
3,3-Dimethylallyl bromide (1.56 ml, 12.1 mmol) was added 
dropwise, via syringe, to stirring benzylamine (8.0 ml, 72.5 
mmol) at room temperature.  After 44 hrs the reaction 
mixture was diluted with water (50 cm
3
) and ether (50 cm
3
).  The resulting aqueous 
layer was extracted using ether (2 x 50 cm
3
) and the combined organic layers were 
washed with brine (50 cm
3
), dried over MgSO4, filtered and concentrated in vacuo.  
The crude liquid was purified via gradient chromatography eluting with 0-10% 
EtOAc in petrol to yield 209 as a pale yellow liquid (1.35 g, 7.8 mmol, 64%).  Rf 
(50% EtOAc/petrol) 0.23; max (cm
–1
) 3293, 2981, 1495, 1461, 1411, 1247, 1166, 
1108, 710, 696; δH (300 MHz, CDCl3) 7.34-7.27 (5H, m, Ar), 5.32 (1H, m, CH), 
3.81 (2H, s, ArCH2) 3.25 (2H, d, JHH 6.9 Hz, N-CH2), 1.75 (3H, s, C(CH3)), 1.64 
(3H, s, C(CH3)), 1.37 (1H, br s, NH); δC (75 MHz, CDCl3) 140.5 (Ar quaternary), 
134.5 (C(CH3)2), 128.4, 128.4, 126.9 (Ar), 123.0 (CH), 60.4 (N-CH2), 53.5 (Ar-CH2), 
25.8 (C(CH3)2), 21.1 (C(CH3)2); m/z (ESI) 176 ([M]
+
H); [Found: C, 81.7; H, 9.9; N, 
7.4; C12H17N requires: C, 82.2; H, 9.8; N, 7.9]. 
 
6.2.1.7  N-Benzyl-2-propynylamine 213
241
 
 
Using the same procedure as 6.2.1.5, propargyl bromide (3.75 
cm
3
, 33.6 mmol) and benzylamine (22.0 cm
3
, 201.3 mmol) 
furnished the crude product.  Gradient chromatography eluting with 0-10% EtOAc in 
pet ether was performed to yield 213 as a yellow liquid (3.01 g, 20.7 mmol, 62%).  
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Rf (50% EtOAc/petrol) 0.52; max (cm
–1
) 3291, 3063, 3030, 2923, 2817, 1495, 1453, 
1328, 1117, 740; δH (300 MHz, CDCl3) 7.27 (5H, m, Ar), 3.80 (2H, s, Ar-CH2), 3.35 
(2H, d, JHH 2.4 Hz, N-CH2), 2.18 (1H, t, JHH 2.4 Hz, CH), 1.46 (1H, br s, NH); δC (75 
MHz, CDCl3) 139.4 (Ar quaternary), 128.5 128.4 127.2 (Ar), 82.1 (CH2CCH), 71.6 
(CH2CCH), 52.3 (Ar-CH2), 37.3 (N-CH2); m/z (EI) 146.1 ([M]
+
H); [Found: 
146.0966; C10H12N requires: 146.0970]. 
 
6.2.1.8  N-Allyl-N-benzyl-N-2-bromo-2-methyl-propanamide 206 
 
N-Allyl-N-benzylamine (0.43 g, 2.9 mmol) was dissolved in 
Et2O (25 cm
3
) and cooled to 0
o
C at which point Et3N (0.70 cm
3
, 
5.0 mmol) was added.  After 20 mins 2-bromoisobutyryl 
bromide (0.36 cm
3
, 2.9 mmol) was added and the reaction mixture was allowed to 
reach room temperature.  After 4 hours the reaction was quenched with sat. NH4Cl 
(10 cm
3
) and partitioned between sat. NaHCO3 (50 cm
3
) and Et2O (50 cm
3
).  The 
organic layer was collected and the aqueous layer was extracted using Et2O (2 x 50 
cm
3
).  The combined organic extracts were dried over MgSO4, filtered and 
concentrated in vacuo to yield 206 as a colourless oil (0.72 g, 2.4 mmol, 84%).  Rf 
(50% EtOAc/petrol) 0.84; max (cm
–1
)
 
2980, 2932, 1633, 1495, 1463, 1410, 1169, 
1106, 925, 727, 696;  δH (300 MHz, CDCl3) 7.35 (5H, m, Ar), 5.83 (1H, br, CH) 
5.25 (1H, dd, JHH 10.3, 1.4 Hz, CH=CH2), 5.16 (1H, br d, JHH 17.9 Hz, CH=CH2), 
4.92 (2H, br, Ar-CH2), 4.24 (2H, br, N-CH2), 2.08 (6H, s, (CH3)2); δC (75.5, CDCl3) 
170.0 (C=O), 136.3 (Ar, quaternary), 132.3 (CH=CH2), 128.1, 127.8, 126.7 (Ar), 
115.6 (CH=CH2), 65.2 (C(CH3)2Br), 56.6 (N-CH2), 48.3 (Ar-CH2), 32.0 (CH3), 31.8 
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(CH3); m/z (ESI) 318 ([M]
+
Na) (
79
Br), 320 ([M]
+
Na) (
81
Br); [Found: 318.0465; 
C14H18
79
BrNNaO requires: 318.0469]. 
 
6.2.1.9  2-Bromo-2-methyl-N-benzyl-N-2-prenyl-propanamide 
 
Using the same procedure as 6.2.1.8 N-(3-methyl-2-butenyl)-
N-benzylamine (0.51 g, 2.9 mmol), Et3N (0.70 cm
3
, 5.0 mmol) 
and 2-bromoisobutyryl bromide (0.36 cm
3
, 2.9 mmol) in 
Et2O (25 cm
3
) produced a crude product which was purified by flash 
chromatography, eluting with 9:1 petrol-EtOAc to yield 210 as a pale yellow oil 
(0.83 g, 2.56 mmol, 88%).  Rf (50% EtOAc/petrol) 0.67; max (cm
–1
)
 
2974, 2931, 
1631, 1495, 1462, 1436, 1415, 1249, 1162, 1108, 726, 696;  δH (300 MHz, d8-Tol) 
7.23-7.15 (5H, m, Ar), 5.20 (1H, br, CH), 4.70 (2H, br, Ar-CH2), 4.14 (2H, br, N-
CH2), 1.88 (6H, s, C(CH3)2Br), 1.59 (3H, s, C(CH3)2), 1.31 (3H, s, C(CH3)2); δC 
(75.5, CDCl3) 169.8 (C=O), 136.8 (Ar, quaternary) 136.2 (C(CH3)2), 128.2, 128.0, 
126.9 (Ar), 119.3 (CH), 56.6 (C(CH3)2Br), 47.9 (Ar-CH2), 45.7 (N-CH2), 33.6 
(C(CH3)2Br), 33.4 (C(CH3)2Br), 26.7 (C(CH3)2), 19.8 (C(CH3)2); m/z (ESI) 346 
([M]
+
Na), 323 [M]
+
; [Found: C, 58.9; H, 6.8; N, 4.3; C16H22BrNO requires: C, 59.3; 
H, 6.8; N, 4.3]. 
 
6.2.1.10   2-Bromo-2-methyl-N-(phenylmethyl)-N-2-propynyl-propanamide 
215 
 
Using the same procedure as 6.2.1.8 N-benzyl-2-propynylamine 
(0.53 g, 3.65 mmol), Et3N (0.70 cm
3
, 5.0 mmol) and 2-
Chapter 6: Experimental 
 
188 
 
bromoisobutyryl bromide (0.45 cm
3
, 3.65 mmol) in Et2O (25 cm
3
) yielded 215 as a 
pale yellow oil (1.06 g, 3.61 mmol, 99%).  Rf (50% EtOAc/petrol) 0.91; max (cm
–1
) 
3289, 3006, 2980, 2932, 1636, 1495, 1462, 1411, 1246, 1168, 1107, 727; δH (300 
MHz, CDCl3) 7.30-7.26 (5H, m, Ar), 4.90 (2H, br, Ar-CH2), 4.30 (2H, br, N-CH2), 
2.04 (6H, s, C(CH3)2), 1.96 (1H, s, CH); δC (75.5 MHz, CDCl3) 136.1 (Ar, 
quaternary), 128.8, 128.2, 127.7 (Ar), 78.4, 65.9 (CC), 56.8 (C(CH3)2), 43.3 (Ar-
CH2), 32.7 (N-CH2), 32.2, 32.1 ((CH3)2); m/z (ESI) 294 ([M]
+
H) (
79
Br), 296 ([M]
+
H) 
(
81
Br); [Found: [M]
+
 294.0494; C14H17
79
BrNO requires 294.0490]. 
 
6.2.1.11   2-Bromo-2-methyl-N-benzyl-2-butynyl-propanamide 216 
 
1-Bromo-2-butyne (0.24 ml, 2.7 mmol) was added dropwise 
via syringe to stirring benzylamine (2.5 ml, 22.9 mmol) at 
room temperature.  Reaction was allowed to proceed for 44 
hrs after which time the reaction mixture was quenched with water (25 cm
3
) and 
ether (25 cm
3
).  The resulting aqueous layer was extracted using ether (2 x 25 cm
3
) 
and the combined organic extracts were washed with brine (25 cm
3
), dried over 
MgSO4, filtered and concentrated in vacuo.  A portion of the crude product (0.30 g, 
1.9 mmol) was dissolved in Et2O (20 cm
3
) and cooled to 0
o
C at which point Et3N 
(0.42 cm
3
, 3.0 mmol).  After 20 mins 2-bromoisobutyryl bromide (0.23 cm
3
, 1.9 
mmol) was added and the reaction mixture was allowed to reach room temperature.  
After 4 hours the reaction was quenched with sat. NH4Cl (10 cm
3
) and partitioned 
between sat. NaHCO3 (50 cm
3
) and Et2O (50 cm
3
).  The organic layer was collected 
and the aqueous layer was extracted using Et2O (2 x 50 cm
3
).  The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo to yield 216 as a 
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yellow oil (0.44 g, 1.4 mmol, 75%).  Rf (50% EtOAc/petrol) 0.86; max (cm
–1
) 3064, 
2981, 2930, 1495, 1450, 1409, 1163, 1118, 696; δH (300 MHz, CDCl3) 7.33-7.27 
(5H, m, Ar), 4.84 (2H, br, Ar-CH2), 4.29 (2H, br, N-CH2), 2.02 (6H, s, (CH3)2), 1.82 
(3H, t, JHH 2.3 Hz, CCH3); δC (75.5 MHz, CDCl3) 170.2 (C=O), 136.5 (Ar 
quaternary) 128.7, 127.6, 127.5 (Ar), 73.6, 73.5 (CC), 57.0 (Ar-CH2), 50.8 
(C(CH3)2Br), 46.0 (N-CH2), 32.7, 30.9 (C(CH3)2), 4.9 (CH3); m/z (ESI) 330 ([M]
+
Na) 
(
79
Br), 332 ([M]
+
Na) (
81
Br); [Found: C, 58.4; H, 5.9; N, 4.7; C15H18BrNO requires: C, 
58.5; H, 5.9; N ,4.5]. 
 
6.2.2  General Procedure for 1,4-DMP Mediated Radical Cyclisation  
 
The precursor (0.3-0.6 mmol) was dissolved in 1,4-DMP (2 cm
3
) at room 
temperature then heated under reflux at 65
o
C overnight.  The solvent was removed in 
vacuo and the resulting residue was dissolved in DCM (20 cm
3
) and washed with 
1M HCl (20 cm
3
).  The aqueous layer was extracted using DCM (2 x 20 cm
3
) and 
the combined organic extracts were washed with water (2 x 20 cm
3
), dried over 
MgSO4, filtered and concentrated in vacuo to isolate the crude product which was 
purified by flash chromatography eluting with 5:1/9:1 petrol-EtOAc. 
 
6.2.2.1  2-Methyl-N-[(4-methylphenyl)sulfonyl]-N-2-propenyl-2-
propenamide 217 
 
N-Allyl-N-(2-bromo-2-methyl-propionyl)-4-methylbenzenesulfon-
amide (200 mg, 0.56 mmol) was subject to the general procedure for 
1,4-DMP radical cyclisation (6.2.2).  Flash chromatography, eluting 
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with 5:1 pet ether/EtOAc yielded 217 as a white solid (134 mg, 0.48 mmol, 86%).  Rf 
(3:1 petrol:EtOAc) 0.48;  mpt 98-99 
o
C; max (film)/cm
–1 
2986, 2923, 1678, 1595, 
1495, 1454, 1422, 1341, 1329, 1158, 1087, 925. 732;  δH 7.82 (2H, d, JHH 8.1 Hz Ar-
H), 7.30 (2H, d, JHH 8.1 Hz Ar-H), 5.84 (1H, ddt, JHH 17.2, 10.2, 5.7 Hz, CH=CH2), 
5.24 (1H, dd, JHH 17.2, 1.5 Hz, CH=CH2) 5.22 (1H, dd, JHH 10.2, 1.5 Hz, CH=CH2), 
5.20 (1H, d, JHH 1.5 Hz C=CH2), 5.18 (1H, d, JHH 1.5 Hz C=CH2), 4.44 (2H, dt, JHH 
5.7, 1.5 Hz, N-CH2), 2.42 (3H, s, Ar-CH), 1.90 (3H, t, JHH 1.5 Hz, C(CH3)CH2); δC 
(75.5 MHz, CDCl3) 171.5 (C=O), 144.4 (C(CH3)CH2), 139.7, 135.7 (Ar quaternary), 
132.3 (CH=CH2), 128.9, 127.9 (Ar), 118.4, 117.9 (=CH2), 46.8 (N-CH2), 21.0 (Ar-
CH3), 19.9 (CH3); m/z (EI) 279 [M]
+
; [Found [M]
+
 279.0931; C14H17NO3S requires 
279.0929]. 
 
6.2.2.2  2-Methyl-N-[(4-methylphenyl)sulfonyl]-N-2-propynyl-2-
propenamide 220 
 
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-prop-2-ynyl-benzene-
sulfonamide (200 mg, 0.56 mmol) was subject to the general 
procedure for 1,4-DMP radical cyclisation (6.2.2). Flash 
chromatography eluting with 5:1 pet ether/EtOAc yielded 220 as a white solid (121 
mg, 0.42 mmol, 78%).  Rf (3:1 petrol:EtOAc) 0.42;  mpt 100-102 
o
C; max (cm
–1
) 
3294, 2904, 1669, 1595, 1450, 1359, 1187, 1064, 820; δH 7.85 (2H, d, JHH 8.1 Hz, 
Ar-H), 7.25 (2H, d, JHH 8.1 Hz, Ar-H), 5.26 (1H, d, JHH 1.5 Hz, C=CH2), 5.14 (1H, d, 
JHH 1.5 Hz, C=CH2), 4.58 (2H, d, JHH 2.4 Hz, N-CH2), 2.37 (3H, s, Ar-CH3), 2.25 
(1H, t, JHH 2.4 Hz, CH), 1.84 (3H, s, CCH3); δC (75.5 MHz, CDCl3) 164.1 (C=O), 
139.9 (C(CH3)CH2), 137.3, 136.1 (Ar, quaternary), 129.5, 128.7 (Ar,), 79.1, 76.2 
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(CC), 36.6 (N-CH2), 21.8, 19.6 (CH3); m/z (ESI) 278 ([M]
+
H); [Found: C, 60.2; H, 
5.6; N, 5.0; C14H15NO3S requires: C, 60.6; H, 5.4; N, 5.1]. 
 
6.2.3  General Procedure for 1,4-DMP Mediated Radical Cyclisation 
Using the Freeze-Pump-Thaw Technique 
 
1,4-DMP was thoroughly degassed using the freeze-pump-thaw and experiments 
were performed on Schlenk line under a nitrogen atmosphere.  The precursor (0.3-
0.6 mmol) was dissolved in dry 1,4-DMP (2 cm
3
) at room temperature then heated 
under reflux at 65
o
C overnight.  The solvent was removed in vacuo and the resulting 
residue was dissolved in DCM (20 cm
3
) and washed with 1M HCl (20 cm
3
).  The 
aqueous layer was extracted using DCM (2 x 20 cm
3
) and the combined organic 
extracts were washed with water (2 x 20 cm
3
), dried over MgSO4, filtered and 
concentrated in vacuo to isolate the crude product which was purified by flash 
chromatography eluting with 5:1/9:1 petrol-EtOAc. 
 
6.2.3.1  3,3-Dimethyl-4-bromomethyl-1-(p-toluenesulfonyl)-pyrrolidin-2-
one 218,
238 
3,3,-Dimethyl-4-methyl-1-[(4-methylphenyl)sulfonyl]-
2-pyrrolidinone 219
238
 
 
N-Allyl-N-(2-bromo-2-methyl-propionyl)-4-
methyl-benzenesulfonamide (200 mg, 0.56 
mmol) was subject to the general procedure for 
1,4-DMP radical cyclisation under inert conditions (6.2.3).  Flash chromatography 
eluting with 5:1 petrol:EtOAc yielded a 1 : 3 mixture of 218 and 219.  Further 
Chapter 6: Experimental 
 
192 
 
purification by flash chromatography eluting with 9:1 petrol:EtOAc allowed 
isolation of pure samples of 218 and 219.    
 
218 isolated as a white solid (39 mg, 0.11 mmol, 20%); mpt 131-132 
o
C, lit
55
 132-
133 
o
C;  Rf (3:1 petrol:EtOAc) 0.41; max (cm
–1
) 2972, 1724, 1596, 1480, 1354, 1169, 
1118 1090; δH (300 MHz, CDCl3) 7.90 (2H, d, JHH 8.1 Hz, Ar), 7.20 (2H, d, JHH 8.1 
Hz, Ar), 4.10 (1H, dd, JHH 10.6, 7.2 Hz, N-CH2), 3.40 (1H, dd, JHH 10.4, 6.9 Hz 
(CH2Br), 3.38 (1H, t, JHH 10.4 Hz (CH2Br), 3.10 (1H, t, JHH 10.6 Hz, N-CH2), 2.42 
(1H, m, CH), 2.40 (3H, s, Ar-CH3), 1.10 (3H, s, C(CH3)2), 0.80 (3H, s, C(CH3)2); δC 
(75.5 MHz, CDCl3) 176.9 (C=O), 145.4, 134.8 (Ar, quaternary), 129.8, 128.0 (Ar), 
48.8 (C(CH3)2), 45.4 (CH), 45.0 (N-CH2), 29.9 (CH2Br). 23.4 (Ar-CH3). 21.7 (CH3), 
17.8 (CH3); m/z (ESI) 360.0 ([M]
+
H) (
79
Br), 362 ([M]
+
H) (
81
Br); [Found: C, 47.1; H, 
5.0; N, 3.8; C14H18BrNO3S requires: C, 46.7; H, 5.0; N, 3.9]. 
 
219 isolated as a white solid (115 mg, 0.41 mmol, 57%); mpt 135-136, lit
238
 136-138 
o
C;  Rf (3:1 petrol:EtOAc) 0.59; δH (300 MHz, CDCl3) 7.89 (2H, d, JHH 8.1 Hz, Ar-
H), 7.32 (2H, d, JHH 8.1 Hz, Ar-H), 3.97 (1H, dd, JHH 10.0, 7.5 Hz, N-CH2), 3.26 
(1H, t, JHH 10.0 Hz, N-CH2), 2.43 (3H, s, Ar-CH3), 1.92 (1H, m, CH), 1.05 (3H, s, 
CH3), 0.96 (3H, d, JHH 6.9 Hz, CH3), 0.79 (3H, s, CH3);  δC (75.5 MHz, CDCl3) 
177.8 (C=O), 144.4, 134.5 (Ar, quaternary), 129.0, 127.3 (Ar), 50.0 (CH2), 44.3 
(C(CH3)2), 37.0 (CHCH3), 21.1 (C(CH3)2), 20.7 (Ar-CH3), 16.7 (C(CH3)2), 11.1 
(CH3); m/z (ESI) (Found 304.1 [M+Na]
+
, requires 281.11 [M]
+
); [Found [M]
+
 
304.0981; C14H19NNaO3S requires 304.0983]. 
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6.2.3.2  3,3-Dimethyl-4-methylene-1-[(4-methylphenyl)sulfonyl]-
pyrrolidin-2-one 221
238
 
 
N-(2-bromo-2-methyl-propionyl)-4-methyl-N-prop-2-ynyl benzene-
sulfonamide (200 mg, 0.56 mmol) was subject to the general procedure 
for 1,4-DMP radical cyclisation under inert conditions (6.2.3).  Flash 
chromatography eluting with 5:1 pet ether/EtOAc yielded 221 as a white solid (128 
mg, 0.46 mmol, 82%);  Rf (3:1 petrol:EtOAc) 0.48; mpt 103-105 
o
C, lit
238
 104-106 
o
C;  max (cm
–1
)
 
2970, 1731, 1596, 1494, 1463, 1360, 1340, 1166, 1118, 1090, 813;  
δH (300 MHz, CDCl3) 7.75 (2H, d, JHH 8.1 Hz, Ar), 7.16 (2H, d, JHH 8.1 Hz, Ar), 
4.90 (1H, dt, JHH 1.5, 1.5 Hz, C=CH2), 4.88 (1H, dt, JHH 1.5, 1.5 Hz, C=CH2),  4.28 
(2H, t, JHH 1.5 Hz, N-CH2), 2.25 (3H, s, Ar-CH3), 1.0 (6H, s, C(CH3)2); δC (75.5 
MHz, CDCl3) 176.9 (C=O), 145.3 (C=CH2), 145.2, 135.0 (Ar quaternary), 129.7, 
128.0 (Ar), 108.5 (C=CH2), 49.3 (C(CH3)2), 46.1 (N-CH2), 24.4 (Ar-CH3), 21.7 
((CH3)2); m/z (ESI) 302 ([M]
+
Na); [Found: 302.0870, 5.0; C14H17NNaO3S requires: 
302.0873]. 
 
6.2.3.3  2-Methyl-N-(phenylmethyl)-N-2-propenyl-2-propenamide 229  
 
 N-Allyl-N-(phenylmethyl)-N-2-bromo-2-methyl propanamide (100 
mg, 0.34 mmol) was subject to the general procedure for 1,4-DMP 
radical cyclisation under inert conditions (6.2.3).  Flash 
chromatography eluting with 9:1 pet ether/ETOAc yielded 229 as a colourless oil 
(4.0 mg, 20.4 μmol, 6 %); Rf (3:1 petrol:EtOAc) 0.50; δH (300 MHz, CDCl3) 7.32-
7.25 (5H, m, Ar-H), 5.73 (1H, br, CH=CH2), 5.19 (2H, br, C(CH3)CH2), 5.12 (1H, 
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dd, JHH 14.7, 1.0 Hz, CHCH2), 5.09 (1H, dd, JHH 7.7, 1.0 Hz, CHCH2), 4.60 (2H, s, 
Ar-CH2), 3.92 (2H, br, CH2) 1.99 (3H, s, CH3); δC (75.5 MHz, CDCl3) 172.3 (C=O), 
140.0 (C(CH3)CH2), 132.6 (Ar, quaternary), 128.1, 127.6, 126.8 (Ar), 117.2 
(C(CH3)CH2), 115.1 (CHCH2), 49.8 (Ar-CH2), 45.6 (CH2), 20.2 (CH3); [Found: 
215.1315, C14H17NO requires: 215.1310]. 
 
6.2.3.4 3,3-Dimethyl-4-bromomethyl-1-(phenylmethyl)-pyrrolidin-2-one 
233 
 
N-Allyl-N-(phenylmethyl)-N-2-bromo-2-meth-yl-propanamide 
(100 mg, 0.34 mmol) was subject to the general procedure for 1,4-
DMP radical cyclisation under inert conditions (6.2.3).  Flash 
chromatography eluting with 9:1 pet ether/EtOAc yielded 233 as a colourless oil (1 
mg, 0.0034 mmol, 1%).  Due to insufficient yields data was collected following 
reactions in chapter 3 (section 6.2.6.1). 
 
6.2.3.5  2-Methyl-N-(phenylmethyl)-N-2-prenyl-propenamide 230 
 
2-Bromo-2-methyl-N-benzyl-N-2-prenyl propanamide (100 mg, 
0.31 mmol) was subject to the general procedure for 1,4-DMP 
radical cyclisation under inert conditions (6.2.3).  Flash 
chromatography eluting with 9:1 pet ether/EtOAc afforded 230 as a 
pale yellow oil (10 mg, 0.04 mmol, 13%).  Rf (3:1 petrol:EtOAc) 0.50; max (cm
–1
) 
3029, 2923, 1659, 1495, 1417, 1185, 925, 734; δH (300 MHz, CDCl3) 7.33-7.25 (5H, 
m, Ar), 5.16 (1H, br, CH=C(CH3)2), 5.09 (2H, br, C(CH)3CH2), 4.57 (2H, s, Ar-CH2), 
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3.92 (2H, br, CH2), 2.00 (3H, s, C(CH3)CH2), 1.72 (3H, s, CH3), 1.50 (3H, s, CH3); 
δC (75.5 MHz, CDCl3) 173.5 (C=O) 141.2 (C(CH3)CH2), 139.9 (Ar, quaternary), 
133.7 (C(CH3)2), 128.6, 128.1, 127.3 (Ar), 115.0 (C(CH3)CH2), 48.7 (Ar-CH2), 46.3 
(CH2), 25.8 (CH3), 20.8, 18.3 (C(CH3)2); m/z (ESI) 244 ([M]
+
H); [Found: ([M]
+
H) 
244.1696, C16H23NO requires, 244.1701]. 
 
6.2.3.6  2-Methyl-N-(phenylmethyl)-N-2-propynyl-2-propenamide 231 
 
2-Bromo-2-methyl-N-(phenylmethyl)-N-2-propynyl propanamide (100 
mg, 0.34) was subject to the general procedure for 1,4-DMP radical 
cyclisation under inert conditions (6.2.3).  Flash chromatography 
eluting with 9:1 pet ether/EtOAc yielded 231 as a colourless oil (50 mg, 0.23 mmol, 
69%).  Rf (3:1 petrol:EtOAc) 0.45; max (cm
–1
) 3280, 3031, 2923, 1647, 1495, 1449, 
1415, 1252, 1206, 925, 733; δH (300 MHz, CDCl3) 7.35-7.28 (5H, m, Ar), 5.25 (2H, 
br, C(CH3)CH2), 4.75 (2H, s, Ar-CH2), 4.06 (2H, br, CH2), 2.27 (1H, s, CCH), 2.02 
(3H, s, CH3); δC (75.5 MHz, CDCl3) 172.8 (C=O) 140.0 (C(CH3)CH2), 137.5 (Ar, 
quaternary), 128.8, 127.8, 127.4 (Ar), 116.2 (C(CH3)CH2), 78.5 (CCH), 73.2 (CCH), 
49.8 (Ar-CH2), 32.7 (CH2), 20.5 (CH3); m/z (ESI) 214 ([M]
+
H); [Found: ([M]
+
H) 
214.1228, C14H17NO requires, 214.1232]. 
 
6.2.3.7  2-Methyl-N-(phenylmethyl)-2-butynyl-propenamide 232 
 
2-Bromo-2-methyl-N-benzyl-2-butynyl-propanamide (100 mg, 0.33 
mmol) was subject to the general procedure for 1,4-DMP radical 
cyclisation under inert conditions (6.2.3).  Flash chromatography 
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eluting with 9:1 pet ether/EtOAc yielded 232 as a yellow oil (53 mg, 0.23 mmol, 
70%).  Rf (3:1 petrol:EtOAc) 0.57; max (cm
–1
) 3064, 3032, 2920, 1648, 1495, 1452, 
1421, 1360, 1191, 698; δH (300 MHz, CDCl3) 7.33-7.28 (5H, m, Ar), 5.22 (2H, br, 
C(CH3)CH2), 4.73 (2H, s, Ar-CH2), 4.04 (2H, br, CH2), 2.01 (3H, s, CH3), 1.82 (3H, 
s, CCH3); δC (75.5 MHz, CDCl3) 174.1 (C=O) 140.2 (C(CH3)CH2), 136.6 (Ar, 
quaternary), 128.7, 127.6, 127.1 (Ar), 115.9 (C(CH3)CH2), 72.8 (CC), 72.0 (CC), 
46.7 (Ar-CH2), 37.9 (CH2), 20.6 (C(CH3)CH2), 3.8 (CH3); m/z (ESI) 250 ([M]
+
Na); 
[Found: ([M]
+
Na) 250.1203, C15H17NNaO requires 250.1208]. 
 
6.2.3.8 N-Allyl-N-(2-methyl-propionyl)-4-methyl-benzenesulfonamide 
225
242
 
 
N-Allyl-N-(2-bromo-2-methyl-propionyl)-4-methyl benzenesulfonami-
de (100 mg, 0.28 mmol) was subject to the general procedure for 1,4-
DMP radical cyclisation under inert condition with the addition of 
diethyl phospite (43 μl, 0.34 mmol).  Flash chromatography eluting with 9:1 
petrol/ETOAc afforded 225 as a white solid (32 mg, 0.11 mmol, 41%). Data match 
those of previously published work.
242
 
 
6.2.4  1,4-DMP Mediated Radical Cyclisation in a Microwave 
 
The precursor (0.2-0.2 mmol) was dissolved in degassed and dried 1,4-DMP (1.5 
cm
3
) at room temperature then heated in a microwave 1 h.  The solvent was removed 
in vacuo and the resulting residue was dissolved in DCM (20 cm
3
) and washed with 
1M HCl (20 cm
3
).  The aqueous layer was extracted using DCM (2 x 20 cm
3
) and 
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the combined organic extracts were washed with water (2 x 20 cm
3
), dried over 
MgSO4, filtered and concentrated in vacuo to isolate the crude product which was 
purified by flash chromatography eluting with 9:1 pet ether/EtOAc. 
 
1,4-DMP mediated radical cyclisation of N-allyl-N-(phenylmethyl)-N-2-bromo-2-
methyl-propanamide (50 mg, 0.17 mmol) in a microwave yielded 229 (7 mg, 0.03 
mmol, 20%) and 233 (2 mg, 6.75 µmol, 4%).  The data obtained match those 
reported in 6.2.3.3 and 6.2.3.4 respectively. 
 
1,4-DMP mediated radical cyclisation of 2-bromo-2-methyl-N-(phenylmethyl)-N-2-
propynyl-propanamide (100 mg, 0.25 mmol) in a microwave yielded 231 (26 mg, 
0.12 mmol, 47%) and 235.  The data obtained for 231 matched that reported in 
6.2.3.6 and the data for 235 is reported in 6.2.4.1. 
 
6.2.4.1  3,3-Dimethyl-4-methylene-1-(phenylmethyl)-2-pyrrolidinone 235  
 
2-Bromo-2-methyl-N-(phenylmethyl)-N-2-propynyl propanamide (75 
mg, 0.34 mmol) was subject to the general procedure for 1,4-DMP 
radical cyclisation carried out in a microwave.  The parameters were 
set at T = 130 
o
C, t = 1 hr, power was set to 300 W and the pressure limit was set at 
20 bar.  Flash chromatography eluting with 9:1 pet ether/EtOAc afforded 235 as a 
pale yellow oil (35 mg, 0.16 mmol, 47 %).  Rf (3:1 petrol:EtOAc) 0.59; max (cm
–1
) 
3066, 2966, 2926, 1693, 1495, 1475, 1455, 1425, 1359, 1255, 1166, 698; δH (300 
MHz, CDCl3) 7.32-7.27 (5H, m, Ar-H), 5.03 (1H, dt, JHH 2.4, 1.5 Hz, C=CH2), 4.96 
(1H, dt, JHH 2.4, 1.5 Hz, C=CH2), 4.51 (2H, s, Ar-CH2), 3.82 (2H, t, JHH 1.5 Hz, 
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CH2), 1.27 (6H, s, (CH3)2); δC (75.5 MHz, CDCl3) 177.5 (C=O) 148.8 (CCH2), 136.3 
(Ar, quaternary), 128.8, 128.1, 127.6 (Ar), 106.7 (C=CH2), 49.7 (C, quaternary), 
46.2 (Ar-CH2), 44.5 (CH2), 25.2, 25.0 (CH3); m/z (ESI) 214 ([M]
+
H); [Found: 
([M]
+
H) 214.1228, C14H17NO requires, 214.1232]. 
 
6.2.5  General Procedure for Substrates Synthesised in Chapter 3 
 
6.2.5.1  2-Bromo-N-[(4-methylphenyl)sulfonyl]-N-2-propenyl-
propanamide 252
55
  
 
Using the same procedure as 6.2.1.3, N-allyl-4-methyl-
benzenesulfonamide (2.00 g, 9.5 mmol) in dry THF (75 cm
3
), 
n-BuLi (1.6 M, 9.40 cm
3
, 15.0 mmol) and 2-bromopropionyl 
bromide (1.57 cm
3
, 15.0 mmol) furnished the crude product which was purified by 
flash chromatography eluting with 5:1 pet ether/EtOAc to yield 252 as a white solid 
(1.12 g, 3.2 mmol, 34%); Rf (3:1 petrol:EtOAc) 0.65; mpt 40-41, lit
55
 39-40; max 
(cm
–1
)
 
2931, 2835, 2823, 1652, 1595, 1438, 1348, 1310, 1217, 1157, 1107, 925, 717;  
δH (300 MHz, CDCl3) 7.84 (2H, d, JHH 8.0 Hz, Ar-H), 7.32 (2H, d, JHH 8.0 Hz, Ar-
H), 5.91 (1H, m, CH), 5.26 (1H, d, JHH 6.7, 2.4 Hz, CH=CH2), 5.21 (1H, br, 
CH=CH2), 4.83 (1H, q, JHH 6.6 Hz, CH(Br)CH3), 4.69 (1H, ddt, JHH 17.5, 4.7, 1.8 Hz, 
N-CH2), 4.40 (1H, ddt, JHH 17.5, 4.7, 1.8 Hz, N-CH2), 2.43 (3H, s, Ar-CH3), 1.72 
(3H, d, JHH 6.6 Hz, CH3); δC (75.5 MHz, CDCl3) 169.4 (C=O), 145.3, 135.6 (Ar 
quaternary), 132.7 (CHCH2), 129.7, 128.3 (Ar), 118.0 (CHCH2), 48.7 (CHCH3Br), 
39.6 (CH2), 21.2 (Ar-CH3), 20.4 (CH3); m/z (ESI) 368 ([M]
+
Na) (
79
Br), 370 ([M]
+
Na) 
(
81
Br); [Found: ([M]
+
Na) 369.9920; C13H16
81
BrNNaO3S requires 369.9911]. 
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6.2.5.2  2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-2-prenyl-
propanamide 249 
 
p-Toluenesulfonamide (3.40 g, 20.0 mmol) was added to a 
suspension of K2CO3 (2.80 g, 20.0 mmol) in acetone (100 
cm
3
) at room temperature.  The reaction was allowed to 
proceed for 15 mins, after which time 3,3-dimethylallyl 
bromide (2.50 g, 16.1 mmol) was added.  The reaction was stirred and heated at 
reflux overnight.  The acetone was removed in vacuo and the resulting residue was 
dissolved an in ether/water mixture (50 cm
3
 each).  The organic layer was collected 
and the aqueous was extracted using ether (2 x 50 cm
3
).  The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo to yield the 
crude product 4-methyl-N-(3-methyl-2-buten-1-yl)-benzenesulfonamide, a portion of 
which (1.27 g, 5.3 mmol) was dissolved in dry THF and taken to -78 
o
C at which 
point n-BuLi (1.6 M in hexanes, 3.75 ml, 6.0 mmol) was added.  The reaction was 
allowed to proceed for 30 mins after which time 2-bromoisbutyryl bromide (0.87 ml, 
7.0 mmol) was added.  The reaction was allowed to reach room temperature 
overnight.  The reaction was quenched with sat. NH4Cl (10 cm
3
) and partitioned 
between sat. NaHCO3 (100 cm
3
) and DCM (100 cm
3
).  The organic layer was 
collected and the aqueous layer extracted using DCM (2 x 100cm
3
).  The combined 
organic extracts were washed with brine (100 cm
3
), dried over MgSO4, filtered and 
concentrated in vacuo to yield a crude product which was purified by flash 
chromatography eluting 5:1 pet ether/EtOAc to yield 249 as a white solid (1.07 g, 
2.8 mmol, 53 %).  Rf (3:1 pet ether:EtOAc) 0.64;  mpt 86-88 
o
C; max (cm
–1
) 3000, 
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2969, 2934, 1676, 1595, 1493, 1462, 1445, 1356, 1292, 1164, 1146, 1076, 823, 706;  
δH (300 MHz, CDCl3) 7.84 (2H, d, JHH 8.1 Hz, Ar-H), 7.28 (2H, d, JHH 8.1 Hz, Ar-
H), 5.22 (1H, m, CHC(CH3)2), 4.89 (2H, d, JHH 6.0 Hz, N-CH2), 2.42 (3H, s, Ar-
CH3), 1.90 (6H, s, C(CH3)2Br), 1.77 (3H, s, CH3), 1.75 (3H, s, CH3); δC (75.5 MHz, 
CDCl3) 170.2 (C=O), 143.9, 135.6 (Ar, quaternary), 135.9 (C(CH3)2), 128.5, 128.3 
(Ar), 119.9 (CH), 56.2 (C(CH3)2Br), 46.8 (N-CH2), 31.2, 31.1 (C(CH3)2Br), 25.0, 
17.8 (CH3)2), 21.1 (Ar-CH3); m/z (ESI) 410 ([M]
+
Na) (
79
Br), 412 ([M]
+
Na) (
81
Br); 
[Found: ([M]
+
Na) 410.0396; C16H22
79
BrNNaO3S requires 410.0401]. 
 
6.2.5.3  2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-2-crotyl-
propanamide 250 
 
Using the same procedure as 6.2.5.2, p-toluenesulfonamide 
(1.37 g, 8.0 mmol), K2CO3 (1.38 g, 10.0 mmol) and crotyl 
bromide (85 %), (1.00 g, 6.3 mmol) in acetone (50 cm
3
) at 
room temperature furnished a crude product 4-methyl-N-
(3-methyl-2-buten-1-yl)-benzenesulfonamide (0.71 g, 3.2 mmol).  This was 
dissolved in dry THF (50 cm
3
) addition of n-BuLi (1.6 M in hexanes, 2.5 ml, 4.0 
mmol) and 2-bromoisobutyryl bromide (0.5 ml, 4.0 mmol) yielded a crude product 
which was purified by flash chromatography eluting 5:1 pet ether/EtOAc to 250 as a 
white solid (0.69 g, 1.8 mmol, 56 %).  Rf (3:1 pet ether:EtOAc) 0.64;  mpt 80-81 
o
C; 
max (cm
–1
) 2938, 1677, 1595, 1494, 1461, 1393, 1349, 1316, 1167, 1118, 1086, 812, 
693;  δH (300 MHz, CDCl3) 7.78 (2H, d, JHH 8.1 Hz, Ar-H), 7.23 (2H, d, JHH 8.1 Hz, 
Ar-H), 5.78 (1H, m, CHCH3), 5.52 (1H, m, CHCH2), 4.79 (2H, d, JHH 5.4 Hz, N-
CH2), 2.36 (3H, s, Ar-CH3). 1.83 (6H, s, (CH3)2), 1.67 (3H, dd, JHH 6.3, 1.2 Hz, 
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CHCH3); δC (75.5, CDCl3) 170.0 (C=O), 144.0, 135.7 (Ar, quaternary), 129.6 
(CHCH2), 128.5, 128.3 (Ar), 125.5 (CH2CH), 49.6 (C(CH3)2Br), 45.6 (N-CH2), 31.4, 
31.1 ((CH3)2), 21.1 (Ar-CH3), 17.2 (CHCH3); m/z (ESI) 396 ([M]
+
Na) (
79
Br), 398 
([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 396.0239; C15H20
79
BrNNaO3S requires 
396.0245].   
 
6.2.5.4  2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-2-cinnamyl-
propanamide 251 
 
Using the same procedure as 6.2.5.2, p-
toluenesulfonamide (1.37 g, 8.0 mmol), K2CO3 (1.38 
g, 10.0 mmol) and cinnamyl chloride (1.00 g, 6.2 
mmol) in acetone (50 cm
3
) at room temperature 
furnished the crude product, 4-methyl-N-(3-phenyl-2-propenyl) benzenesulfonamide 
(0.45 g, 1.6 mmol).  This was dissolved in dry THF (50 cm
3
) and addition of n-BuLi 
(1.6 M in hexanes, 1.25 ml, 2.0 mmol) and 2-bromoisobutyryl bromide (0.25 ml, 2.0 
mmol) yielded a crude product which was purified by flash chromatography eluting 
5:1 pet ether/EtOAc to give 251 as a white solid (0.40 g, 0.9 mmol, 56 %).  Rf (3:1 
pet ether:EtOAc) 0.62;  mpt 101-102 
o
C; max (cm
–1
) 2968, 2923, 1676, 1595, 1445, 
1392, 1356, 1291, 1164, 1076, 823, 658; δH (300 MHz, CDCl3) 7.88 (2H, d, JHH 8.4 
Hz, Ar-H), 7.30 (7H, m, Ar-H), 6.69 (1H, dt, JHH 16.2, 1.2 Hz, CHPh), 6.25 (1H, dt, 
JHH 16.2, 5.7 Hz, CHCH2), 5.11 (2H, dd, JHH 5.7, 1.2 Hz, N-CH2), 2.41 (3H, s, Ar-
CH3), 1.94 (6H, s, (CH3)2); δC (75.5 MHz, CDCl3) 170.6 (C=O), 144.7, 136.2, 136.0 
(Ar, quaternary), 133.6 (CH2CH), 129.2, 129.1, 128.7, 128.1, 126.6 (Ar), 124.4 
(CHPh), 56.9 (C(CH3)2Br), 50.5 (N-CH2), 32.0 ((CH3)2), 21.7 (Ar-CH3); m/z (ESI) 
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458 ([M]
+
Na) (
79
Br), 460 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 458.0396; 
C20H22
79
BrNNaO3S requires 458.0401].   
 
6.2.6  General Procedure for Copper Mediated ATRC Using AIBN 
  in Chapter 3 
 
The precursor (0.20-0.31 mmol) was dissolved in DCM (0.12 M) at room 
temperature.  A solution (0.01 M) of CuBr/TPA (1.0 mol%) was added followed by 
AIBN (10 mol%).  The reaction mixture was then heated at reflux for 1-24 h.  The 
mixture was allowed to cool to room temperature and filtered through a silica plug 
using DCM (50 ml).  The filtrate was dried over MgSO4, filtered and concentrated in 
vacuo to isolate the crude product which was purified by flash chromatography 
eluting with 5:1/9:1 petrol-EtOAc. 
 
Following the general procedure, precursor 202 (100 mg, 0.28 mmol) was cyclised 
to give 218 (95 mg, 0.27 mmol, 95%). 
 
6.2.6.1 3,3-Dimethyl-4-bromomethyl-1-(phenylmethyl)-pyrrolidin-2-one 
233 
 
N-Allyl-N-(phenylmethyl)-N-2-bromo-2-methyl-propanamide (100 
mg, 0.34 mmol) was subjected to the general procedure for copper-
mediated ATRC using AIBN (6.2.6).  Flash chromatography 
eluting with 9:1 pet ether/EtOAc yielded 233 as a colourless oil (84 mg, 0.29 mmol, 
84%); Rf (3:1 petrol:EtOAc) 0.30; υmax 2964, 2929, 1684, 1427, 1269, 699 cm
-1; δH 
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(300 MHz, CDCl3) 7.34-7.27 (5H, m, Ar), 4.52 (1H, d, JHH 14.4 Hz, Ar-CH2), 4.35 
(1H, d, JHH 14.4 Hz, Ar-CH2), 3.46 (1H, dd, JHH 10.0, 4.8 Hz, CH2Br), 3.35 (1H, dd, 
JHH 10.0, 7.5 Hz, N-CH2), 3.22 (1H, t, JHH 10.0 Hz, CH2Br), 2.88 (1H, t, JHH 10.0 Hz, 
N-CH2), 2.40 (1H, m, CHCH2Br), 1.24 (3H, s, CH3), 0.99 (3H, s, CH3); δC (75.5 
MHz, CDCl3) 178.5 (C=O), 136.3 (Ar, quaternary), 128.8, 128.1, 127.7 (Ar), 48.9 
(C(CH3)2), 46.7 (Ar-CH2), 46.1 (N-CH2), 44.0 (CH(CH2Br), 31.5 (CH2Br), 24.3 
(CH3), 19.6 (CH3); [Found: 318.0464, C14H18NNaO
79
Br requires: 318.0469]. 
 
6.2.6.2  3,3-Dimethyl-4-(2-bromo)isopropyl-1-(p-toluenesulfonyl)-
pyrrolidin-2-one 253  
 
2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-2-prenyl-
propanamide (100 mg, 0.26 mmol) was subjected to the general 
procedure for copper-mediated ATRC using AIBN (6.2.6).  Flash 
chromatography eluting with 5:1 pet ether/EtOAc yielded 253 as 
a white solid (100 mg, 0.26 mmol, 100%);  Rf (3:1 pet 
ether:EtOAc) 0.60; mpt 118-119 
o
C; max (cm
–1
) 2970, 2922, 1720, 1595, 1485, 1465, 
1355, 1257, 1229, 1118, 1090, 817, 759, 668; δH (300 MHz, CDCl3) 7.92 (2H, d, JHH 
8.2 Hz, Ar-H), 7.34 (2H, d, JHH 8.2 Hz, Ar-H), 4,15 (1H, dd, JHH 10.0, 7.6 Hz, N-
CH2), 3.80 (1H, t, JHH 10.0 Hz, N-CH2), 2.43 (3H, s, Ar-CH3), 2.27 (1H, dd, JHH 
10.0, 7.6 Hz, CH), 1.86 (3H, s, C(CH3)2Br), 1.84 (3H, s, C(CH3)2Br),  1.28 (3H, s, 
C(CH3)2), 1.05 (3H, s, C(CH3)2); δC (75.5 MHz, CDCl3) 177.1 (C=O), 145.3, 134.6 
(Ar, quaternary), 129.8, 128.0 (Ar), 65.2 (C(CH3)2Br), 54.9 (N-CH2), 47.7 (CH), 
46.7 (C(CH3)2), 35.9, 32.9, 26.1, 21.8, 18.9 (CH3); m/z (ESI) 410 ([M]
+
Na) (
79
Br), 
412 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 410.0396, C20H22
79
BrNNaO3S requires 
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410.0401]; [Found: C, 50.3; H, 5.8; N, 3.5; C20H22BrNNaO3S requires C, 49.5; H, 
5.7; N, 3.6]. 
 
6.2.6.3  3,3-Dimethyl-4-(1-bromo)ethyl-1-(p-toluenesulfonyl) pyrrolidin-2-
one 254 
 
2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-2-crotyl-
propanamide (100 mg, 0.27 mmol), was subjected to the general 
procedure for copper-mediated ATRC using AIBN (6.2.6).  Flash 
chromatography eluting with 5:1 pet ether/EtOAc yielded 254 as 
a white solid, as a 3.5 : 1.0 mixture of diastereomers (100 mg, 
0.25 mmol, 100%).   
 
(±)(S,S)-254;  Rf (3:1 pet ether:EtOAc) 0.59; max (cm
–1
) 2969, 1723, 1597, 1485, 
1464, 1393, 1356, 1168, 1115, 1089, 876, 817, 776, 659; δH (300 MHz, CDCl3) 7.86 
(2H, d, JHH 8.1 Hz, Ar-H), 7.26 (2H, d, JHH 8.1 Hz, Ar-H), 4.10 (1H, dd, JHH 10.5, 
7.7 Hz, N-CH2), 4.01 (1H, dq, JHH 8.6, 6.7 Hz CH(CH3)Br) 3.40 (1H, dd, JHH 10.5, 
7.7 Hz, N-CH2), 2.37 (3H, s, Ar-CH3), 2.20 (1H, dt, JHH 8.6, 7.7 Hz, CH), 1.71 (3H, 
d, JHH 6.7 Hz, CH(Br)CH3), 1.17 (3H, s, C(CH3)2), 0.87 (3H, s, C(CH3)2); δC (75.5 
MHz, CDCl3) 174.2 (C=O) 145.3, 134.9 (Ar, quaternary), 129.7, 128.1 (Ar), 50.5 
(CH(Br)CH3), 48.9 (N-CH2), 48.8 (CH), 45.4 (C(CH3)), 25.7 (Ar-CH3), 25.1 
(CH(Br)CH3), 21.7 (C(CH3)2), 17.5 (C(CH3)2); m/z (ESI) 396 ([M]
+
Na) (
79
Br), 398 
([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 396.0239, C20H22
79
BrNNaO3S requires 
396.0245]. 
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(±)(R,S)-254;  Rf (3:1 pet ether:EtOAc) 0.59; max (cm
–1
) 2969, 1723, 1597, 1485, 
1464, 1393, 1356, 1168, 1115, 1089, 876, 817, 776, 659; δH (300 MHz, CDCl3) 7.86 
(2H, d, JHH 8.1 Hz, Ar-H), 7.26 (2H, d, JHH 8.1 Hz, Ar-H), 4.10 (1H, dd, JHH 10.3, 
8.6 Hz, N-CH2), 3.99 (1H, dq, JHH 8.6, 6.7 Hz CH(CH3)Br) 3.32 (1H, dd, JHH 10.3, 
8.6 Hz, N-CH2), 2.37 (3H, s, Ar-CH3), 2.20 (1H, dt, JHH 8.6, 7.7 Hz, CH), 1.71 (3H, 
d, JHH 6.7 Hz, CH(Br)CH3), 1.17 (3H, s, C(CH3)2), 0.87 (3H, s, C(CH3)2); δC (75.5 
MHz, CDCl3) 173.8 (C=O) 145.6, 134.5 (Ar, quaternary), 129.7, 128.1 (Ar), 50.5 
(CH(Br)CH3), 48.9 (N-CH2), 48.8 (CH), 45.4 (C(CH3)), 25.7 (Ar-CH3), 25.1 
(CH(Br)CH3), 21.7 (C(CH3)2), 17.5 (C(CH3)2); m/z 396 ([M]
+
Na) (
79
Br), 398 
([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 396.0239, C20H22
79
BrNNaO3S requires 
396.0245]. 
 
6.2.6.4  3,3-Dimethyl-4-(1-bromo)phenylmethyl-1-(p-toluenesulfonyl)-
pyrrolidin-2-one 255 
 
 
2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-2-cinnam-
yl-propanamide (100 mg, 0.23 mmol) was subjected to the 
general procedure for copper-mediated ATRC using AIBN 
(6.2.6).  Flash chromatography eluting with 5:1 pet 
ether/EtOAc yielded 255 as a white solid, as a 6.0 : 1.0 mixture 
of diastereomers (100 mg, 0.23 mmol, 100%).   
 
(±)(S,S)-255;  Rf (3:1 pet ether:EtOAc) 0.57; max (cm
–1
) 2961, 1728, 1597, 1497, 
1461, 1388, 1353, 1261, 1164, 1118, 1091, 1017, 807, 699; δH (400 MHz, CDCl3) 
7.88 (2H, d, JHH 8.3 Hz, Ar-H), 7.33-7.28 (7H, m, Ar-H), 4.84 (1H, d, JHH 11.3 Hz, 
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CH(Br)Ph), 4.32 (1H, dd, JHH 10.5, 7.5 Hz, N-CH2), 3.45 (1H, t, JHH 10.5 Hz, N-
CH2), 2.89 (1H, m, CH), 2.38 (3H, s, Ar-CH3), 0.76 (3H, s, C(CH3)2), 0.45 (3H, s, 
C(CH3)2); δC (100 MHz, CDCl3) 145.3, 139.7, 134.9 (Ar, quaternary), 177.1 (C=O), 
129.8, 129.4, 129.0, 128.1, 127.8 (Ar), 50.5 (CH(Br)Ph), 49.9 (N-CH2), 49.6 (CH), 
45.8 (C(CH3)2), 25.2 (Ar-CH3), 21.7 (C(CH3)2), 17.6 (C(CH3)2); m/z (ESI) 458 
([M]
+
Na) (
79
Br), 460 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 458.0396, 
C20H22
79
BrNNaO3S requires 458.0401]. 
 
(±)(R,S)-255;  Rf (3:1 pet ether:EtOAc) 0.57; max (cm
–1
) 2961, 1728, 1597, 1497, 
1461, 1388, 1353, 1261, 1164, 1118, 1091, 1017, 807, 699; δH (400 MHz, CDCl3) 
7.77 (2H, d, JHH 8.3 Hz, Ar-H), 7.33-7.28 (7H, m, Ar-H), 4.66 (1H, d, JHH 10.5 Hz, 
CH(Br)Ph), 4.32 (1H, dd, JHH 9.5, 7.3 Hz, N-CH2), 3.37 (1H, dd, JHH 9.5, 7.3 Hz, N-
CH2), 2.89 (1H, m, CH), 2.36 (3H, s, Ar-CH3), 1.43 (3H, s, C(CH3)2), 1.02 (3H, s, 
C(CH3)2); δC (100 MHz, CDCl3) 174.0 (C=O), 145.4, 139.7, 134.9 (Ar, quaternary), 
129.8, 129.4, 129.0, 128.1, 127.8 (Ar), 50.5 (CH(Br)Ph), 49.9 (N-CH2), 49.6 (CH), 
45.8 (C(CH3)2), 25.2 (Ar-CH3), 21.7 (C(CH3)2), 17.6 (C(CH3)2); m/z (ESI) 458 
([M]
+
Na) (
79
Br), 460 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 458.0396, 
C20H22
79
BrNNaO3S requires 458.0401]. 
 
6.2.6.5  3,3-Dimethyl-4-(2-prop-1-ene)-1-(phenylmethyl) pyrrolidin-2-one 
256a, 3,3-Dimethyl-4-enyl-(2-propenyl)-1-(phenylmethyl) 
pyrrolidin-2-one 256b  
 
2-Bromo-2-methyl-N-benzyl-N-2-prenyl-
propanamide (100 mg, 0.31 mmol) was 
Chapter 6: Experimental 
 
207 
 
subjected to the general procedure for copper-mediated ATRC using AIBN (6.2.6).  
Flash chromatography eluting with 9:1 pet ether/EtOAc yielded 256a and 256b as a 
colourless oil, as a 2:1 mixture (75 mg, 0.30 mmol, 99%).  
 
256a;  Rf (3:1 pet ether:EtOAc) 0.68; max (cm
–1
) 2970, 2929, 2869, 1697, 1495, 
1430, 1270, 920, 730, 702; δH (400 MHz CDCl3) 7.35-7.22 (5H, m, Ar), 4.89 (1H, 
brs, C=CH2), 4.68 (1H, brs, C=CH2), 4.52 (2H, s, Ar-CH2), 3.17 (1H, dd, JHH 9.8, 
7.8 Hz, N-CH2), 3.16 (1H, dd, JHH 9.8, 7.8 Hz, N-CH2), 2.59 (1H, t, JHH 7.8 Hz CH), 
1.71 (3H, s, CCH3), 1.38 (3H, s, C(CH3)2, 1.29 (3H, s, C(CH3)2); δC (100 MHz 
CDCl3) 179.6 (C=O), 142.3 (Ar, quaternary), 135.6 (C=CH2), 128.7, 128.2, 127.5 
(Ar), 113.2 (C=CH2), 50.6 (CH), 46.8 (C(CH3)2), 46.7 (N-CH2), 46.3 (Ar-CH2), 25.3, 
25.0 (C(CH3)2), 23.0 (CCH3); m/z (ESI) 266 ([M]
+
Na), 244 ([M]
+
H); [Found: 
([M]
+
H) 244.1696, C16H22NO requires 244.1701]. 
 
256b; Rf (3:1 pet ether:EtOAc) 0.68; max (cm
–1
) 2970, 2929, 2869, 1697, 1495, 1430, 
1270, 920, 730, 702; δH (400 MHz CDCl3) 7.35-7.22 (5H, m, Ar), 4.52 (2H, s, Ar-
CH2), 3.73 (2H, s, N-CH2), 1.78 (3H, s, C=C(CH3)2), 1.51 (3H, s, C=C(CH3)2), 1.38 
(6H, s, C(CH3)2); δC (100 MHz CDCl3) 179.6 (C=O), 136.5 (Ar, quaternary), 130.3, 
126.0 (C=C), 128.4, 128.0, 127.6, (Ar), 49.3 (N-CH2), 46.3 (Ar-CH2), 44.1 
(C(CH3)2), 24.3 (C(CH3)2), 21.3, 20.1 (C=CCH2); m/z (ESI) 266 ([M]
+
Na), 244 
([M]
+
H); [Found: ([M]
+
H) 244.1696, C16H22NO requires 244.1701]. 
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6.2.6.6  (±)(S,S)-3-Methyl-4-bromomethyl-1-(p-toluenesulfonyl)-
pyrrolidin-2-one 257a
55 
 
2-bromo-N-[(4-methylphenyl)sulfonyl]-N-2-propenyl propanami-
de (100 mg, 0.29 mmol) was subjected to the general procedure 
for copper-mediated ATRC using AIBN (6.2.6).  Flash 
chromatography eluting with 5:1 pet ether/EtOAc yielded 257a as 
a white solid (90 mg, 0.26 mmol, 90%). Rf (3:1 pet ether:EtOAc) 0.52; mpt 122-124 
o
C, lit
55
 124-125 
o
C;  max (cm
–1
) 2917, 1731, 1597, 1482, 1451, 1439, 1362, 1335, 
1240, 1181, 1167, 1124, 1076, 708, 661; δH (300 MHz, CDCl3) 7.86 (2H, d, JHH 8.1 
Hz, Ar-H), 7.28 (2H, d, JHH 8.1 Hz, Ar-H), 4.04 (1H, dd, JHH 10.2, 7.3 Hz, CH2Br), 
3.46 (1H, m, CH2Br), 3.45 (1H, m, N-CH2),  3.29 (1H, dd, JHH 10.7, 7.1 Hz, N-CH2), 
2.37 (3H, s, Ar-CH3), 2.26 (2H, br, CH), 1.1 (3H, d, JHH 6.6 Hz, CH3);  δC (75.5 
MHz, CDCl3) 174.0 (C=O), 145.4, 134.9 (Ar quaternary), 129.8, 128.1 (Ar), 49.6 
(CHCH3), 42.8 (CHCH2), 41.8 (CH2Br), 32.8 (N-CH2), 21.7 (Ar-CH3), 12.9 (CH3); 
m/z (ESI) 368 ([M]
+
Na) (
79
Br), 370 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 367.9926, 
C13H16
79
BrNNaO3S requires 367.9932]; [Found: C, 44.9; H, 4.7; N, 3.9; 
C13H16BrNO3S requires C, 45.1; H, 4.7; N 4.1].  
 
6.2.6.7  3,3-Dimethyl-4-bromomethylene-1-[(4-methylphenyl)sulfonyl]-
pyrrolidin-2-one 222,
238
 3,3-dimethyl-4-methylene-1-[(4-
methylphen-yl)sulfonyl]-pyrrolidin-2-one 221
238
 
 
N-(2-bromo-2-methyl-propionyl)-4-me-
thyl-N-prop-2-ynyl-benzenesulfonamide 
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(100 mg, 0.28 mmol) was subjected to the general procedure for copper-mediated 
ATRC using AIBN (6.2.6).  Flash chromatography eluting with 5:1 pet ether/EtOAc 
yielded 222 and 221 (70 mg, 80%) as a 1:1 mixture of an off-white solid.  
 
221;  Rf (3:1 petrol:EtOAc) 0.48;  mpt 103-105 
o
C, lit
238
 104-106 
o
C;  max (cm
–1
)
 
2970, 1731, 1596, 1494, 1463, 1360, 1340, 1166, 1118, 1090, 813;  δH (300 MHz, 
CDCl3) 7.84 (2H, d, JHH 8.1 Hz, Ar-H), 7.26 (2H, d, JHH 8.1 Hz, Ar-H), 4.90 (1H, dt, 
JHH 1.5, 1.5 Hz, C=CH2), 4.88 (1H, dt, JHH 1.5, 1.5 Hz, C=CH2),  4.28 (2H, t, JHH 1.5 
Hz, N-CH2), 2.25 (3H, s, Ar-CH3), 1.0 (6H, s, C(CH3)2); δC (75.5 MHz, CDCl3) 
176.9 (C=O), 145.3 (C=CH2), 145.2, 135.0 (Ar quaternary), 129.7, 128.0 (Ar), 108.5 
(C=CH2), 49.3 (C(CH3)2), 46.1 (N-CH2), 24.4 (Ar-CH3), 21.7 ((CH3)2); m/z (ESI) 
302 ([M]
+
Na); [Found: 302.0870, 5.0; C14H17NNaO3S requires: 302.0873].  
 
222; Rf (3:1 petrol:EtOAc) 0.48; mpt 123-125 
o
C, lit
238
 126-128 
o
C; max (cm
–1
) 2970, 
1731, 1596, 1494, 1463, 1360, 1340, 1166, 1118, 1090, 813; δH (300 MHz, CDCl3), 
7.86 (2H, d, JHH 8.3 Hz, Ar-H), 7.27 ((2H, d, JHH 8.3 Hz, Ar-H)), 6.10 (1H, t, JHH 2.6 
Hz, CHBr,), 4.37 (2H, m, N-CH2), 2.37 (3H, s, Ar-CH3), 1.14 (3H, s, C(CH3)2), 1.08 
(3H, s, C(CH3)2); δC (75.5 MHz, CDCl3); 175.9 (C=O), 145.6, 142.6 (Ar quaternary), 
134.7 (CCH2), 129.8, 128.0 (Ar), 102.4 (CHBr), 50.1 (N-CH2), 47.7 (C(CH3)2), 25.1 
(CH3), 24.4 (CH3), 21.7 (Ar-CH3); m/z (ESI); 380 ([M]
+
Na) (
79
Br), 382 ([M]
+
Na) 
(
81
Br), [Found: ([M]
+
Na), 381.9917, C14H16
81
BrNNaO3S requires 381.9911]. 
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6.2.6.8  3,3-Dimethyl-4-bromomethylene-1-(phenylmethyl)-2-pyrrolidin-
one 258,  3,3-Dimethyl-4-methylene-1-(phenylmethyl)-2-
pyrrolidin-one 235 
 
2-Bromo-2-methyl-N-(phenylmethyl)-N-2-
propynyl-propanamide (100 mg, 0.34 mmol) was 
subjected to the general procedure for copper-
mediated ATRC using AIBN (6.2.6).  Flash 
chromatography eluting with 9:1 pet ether/EtOAc yielded 258 and 235 (76 mg, 82%) 
as a 2:1 mixture of a colourless oil.  
 
235;  Rf (3:1 petrol:EtOAc) 0.59; max (cm
–1
) 3066, 2966, 2926, 1693, 1495, 1475, 
1455, 1425, 1359, 1255, 1166, 698; δH (300 MHz, CDCl3) 732-7.13 (5H, m, Ar-H), 
5.03 (1H, dt, JHH 2.4, 1.5 Hz, C=CH2), 4.96 (1H, dt, JHH 2.4, 1.5 Hz, C=CH2), 4.51 
(2H, s, Ar-CH2), 3.82 (2H, t, JHH 1.5 Hz, CH2), 1.27 (6H, s, (CH3)2); δC (75.5 MHz, 
CDCl3) 177.5 (C=O) 148.8 (CCH2), 136.3 (Ar, quaternary), 128.8, 128.1, 127.6 (Ar), 
106.7 (C=CH2), 49.7 (C, quaternary), 46.2 (Ar-CH2), 44.5 (CH2), 25.2, 25.0 (CH3); 
m/z (ESI) 214 ([M]
+
H); [Found: ([M]
+
H) 214.1228, C14H17NO requires, 214.1232].    
 
258 as a pale yellow oil; Rf (3:1 pet ether:EtOAc) 0.57; max (cm
–1
) 3066, 2966, 2926, 
1693, 1495, 1475, 1455, 1425, 1359, 1255, 1166, 698; δH (300 MHz, CDCl3) 7.32-
713 (5H, m, Ar), 6.11 (1H, t, JHH 2.7 Hz, CHBr), 4.53 (2H, s, Ar-CH2), 3.82 (2H, m, 
N-CH2), 1.31 (3H, s, C(CH3)2), 1.27 (3H, s, C(CH3)2); δC (75.5, CDCl3) 177.5 (C=O), 
146.1 (Ar, quaternary), 135.9 (C=C), 128.8, 127.8, 127.6 (Ar), 106.7 (CHBr), 49.6 
(Ar-CH2), 46.2 (N-CH2), 44.0 (C(CH3)2), 25.6, 25.2 (C(CH3)2); m/z (ESI) 316 
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([M]
+
Na), (
79
Br), 318 ([M]
+
Na), (
81
Br);  [Found: ([M]
+
Na) 316.0307, 
C20H22
79
BrNNaO3S requires 316.0313]. 
 
6.2.7  General Procedure for Substrates Synthesised in Chapter 4 
 
Substrates 202, 203, 210, 215 (6.2.1) and 249-252 (6.2.5) were prepared previously 
and procedures and data can be found in the relevant sections above.  In addition, 
compounds 268 and 269 were prepared for 5-exo trig radical cyclisation.  Substrates 
270-275, 305 and 306 were prepared for 4-exo and 5-endo trig radical cyclisation via 
the same general procedure (6.2.8).  
 
6.2.7.1  2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-(2-methyl-2-
propenyl)-propanamide 268
21
 
 
2-Methylallylamine (0.15 g, 2.17 mmol) was dissolved in 
dichloromethane (10 cm
3
) and cooled to 0
o
C.  Triethylamine 
(0.3 cm
3
, 2.17 mmol) was added followed by p-
toluenesulfonyl chloride (0.41 g, 2.17 mmol) in 
dichloromethane (10 cm
3
), which was added via a dropping funnel over 5 minutes.  
The reaction was allowed to reach room temperature overnight.  The reaction was 
quenched with 1 M HCl (10 cm
3
) and the aqueous layer was extracted using 
dichloromethane (3 x 20 cm
3
).  The combined organic extracts were washed with 
brine (20 cm
3
), dried using MgSO4, filtered and concentrated in vacuo to yield a 
crude product, a portion of which (0.3 g, 1.33 mmol) was dissolved in dry THF (10 
cm
3
) and taken to -78
o
C at which point n-BuLi (1.6 M in hexanes, 0.94 cm
3
, 1.5 
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mmol) was added dropwise via syringe.  The reaction was allowed to proceed for 30 
mins.  2-Bromoisobutyryl bromide (0.19ml, 1.5 mmol) was added and the reaction 
was allowed to reach room temperature overnight.  The reaction was quenched with 
NH4Cl (5 cm
3
) and partitioned between NaHCO3 (20 cm
3
) and dichloromethane (20 
cm
3
). The aqueous layer was extracted using dichloromethane (2 x 20 cm
3
).  The 
combined organic extracts were washed with brine (20 cm
3
), dried with MgSO4, 
filtered and concentrated in vacuo to yield a crude yellow which was purified by 
flash chromatography to yield 268 as a colourless oil (180 mg, 0.48 mmol, 36%).  Rf 
(3:1 pet ether:EtOAc) 0.85; mpt 110-112 
o
C, lit
21
 112-113 
o
C;  max (cm
–1
) 3088, 
3001, 2974, 2919, 1673, 1597, 1494, 1453, 1352, 1317, 1237, 1165, 1096, 717;  δH 
(300 MHz, CDCl3) 7.86 (2H, d, JHH 8.1 Hz, Ar), 7.30 (2H, d, JHH 8.1 Hz, Ar), 5.03 
(1H, d, JHH 1.6 Hz, C(CH3)C=CH2), 5.02 (1H, d, JHH 1.6 Hz, C(CH3)C=CH2), 4.81 
(2H, br s, N-CH2), 2.43 (3H, s, Ar-CH3), 1.83 (6H, s, (CH3)2), 1.81 (3H, s, CH3);  δC 
(75.5 MHz, CDCl3) 169.8 (C=O), 144.0, 135.3 (Ar, quaternary), 140.2 (C(CH3)CH2), 
128.5, 128.2 (Ar), 111.5 (C(CH3)CH2), 57.0 (C(CH3)Br), 52.7 (N-CH2), 31.5 
(C(CH3)2Br), 21.1 (Ar-CH3), 19.7 (C(CH3)CH2); m/z 396 ([M]
+
Na) (
79
Br), 398 
([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 396.0239, C15H20
79
BrNNaO3S requires 
396.0345]. 
 
6.2.7.2  2-Bromo-N-[(4-methylphenyl)sulfonyl]-N-2-propynyl 
propanamide 269
15
  
 
 Using the same procedure as 6.2.1.3, 4-methyl-N-prop-2-
ynyl-benzenesulfonamide (1.02 g, 4.9 mmol) in dry THF (50 
cm
3
), n-BuLi (1.6 M, 4.7 cm
3
, 7.5 mmol) and 2-
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bromopropionyl bromide (0.79 cm
3
, 7.5 mmol) furnished the crude product as a 
yellow oil which was purified by flash chromatography eluting with 5:1 pet 
ether/EtOAc to yield 269 as a pale yellow oil (0.89 g, 2.6 mmol, 53%). Rf (3:1 Pet 
ether: EtOAc) 0.50; max (cm
–1
) 3276, 2989, 2972, 2937, 1698, 1599, 1498, 1369, 
1283, 1167, 1088, 812, 718; δH (300 MHz, CDCl3) 7.91 (2H, d, JHH 8.1 Hz, Ar-H) 
7.34 (2H, d, JHH 8.1 Hz, Ar-H), 4.97 (1H, q, JHH 6.6 Hz, CH(Br)CH3), 4.84 (1H, dd, 
JHH 18.6, 2.3 Hz N-CH2), 4.60 (1H, dd, JHH 18.6, 2.3 Hz, N-CH2), 2.44 (3H, s, Ar-
CH3), 2.34 (1H, t, JHH 2.3 Hz, CH), 1.74 (3H, d, JHH 6.6 Hz, CH3); δC (75.5 MHz, 
CDCl3) 168.9 (C=O), 145.5, 135.3 (Ar quaternary), 129.8, 128.4 (Ar ), 77.7, 73.5 
(CCH), 39.3 (CH(Br)CH3), 35.7 (N-CH2), 21.1, 20.2 (CH3); m/z (ESI) 366 ([M]
+
Na) 
(
79
Br), 368 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 365.9770, C13H14
79
BrNNaO3S 
requires 365.9775]. 
 
6.2.8  General Procedure for the Synthesis of Enamides in Chapter 4 
 
Aldehyde or cyclic ketone (1 equiv) and benzylamine (1 equiv) were added to dry 
toluene at room temperature.  The reaction mixture was heated at reflux overnight, 
using a dean-stark apparatus.  The crude reaction mixture was allowed to cool to 
room temperature, then cooled further to 0
o
C before addition of acyl halide (1 equiv), 
followed by diethylaniline (1 equiv).  The reaction was allowed to reach room 
temperature and stirred for 4 hrs.  The reaction mixture was washed with 2M HCl.  
The resulting organic layer was dried over MgSO4, filtered and concentrated in 
vacuo to yield a crude product purified via flash chromatography eluting with 9:1 pet 
ether-EtOAc.  
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6.2.8.1  N-Benzyl-2-bromo-N-(isobutenyl)-2-methyl-propionamide 270
35
   
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (3.00 ml, 27.5 mmol), isobutyraldehyde 
(2.51 ml, 27.5 mmol) and 2-bromoisobutyryl bromide (3.40 ml, 27.5 
mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 270 as a colourless oil 
(4.97 g, 15.8 mmol, 57%).  Rf (3:1 pet ether:EtOAc) 0.74; max (cm
–1
) 3030, 2975, 
2933, 1637, 1496, 1463, 1447, 1390, 1366, 1263, 1173, 1107,829, 697; δH (400 MHz, 
CDCl3) 732-7.28 (5H, m, Ar), 6.36 (1H, s, N-CH), 4.72 (2H, s, Ar-CH2), 1.99 (6H, s, 
C(CH3)2Br), 1.75 (3H, s, CH3), 1.63 (3H, s, CH3); δC (100 MHz, CDCl3) 170.6 
(C=O), 137.3 (Ar quaternary), 134.9 (C(CH3)2), 128.4, 127.9, 127.2 (Ar), 125.8 (N-
CH), 58.3 (C(CH3)2Br), 54.4 (Ar-CH2), 32.1 (C(CH3)2Br), 21.8 (C(CH3)2), 18.2 
(C(CH3)2); m/z (ESI) 332 ([M]
+
Na) (
79
Br), 334 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 
332.0620, C15H20
79
BrNNaO requires 332.0626]. 
 
6.2.8.2  N-Benzyl-2-bromo-N-(2-methylbut-1-enyl)-2-methyl-propion-
amide 271
35
   
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.32 ml, 22.1 mmol), 2-
methylbutyraldehyde (2.37 ml, 22.1 mmol) and 2-bromoisobutyryl 
bromide (2.73 ml, 22.1 mmol) to furnish a crude product which was 
purified by flash chromatography, eluting with 9:1 pet ether/EtOAc to yield 271 as a 
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pale yellow oil (2.80 g, 8.6 mmol, 39%).  Rf (3:1 pet ether:EtOAc) 0.81; max (cm
–1
) 
3031, 2968, 2934, 1637, 1496, 1454, 1388, 1366, 1284, 1263, 1172, 1107, 844, 749, 
726, 697; δH (300 MHz, CDCl3) 733-7.29 (5H, m, Ar), 6.37 (1H, s, N-CH), 4.70 (2H, 
s, Ar-CH2), 2.08 (2H, q, JHH 7.5 Hz, CH2CH3), 1.98 (6H, s, (CH3)2), 1.62 (3H, s, 
CCH3), 1.04 (3H, t, JHH 7.5 Hz, CH2CH3); δC (75.5 Hz, CDCl3) 170.6 (C=O), 139.8 
(Ar quaternary), 137.3 (NC=C), 128.4, 128.0, 127.2 (Ar), 125.2 (N-CH), 58.5 
(C(CH3)2Br), 54.3 (Ar-CH2), 32.2 (C(CH3)2), 29.0 (CCH3), 16.2 (CCH2CH3), 12.2 
(CCH2CH3); m/z (ESI) 346 ([M]
+
Na) (
79
Br), 348 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 
346.0779, C16H22
79
BrNNaO requires 346.0782]. 
 
6.2.8.3  N-Benzyl-2-bromo-N-(methylenecyclohexane)-2-methylpropion-
amide 272
56
   
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.73 ml, 16.5 mmol), cyclohexane 
carboxaldehyde (2.00 ml, 16.5 mmol) and 2-bromoisobutyryl 
bromide (2.04 ml, 16.5 mmol) to furnish a crude product which was 
purified by flash chromatography, eluting with 9:1 pet ether/EtOAc 
to yield 272 as a yellow oil (3.90 g, 11.1 mmol, 67%).  Rf (3:1 pet ether:EtOAc) 0.83; 
max (cm
–1
) 3028, 2929, 2854, 1636, 1495, 1463, 1448, 1389, 1365, 1264, 1177, 
1108, 836, 697; δH (300 MHz, CDCl3) 732-7.27 (5H, m, Ar), 6.33 (1H, s, N-CH), 
4.70 (Ar-CH2), 2.13 (4H, br, CCH2), 2.00 (6H, s, C(CH3)2), 1,57 (6H, br, CH2); δC 
(75.5 MHz, CDCl3) 170.0 (C=O), 140.5 (Ar quaternary), 136.7 (N-CH), 127.8, 127.3, 
126.5 (Ar), 122.2 (N-C(H)C), 57.9 (C(CH3)2), 54.4 (Ar-CH2), 32.2 (C(CH3)2), 31.7 
(C(CH3)2), 28.0 (CH2), 26.8 (CH2), 25.5 (CH2); m/z (ESI) 372 ([M]
+
Na) (
79
Br), 374 
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([M]
+
Na) (
81
Br), 350 [M]
+
; [Found: ([M]
+
Na) 372.0933, C18H24
79
BrNNaO requires 
372.0939]. 
 
6.2.8.4 N-Benzyl-2-bromo-N-(cyclohex-1-enyl)-2-methyl-propionamide 
273
55
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.63 ml, 24.1 mmol), cyclohexanone 
(2.50 ml, 24.1 mmol) and 2-bromoisobutyryl bromide (2.98 ml, 24.1 
mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 273 as a colourless oil 
(5.60 g, 16.6 mmol, 69%).  Rf (3:1 pet ether:EtOAc) 0.8; max (cm
–1
) 2931, 2859, 
1630, 1495, 1449, 1390, 1364, 1257, 1171, 1107, 920, 726, 697; δH (300 MHz 
CDCl3) 725-7.19 (5H, m, Ar), 5.53 (1H, m, CH), 4.90 (1H, br, Ar-CH2), 4.19 (1H, br, 
Ar-CH2), 2.12 (2H, br, CH2), 1.96 (8H, br-s, (CH3)2 and CH2), 1.63 (2H, m, CH2), 
1.47 (CH2); δC (75 MHz CDCl3) 170.5 (C=O), 137.7 (Ar, quaternary), 128.4, 128.2, 
127.2 (Ar), 58.5 (C(CH3)2Br), 52.4 (Ar-CH2), 28.0 (CH2), 24.6 (C(CH3)2Br), 22.6 
(CH2), 21.3 (CH2); m/z (ESI) 358 ([M]
+
Na) (
79
Br), 360 ([M]
+
Na) (
81
Br); [Found: 
([M]
+
Na) 358.0777; C17H22BrNNaO requires 358.0782]; [Found: C, 60.7; H, 6.7; N, 
4.1. C17H22BrNO requires C, 60.7; H, 6.6; N, 4.2]. 
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6.2.8.5 N-Benzyl-2-bromo-N-(cyclooct-1-enyl)-2-methyl-propionamide 
274
25
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclooctanone 
(1.32 ml, 10.0 mmol) and 2-bromoisobutyryl bromide (1.24 ml, 
10.0 mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 274 as a colourless oil 
(3.50 g, 9.5 mmol, 95%).  Rf (3:1 pet ether:EtOAc) 0.77; max (cm
–1
) 2925, 2852, 
1630, 1495, 1463, 1453, 1390, 1364, 1273, 1171 1107, 733, 698; δH (300 MHz, 
CDCl3) 734-7.28 (5H, m, Ar), 5.61 (1H, t, JHH 8.5 Hz, CH), 5.08-4.45 (2H, br, Ar-
CH2), 2.07-1.39 (12H, br, CH2), 2.04 (6H, s, (CH3)2); δC (75 MHz, CDCl3) 170.7 
(C=O), 137.6 (Ar, quaternary), 129.1 (N-C), 128.3, 127.9, 127.1 (Ar), 58.6 
(C(CH3)2), 42.0 (Ar-CH2), 33.7, 33.3, 32.4, 29.4, 22.6, 21.1 (CH2), 26.3 (C(CH3)2); 
m/z (ESI) 386 ([M]
+
Na) (
79
Br), 386 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 386.1090; 
C19H26
79
BrNNaO requires 386.1095]. 
 
 
6.2.8.6 N-Benzyl-2-bromo-N-(cyclododec-1-enyl)-2-methyl-propionamide 
275 
 
The general procedure for the synthesis of enamides (6.2.8) 
was applied using benzylamine (1.10 ml, 10.0 mmol), 
cyclododecanone (1.82 g, 10.0 mmol) and 2-bromoisobutyryl 
bromide (1.24 ml, 10.0 mmol) to furnish a crude product 
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which was purified by flash chromatography, eluting with 9:1 pet ether/EtOAc to 
yield 275 as a yellow oil (3.30 g, 7.8 mmol, 78%).  Rf (3:1 pet ether:EtOAc) 0.84; 
max (cm
–1
) 2928, 2861, 1707, 1633, 1495, 1467, 1390, 1366, 1265, 1169, 1107, 734, 
696; δH (300 MHz, CDCl3) 733-7.27 (5H, m, Ar), 5.18 (1H, t, JHH 8.3 Hz, CH), 5.12-
4.19 (2H, br, Ar-CH2), 2.37, 2.00, 1.72, 1.62, 1.5-1.2 (20H, br, CH2), 2.04 (6H, s, 
(CH3)2); δC (75 MHz, CDCl3) 170.4 (C=O), 139.0 (Ar, quaternary), 137.6 (N-C), 
128.5, 128.2, 127.2 (Ar), 54.1 (C(CH3)2Br), 40.4 (Ar-CH2), 33.6, 27.5, 26.3, 25.4, 
24.7, 24.6, 24.4, 24.2, 22.7, 22.6 (CH2), 22.3 ((CH3)2); m/z (ESI) 442 ([M]
+
Na) 
(
79
Br), 444 ([M]
+
Na) (
81
Br), [Found: ([M]
+
Na) 442.1716; C23H34
79
BrNNaO requires 
442.1721]. 
 
6.2.8.7  N-Benzyl-2-bromo-N-(9,10-dihydronaphthalen-1-yl)-2-methyl-
propionamide 305
25
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (0.37 ml, 3.4 mmol), β-tetralone (0.45 
ml, 3.4 mmol) and 2-bromoisobutyryl bromide (0.42 ml, 3.4 
mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 305  as 
a brown oil (1.10 g, 2.9 mmol, 84%).   Rf (3:1 pet ether: EtOAc) 0.74; max (cm
–1
) 
3030, 2937, 2835, 1630, 1495, 1486, 1453, 1436, 1390, 1365, 1266, 1166, 1106, 751, 
666; δH (400 MHz, CDCl3) 7.34-7.08 (9H, m, Ar), 6.27 (1H, s, CH), 4.79 (2H, br s, 
Ar-CH2), 2.96 (2H, t, JHH 8.0 Hz, CH2), 2.55 (2H, t, JHH 8.0 Hz, CH2), 2.06 (6H, s, 
(CH3)2); δC (100 MHz, CDCl3); 170.7 (C=O), 139.6, 137.2, 134.1 (Ar, quaternary), 
132.8 (N-C), 128.6, 128.4, 127.9, 127.6, 127.5, 127.4, 126.9, 126.8, 126.7 (Ar), 
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126.6 (CH), 58.4 (C(CH3)2), 53.1 (Ar-CH2), 33.6 (C(CH3)2), 28.3, 27.5 (CH2); m/z 
(ESI) 384 ([M]
+
H) (
79
Br), 386 ([M]
+
H) (
81
Br); [Found: ([M]
+
H) 383.0963; 
C21H23
79
BrNO requires 383.0961].  
 
6.2.8.8  N-Benzyl-2-bromo-N-(3,4-dihydronaphthalen-1-yl)-2-methyl-
propion-amide 306
25
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (3.00ml, 27.5 mmol), α-tetralone 
(3.66 ml, 27.5 mmol) and 2-bromoisobutyryl bromide (3.40 ml, 
27.5 mmol) to furnish a crude product which was purified by 
flash chromatography, eluting with 9:1 pet ether/EtOAc to yield 306 as a yellow oil 
(6.10 g, 16.0 mmol, 58%).   Rf (3:1 per ether:EtOAc) 0.77; max (cm
–1
) 3062, 2968, 
2939, 2893, 2826, 1634, 1497, 1483, 1448, 1425, 1391, 1361, 1351, 1274, 1173, 
1102, 978, 916, 782, 773, 733, 696; δH (400 MHz, CDCl3) 7.20-7.09 (9H, m, Ar), 
5.82 (1H, t, JHH 4.7 Hz, CH), 5.55 (1H, d, JHH 14.2 Hz, Ar-CH2), 3.68 (1H, br d JHH 
14.2 Hz, Ar-CH2), 2.71 (2H, t, JHH 7.7 Hz, CH2), 2.23 (2H, m, CHCH2), 1.97 (3H, s, 
CH3), 1.76 (3H, s, CH3); δC (100 MHz, CDCl3) 171.2 (C=O), 137.4, 137.0, 136.8 (Ar 
quaternary), 132.0 (N-C), 130.3, 129.0, 128.3, 128.2, 128.1, 127.4, 126.8 (Ar), 122.6 
(CH), 58.1 (C(CH3)2), 52.9 (Ar-CH2), 34.6, 31.6 (CH2), 27.0, 22.7 (CH3); m/z (ESI) 
384 ([M]
+
H) (
79
Br), 386 ([M]
+
H) (
81
Br); [Found: ([M]
+
H) 383.0959; C21H23
79
BrNO 
requires 383.0963]; [Found: C, 65.7; H, 5.8; N, 3.5 C21H22BrNO requires C, 65.6; H, 
5.8; N, 3.6].  
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6.2.9  General Procedure for Copper Mediated ATRC Using KBH4  
in Chapter 4 
 
The precursor (0.20-0.31 mmol) was dissolved in methanol (0.12 M) at room 
temperature.  A solution (0.01 M) of CuSO4/TPA (0.1 mol%) was added followed by 
KBH4 (10 mol%).  The reaction mixture was then stirred at room temperature for 10-
30 minutes.  The mixture was filtered through a silica plug using DCM (50 ml) and 
the resulting filtrate was washed with H2O (30 ml).  The organic layer was dried over 
MgSO4, filtered and concentrated in vacuo to isolate the crude product which was 
purified by flash chromatography eluting with 5:1/9:1 petrol-EtOAc. 
 
The cyclisation of substrates 202, 203, 206, 210, 215 and 249-251 yielded products 
218, 221, 222, 233, 235, 253-256 and 258, the data for which can be found in 
sections above. 
 
6.2.9.1  3,3-Dimethyl-4-methyl-4-bromomethyl-1-(p-toluenesulfonyl)-
pyrrolidin-2-one 282
55
 
 
2-Bromo-2-methyl-N-[(4-methylphenyl)sulfonyl]-N-(2-methyl-2-
propenyl)-propanamide (100 mg, 0.27 mmol) was subjected to 
the general procedure for copper-mediated ATRC using KBH4 
(6.2.9) to yield a crude product.  Flash chromatography eluting 
with 5:1 pet ether/EtOAc yielded 282 as a white solid (84 mg, 0.23 mmol, 84 %).  Rf 
(3:1 pet ether:EtOAc) 0.48; mpt 174-176 
o
C, lit
55
 175-176; max (cm
–1
) 3052, 2982, 
2937, 1722, 1596, 1489, 1458, 1383, 1349, 1292, 1261, 1158, 1105, 1091, 817, 767; 
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δH (400 MHz CDCl3) 7.91 (2H, d, JHH 8.3 Hz, Ar-H), 7.34 (2H, d, JHH 8.3 Hz, Ar-H), 
3.85 (1H, d, JHH 10.8 Hz N-CH2), 3.57 (1H, d, JHH 10.8 Hz N-CH2), 3.27 (1H, d, JHH 
10.5 Hz, CH2Br), 3.22 (1H, d, JHH 10.5 Hz, CH2Br), 2.44 (3H, s, Ar-CH3), 1.09 (3H, 
s, C(CH3)2), 1.07 (3H, s, C(CH3)2), 0.97 (3H, s, CH3); δC (100 MHz CDCl3) 165.2 
(C=O), 145.3 (Ar, quaternary), 135.0 (Ar, quaternary), 129.7, 128.0 (Ar), 54.1 (N-
CH2), 48.5 (C(CH3)2), 48.2 (C(CH3)CH2Br), 38.5 (CH2Br), 21.7 (Ar-CH3), 20.0, 
19.1 (C(CH3)2), 18.5 (CH3); m/z (ESI) 396 ([M]
+
Na) (
79
Br), 398 ([M]
+
Na) (
81
Br); 
[Found: ([M]
+
Na) 396.0244, C15H20
79
BrNNaO3S requires 396.0245]. 
 
6.2.9.2 3-Methyl-4-methyl-1-(p-toluenesulfonyl)-pyrrolidin-3-en-2-one 
286
15
  
 
2-Bromo-N-[(4-methylphenyl)sulfonyl]-N-2-propynyl-propan-
amide (100 mg, 0.29 mmol) was subjected to the general 
procedure for copper-mediated ATRC using KBH4 (6.2.9) to yield 
a crude product.  Flash chromatography eluting with 5:1 pet 
ether/EtOAc yielded 286 as a pale yellow oil (35 mg, 0.13 mmol, 45 %).  Rf (3:1 pet 
ether:EtOAc) 0.23; max (cm
–1
) 2923, 2858, 1709, 1595, 1446, 1355, 1317, 1160, 
1121, 1084, 749; δH (400 MHz CDCl3) 7.94 (2H, d, JHH 8.5 Hz, Ar-H), 7.32 (2H, d, 
JHH 8.5 Hz, Ar-H), 4.23 (2H, s, N-CH2), 2.41 (3H, s, Ar-CH3), 1.98, 1.70 (CH3);  δC 
(100 MHz CDCl3) 169.8 (C=O), 150.8 (C(CH3)), 144.9, 135.6 (Ar quaternary), 
128.5 (C(CH3)), 129.7, 128.0 (Ar), 53.4 (N-CH2), 21.7 (Ar-CH3),  13.5, 8.3 (CH3); 
m/z (ESI) 288 ([M]
+
Na); [Found: ([M]
+
Na) 288.0665, C13H15NNaO3S requires 
288.0670]. 
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6.2.9.3  N-Benzyl-4-(2-methyl-2-bromoethyl)-3,3-dimethylazetidine-2-one 
287,
35
  
N-Benzyl-4-(isoprop-1-enyl)-3,3-dimethylazetidine-2-one 290a
170
 
 
2-Bromo-N-[(4-methylphenyl)sulfonyl]-N-2-propyn-
yl-propanamide (100 mg, 0.32 mmol) was subjected 
to the general procedure for copper-mediated ATRC 
using KBH4 (6.2.9) to yield a crude product.  Flash 
chromatography eluting with 9:1 pet ether/EtOAc 
yielded 287 and 290a as a pale yellow oil (76 mg, 81 %) of a 3 : 1 mixture.   
 
287;  Rf (3:1 pet ether:EtOAc) 0.46; max (cm
–1
) 2962, 2925, 1751, 1496, 1455, 1397, 
1368, 1349, 1092, 1076, 736, 698; δH (400 MHz CDCl3) 7.30-7.15 (5H, m, Ar-H), 
4.86 (1H, d JHH 15.1 Hz, Ar-CH2), 4.16 (1H, d JHH 15.1 Hz, Ar-CH2), 3.54 (1H, s, N-
CH), 1.75 (3H, s, C(CH3)Br), 1.74 (3H, s, C(CH3)Br), 1.32 (3H, s, C(CH3)2), 1.21 
(3H, s, C(CH3)2); δC (100 MHz CDCl3) 174.8 (C=O), 140.3 (Ar, quaternary), 128.7, 
128.5, 127.7 (Ar), 72.8 (N-CH), 65.2 (C(CH3)2Br), 55.4 (C(CH3)2), 45.0 (Ar-CH2), 
31.5, 31.3 (C(CH3)2Br), 24.1, 17.9 (C(CH3)2); m/z (ESI) 332 ([M]
+
Na) (
79
Br), 334 
([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 332.0628, C15H20
79
BrNNaO requires 332.0626].   
 
290a; Rf (3:1 pet ether:EtOAc) 0.46; max (cm
–1
) 2962, 2925, 1751, 1496, 1455, 1397, 
1368, 1349, 1092, 1076, 736, 698; δH (400 MHz CDCl3) 7.30-7.15 (5H, m, Ar-H), 
4.99 (1H, brs, CCH2), 4.81 (1H, brs, CCH2), 4.79 (1H, d JHH 14.6 Hz, Ar-CH2), 3.81 
(1H, d JHH 14.6 Hz, Ar-CH2), 3.34 (1H, s, N-CH), 1.55 (3H, s, CCH3), 1.20 (3H, s, 
C(CH3)2), 1.04 (3H, s, C(CH3)2); δC (100 MHz CDCl3) 168.4 (C=O), 136.2 (Ar, 
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quaternary), 135.9 (CCH2), 128.8, 128.4, 127.7 (Ar), 111.9 (CCH2), 66.2 (N-CH), 
44.4 (Ar-CH2), 31.2 (C(CH3)2), 29.7 (C(CH3)2), 21.0 (CCH3), 16.6 (C(CH3)2); m/z 
(ESI) 252 ([M]
+
Na), 230 ([M]
+
H); [Found: ([M]
+
Na) 252.1361, C15H19NNaO 
requires 252.1364]. 
 
6.2.9.4  N-Benzyl-4-(3-methyl-3-bromopropyl)-3,3-dimethylazetidine-2-
one 288,
35
 N-Benzyl-4-(3-methylprop-2-enyl)-3,3-
dimethylazetidine-2-one 291a, N-Benzyl-4-(but-1-en-2-yl)-
3,3-dimethylazetidine-2-one 291b 
  
N-Benzyl-2-bromo-N-(2-methylbut-1-
enyl)-2-methyl-propionamide (100 mg, 
0.31 mmol) was subjected to the 
general procedure for copper-mediated 
ATRC using KBH4 (6.2.9) to furnish a 
crude product.  Flash chromatography eluting with 9:1 pet ether/EtOAc yielded a 
1.7 : 3.7 : 1 mixture of 288, 291a and 291b (78 mg, 89 %) of a pale yellow oil.   
 
288 as a single diastereomer; Rf (3:1 pet ether:EtOAc) 0.30; max (cm
–1
) 2962, 2925, 
1751, 1496, 1455, 1397, 1368, 1349, 1092, 1076, 736, 698; δH (400 MHz CDCl3) 
7.35-7.21 (5H, m, Ar-H), 4.94 (1H, d, JHH 14.8 Hz, Ar-CH2), 4.32 (1H, d, JHH 14.8 
Hz, Ar-CH2), 3.76 (1H, s, N-CH), 1.99-1.74 (2H, m, C(Br)CH2), 1.78 (3H, s, 
C(CH3)2), 1.49 (3H, s, C(Br)CH3), 1.35 (3H, s, C(CH3)2), 1.06 (3H, dd, JHH 9.3, 7.8 
Hz, CH2CH3); δC (100 MHz CDCl3) 174.6 (C=O), 145.7 (Ar, quaternary), 128.8, 
128.6, 127.7 (Ar), 73.3 (CBr), 72.1 (N-CH), 55.1 (C(CH3)2), 44.6 (Ar-CH2), 35.8 
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(C(Br)CH2), 27.2 (C(CH3)2), 18.2 (C(CH3)2), 14.8 (C(Br)CH3), 10.0 (CH2CH3); m/z 
(ESI) 346 ([M]
+
Na) (
79
Br), 348 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 346.0779, 
C16H22
79
BrNNaO  requires 346.0782]. 
 
291a as a 3:1 mixture of E and Z isomers; Rf (3:1 pet ether:EtOAc) 0.30; max (cm
–1
) 
2962, 2926, 1746, 1496, 1455, 1398, 1366, 1352, 1115, 1076, 734, 698; δH (400 
MHz CDCl3) 7.35-7.21 (10H, m, Ar-H), 5.54 (1H, q, JHH  7.3 Hz, CCHCH3, Z), 5.39 
(1H, q, JHH  6.8 Hz, CCHCH3, E), 4.85 (1H, d, JHH 14.8 Hz, Ar-CH2, E), 4.83 (1H, d, 
JHH 14.8 Hz, Ar-CH2, Z), 3.85 (1H, d, JHH 14.8 Hz, Ar-CH2, Z), 3.80 (1H, d, JHH 
14.8 Hz, Ar-CH2, E), 3.42 (2H, s, N-CH, E + Z), 1.68 (3H, d, JHH 6.8 Hz, CHCH3, E), 
1.47 (3H, d, JHH 7.3 Hz, CHCH3, Z), 1.27 (6H, s, CCH3, E + Z), 1.26 (6H, s C(CH3)2, 
E + Z), 1.04 (6H, s, C(CH3)2, E + Z); δC (100 MHz CDCl3, E + Z) 174.4 (C=O), 
136.4, 136.1 (Ar, quaternary), 131.8, 130.8 (CCH), 128.8, 128.7, 128.6, 128.4, 127.7, 
127.6 (Ar), 124.5, 121.1 (CCH), 67.6, 65.5 (N-CH), 54.9, 54.8 (C(CH3)2), 45.8, 44.5 
(Ar-CH2), 23.0 (CCH3), 22.4, 22.2, 16.8, 16.7 (C(CH3)2), 14.8 (CHCH3), 13.1 (CH-
CH3); m/z (ESI) 266 ([M]
+
Na), 244 ([M]
+
H); [Found: ([M]
+
H) 244.1696, C16H22NO 
requires 244.1701]. 
 
291b; Rf (3:1 pet ether:EtOAc) 0.30; max (cm
–1
) 2962, 2926, 1746, 1496, 1455, 1398, 
1366, 1352, 1115, 1076, 734, 698; δH (400 MHz CDCl3) 7.35-7.21 (5H, m, Ar-H), 
5.08 (1H, brs, CCH2), 4.92 (1H, brs, CCH2), 4.90 (1H, d, JHH 14.6 Hz, Ar-CH2), 3.85 
(1H, d, JHH 14.6 Hz, Ar-CH2), 3.92 (1H, s, N-CH), 1.84 (2H, m, CH2CH3), 1.35 (3H, 
s, C(CH3)2), 1.26 (3H, s, C(CH3)2), 0.99 (3H, t, JHH 7.5 Hz, CH2CH3); δC (100 MHz 
CDCl3) 174.2 (C=O), 135.9 (Ar, quaternary), 135.8 (CCH2), 128.7, 128.5 127.7 (Ar), 
109.8 (CCH2), 62.3 (N-CH), 55.9 (C(CH3)2), 44.1 (Ar-CH2), 27.5 (CCH2), 20.9, 13.4, 
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11.9 (CH3); m/z (ESI) 266 ([M]
+
Na), 244 ([M]
+
H); [Found: ([M]
+
H) 244.1696, 
C16H22NO requires 244.1701]. 
 
6.2.9.5  N-Benzyl-4-bromo-4-cyclohexyl-3,3-dimethylazetidine-2-one 
289,
35
  
N-Benzyl-4-cyclohex-1-enyl-3,3-dimethylazetidine-2-one 292a,
 56
  
N-Benz-yl-N-(methylenecyclohexane)-2-methyl-propionamide 293,  
N-Benzyl-N-(methylene-cyclochexane)-2-methylacrylate 294 
 
N-Benzyl-2-bromo-
N-(methylenecyclo-
hexane)-2-methyl-
propionamide (100 
mg, 0.29 mmol) 
was subjected to the general procedure for copper-mediated ATRC using KBH4 
(6.2.9) to furnish a crude product.  Flash chromatography eluting with 9:1 pet 
ether/EtOAc yielded 289 and 292a as a 1:1 mixture (74 mg, 80 %) of a pale yellow 
oil.  Compounds 293 (8 mg, 0.03 mmol, 12 %) and 294 (5 mg, 0.02 mmol, 8%) were 
also isolated as minor byproducts.  
 
289; Rf (3:1 pet ether:EtOAc) 0.33; max (cm
–1
) 2929, 1736, 1496, 1455, 1399, 1366, 
1350, 1260, 1106, 1074, 918 806, 729; δH (400 MHz CDCl3) 7.29-7.15 (5H, m, Ar-
H), 4.86 (1H, d, JHH 15.6 Hz, Ar-CH2), 4.09 (1H, d, JHH 15.6 Hz, Ar-CH2), 3.44 (1H, 
s, N-CH), 2.08-1.48 (10H, m, CH2) 1.42 (3H, s, C(CH3)2), 1.23 (3H, s, C(CH3)2); δC 
(100 MHz CDCl3) 175.0 (C=O), 136.2 (Ar, quaternary) 127.8, 128.4, 127.7 (Ar), 
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74.4 (CBr), 72.7 (N-CH), 55.5 (C(CH3)2), 45.5 (Ar-CH2), 37.6, 25.0, 22.6, 22.4, 21.9 
(CH2), 24.5, 18.4 (C(CH3)2); m/z (ESI) 372 ([M]
+
Na) (
79
Br), 374 ([M]
+
Na) (
81
Br); 
[Found: ([M]
+
Na) 372.0933, C18H24
79
BrNNaO requires 372.0939]. 
 
292a; Rf (3:1 pet ether:EtOAc) 0.33; max (cm
–1
) 2929, 1736, 1496, 1455, 1399, 1366, 
1350, 1260, 1106, 1074, 918 806, 729; δH (400 MHz CDCl3) 7.29-7.15 (5H, m, Ar-
H), 5.50 (1H, brs, CH), 4.75 (1H, d, JHH 14.8 Hz, Ar-CH2), 3.79 (1H, d, JHH 14.8 Hz, 
Ar-CH2), 3.28 (1H, s, N-CH), 2.08-1.48 (8H, m, CH2) 1.19 (3H, s, C(CH3)2), 0.99 
(3H, s, C(CH3)2); δC (100 MHz CDCl3) 174.4 (C=O), 136.2 (Ar, quaternary), 132.8 
(CCH), 128.7, 128.4. 127.6 (Ar), 123.4 (CCH), 66.4 (N-CH), 54.9 (C(CH3)2), 44.4 
(Ar-CH2), 27.3, 24.8, 22.4, 22.3 (CH2), 22.5, 16.8 (C(CH3)2); m/z (ESI) 292 
([M]
+
Na), 270 ([M]
+
H); [Found: ([M]
+
H) 270.1852, C18H24NO requires 270.1858]. 
 
293 as a colourless oil; Rf (3:1 pet ether:EtOAc) 0.57; max (cm
–1
) 2931, 2855, 1639, 
1495, 1447, 1412, 1240, 1223, 1089, 1078, 908, 714; δH (400 MHz CDCl3) 7.30-
7.21 (5H, m, Ar-H), 5.74 (1H, brs, N-CH), 4.59 (2H, s, Ar-CH2), 2.83 (1H, sept, JHH 
6.8 Hz, CH(CH3)2), 2.06 (2H, brt, JHH 5.8 Hz, CCH2), 1.90 (2H, t, JHH 5.8 Hz, 
CCH2), 1.50 (4H, tt, JHH 5.8, 2.7 Hz, CH2), 1.29-1.23 (2H, m, CH2), 1.08 (6H, d, JHH 
6.8 Hz, CH(CH3)2); δC (100 MHz CDCl3) 177.6 (C=O), 143.2 Ar, quaternary), 137.7 
(N-C(H)C), 128.9, 128.3, 127.1 (Ar), 120.1 (N-CH), 51.0 (Ar-CH2), 33.0 (CH2), 
30.9 (CH(CH3)2), 28.0, 27.9, 26.4, 26.3 (CH2), 19.2 (CH(CH3)2); m/z (ESI) 294 
([M]
+
Na), 272 ([M]
+
H); [Found: ([M]
+
H) 272.2009, C18H26NO requires 272.2014]. 
 
294 as a colourless oil; Rf (3:1 pet ether:EtOAc) 0.48; max (cm
–1
) 2927, 2854, 1619, 
1495, 1448, 1417, 1368, 1211, 1196, 1078, 909, 729; δH (400 MHz CDCl3) 7.31-
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7.23 (5H, m, Ar-H), 5.69 (1H, brs, N-CH), 5.19 (1H, brs, CCH2), 5.17 (1H, brs, 
CCH2), 4.62 (2H, s, Ar-CH2), 1.99 (2H, brs, CH2), 1.92 (3H, s, CCH3), 1.79 (2H, brs, 
CH2), 1.45 (4H, brs, CH2), 1.19 (2H, brs, CH2); δC (100 MHz CDCl3) 171.5 (C=O), 
141.0 (Ar, quaternary), 138.9 (CCH2), 137.3 (N-C(H)C), 129.0, 128,3, 127.3 (Ar), 
120.7 (N-CH), 117.9 (CCH2), 51.2 (Ar-CH2), 33.0, 28.2, 27.6, 26.2 (CH2), 19.8 
(CH3); m/z (ESI) 292 ([M]
+
Na), 270 ([M]
+
H); [Found: ([M]
+
H) 270.1852, C18H24NO 
requires 270.1858]. 
 
6.2.9.6  N-Benzyl-3,3-dimethyl-1,3,4,5,6,7-hexahydroindol-2-one 301a,
 55
  
N-Benzyl-3,3-dimethyl-1,3,3’,4,5,6-hexahydroindol-2-one 301b, 55  
N-Benzyl-3,3-dimethyl-2,3,4,5,6,7-hexahydroindol-2-one 301 c
243
 
 
N-Benzyl-2-bromo-N-(cyclo-
hex-1-enyl)-2-methyl-propion-
amide (100 mg, 0.30 mmol) 
was subjected to the general 
procedure for copper-mediated ATRC using KBH4 (6.2.9) to furnish a crude product.  
Flash chromatography eluting with 9:1 pet ether/EtOAc yielded a 2 : 4 : 1 mixture of 
products 301a, 301b and 301c as a colourless oil (64 mg, 0.25 mmol, 83%).  Further 
purification was achieved via flash chromatography eluting with 20:1 pet 
ether/EtOAc to yield 301b as a colourless oil (36 mg, 0.14 mmol, 47%), as well as 
301a and 301c as a 2:1 mixture (28 mg, 0.11 mmol, 36%) of a colourless oil.  
 
301a;  Rf (3:1 pet ether:EtOAc) 0.67; max (cm
–1
) 2924, 2855, 1680, 1495, 1445, 
1361, 1273, 1079, 922, 729; δH (400 MHz CDCl3) 7.31-7.16 (5H, m, Ar-H), 4.63 
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(2H, s, Ar-CH2), 1.97 (2H, m, CH2), 1.64-1.47 (6H, m, CH2), 1.26 (6H, s, C(CH3)2); 
δC (100 MHz CDCl3) 181.1 (C=O), 138.7 (Ar, quaternary), 133.6 (N-C), 128.5, 17.9, 
127.3 (Ar), 121.4 (N-CC), 42.7 (Ar-CH2), 28.5 (C(CH3)2), 24.8, 22.6, 22.5, 21.9 
(CH2), 22.2 (C(CH3)2); m/z (ESI) 278 ([M]
+
Na), 256 ([M]
+
H); [Found: ([M]
+
Na) 
278.1515, C17H21NNaO requires 278.1521]. 
 
301b;  Rf (3:1 pet ether:EtOAc) 0.56; max (cm
–1
) 2962, 1669, 1405, 1257, 1078, 
1008, 798; δH (400 MHz CDCl3) 7.25-7.12 (5H, m, Ar-H), 4.72 (1H, dd, JHH 6.8, 3.0 
Hz, CCH), 4.58 (1H, d, JHH 15.6 Hz, Ar-CH2), 4.49 (1H, d, JHH 15.6 Hz, Ar-CH2), 
2.35 (1H, m, CH), 1.99, 1.44 (1H, m, CH2), 1.96, 1.83 (1H, m, CHCH2), 1.70, 1.32 
(1H, m, CH2), 1.19 (3H, s, C(CH3)2) 0.94 (3H, s, C(CH3)2); δC (100 MHz CDCl3) 
180.6 (C=O), 139.7 (Ar, quaternary), 137.0 (N-C), 128.7, 128.5, 127.2 (Ar), 98.5 
(CCH), 45.8 (CH), 43.6 (Ar-CH2), 43.0 (C(CH3)3) 23.5 (CCHCH2), 23.1 (C(CH3)2), 
22.2 (CH2), 21.9 (CH2), 20.8 (C(CH3)2); m/z (ESI) 278 ([M]
+
Na), 256 ([M]
+
H); 
[Found: ([M]
+
Na) 278.1515, C17H21NNaO requires 278.1521]. 
 
301c;  Rf (3:1 pet ether:EtOAc) 0.56; max (cm
–1
) 2924, 2855, 1680, 1495, 1445, 
1361, 1273, 1079, 922, 729; δH (400 MHz CDCl3) 7.31-7.16 (5H, m, Ar-H), 5.00 
(1H, d, JHH 15.1 Hz, Ar-CH2), 3.91 (1H, d, JHH 15.1 Hz, Ar-CH2), 2.81 (1H, ddd, JHH 
10.0, 3.5, 2.8 Hz, N-CH), 2.00 (1H, m, CH), 1.78 (4H, m, CH2), 1.41 (2H, m, CH2), 
1.17 (2H, m, CH2), 1.13 (3H, s, C(CH3)2), 1.10 (3H, s, C(CH3)2); δC (100 MHz 
CDCl3) 180.6 (C=O), 138.3 (Ar, quaternary), 128.6, 128.2, 127.2 (Ar), 58.7 (N-CH), 
43.0 (Ar-CH2),  32.6 (CH), 29.8 (C(CH3)2), 24.6 23.9, 23.6, 19.5 (CH2), 20.8, 20.6 
(C(CH3)2); m/z (ESI) 280 ([M]
+
Na), 258 ([M]
+
H); [Found: ([M]
+
Na) 280.1672, 
C17H23NNaO requires 280.1677]. 
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6.2.9.7  N-Benzyl-3,3-dimethyl-N-(cyclooct-1-enyl)-pyrrolidin-2-one 
302a,
25
   
N-Benzyl-3,3-dimethyl-N-(cyclooct-2-enyl)-pyrrolidin-2-one 
302b,
25
  
N-Benzyl-3,3-dimethyl-N-(cyclooctyl)-pyrrolidin-2-one 302c 
 
N-Benzyl-2-bromo-N-
(cyclooct-1-enyl)-2-
methyl-propionamide 
(100 mg, 0.27 mmol) 
was subjected to the general procedure for copper-mediated ATRC using KBH4 
(6.2.9) to furnish a crude product.  Flash chromatography eluting with 9:1 pet 
ether/EtOAc yielded 302b as a pale yellow oil (53 mg, 0.19 mmol, 69%), as well as 
302a
25
 and 302c as a 1:2 mixture (15 mg, 0.05 mmol, 17%) of a yellow oil.   
 
302a; Rf (3:1 pet ether:EtOAc) 0.63; max (cm
–1
) 2925, 2855, 1755, 1596, 1454, 1404, 
1353, 1152, 1066, 730, 670; δH (400 MHz CDCl3) 7.35-7.12 (5H, m, Ar-H), 4.68 
(2H, s, Ar-CH2), 2.28 (2H, t, JHH 6.5 Hz, N-CCH2), 2.22 (2H, t, JHH 6.5 Hz, CCH2), 
2.04-1.39 (8H, m, CH2), 1.20 (6H, s, C(CH3)2); δC (100 MHz CDCl3) 175.3 (C=O), 
142.3 (Ar, quaternary), 142.2 (N-C), 128.6, 127.2, 127.0 (Ar), 120.8 (N-CC), 49.0 
(C(CH3)2), 43.0 (Ar-CH2), 32.3, 30.3, 30.0, 28.5, 26.0, 23.0 (CH2), 22.4 (C(CH3)2); 
m/z (ESI) 306 ([M]
+
Na), 284 ([M]
+
H); [Found: ([M]
+
Na) 306.1828, C19H25NNaO 
requires 306.1834]. 
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302b; Rf (3:1 pet ether:EtOAc) 0.74; max (cm
–1
) 2926, 2854, 1702, 1496, 1454, 1407, 
1385, 1338, 1153, 1078, 909, 696; δH (400 MHz CDCl3) 7.33-7.17 (5H, m, Ar-H), 
4.74 (1H, dd, JHH 9.8, 7.2 Hz, N-CCH), 4.71 (1H, d, JHH 15.1 Hz, Ar-CH2), 4.59 (1H, 
d, JHH 15.1 Hz, Ar-CH2), 2.55 (1H, dd, JHH 12.5, 3.0 Hz, CH), 2.21-2.10 (1H, m, N-
CCHCH2), 2.08-2.00 (1H, m, N-CCHCH2), 1.82-1.69 (2H, m, CH2), 1.57-1.46 (2H, 
m, CH2), 1.37-1.09 (4H, m, CH2) 1.19 (3H, s, C(CH3)2), 1.18 (3H, s, C(CH3)2); δC 
(100 MHz CDCl3) 180.4 (C=O), 142.3, Ar, quaternary), 136.8 (N-C), 128.4, 127.1 
(Ar), 101.9 (N-CCH), 47.3 (CH), 43.6 (Ar-CH2), 41.4 (C(CH3)2), 32.1, 29.4, 25.4, 
23.8, 20.5 (CH2), 27.6, 22.6 (C(CH3)2); m/z (ESI) 306 ([M]
+
Na), 284 ([M]
+
H); 
[Found: ([M]
+
Na) 306.1829, C19H25NNaO requires 306.1834]. 
 
302c; Rf (3:1 pet ether:EtOAc) 0.63; max (cm
–1
) 2925, 2855, 1755, 1596, 1454, 1404, 
1353, 1152, 1066, 730, 670; δH (400 MHz CDCl3) 7.28-7.10 (5H, m, Ar-H), 4.95 
(1H, d, JHH 14.8 Hz, Ar-CH2), 3.90 (1H, d, JHH 14.8 Hz, Ar-CH2), 3.04 (1H, ddd, JHH 
9.5, 5.0, 4.0 Hz, N-CH), 1.98 (1H, m, CH2), 1.80-1.16 (11H, m, CH2), 1.10 (3H, s, 
C(CH3)2), 0.88 (3H, s, C(CH3)2), 0.81 (1H, m, CH2); δC (100 MHz CDCl3) 174.9 
(C=O), 137.0 (Ar, quaternary), 128.6, 127.9, 127.3 (Ar), 59.4 (N-CH), 48.8 (CH), 
44.2 (C(CH3)2), 43.6 (Ar-CH2), 32.1, 29.8, 27.4, 27.1, 25.5, 20.9 (CH2), 24.1, 19.7 
(C(CH3)2); m/z (ESI) 308 ([M]
+
Na), 286 ([M]
+
H); [Found: ([M]
+
Na) 308.1985, 
C19H27NNaO requires 308.1990]. 
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6.2.9.8 N-Benzyl-3,3-dimethyl-N-(cyclododec-2-enyl)-pyrrolidin-2-one 
303b  
 
N-Benzyl-2-bromo-N-(cyclododec-1-enyl)-2-methyl-prop-
ionamide (100 mg, 0.24 mmol) was subjected to the general 
procedure for copper-mediated ATRC using KBH4 (6.2.9) to 
furnish a crude product.  Flash chromatography eluting with 
9:1 pet ether/EtOAc yielded 303b as a pale yellow oil (44 mg, 0.13 mmol, 55%).  Rf 
(3:1 pet ether:EtOAc) 0.43; max (cm
–1
) 2928, 2859, 1687, 1496, 1467, 1444, 1383, 
1361, 1148, 1079, 908, 710; δH (400 MHz CDCl3) 7.30-7.19 (5H, m, Ar-H), 4.79 
(1H, dd, JHH 12.0, 3.8 Hz, N-CCH), 4.65 (1H, d, JHH 15.3 Hz, Ar-CH2), 4.60 (1H, d, 
JHH 15.3 Hz, Ar-CH2), 2.64 (1H, dd, JHH 8.8, 4.3 Hz, CH), 2.15 (1H, m, N-CCHCH2), 
1.80 (1H, m, N-CCHCH2), 1.65-1.51, 1.36-1.12 (15H, m, CH2), 1.19 (3H, s, 
C(CH3)2), 1.17 (3H, s, C(CH3)2), 0.87 (1H, m, CH2); δC (100 MHz CDCl3) 180.1 
(C=O), 140.7 (N-C), 137.0 (Ar, quaternary), 128.4, 127.2, 127.1 (Ar), 106.6 (N-
CCH), 45.5 (CH), 44.2 (C(CH3)2), 43.7 (Ar-CH2), 30.2, 27.1, 26.5, 25.9, 25.8, 25.1, 
23.9, 23.2, 22.3 (CH2), 27.0, 18.5 (C(CH3)2); m/z (ESI) 362 ([M]
+
Na) 340 ([M]
+
H); 
[Found: ([M]
+
Na) 362.2459, C10H17NNaO requires 362.2460]. 
 
6.2.9.9   N-Benzyl-4-(1,8,9-hexahydronaphthalenyl)-3,3-dimethylazetidine-
2-one 308 
 
N-Benzyl-2-bromo-N-(9,10-dihydronaphthalen-1-yl)-2-methyl-prop-
ionamide (100 mg, 0.26 mmol) was subjected to the general 
procedure for copper-mediated ATRC using KBH4 (6.2.9) to furnish a 
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crude product.  Flash chromatography eluting with 9:1 pet ether/EtOAc afforded 308 
as a pale yellow oil (18 mg, 0.06 mmol, 23%).  Rf (3:1 pet ether:EtOAc) 0.19; max 
(cm
–1
) 2962, 2927, 1731, 1495, 1454, 1401, 1257, 1078, 1009, 790; δH (400 MHz 
CDCl3) 7.21-6.85 (9H, m, Ar-H), 4.27 (1H, d, JHH 15.3 Hz, Ar-CH2), 4.09 (1H, d, 
JHH 15.3 Hz, Ar-CH2), 2.80 (2H, s, CH2), 2.80 (1H, dt JHH 17.8, 6.5 Hz, N-CCH2), 
2.69 (1H, dt JHH 17.8, 6.5 Hz, N-CCH2), 1.85 (2H, t, JHH 6.5 Hz, CH2), 1.25 (3H, s, 
C(CH3)2), 1.09 (3H, s, C(CH3)2); δC (100 MHz CDCl3) 174.3 (C=O), 137.8, 134.8, 
134.2 (Ar, quaternary), 129.1, 128.5, 128.5, 127.9, 127.4, 126.3, 126.1 (Ar), 64.5 
(C(CH3)2), 55.6 (N-C), 43.0 (Ar-CH2), 35.9, 29.1, 27.1 (CH2), 18.7, 18.6 (C(CH3)2); 
m/z 328 ([M]
+
Na); [Found: ([M]
+
Na) 328.1672, C21H23NNaO requires 328.1677]. 
 
6.2.9.10  N-Benzyl-4-(naphthalenyl)-pyrrolidin-2-one 312,  
N-Benzyl-4-(2,4,5,6-tetrahydronaphthalenyl)-pyrrolidin-2-one 313 
 
N-Benzyl-2-bromo-N-(3,4-dihydro-
naphthalen-1-yl)-2-methyl-propionamide 
(100 mg, 0.26 mmol) was subjected to 
the general procedure for copper-
mediated ATRC using KBH4 (6.2.9) to furnish a crude product.  Flash 
chromatography eluting with 9:1 pet ether/EtOAc yielded the pure products 312 (24 
mg, 0.08 mmol, 31%), and 313 (31 mg, 0.10 mmol, 38%).   
 
312 as a colourless oil; Rf (3:1 pet ether:EtOAc) 0.59; max (cm
–1
) 3031, 2964, 2928, 
1703, 1523, 1495, 1454, 1440, 1368, 1339, 1159, 1076, 731; δH (400 MHz CDCl3) 
8.00 (1H, d, JHH 9.0 Hz, Ar-H), 7.81 (1H, d, JHH 9.0 Hz, Ar-H), 7.62 (1H, d, JHH 8.5 
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Hz, Ar-H), 7.42 (1H, d, JHH 8.5 Hz, Ar-H), 7.36-7.21 (7H, m, Ar-H), 5.51 (2H, s, Ar-
CH2), 1.53 (6H, s, C(CH3)2); δC (100 MHz CDCl3) 170.7 (C=O), 129.0, 127.3, 125.9, 
125.8, 125.1, 122.0, 120.1 (Ar), 45.8 (Ar-CH2), 24.7 (C(CH3)2); m/z (ESI) 324 
([M]
+
Na); [Found: ([M]
+
Na) 324.1359, C21H19NNaO requires 324.1364]. 
 
313 as a colourless oil; Rf (3:1 pet ether:EtOAc) 0.48; max (cm
–1
) 3029, 2927, 1679, 
1495, 1454, 1408, 1361, 1269, 908, 726, 697; δH (400 MHz CDCl3) 7.27-6.92 (9H, 
m, Ar-H), 4.93 (1H, d, JHH 15.1 Hz, Ar-CH2), 4.58 (1H, d, JHH 5.3 Hz, N-CH), 3.56 
(1H, d, JHH 15.1 Hz, Ar-CH2), 2.66 (1H, dt, JHH 16.1, 5.5 Hz, CH2), 2.55 (1H, dt, JHH 
16.1, 5.5 Hz, CH2), 2.20 (1H, m, CH), 1.66 (2H, m, Hz, CHCH2), 1.27 (3H, s, 
C(CH3)2), 1.17 (3H, s, C(CH3)2); δC (100 MHz CDCl3) 169.5 (C=O), 139.7, 137.3, 
131.8 (Ar, quaternary), 131.1, 128.7, 128.6, 128.2, 127.5, 127.1, 125.7 (Ar), 61.8 
(C(CH3)2), 55.8 (N-CH), 43.5 (Ar-CH2), 43.4 (CH), 28.1, 22.9 (CH2), 25.1, 20.1 
(C(CH3)2); m/z (ESI) 328 ([M]
+
Na); [Found: ([M]
+
Na) 328.1672, C21H23NNaO 
requires 328.1677]. 
 
6.2.10  General Procedures for the Synthesis of Enamides in Chapter 5 
 
Substrates 273-275, 305 and 306 were prepared for use in chapter 4 and the relevant 
procedures and data can be found in section 6.2.8.  The majority of the other 
enamides were prepared in identical fashion.  For tetrasubsubstituted enamides an 
alternative approach was used detailed in section 6.2.11. 
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6.2.10.1   N-Benzyl-2-bromo-N-(cyclopent-1-enyl)-2-methyl-propionamide 
331
25
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclopentanone 
(1.04 ml, 10.0 mmol) and 2-bromoisobutyryl bromide (1.24 ml, 10.0 
mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 331 as a yellow oil (1.90 
g, 6.0 mmol, 60%).  Rf (3:1 pet ether:EtOAc) 0.83; max (cm
–1
) 2932, 2850, 1633, 
1496, 1464, 1453, 1392, 1365, 1173, 1108, 729, 697; δH (300 MHz, CDCl3) 7-25-
7.19 (5H, m, Ar-H), 5.53 (1H, t, JHH 6.0 Hz, CH), 4.62 (2H, s, Ar-CH2), 2.39 (2H, m, 
CCH2), 2.22 (2H, m, CHCH2), 1.94 (6H, s, (CH3)2), 1.85 (2H, m, CH2CH2CH2); δC 
(100 MHz CDCl3) 170.5 (C=O), 142.3 (Ar, quaternary), 137.6 (N-C), 128.3, 127.9, 
127.2 (Ar), 58.0 (C(CH3)2Br), 52.1 (Ar-CH2) 33.3 (CH2), 32.6 (CH2), 30.2 (CH2), 
22.1 (C(CH3)2Br); m/z (ESI) 344 ([M]
+
Na) (
79
Br), 346 ([M]
+
Na) (
81
Br); [Found: 
([M]
+
Na) 344.0620; C16H20
79
BrNNaO requires 344.0626]. 
 
6.2.10.2   N-Benzyl-2-bromo-N-(cyclohept-1-enyl)-2-methyl-propionamide 
332 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and bromoacetyl bromide (1.24 ml, 10.0 
mmol) to furnish a crude product which was purified by flash 
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chromatography, eluting with 9:1 pet ether/EtOAc to yield 332 as a pale yellow oil 
(2.51 g, 7.1 mmol, 71%).  Rf (3:1 pet ether:EtOAc) 0.77; max (cm
–1
) 2922, 2851, 
1629, 1495, 1446, 1392, 1365, 1173, 1108, 739, 693; δH (300 MHz, CDCl3) 7.26-
7.20 (5H, m, Ar-H), 5.54 (1H, t, JHH 6.6 Hz, CH), 5.07 (1H, br, Ar-CH2), 3.99 (1H, 
br, Ar-CH2), 2.54-1.19 (10H, br, CH2), 1.95 (6H, s, (CH3)2); δC (75 MHz CDCl3) 
170.1 (C=O), 137.4 (Ar quaternary), 129.1 (N-C), 128.9, 128.2, 127.3 (Ar), 125.3 
(CH), 47.8 (C(CH3)2), 44.4 (Ar-CH2), 34.8, 33.2, 31.7, 26.6, 26.0 (CH2), 26.9 
(C(CH3)2); m/z (ESI) 372 ([M]
+
Na) (
79
Br), 374 ([M]
+
Na) (
81
Br); [Found: ([M]
+
Na) 
372.0933; C18H24
79
BrNNaO requires 372.0939]; [Found: C, 61.6; H, 6.9; N, 3.9; 
C18H24BrNNaO requires C, 61.7; H, 6.9; N, 4.0].  
 
6.2.10.3 (R)-N-(1-phenylethyl)-2-bromo-N-(cyclohex-1-enyl)-2-methyl-
propionamide 333
25
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using (R)-α-methylbenzylamine (1.29 ml, 10.0 mmol), 
cyclohexanone (1.04 ml, 10.0 mmol) and bromoacetyl bromide 
(1.24 ml, 10.0 mmol) to furnish a crude product which was 
purified by flash chromatography, eluting with 9:1 pet ether/EtOAc to yield 333 as a 
pale yellow oil (1.49 g, 4.4 mmol, 44%).  Rf (3:1 pet ether:EtOAc) 0.81; υmax (cm
–1
) 
3061, 2966, 2963, 2857, 1615, 1486, 1454, 1379, 1367, 1318, 1168, 773, 700; δH 
(400 MHz, CDCl3) 7.35-7.27 (5H, m, Ar-H), 5.86 (1H, br, CH), 5.44 (1H, br, 
CHCH3), 2.53-1.93 (9H, br, CH3), 1.92-1.04 (8H, br, CH2); δC (100 MHz, CDCl3) 
170.6 (C=O), 140.9 (Ar quaternary), 135.7 (N-C), 131.7 (CH), 128.1, 127.6, 127.1 
(Ar), 59.5 (C(CH3)2), 54.5 (N-CH), 34.8 (N-C(H)CH3), 32.4, 30.6, 24.9, 22.7 (CH2), 
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21.1, 16.6 (C(CH3)2); m/z (ESI) 372 ([M]
+
Na) (
79
Br), 374 ([M]
+
Na) (
81
Br); [Found: 
([M]
+
Na) 372.0933; C18H24
79
BrNNaO expect 372.0939]. 
 
6.2.10.4   N-cyclohex-1-enyl-N-benzylacetamide 334
213
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and acetyl chloride (0.62 ml, 10.0 mmol) to 
furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 334 as a colourless oil 
(757 mg, 3.3 mmol, 33%).  Rf (3:1 pet ether:EtOAc) 0.6; max (cm
–1
) 2928, 1644; δH 
(CDCl3, 300MHz) 727-7.21 (5H, m, Ar-H), 5.37 (1H, m, N-CCH), 4.60 (2H, s, Ar-
CH2), 2.06 (3H, s, CH3), 1.95 (4H, m, CH2), 1.62 (2H, m, CH2), 1.49 (2H, m, N-
CH2); δC (CDCl3, 75.5MHz) 170.1 (C=O), 138.9 (Ar, quaternary), 138.1 (N-C), 
128.7, 128.2, 128.1 (Ar), 127.1 (C-H), 49.5 (Ar-CH2), 28.1, 24.7, 23.9, 21.7 (CH2), 
21.7 (CH3); m/z (ESI) 252 ([M]
+
Na); [Found ([M]
+
Na) 252.1359, C15H19NNaO 
requires 252.1364]. 
 
6.2.10.5  N-cyclohex-1-enyl-N-benzylpropionamide 335 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and propionyl chloride (0.87 ml, 10.0 mmol) 
to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to 335 as a pale yellow oil (487 
Chapter 6: Experimental 
 
237 
 
mg, 2.0 mmol, 20%).  Rf (3:1 pet ether:EtOAc) 0.6;  max (cm
–1
)
 
2935, 1634; δH 
(CDCl3, 300MHz)  7.31-7.28 (5H, m, Ar-H), 5.38, (1H, s, N-CCH), 4.60 (2H, s, Ar-
CH2), 2.33 (2H, q, JHH 7.5 Hz, CH2CH3), 2.00 (4H, m, CH2), 1.64 (2H, m, CH2), 
1.53 (2H, m, CH2), 1.12 (3H, t, JHH 7.5 Hz, CH2CH3); δC (CDCl3, 75.5MHz) 164.3 
(C=O), 138.5 (Ar, quaternary), 138.3 (N-C), 128.8, 128.2, 128.1 (Ar), 127.1 (C-H), 
49.6 (Ar-CH2), 28.2, 26.8, 24.8, 22.8 (CH2), 21.3 (CH2CH3), 10.1 (CH2CH3); m/z 
(ESI) 266 ([M]
+
Na); [Found ([M]
+
Na) 266.1515, C16H21NNaO requires 266.1521].        
 
6.2.10.6  N-cyclohex-1-enyl-N-benzyl-2-methylpropionamide 336 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and 2-methylpropionyl chloride (1.05 ml, 
10.0 mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 336 as a pale yellow oil 
(206 mg, 0.8 mmol, 8%).  Rf (3:1 pet ether:EtOAc) 0.8; max (cm
–1
) 2929, 1634; δH 
(CDCl3, 400MHz)  7.25-7.20 (5H, m, Ar-H), 5.40 (1H, s, N-CCH), 4.59 (2H, s, Ar-
CH2), 2.81 (1H, sept, JHH 6.5 Hz,  CH(CH3)2), 1.99 (4H, m, CH2), 1.68 (2H, m, CH2), 
1.52 (2H, m, CH2), 1.12 (6H, d, JHH 6.5 Hz,  CH(CH3)2); δC (CDCl3, 100 MHz) 
177.0 (C=O), 138.6 (Ar, quaternary), 138.5 (N-C), 128.7, 128.2, 127.5 (Ar), 127.0 
(CH), 49.7 (Ar-CH2), 31.4 (CH(CH3)2), 28.8 (CH(CH3)2), 24.7, 22.9, 21.5, 20.2 
(CH2); m/z (ESI) 280 ([M]
+
Na); [Found ([M]
+
Na) 280.1672, C17H23NNaO requires 
280.1677]. 
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6.2.10.7  N-cyclohex-1-enyl-N-benzyl-2-dimethylpropionamide 337 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and pivavoyl chloride (1.23 ml, 10.0 mmol) 
to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 337 as a brown oil (163 
mg, 0.6 mmol, 6%).  Rf (3:1 pet ether:EtOAc) 0.9; max (cm
–1
)
 
2928, 1625; δH 
(CDCl3, 400MHz) 7.25-7.19 (5H, m, Ar-H), 5.28 (1H, m, N-CCH), 4.42 (2H, brs,  
Ar-CH2), 2.07 (4H, m, CH2), 1.67 (2H, m, CH2), 1.54 (2H, m, CH2), 1.25 (9H, s, 
(C(CH3)3); δC (CDCl3, 75.5MHz) 178.0 (C=O), 138.7 (Ar, quaternary), 132.6 (N-C) 
128.5, 128.2, 128.1 (Ar), 126.9 (CH), 51.7 (Ar-CH2), 40.9 (C(CH3)3), 29.3, 28.5, 
24.7, 22.7 (CH2), 21.4 (C(CH3)3); m/z (ESI) 294 ([M]
+
Na); [Found ([M]
+
Na) 
294.1828, C18H25NNaO requires ([M]
+
Na) 294.1834]. 
 
6.2.10.8  2-Bromo-N-cyclohex-1-enyl-N-benzylacetamide 338
213
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and bromoacetyl bromide (0.87 ml, 10.0 
mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 338 as a pale yellow oil 
(925 mg, 3.0 mmol, 30%).  Rf (3:1 pet ether:EtOAc) 0.6; max (cm
–1
) 2934, 1646; δH 
(CDCl3, 400MHz) 7.31-7.25 (5H, m, Ar-H), 5.50 (1H, s, N-CCH), 4.62 (2H, s, Ar-
CH2), 3.95 (2H, s, CH2Br), 2.07 (4H, m, CH2), 1.69 (2H, m, CH2), 1.4 (2H, m, CH2); 
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δC (CDCl3, 100 MHz) 166.1 (C=O), 137.8 (Ar, quaternary), 137.4 (N-C), 129.2, 
128.7, 128.4 (Ar), 127.4 (CH), 49.9 (Ar-CH2), 41.9 (CH2Br), 27.4, 25.0, 24.7, 21.4 
(CH2); m/z (ESI) 330 ([M]
+
Na) (
79
Br), 332 ([M]
+
Na) (
81
Br); [Found ([M]
+
Na) 
330.0464, C15H18
79
BrNNaO requires 330.0469]. 
 
6.2.10.9  N-Cyclohex-1-enyl-N-benzyl-2-bromopropionamide 339
56
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (1.10 ml, 10.0 mmol), cyclohexanone 
(1.04 ml, 10.0 mmol) and 2-bromopropionyl bromide (1.05 ml, 
10.0 mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 339 as a pale brown solid 
(1.31 g, 3.9 mmol, 39%).  Rf (3:1 pet ether:EtOAc) 0.8;  mpt 86-88 
o
C, lit
56
 87-88
o
C; 
max (cm
–1
)
 
2922, 1651; δH (CDCl3, 400MHz) 7.25-7.17 (5H, m, Ar-H), 5.50 (1H, m, 
N-CCH), 4.64 (2H, brs,  N-CH2), 2.16 (2H, m, CH2), 2.00 (2H, m, CH2), 1.79 (3H, d, 
JHH 6.8 Hz, CH(Br)CH3), 1.64 (2H, m, CH2), 1.60 (1H, q, JHH 6.8 Hz, (CH(Br)CH3), 
1.53 (2H, m, CH2);  (CDCl3, 100 MHz) 169.3 (C=O), 137.4 (Ar, quaternary), 136.5 
(N-C), 129.0, 128.7, 128.4 (Ar), 127.4 (CH), 50.0 (Ar-CH2), 39.5 (C(CH3)Br), 28.0, 
24.7, 22.7, 21.4 (CH2), 20.9 (CH3); m/z (ESI) 344 ([M]
+
Na) (
79
Br), 346 ([M]
+
Na) 
(
81
Br); [Found ([M]
+
Na) 344.0620, C16H20
79
BrNNaO requires 344.0626]. 
 
6.2.10.10  N-Cyclohex-1-enyl-N-benzyldichloroacetamide 340 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.73 ml, 25.0 mmol), cyclohexanone 
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(2.60 ml, 25.0 mmol) and dichloroacetyl chloride (2.41 ml, 25.0 mmol) to furnish a 
crude product which was purified by flash chromatography, eluting with 9:1 pet 
ether/EtOAc to yield 340 as a pale yellow oil (2.32 g, 7.8 mmol, 31%).  Rf (3:1 pet 
ether:EtOAc) 0.67; max (cm
–1
) 3030, 2927, 1673, 1495, 1440, 1403, 1210, 1177, 
1078, 922, 803, 744, 670; δH (300 MHz CDCl3) 7.34-7.24 (5H, m, Ar-H), 6.39 (1H, 
s, CHCl2), 5.53 (1H, br m, CH), 4.65 (2H, br s, Ar-CH2), 2.06 (4H, m, CH2), 1.74-
1.52 (4H, m, CH2); δC (75 MHz CDCl3) 164.2 (C=O), 136.3 (N-C), 135.8 (Ar, 
quaternary), 129.8, 128.2, 127.9 (Ar), 127.1 (N-CCH), 63.5 (CHCl2), 49.8 (Ar-CH2), 
27.3, 24.1, 21.9, 20.6 (CH2); m/z (ESI) 320 ([M]
+
Na) (
35
Cl), (ESI) 322 ([M]
+
Na) 
(
37
Cl); [Found: ([M]
+
Na) 320.0579, C15H17
35
Cl2NNaO requires 320.0585]. 
 
6.2.10.11  N-Cyclohex-1-enyl-N-benzyltrichloroacetamide 341
36
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.73 ml, 25.0 mmol), cyclohexanone 
(2.60 ml, 25.0 mmol) and trichloroacetyl chloride (2.79 ml, 25.0 
mmol) to furnish a crude product which was purified by flash 
chromatography, eluting with 9:1 pet ether/EtOAc to yield 341 as a pale brown oil 
(1.69 g, 5.1 mmol, 20%).  Rf (3:1 pet ether:EtOAc) 0.78; max (cm
–1
) 3032, 2928, 
2859, 1665, 1496, 1438, 1389, 1246, 1175, 848, 808, 697; δH (300 MHz CDCl3) 
7.34-7.28 (5H, m, Ar-H), 5.59 (1H, m, CH), 5.05 (1H, br s, Ar-CH2), 4.26 (1H, br s, 
Ar-CH2), 2.22 (2H, br, CH2), 2.01 (2H, br, CH2), 1.68-1.51 (4H, br, CH2); δC (75 
MHz CDCl3) 178.1 (C=O), 141.4 (N-C), 131.8 (Ar, quaternary), 128.2, 127.8, 127.1 
(Ar), 127.6 (N-CCH), 74.0 (CCl3), 52.7 (Ar-CH2), 27.0, 24.0, 21.8, 20.5 (CH2); m/z 
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(ESI) 354 ([M]
+
Na) (
35
Cl), 356 ([M]
+
Na) (
37
Cl); [Found: ([M]
+
Na) 354.0193, 
C15H16
35
Cl3NNaO requires 354.0195]. 
 
6.2.10.12  N-Cyclohex-1-enyl-N-benzamide 342
244
 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.73 ml, 25.0 mmol), cyclohexanone 
(2.60 ml, 25.0 mmol) and benzoyl chloride (2.90 ml, 25.0 mmol) to 
furnish a crude product which was purified by flash chromatography, 
eluting with 9:1 pet ether/EtOAc to yield 342 as a brown oil (2.61 g, 
9.0 mmol, 36%).  Rf (3:1 pet ether:EtOAc) 0.54; max (cm
–1
)
 
3061, 3029, 2929, 2858, 
2837, 1632, 1576, 1495, 1446, 1436, 1388;  δH (300 MHz, CDCl3) 7.44-7.40 (2H, m, 
Ar-H), 7.29-7.15 (8H, m, Ar-H), 5.18 (1H, br t, JHH 3.5 Hz, N-C=CH), 4.73 (2H, s, 
Ar-CH2), 1.84-1.66 (4H, m, CH2), 1.40-1.19 (4H, m, CH2);  δC (75.5 MHz CDCl3) 
169.9 (C=O), 138.2, 136.5 (Ar, quaternary), 137.4 (N-C=CH), 128.9, 127.9, 127.7, 
127.5, 127.1, 126.9 (Ar), 126.6 (NC=CH), 50.0 (CH2Ph), 28.2, 24.1, 21.9, 20.7 
(CH2);  m/z (ESI) 314 ([M]
+
Na);  [Found: [M]
+
 292.1696, C20H22NO requires 
292.1701]; [Found: C, 81.9; H, 7.3; N, 4.5. C20H21NO requires C, 82.4; H, 7.3; N, 
4.8]. 
 
6.2.10.13  N-Cyclohex-1-enyl-N-benzylprop-2-enamide 343245 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.73 ml, 25.0 mmol), cyclohexanone 
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(2.60 ml, 25.0 mmol) and acryloyl chloride (2.03 ml, 25.0 mmol) to furnish a crude 
product which was purified by flash chromatography, eluting with 9:1 pet 
ether/EtOAc to yield 343 as an off-white solid (2.78 g, 11.5 mmol, 46%).  Rf (3:1 pet 
ether:EtOAc) 0.41;  mpt 66-67 
o
C, lit
245
 67-68 
o
C;  max (cm
–1
) 2926, 1648, 1408, 
1350, 1236, 1138, 1079, 980, 698;  δH (300 MHz, CDCl3) 7.29-7.18 (5H, m, Ar-H), 
6.54-6,45 (1H, dd, JHH 17.0, 9.7 Hz, CH2=CH), 6.42-6.35 (1H, dd, JHH 17.0, 2.8 Hz, 
CH2=CH), 5.63-5.59 (1H, dd, JHH 9.7, 2.8 Hz, CH2=CH), 5.39 (1H, brs, NCCH), 
4.67 (2H, s, Ar-CH2), 2.06-1.92 (4H, m, CH2), 1.68-1.48 (4H, m, CH2);  δC (75.5 
MHz CDCl3) 165.2 (C=O), 137.9 (NCCH), 136.6 (Ar, quaternary) 128.7, 128.6, 
128.6, 128.3, 128.3, 127.2 (Ar, CH2=CH, CH2=CH, NCCH), 49.8 (Ar-CH2), 28.7, 
24.7, 22.7, 21.5 (CH2);  m/z (ESI) 264 ([M]
+
Na);  [Found: ([M]
+
Na) 264.1359, 
C16H19NNaO requires 264.1364].  
 
6.2.10.14  N-Cyclohex-1-enyl-N-benzyl-2-phenylacetamide 344 
 
The general procedure for the synthesis of enamides (6.2.8) was 
applied using benzylamine (2.73 ml, 25.0 mmol), 
cyclohexanone (2.60 ml, 25.0 mmol) and phenylacetyl chloride 
(3.31 ml, 25.0 mmol) to furnish a crude product which was 
purified by flash chromatography, eluting with 9:1 pet 
ether/EtOAc to yield 344 as a pale yellow oil (1.72 g, 5.6 mmol, 23%).  Rf (3:1 pet 
ether:EtOAc) 0.52;  max (cm
–1
) 3028, 2937, 1632, 1581, 1451, 1427, 1399, 1248, 
1166, 1026, 702;  δH (300 MHz, CDCl3) 7.33-7.19 (10H, m, Ar-H), 5.29 (1H, brs, 
NCCH), 4.61 (2H, s, Ar-CH2), 3.70 (2H, s, Ar-CH2), 2.03-1.86 (4H, m, CH2), 1.67-
1.49 (4H, m, CH2);  δC (75.5 MHz CDCl3) 169.9 (C=O), 137.5, 137.4 (Ar, 
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quaternary), 135.5 (NCCH), 128.4, 128.3, 128.1, 127.8, 127.7, 126.5 (Ar), 125.9 
(NCCH), 49.0 (Ar-CH2), 40.3, (Ar-CH2), 27.6, 24.1, 22.1, 20.9 (CH2);  m/z (ESI) 
328 ([M]
+
Na);  [Found: ([M]
+
Na) 328.1672, C21H23NNaO requires 328.1677]; 
[Found: C, 82.4; H, 7.5; N, 4.5. C21H23NO requires C, 82.6; H, 7.6; N, 4.6].  
 
6.2.11  General Procedures for the Synthesis of Tetrasubsituted 
enamides in Chapter 5 
 
Cyclic ketone (1 equiv) was dissolved in methanol.  Hydroxylamine hydrochloride 
(1.1 equiv) was added followed by sodium acetate (1.1 equiv) and the reaction 
mixture was heated at reflux for 5 h.  The reaction was allowed to cool and quenched 
by addition of H2O (50 ml) over 1 h.  After stirring at room temperature for a further 
hour, Et2O (50 ml) was added and the organic layer was dried, filtered and 
concentrated in vacuo to yield a crude product.  The crude product (1 equiv) was 
dissolved in dry toluene at room temperature.  An anhydride (3 equiv) was added 
followed by acetic acid (3 equiv).  Finally Fe powder (2 equiv) was added and the 
mixture was heated at 70 
o
C for 4 h.  The mixture was allowed to cool to room 
temperature then filtered through celite and diluted with DCM (50 ml).  The filtrate 
was then washed with 2 M NaOH (2 x 25 ml).  The resulting organic layer was dried, 
filtered and concentrated in vacuo to yield a crude product that was purified by flash 
chromatography eluting with 5:1 hexane-EtOAc.  
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6.2.11.1  N-(2,4-dimethylpent-2-en-3-yl)-acetamide 355 
 
The general procedure for the synthesis of tetrasubstituted enamides 
(6.2.11) was applied using diisopropylketone (1.74 ml, 12.3 mmol), 
acetic acid (2.11 ml, 36.9 mmol), acetic anhydride (3.49 ml, 36.9 
mmol) and Fe powder (1.37 g, 24.6 mmol).  Flash chromatograohy eluting with 5:1 
hexane/EtOAc yielded 355 as a pale yellow oil (435 mg, 2.8 mmol, 23%) of a 2:1 
mixture of rotamers.   Rf (3:1 pet ether:EtOAc) 0.09; max (cm
–1
) 3243, 2965, 2930, 
1643, 1522, 1465, 1370, 1280, 715; δH (300 MHz CDCl3) 6.19 (1H, brs, NH, min), 
6.09 (1H, brs, NH, maj), 3.02-2.88 (1H, sept, JHH 7.0 Hz, CH(CH3)2, min), 2.99-2.86 
(1H, sept, JHH 7.0 Hz, CH(CH3)2, maj), 2.07 (3H, s, COCH3, maj), 1.87 (3H, s, 
COCH3, min), 1.76 (3H, s, C(CH3)2, maj), 1.74 (3H, s, C(CH3)2, min), 1.66 (3H, s, 
C(CH3)2, min), 1.58 (3H, s, C(CH3)2, maj), 0.95 (6H, d, JHH 7.0 Hz, CH(CH3)2, min), 
0.94 (6H, d, JHH 7.0 Hz, CH(CH3)2, maj),; δC (75 MHz CDCl3); 173.8 (min), 168.8 
(maj) (C=O), 133.6 (min), 131.3 (maj) (N-C), 128.4 (min), 127.4 (maj) (C(CH3)2), 
29.5 (min), 29.2 (maj) (COCH3), 23.2 (min), 20.0 (maj) (C(CH3)2), 20.5 (maj), 20.4 
(min) (CH), 20.0 (min), 19.7 (maj), 19.5 (min), 19.2 (maj) (CH(CH3)2); m/z (ESI) 
178 ([M]
+
Na); [Found: ([M]
+
Na) 178.1202, C9H17NNaO requires 178.1208]. 
 
6.2.11.2  N-(2,6- dimethylcyclohexen-1-yl)-acetamide 357 
 
The general procedure for the synthesis of tetrasubstituted enamides 
(6.2.11) was applied using 2,6-dimethylcyclohexanone (1.60 ml, 
12.7 mmol), acetic acid (2.18 ml, 38.1 mmol), acetic anhydride 
(38.1 mmol) and Fe powder (1.42 g, 25.4 mmol).  Flash chromatography eluting 
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with 5:1 hexane/EtOAc yielded 357 as a yellow oil (552 mg, 3.3 mmol, 26%) of a 5 : 
1 mixture of rotomers.  Rf (3:1 pet ether:EtOAc) 0.13; max (cm
–1
) 3260, 2928, 2864, 
1641, 1514, 1453, 1369, 1280, 709; δH (300 MHz CDCl3) 6.43 (1H, br, NH, min), 
6.43 (1H, br, NH, maj), 2.42 (1H, br, C(H)CH3, maj), 2.40 (1H, br, C(H)CH3, min), 
2.06 (2H, m, CH2, min), 2.05 (3H, s, C(O)CH3, maj), 1.99 (2H, m, CH2, maj), 1.84 
(3H, s, C(O)CH3, min), 1.79-1.69 (4H, m, CH2, min), 1.58 (3H, s, CH3) 1.61-1.48 
(4H, m, CH2, maj), 1.01 (3H, s, CH3, maj), 0.99 (3H, s, CH3, min), 0.98 (3H, d, JHH 
7.0 Hz, C(H)CH3, min), 0.93 (3H, d, JHH 7.0 Hz, C(H)CH3, maj); δC (75 MHz CDCl3) 
169.0 (min), 168.5 (maj) (C=O), 138.1 (maj) 138.0 (min) (N-C), 132.0 (maj) 131.8 
(min) (N-CC), 34.1 (min) 32.0 (maj) (CH), 33.3 (min) 31.2 (maj) (CH2), 31.1 (min) 
30.9 (maj) (CH2), 27.2 (maj) 26.6 (min) (CH3), 24.3 (min) 23.3 (maj) (CH3),  19.4 
(maj), 18.8 (min) (CH2); m/z (ESI) 190 ([M]
+
Na); [Found: ([M]
+
Na) 190.1204, 
C10H17NNaO requires 190.1208]. 
 
6.2.11.3  N-(3,4-dihydronaphthalen-1-yl)-acetamide 358
246
 
 
The general procedure for the synthesis of tetrasubstituted 
enamides (6.2.11) was applied using α-tetralone (0.82 ml, 6.2 
mmol), acetic acid (1.06 mmol, 18.6 mmol), acetic anhydride 
(1.76 mmol, 18.6 mmol) and Fe powder (693 mg, 12.4 mmol).  Flash 
chromatograohy eluting with 5:1 hexane/EtOAc yielded 358 as an off-white solid 
(580 mg, 3.1 mmol, 50%) of a 3:1 mixture of amide rotomers.  Rf (3:1 pet 
ether:EtOAc) 0.11;  mpt 130-132, lit
246
 133-134 
o
C;  max (cm
–1
)  3243, 3028, 2930, 
2833, 1655, 1522, 1486, 1368, 1284, 768, 731; δH (300 MHz CDCl3) 7.36-7.21 (8H, 
m, Ar-H, maj + min), 7.06 (1H, brs, NH maj), 6.91 (1H, brs, NH min), 6.50 (1H, t, 
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JHH 4.9 Hz, N-CCH  maj), 6.06 (1H, t, JHH 4.9 Hz, N-CCH  min), 2.93 (2H, t, JHH 7.7 
Hz, CH2 min), 2.85 (2H, t, JHH 7.7 Hz, CH2 maj), 2.55-2.38 (4H, m, CHCH2, maj + 
min), 2.25 (3H, s, C(O)CH3 maj), 2.05 (3H, s, C(O)CH3 min); δC (75 MHz CDCl3) 
169.3, 164.2 (C=O), 149.1, 147.9, 136.9, 136.8, 131.6, 131.5, (quaternary), 128.2, 
127.9, 127.6, 126.9, 126.4, 120.6 (Ar), 126.0, 119.7 (CH), 27.6, 27.3 (CH2), 22.6, 
22.2 (CHCH2), 24.2, 20.4 (CH3); m/z (ESI) 210 ([M]
+
Na), 188 ([M]
+
H); [Found 
([M]
+
H) 188.1070, C12H14NO requires 188.1075]. 
 
6.2.11.4  N-(2-methyl-3,4-dihydronaphthalen-1-yl)-acetamide 359
229
 
 
The general procedure for the synthesis of tetrasubstituted 
enamides (6.2.11) was applied using 2-methyl-1-tetralone (0.90 
ml, 5.6 mmol), acetic acid (0.96 ml, 16.8 mmol), acetic anhydride 
(1.57 ml, 16.8 mmol) and Fe powder (626 mg, 11.2 mmol).  Flash chromatograohy 
eluting with 5:1 hexane/EtOAc yielded 359 as a white solid (403 mg, 2.0 mmol, 36%) 
of a 1 : 1 mixture of amide rotomers (1 + 2). Rf (3:1 pet ether:EtOAc) 0.07;  mpt 151-
153 
o
C, lit
229
 152-154 
o
C;  max (cm
–1
) 3225, 2936, 2892, 2831, 1646, 1531, 1487, 
1368, 1283, 1229, 990, 761; δH (300 MHz CDCl3) 7.43-7.21 (8H, m, Ar-H, 1 + 2), 
6.94 (2H, brs, NH, 1 + 2), 3.02-2.96 (2H, t, JHH 8.4 Hz, CH2CH, 2), 2.99-2.93 (2H, t, 
JHH 8.8 Hz, CH2CH, 1), 2.58-2.53 (2H, t, JHH 8.4 Hz, CHCH2, 2), 2.56-2.51 (2H, t, 
JHH 8.8 Hz, CHCH2, 1), 2.33 (3H, s, COCH3, 1), 2.10 (3H, s, CCH3, 2), 2.01 (3H, s, 
CCH3, 1), 1.99 (3H, s, COCH3, 2); δC (75 MHz CDCl3) 174.1 (2), 169.1 (1) (C=O), 
135.2 (2) 135.1 (1) (N-C), 135.7 (1), 134.4 (1), 133.5 (2), 133.0 (2) (Ar quaternary), 
127.9 (1), 126.2 (2) (CCH3), 127.5, 127.3, 127.2, 126.8, 126.4, 126.2, 121.8, 121.5 
(Ar 1 + 2), 29.6 (2), 29.5 (1), 27.5 (1), 27.4 (2) (CH2), 23.2 (2), 19.9 (1) (COCH3), 
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19.5 (1), 19.1 (2) (CCH3); m/z (ESI) 224 ([M]
+
Na), 202 ([M]
+
H); [Found: ([M]
+
H) 
202.1226, C13H16NO requires 202.1232]; [Found: C, 77.5; H, 7.5; N, 6.9. C13H15NO 
requires C, 77.6; H, 7.5; N, 6.9]. 
 
6.2.11.5  N-(2,4-dimethylpent-2-en-3-yl)-2-chloroacetamide 367 
 
The general procedure for the synthesis of tetrasubstituted 
enamides (6.2.11) was applied using diisopropyl ketone (1.09 ml, 
7.7 mmol), acetic acid (1.32 ml, 23.0 mmol), chloroacetic 
anhydride (3.81 ml, 23.0 mmol) and Fe powder (860 mg, 15.4 mmol).  Flash 
chromatograohy eluting with 5 : 1 hexane/EtOAc yielded 367 as a yellow oil (550 
mg, 2.9 mmol, 38%) of a 20 : 1 mixture of amide rotamers.  Rf (3:1 pet ether:EtOAc) 
0.41; max (cm
–1
) 3243, 2973, 2933, 2869, 1656, 1535, 1461, 1421, 1329, 1231, 804, 
717, 678; δH (300 MHz CDCl3) 7.18 (2H, brs, NH, maj + min), 4.10 (2H, s, CH2Cl, 
maj), 4.07 (2H, s, CH2Cl, min), 2.90 (2H, sept, JHH 6.9 Hz, CH, maj + min), 1.75 
(3H, s, C(CH3)2, maj), 1.67 (3H, s, C(CH3)2, min), 1.61 (3H, s, C(CH3)2, min), 1.56 
(3H, s, C(CH3)2, maj), 1.18 (6H, d, JHH 6.9 Hz, CH(CH3)2, min), 0.91 (6H, d, JHH 6.9 
Hz, CH(CH3)2, maj); δC (75 MHz CDCl3) 164.4 (min) 163.6 (maj) (C=O), 129.6 
(maj) 129.5 (min) (N-C), 127.4 (min) 127.3 (maj) (C=C), 42.4 (maj) 42.1 (min) 
(CH2Cl), 28.7 (maj) 28.4 (min) (CH), 19.8, 18.6 (C(CH3)2 maj + min), 19.3 
(CH(CH3)2 maj + min); m/z (ESI) 190 ([M]
+
H) (
35
Cl), 192 ([M]
+
H) (
37
Cl); [Found: 
([M]
+
H) 190.0993, C9H17
35
ClNO requires 190.0999]; [Found: C, 56.9; H, 8.4; N, 7.3. 
C10H17NO requires C, 57.0; H, 8.5; N, 7.4]. 
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6.2.11.6  N-(2,4-dimethylpent-2-en-3-yl)-trichloroacetamide 368 
 
The general procedure for the synthesis of tetrasubstituted enamides 
(6.2.11) was applied using diisopropyl ketone (1.18 ml, 8.3 mmol), 
acetic acid (1.43 ml, 24.9 mmol), trichloroacetic anhydride (4.55 ml, 
24.9 mmol) and Fe powder (927 mg, 16.6 mmol).  Flash chromatograohy eluting 
with 5:1 hexane/EtOAc yielded 368 as a yellow oil (517 mg, 2.0 mmol, 24%) of a 1 : 
1 mixture of amide rotamers (1 + 2).  Rf (3:1 pet ether:EtOAc) 0.77; max (cm
–1
) 3275, 
2965, 2917, 2856, 1699, 1496, 1459, 1263, 1249, 843, 818, 681; δH (300 MHz 
CDCl3) 7.29 (1H, brs, NH, 1), 7.12 (1H, brs, NH, 2), 3.07-2.94 (1H, sept, JHH 6.9 Hz, 
CH(CH3)2, 1), 3.05, 2.92 (1H, sept, JHH 6.9 Hz, CH(CH3)2, 2), 1.78 (H, brs, C(CH3)2, 
1), 1.77 (H, brs, C(CH3)2, 2), 1.64 (3H, brs, C(CH3)2, 1), 1.62 (3H, brs, C(CH3)2, 2), 
1.02 (6H, d, JHH 6.9 Hz, CH(CH3)2, 1), 1.00 (6H, d, JHH 6.9 Hz, CH(CH3)2, 2); δC 
(75 MHz CDCl3) 164.1, 162.7 (C=O 1 + 2), 129.8, 129.5, (N-C 1 + 2) 129.2, 128.8 
(C(CH3)2 1 + 2), 29.6, 29.5 (CH(CH3)2 1 + 2), 20.1, 20.0, 19.9, 19.9, 19.3, 19.3 (CH3 
1 + 2); m/z (ESI) 280 ([M]
+
Na) (
35
Cl), 282 ([M]
+
Na) (
37
Cl); [Found: ([M]
+
Na) 
280.0033, C9H14Cl3NNaO requires 280.0039]. 
 
6.2.11.7  N-(2,6-dimethylcyclohexen-1-yl)-2-chloroacetamide 369 
 
The general procedure for the synthesis of tetrasubstituted 
enamides was applied using 2,6-dimethylcyclohexanone (1.09 ml, 
8.6 mmol), acetic acid (1.48 ml, 25.8 mmol) chloroacetic anhydride 
(4.27 ml, 25.8 mmol) and Fe powder (961 mg, 17.2 mmol).  Flash chromatograohy 
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eluting with 5:1 hexane/EtOAc yielded 369 (666 mg, 3.3 mmol, 38%) as a pale 
yellow oil.  Rf (3:1 pet ether:EtOAc) 0.48; max (cm
–1
) 3246, 2928, 2867, 1672, 1527, 
1452, 1426, 1329, 1230, 1174, 971, 788; δH (300 MHz CDCl3) 7.30 (1H, brs, NH), 
4.11 (2H, s, CH2Cl), 2.47 (1H, m, CH(CH3)), 2.06 (2H, br t, JHH 6.0 Hz, 
C(CH3)CH2), 1.59 (3H, s, C(CH)3), 1.87-1.77 (1H, m, CH(CH3)CH2) 1.73-1.51 (2H, 
m, CH2CH2CH2), 1.47-1.37 (1H, m, CH(CH3)CH2), 1.00 (3H, d, JHH 6.7 Hz, 
CH(CH3)); δC (75 MHz CDCl3) 164.1 (C=O), 139.9 (N-C), 128.9 (C=C), 42.2 
(CH2Cl), 30.7, 30.4, 18.9 (CH2) 31.3 (CH), 18.3, 18.1 (CH3); m/z (ESI) 202 ([M]
+
Na) 
(
35
Cl), 204 ([M]
+
H) (
37
Cl); [Found: ([M]
+
H) 202.0993, C10H17
35
ClNO requires 
202.0999]; [Found: C, 59.2; H, 7.9; N, 6.8. C10H17NO requires C, 59.6; H, 8.0; N, 
6.9]. 
 
6.2.11.8  N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-chloroacetamide 370 
 
The general procedure for the synthesis of tetrasubstituted 
enamides was applied using 2-methyl-1-tetralone (0.70 ml, 4.6 
mmol), acetic acid (0.79 ml, 13.8 mmol), chloroacetic anhydride 
(2.29 ml, 13.8 mmol) and Fe powder (514 mg, 9.2 mmol).  Flash chromatograohy 
eluting with 5:1 hexane/EtOAc yielded 370 (236 mg, 1.0 mmol, 22%) as an off 
white solid.  Rf (3:1 pet ether:EtOAc) 0.36;  mpt 140-142 
o
C;  max (cm
–1
)
 
3180, 3026, 
2937, 1664, 1535, 1419, 1238, 1161, 807, 742, 728; δH (300 MHz CDCl3) 7.53 (1H, 
brs, NH), 7.14-6.98 (4H, m, Ar-H), 4.18 (2H, s, CH2Cl), 2.77 (2H, t, JHH 8.2 Hz, 
CH2-Ar), 2.36 (2H, t, JHH 8.2 Hz, CH2C), 1.81 (3H, s, CH3); δC (75 MHz CDCl3) 
170.2 (C=O), 134.5, 124.4 (Ar quaternary), 126.9, 126.3, 125.9, 120.5 (Ar), 42.2 
(CH2Cl), 29.0 (CH2C), 26.8 (CH2-Ar), 18.8 (CH3); m/z (ESI) 258 ([M]
+
Na), 236 
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([M]
+
H); [Found: ([M]
+
H) 236.0838, C13H15
35
ClNO requires 236.0842]; [Found: C, 
66.2; H, 5.9; N, 5.8. C13H14ClNO requires C, 66.2; H, 6.0; N 5.8]. 
 
6.2.11.9  N-(2-methyl-3,4-dihydronaphthalen-1-yl)-trichloroacetamide 371 
 
The general procedure for the synthesis of tetrasubstituted 
enamides was applied using 2-methyl-1-tetralone (0.58 ml, 3.8 
mmol), acetic acid (0.65 ml, 11.4 mmol), trichloroacetic 
anhydride (2.08 ml, 11.4 mmol) and Fe powder (424 mg, 7.6 mmol).  Flash 
chromatograohy eluting with 5:1 hexane/EtOAc yielded 371 (287 mg, 0.95 mmol, 
25%) as a yellow oil.  Rf (3:1 pet ether:EtOAc) 0.50; max (cm
–1
) 3302, 3027, 2939, 
2894, 2831, 1698, 1486, 1454, 1224, 809, 798, 756, 679; δH (300 MHz CDCl3) 7.66 
(1H, brs, NH),  7.22-7.09 (4H, m, Ar-H), 2.85 (2H, t, JHH 7.9 Hz, CH2-Ar), 2.44 (2H, 
t, JHH 7.9 Hz, CH2), 1.92 (3H, s, CH3); δC (75 MHz CDCl3) 160.3 (C=O), 135.9, 
135.1 (NCCCH3), 132.0, 124.6 (Ar quaternary), 127.6, 127.2, 126.7, 120.9 (Ar), 
29.7, 27.4 (CH2), 19,2 (CH3); m/z (ESI) 304 ([M]
+
H) (
35
Cl), 306 ([M]
+
H) (
37
Cl); 
[Found: ([M]
+
H) 304.0057, C13H13
35
Cl3NO requires 304.0063]. 
 
6.2.12  General Procedures for the Akylation of Enamides 
 
Enamide (1 equiv) in dry THF was added to NaH (5 equiv) in dry THF and cooled to 
0
o
C.  Alkyl halide (1.05-8.00 equiv) was then added in the single portion and the 
reaction was heated at reflux for 24 hrs.  The reaction was allowed to cool to room 
temperature then poured into H2O.  The aqueous layer was then extracted using three 
portions of DCM.  The resulting organic layer was dried over MgSO4, filtered and 
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concentrated in vacuo to yield a crude product which could be purified via flash 
chromatography eluting with pet ether and EtOAc.   
 
6.2.12.1  N-Benzyl-N-(2,4-dimethylpent-2-en-3-yl)-acetamide 360220 
 
The general procedure for enamide alkylation (6.2.12) was applied 
using N-(2,4-dimethylpent-2-en-3-yl)-acetamide (149 mg, 0.96 
mmol), sodium hydride (192 mg, 4.8 mmol) and benzyl bromide 
(0.12 ml, 1.01 mmol).  Flash chromatography eluting with 9:1 pet 
ether/EtOAc yielded 360 as a colourless oil (52 mg, 0.21 mmol, 22%).  Rf (3:1 pet 
ether:EtOAc) 0.36; max (cm
–1
)  2965, 1642, 1438, 1395, 1278, 1238, 682; δH (300 
MHz CDCl3) 7.38-7.22 (5H, m, Ar-H), 5.25 (1H, d, JHH 14.0 Hz, Ar-CH2), 3.96 (1H, 
d, JHH 14.0 Hz, Ar-CH2), 2.96 (1H, sept, JHH 7.5 Hz, CH), 1.94 (3H, s, CH3), 1.69 
(3H, s, C(CH3)2), 1.25 (3H, d, JHH 7.5 Hz, CH(CH3)2), 1.02 (3H, d, JHH 7.5 Hz, 
CH(CH3)2), 1.01 (3H, s, C(CH3)2); δC (75 MHz CDCl3) 170.5 (C=O), 136.8 (Ar, 
quaternary), 136.8, (N-C), 130.9 (C(CH3)2), 129.2, 127.5, 126.6 (Ar), 49.9 (Ar-CH2), 
29.4 (CH), 23.2 (CH(CH3)2), 21.0 (C(CH3)2), 19.7(CH(CH3)2), 18.8 (CH3), 18.7 
(C(CH3)2); m/z (ESI) 268 ([M]
+
Na), 268 ([M]
+
Na); [Found: ([M]
+
Na) 268.1672, 
C16H23NNaO requires 268.1677]. 
 
6.1.12.2  N-Methyl-N-(2,4-dimethylpent-2-en-3-yl)-acetamide 361 
 
The general procedure for enamide alkylation (6.2.12) was applied 
using N-(2,4-dimethylpent-2-en-3-yl)-acetamide (497 mg, 3.2 
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mmol), sodium hydride (640 mg, 16.0 mmol) and methyl iodide (1.60 ml, 25.6 
mmol).  Flash chromatography eluting with 9:1 pet ether/EtOAc yielded 361 as a 
colourless oil (186 mg, 1.1 mmol, 33%).  Rf (3:1 pet ether:EtOAc) 0.16; max (cm
–1
) 
2965, 2931, 2873, 1637, 1421, 1371, 1345, 1138, 1027; δH (300 MHz CDCl3) 3.05-
2.91 (1H, sept, JHH 6.9 Hz, CH), 2.99 (3H, s, N-CH3), 1.94 (3H, COCH3), 1.76 (3H, 
s, C(CH3)2), 1.58 (3H, s, C(CH3)2), 1.11 (3H, d, JHH 6.9 Hz, CH(CH3)2), 0.99 (3H, d, 
JHH 6.9 Hz, CH(CH3)2); δC (75 MHz CDCl3) 170.8 (C=O), 139.8 (N-C), 128.7 
(C(CH3)2), 35.6 (N-CH3), 29.5 (CH), 22.2 (CH(CH3)2), 20.6 (COCH3), 19.2 
(C(CH3)2), 19.0 (CH(CH3)2), 18.6 (C(CH3)2); m/z (ESI) 192 ([M]
+
Na), 170 ([M]
+
H); 
[Found: ([M]
+
H) 170.1541, C10H20NO requires 170.1545]; [Found: C, 69.6; H, 11.2; 
N, 7.9. C10H20NO requires C, 71.0; H, 11.3; N, 8.3]. 
 
6.2.12.3  N-Benzyl-N-(2,6-dimethylcyclohexen-1-yl)-acetamide 362 
 
The general procedure for enamide alkylation (6.2.12) was applied 
using N-(2,6- dimethylcyclohexen-1-yl)-acetamide (184 mg, 1.1 
mmol), sodium hydride (220 mg, 5.5 mmol) and benzyl bromide 
(0.14 ml, 1.2 mmol).  Flash chromatography eluting with 9:1 pet 
ether/EtOAc yielded 362 as a pale yellow oil (111 mg, 0.43 mmol, 39%) of a 2 : 1 
mixture of diastereomers.  Rf (3:1 pet ether:EtOAc) 0.25; max (cm
–1
) 2930, 1641, 
1454, 1385, 1358, 1268, 1178, 702; δH (300 MHz CDCl3) 7.33-7.22 (10H, m Ar-H, 
maj + min), 5.40 (1H, d, JHH 14.6 Hz, Ar-CH2, min), 5.13 (1H, d, JHH 13.8 Hz, Ar-
CH2, maj), 4.05 (1H, d, JHH 13.8 Hz, Ar-CH2, maj), 3.96 (1H, d, JHH 14.6 Hz, Ar-
CH2, min), 2.43 (1H, m, CH(CH3), maj), 2.41 (1H, m, CH(CH3), min), 2.04 (3H, s, 
CH3, min), 2.02-1.41 (12H, m, CH2, maj + min), 1.97 (3H, s, CH3, maj), 1.19 (3H, 
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brs, C(CH3), min), 1.08 (3H, brs, C(CH3), maj), 1.03 (3H, br d, CH(CH3), min), 0.95 
(3H, d, JHH 7.1 Hz, CH(CH3), maj); δC (75 MHz CDCl3) 171.6 (C=O) (min), 170.9 
(C=O) (maj), 138.0 (N-C) (maj), 137.9 (N-C) (min), 135.1 (Ar, quaternary) (maj), 
135.0 (Ar, quaternary) (min), 133.3 (C(CH3) (maj), 133.2 (C(CH3) (min), 130.1, 
128.9, 128.8, 128.1, 127.3, 127.0 (Ar) (maj + min), 50.8 (Ar-CH2) (min), 48.1 (Ar-
CH2) (maj), 31.6, 31.4, 25.6 (CH2) (maj + min), 29.9 (CH3) (maj + min), 27.6 (CH) 
(maj + min), 18.8 (C(CH3) (maj + min), 18.4 (CH(CH3) (maj + min); m/z (ESI) 280 
([M]
+
Na), 258 ([M]
+
H); [Found: ([M]
+
H) 258.1852, C17H24NO requires 258.1858]. 
 
6.2.12.4  N-Benzyl-N-(3,4-dihydronaphthalen-1-yl)-acetamide 363 
 
The general procedure for enamide alkylation (6.2.12) was 
applied using N-(3,4-dihydronaphthalen-1-yl)-acetamide (100 
mg, 0.53 mmol), sodium hydride (108 mg, 2.7 mmol) and 
benzyl bromide (0.067 ml, 0.56 mmol).  Flash chromatography 
eluting with 9:1 pet ether/EtOAc yielded 363 as an off white solid (33 mg, 0.12 
mmol, 22%).  Rf (3:1 pet ether:EtOAc) 0.36;  mpt 152-154 
o
C;  max (cm
–1
) 2934, 
1646, 1427, 1393, 1273, 1224, 982, 912, 728; δH (300 MHz CDCl3) 7.28-7.04 (9H, 
m, Ar-H), 5.58 (1H, t, JHH 4.3 Hz, CH), 5.54 (1H, d, JHH 14.6 Hz, Ar-CH2), 3.84 (1H, 
d, JHH 14.6 Hz, Ar-CH2), 2.77 (2H, t, JHH 8.2 Hz, CH2), 2.29 (2H, m, CHCH2), 2.02 
(3H, s, CH3); δC (75 MHz CDCl3) 170.6 (C=O), 137.6 (N-C), 137.3, 136.3, 130.7 
(Ar quaternary), 128.5, 128.1, 127.6, 127.6, 127.4, 126.7, 126.3 (Ar), 121.3 (CH), 
49.4 (Ar-CH2), 26.6 (CH2), 22.1 (CHCH2CH2), 21.1 (CH3); m/z (ESI) 300 ([M]
+
Na), 
278 ([M]
+
H); [Found ([M]
+
H) 278.1546, C19H20NO requires 278.1545]. 
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6.2.12.5  N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-acetamide 
364 
 
The general procedure for enamide alkylation (6.2.12) was 
applied using N-(2-methyl-3,4-dihydronaphthalen-1-yl)-
acetamide (141 mg, 0.70 mmol), sodium hydride (140 mg, 3.5 
mmol) and benzyl bromide (0.088 ml, 0.74 mmol).  Flash 
chromatography eluting with 9:1 pet ether/EtOAc yielded 364 as a white solid (99 
mg, 0.34 mmol, 49%).  Rf (3:1 pet ether:EtOAc) 0.36;  mpt 158-159 
o
C;  max (cm
–1
) 
2927, 2882, 2924, 1643, 1488, 1396, 1297, 1249, 774, 757, 706; δH (300 MHz 
CDCl3) 7.30-7.17 (8H, m, Ar-H), 6.98 (1H, m, Ar-H), 5.49 (1H, d, JHH 13.5 Hz, Ar-
CH2), 3.74 (1H, d, JHH 13.5 Hz, Ar-CH2), 2.87-2.69 (2H, m, CH2), 2.35 (1H, ddd, 
JHH 16.5, 6.4, 4.1 Hz C(CH3)CH2), 2.14 (1H, ddd, JHH 16.6, 6.4, 4.1 Hz, C(CH3)CH2), 
1.90 (3H, s, C(O)CH3), 1.24 (3H, brs, CCH3); δC (75 MHz CDCl3) 170.6 (C=O), 
136.5, 136.2, 135.6 (Ar, quaternary), 135.5 (N-C), 131.2 (N-CCCH3), 129.6, 127.5, 
127.1, 126.8, 126.6, 126.3, 121.2 (Ar), 48.8 (Ar-CH2), 28.9 C(CH3)CH2), 26.8 (CH2), 
20.6 (C(O)CH3), 18.3 (CH3); m/z (ESI) 314 ([M]
+
Na), 292 ([M]
+
H); [Found: ([M]
+
H) 
292.1696, C20H22NO requires 292.1701]. 
 
6.2.12.6  N-2-Bromobenzyl-N-(2-methylnaphthalen-1-yl)-2-iodoacetamide 
372 
 
The general procedure for enamide alkylation (6.2.12) was 
applied using N-(2-methyl-3,4-dihydronaphthalen-1-yl)-
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acetamide (60 mg, 0.30 mmol), sodium hydride (60 mg, 1.5 mmol) and 2-
bromobenzyl bromide (0.038 ml, 0.32 mmol).  Flash chromatography eluting with 
9:1 pet ether/EtOAc yielded 372 as a white solid (59 mg, 0.16 mmol, 54%).  Rf (3:1 
pet ether:EtOAc) 0.46;  mpt 179-180 
o
C;  max (cm
–1
) 2927, 2881, 2824, 1654, 
1566,1488, 1425, 1390, 1298, 1241, 1026, 760; δH (300 MHz CDCl3) 7.51 (1H, dd, 
JHH 7.7, 1.7 Hz, Ar-H), 7.36 (1H, dd, JHH 7.7, 1.7 Hz, Ar-H), 7.19-6.86 (6H, m, Ar-
H), 5.45 (2H, d, JHH 13.8 Hz, Ar-CH2), 4.20 (2H, d, JHH 13.8 Hz, Ar-CH2), 2.80 (1H, 
dt, JHH 15.1, 6.5 Hz CH2), 2.62 (1H, ddd, JHH 15.1, 6.5, 4.1 Hz, CH2), 2.28 (1H, dt, 
JHH 15.1, 6.5 Hz, C(CH3)CH2), 2.07 (1H, ddd, 15.1, 6.5, 4.1 Hz, C(CH3)CH2), 1.85 
(3H, s, CH3), 1.27 (3H, s, C(CH3); δC (75 MHz CDCl3) 171.0 (C=O), 136.4 (Ar-Br), 
135.8 (N-C), 135.6, 131.4, 131.3 (Ar, quaternary), 132.4, 131.9, 128.5, 127.0, 126.5, 
126.8, 126.2, 120.9 (Ar), 124.4 (C(CH3)), 47.4 (Ar-CH2), 28.9 (C(CH3)CH2), 26.6 
(CH2), 20.5 (CH3), 18.1 (C(CH3)); m/z (ESI) 392 ([M]
+
Na) (
79
Br), 394 ([M]
+
Na) 
(
81
Br); [Found: ([M]
+
Na) 392.0627, C20H20
79
BrNNaO requires 392.0626]; [Found: C, 
64.8; H, 5.4; N, 3.6. C20H20BrNO requires C, 64.9; H, 5.4; N, 3.8]. 
 
6.2.12.7  N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-
iodoacetamide 375 
 
The general procedure for enamide alkylation (6.2.12) was 
applied using N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-
chloroacetamide (146 mg, 0.62 mmol), sodium hydride (214 mg, 
3.1 mmol) and benzyl bromide (0.077 ml, 0.65 mmol) afforded 
a 5:1 mixture of N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-
chloroacetamide 373 and N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-
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bromoacetamide 374.  The mixture was dissolved in acetone and sodium iodide was 
added before being stirred at room temperature for 36 hours.  The mixture was then 
diluted with H2O (20 ml), and extracted using EtOAc (2 x 50 ml).  The organic 
extracts were washed consecutively with Na2S2O3 (100 ml) and brine (100 ml), then 
dried filtered and concentrated in vacuo to yield a crude product which was purified 
by flash chromatography to yield 375 as an off-white solid (191 mg, 0.46 mmol, 
74%  Rf (3:1 pet ether:EtOAc) 0.60;  mpt 163-165 
o
C;  max (cm
–1
) 3062, 3030, 2929, 
2830, 1652, 1493, 1454, 1415, 1388, 1293, 1246, 1164, 1976, 757;  δH (300 MHz, 
CDCl3) 7.31-7.18 (8H, m, Ar-H), 6.96 (1H, m, Ar-H), 5.36 (1H, d, JHH 14.1 Hz, Ar-
CH2), 3.98 (1H, d, JHH 14.1 Hz, Ar-CH2), 3.73 (1H, d, JHH 12.1 Hz, CH2I), 3.70 (1H, 
d, JHH 12.1 Hz, CH2I), 2.83-2.77 (2H, m, CH2), 2.40 (1H, m, C(CH3)CH2), 2.20 (1H, 
dt, JHH 16.6, 6.0 Hz, C(CH3)CH2), 1.34 (3H, s, CH3); δC (75.5 MHz, CDCl3) 168.3 
(C=O), 137.7 (N-C), 136.4, 136.1, 131.6 (Ar, quaternary), 131.4 (C(CH3)), 130.3, 
128.2, 128.1, 127.9, 127.8, 127.7, 127.4, 126.9, 122.3 (Ar), 50.7 (Ar-CH2), 29.6 
(CH2), 27.4 (CH2), 19.8 (CH3), -1.7 (CH2I); m/z 440 ([M]
+
Na), 418 ([M]
+
H); [Found: 
([M]
+
Na) 440.0482, C20H20INNaO requires 440.0487]. 
 
6.2.13  Products of Attempted Cyclisations Performed in Chapter 5 
 
6.2.13.1   N-Benzyl-N-(2-methylnaphthalen-1-yl)-2-iodoacetamide 376 
 
N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-iodoacet-
amide (62 mg, 0.15 mmol) was dissolved in dry toluene (7.5 ml) 
and a mixture of Bu3SnH (52 μl, 0.18 mmol) and AIBN (2.5 mg, 
0.015 mmol) in toluene (7.5 ml) was degassed simultaneously.  
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N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-iodoacetamide in dry toluene 
was heated to reflux and the reagent mixture was added via syringe pump over 2 
hours.  A second portion of the Bu3SnH and AIBN was then added over 1 hour and 
the resulting mixture was stirred at reflux overnight.  The solvent was removed in 
vacuo and the residue was partitioned between 8% KF (50 ml) and Et2O (20 ml) and 
stirred for 3 hours.  The resulting organic layer was filtered through celite and 
concentrated to yield a crude product which was purified by gradient chromatogrphy 
eluting with 100-50% pet ether/EtOAc to yield 376  as a white solid (12 mg, 0.03 
mmol, 21%).  Rf (3:1 pet ether:EtOAc) 0.68;  mpt 174-175 
o
C;  max (cm
–1
) 3064, 
2838, 1662, 1495, 1452, 1415, 1388, 1290, 1245, 1164, 1084, 760;  δH (300 MHz, 
CDCl3) 7.75-7.62 (2H, m, Ar-H), 7.38-7.19 (9H, m, Ar-H), 5.07 (1H, d, JHH 13.4 Hz, 
Ar-CH2), 4.49 (1H, d, JHH 13.4 Hz, Ar-CH2), 3.32 (1H, d, JHH 10.7 Hz, CH2I), 3.28 
(1H, d, JHH 10.7 Hz, CH2I), 1.85 (CH3);  δC (75.5 MHz, CDCl3) 170.3 (C=O), 137.9 
(N-C), 136.3, 135.1, 133.2 (Ar, quaternary), 132.1, 130.8, 130.4, 130.1, 130.1, 130.0, 
129.7, 129.5, 129.2, 127.7, 124.4 (Ar), 123.2 (C(CH3)), 55.1 (Ar-CH2), 25.2 (CH3), -
0.1 (CH2I); m/z 438 ([M]
+
Na), 416 ([M]
+
H); [Found: ([M]
+
Na) 438.0329, 
C20H20INNaO requires 438.0331]. 
 
6.2.13.2   2-(3-Oxobutyl)benzoic acid benzyl carbamoyl methyl ester 377 
 
N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-2-iodo-
acetamide (62 mg, 0.15 mmol) was dissolved in dry toluene 
(7.5 ml) and a mixture of Bu3SnH (52 μl, 0.18 mmol) and 
AIBN (2.5 mg, 0.015 mmol) in toluene (7.5 ml) were 
degassed simultaneously.  N-Benzyl-N-(2-methyl-3,4-
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dihydronaphthalen-1-yl)-2-iodoacetamide in dry toluene was heated to reflux and the 
reagent mixture was added via syringe pump over 2 hours.  A second portion of the 
Bu3SnH and AIBN was then added over 1 hour and the resulting mixture was stirred 
at reflux overnight.  The solvent was removed in vacuo and the residue was 
partitioned between 8% KF (50 ml) and Et2O (20 ml) and stirred for 3 hours.  The 
resulting organic layer was filtered through celite and concentrated to yield a crude 
product which was purified to gradient chromatogrphy eluting with 100-50% pet 
ether/EtOAc to yield 377 as a colourless oil (14 mg, 0.04 mmol, 26%).  Rf (3:1 pet 
ether:EtOAc) 0.23; max (cm
–1
) 3278, 3067, 2988, 2902, 1730, 1707, 1664, 1555, 
1499, 1485, 1454, 1421, 1270, 1248, 1167, 1136, 1102, 744, 691;  δH (300 MHz, 
CDCl3) 7.84 (1H, d, JHH 8.3 Hz, Ar-H), 7.45 (1H, dd, JHH 8.3, 1.5 Hz, Ar-H) 7.36-
7.24 (8H, m, Ar-H), 6.83 (1H, br, NH), 4.87 (2H, s, C(O)CH2O), 4.54 (2H, d, JHH 
6.0 Hz, Ar-CH2NH), 3.18 (2H, t, JHH 7.3 Hz, Ar-CH2), 2.75 (2H, t, JHH 7.3 Hz, 
CH2C(O)), 2.04 (3H, s, CH3);  δC (75.5 MHz, CDCl3) 208.2, 167.3, 166.1 (C=O), 
143.4, 137.9, 128.8 (Ar, quaternary), 132.7, 131.2, 130.5, 128.7, 127.9, 127.7, 127.6, 
126.5, 126.4 (Ar), 63.5 (C(O)CH2O), 44.9 (Ar-CH2CH2), 43.2 (Ar-CH2), 29.9 (CH3), 
28.0 (Ar-CH2CH2); m/z 362 ([M]
+
Na); [Found: ([M]
+
Na) 362.1363, C20H21NNaO 
requires 362.1368]. 
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Appendix A 
 
N-CYCLOALKENYL BOND ROTATION STUDIES 
 
 For each compound a sample was dissolved in the appropriate solvent, which 
had been spiked with tetramethylsilane, and placed in a precision 5 mm NMR tube.  
The samples were submitted to the NMR service for variable temperature NMR at 
temperature intervals which were solvent dependant.  Experiments were performed 
by Dr Adam Clarke or Dr Ivan Prokes then processed using NUTS data processing 
software (www.acornnmr.com).  As the benzylic signals were well defined at lower 
temperature they were ideal for line-shape analysis.   
 At all temperatures, for each compound, the standard peak width was 
determined by measuring the half-height width of the tetramethylsilane internal 
standard.  In order to calculate the Δν at higher temperatures (during coalescence), 
for at least two of low temperature spectra (decoalesced) νa and νb were measured 
and plotted as log Δν (y-axis) verses 1/T (x-axis). 
 Line-shape analysis was performed using WINDNMR software.  Appropriate 
values for Δν and line width were inputted and line-shape analysis was accomplished 
by altering the rate (k) variable until the best fit was achieved.  An Eyring plot was 
then derived from the rate data by plotting 1/T (x-axis) verses ln (k/T) (y-axis) 
according to the equation: 
 



















 






h
kS
TR
H
T
k Bln
R
1
ln
ąą
 
 
Appendix A 
 
260 
 
 From the Eyring plots, it was possible to calculate the thermodynamic 
parameters for rotation from the following equations: 
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 To obtain thermodynamic parameters in calories the conversion factor 1 cal = 
4.184 J was used in all calculations. 
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Table A1. Rotational Data for 328 in CDCl3 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
216 21.5 263.0 263.0 
220 30.1 259.5 259.5 
227 52.2 253.8 253.8 
232 82.2 250.0 250.0 
238 159 245.8 245.8 
244 242 241.8 241.8 
249 386 238.7 238.7 
257 673 234.0 234.0 
263 1.06 x 10
3 
230.8 230.8 
270 1.51 x 10
3 
227.2 227.2 
 
Figure A1.  Eyring Plot for 328 in CDCl3 
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Table A2. Rotational Data for 338 in CDCl3 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
213 32.8 408.3 408.3 
223 81.0 394.9 394.9 
233 230 383.0 383.0 
243 421 372.5 372.5 
245 661 370.5 370.5 
247 755 368.5 368.5 
249 895 366.7 366.7 
251 989 364.8 364.8 
253 1.01 x 10
3
 363.0 363.0 
263 1.99 x 10
3
 354.4 354.4 
273 3.90 x 10
3
 346.7 346.7 
283 7.46 x 10
3
 339.7 339.7 
298 1.69 x 10
4
 330.2 330.2 
313 3.19 x 10
4
 321.9 321.9 
323 4.53 x 10
4
 316.9 316.9 
 
Figure A2.  Eyring Plot for X in CDCl3 
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Table A3. Rotational Data for 338 in methanol-d4 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
213 56.2 390.3 390.0 
223 140 379.2 379.2 
233 298 369.3 369.3 
235 336 367.5 367.5 
237 484 365.7 365.7 
239 513 363.9 363.9 
241 605 362.2 362.2 
243 686 360.5 360.5 
245 806 358.8 358.8 
247 915 357.2 357.2 
249 1.08 x 10
3
 355.6 355.6 
251 1.23 x 10
3 
354.1 354.1 
253 1.38 x 10
3
 352.5 352.5 
263 2.68 x 10
3 
345.4 345.4 
273 4.70 x 10
3 
338.8 338.8 
283 9.00 x 10
3
 332.9 332.9 
298 2.06 x 10
4 
324.9 324.9 
 
Figure A3.  Eyring Plot for 338 in methanol-d4 
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Table A4. Rotational Data for 338 in toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
193 18.6 744.7 744.6 
203 46.5 712.1 712.1 
213 124 683.8 683.8 
223 360 659.0 659.0 
233 752 637.1 637.1 
243 1.65 x 10
3
 617.7 617.7 
253 3.26 x 10
3
 600.3 600.3 
263 6.83 x 10
3
 584.7 584.7 
273 1.31 x 10
4
 570.6 570.6 
283 2.36 x 10
4 
557.8 557.8 
293 4.20 x 10
4
 546.1 546.1 
298 4.55 x 10
4 
540.7 540.7 
303 5.70 x 10
4 
535.5 535.5 
313 8.31 x 10
4
 525.7 525.7 
323 1.21 x 10
5 
516.6 516.6 
 
Figure A4.  Eyring Plot for 338 in toluene-d8 
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Table A5.  Rotational Data for 330 in CDCl3 
 
 
 
Temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
215 20.5 246.5 246.5 
220 32.2 242.6 242.6 
228  68.2 236.8 236.8 
234 131 232.9 232.9 
237 166 231.0 231.0 
240 211 229.2 229.2 
249 418 224.0 224.0 
252 508 222.4 222.4 
254 632 221.4 221.4 
258 826 219.3 219.3 
265 1.35 x 10
3 
216.0 216.0 
275 2.92 x 10
3 
211.6 211.6 
297 1.14 x 10
4 
203.2 203.2 
 
 
Figure A5. Eyring Plot for 330 in CDCl3 
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Table A6.  Rotational Data for 331 in toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
Calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
186 57.7 546.3 546.5 
191 102 533.3 533.5 
202 303 507.9 507.9 
222 2.40 x 10
3 
470.6 470.6 
233 6.90 x 10
3
 453.8 453.8 
245 1.42 x 10
4
 437.7 437.7 
256 2.90 x 10
4
 424.8 424.8 
266 5.75 x 10
4
 414.3 414.3 
279 1.05 x 10
5 
402.0 402.0 
290 1.97 x 10
5 
392.8 392.8 
 
 
Figure A6. Eyring Plot for 331 toluene-d8 
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Table A7. Rotational Data for 273 in toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
233 5.4 431.8 432.8 
245 15.0 409.7 411.1 
256 31.9 392.1 391.8 
266 80.0 378.0 366.9 
279 207 361.9 346.7 
311 2.43 x 10
3
 330.0 331.2 
327 5.99 x 10
3 
317.3 318.2 
339 1.67 x 10
4 
308.9 308.2 
 
 
Figure A7. Eyring Plot for 273 toluene-d8 
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Table A8. Rotational Data for 273 in CDCl3 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
273 26.7 418.5 417.9 
283 51.6 415.0 415.0 
298 210 410.3 410.1 
303 335 408.8 408.5 
305 438 408.2 408.0 
307 611 407.6 407.6 
309 690
 
407.1 406.8 
311 790
 
406.5 405.9 
313 863 406.0 405.7 
315 1.12 x 10
3
 405.4 405.4 
317 1.34 x 10
3
  404.9 404.4 
319 1.60 x 10
3
 404.4 404.0 
321 1.83 x 10
3
 403.9 403.9 
323 2.12 x 10
3
 403.4 403.2 
 
 
Figure A8. Eyring Plot for 273 CDCl3 
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Table A9. Rotational Data for 273 in methanol-d4 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
253 8.7 445.0 444.6 
263 14.9 440.1 440.5 
273 37.0 435.5 435.5 
283 84.0 431.3 431.1 
298 257 425.6 425.6 
303 437 423.9 423.7 
305 539 423.2 423.1 
307 606 422.5 422.5 
309 699 421.9 421.8 
311 777 421.2 421.1 
313 908 420.6 420.2 
315 1.16 x 10
3
 419.9 419.8 
317 1.37 x 10
3
 419.3 419.0 
319 1.51 x 10
3
 418.7 418.5 
321 1.83 x 10
3
 418.1 418.0 
323 2.14 x 10
3
 417.5 417.3 
333 3.98 x 10
3
 414.6 414.0 
 
 
Figure A9. Eyring Plot for 273 methanol-d4 
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Table A10. Rotational Data for 273 in CD3CN 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
263 9.2 347.8 347.3 
273 30.2 338.4 337.9 
283 68.2 329.9 330.0 
298 381 318.5 318.2 
300 473 317.1 317.3 
302 539 315.8 315.5 
304 601 314.4 314.4 
306 856 313.1 312.6 
308 991 311.8 311.1 
310 1.12 x 10
3
 310.5 310.0 
312 1.38 x 10
3
 309.2 309.1 
318 2.10 x 10
3
 305.6 305.3 
323 3.36 x 10
3
 302.7 302.7 
333 6.33 x 10
3
 297.2 297.2 
 
 
Figure 10. Eyring Plot for 273 CD3CN 
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Table A11. Rotational Data for 273 in THF-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
Calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
243 4.2 498.2 498.2 
253 12.0 491.8 491.2 
263 34.1 486.0 486.1 
273 86.8 480.7 480.5 
283 207 475.8 475.5 
298 810 469.2 469.0 
300 1.21 x 10
3
 468.3 468.2 
302 1.48 x 10
3
 467.5 465.1 
304 1.67 x 10
3
 466.7 466.0 
306 2.01 x 10
3
 465.9 465.7 
308 2.40 x 10
3
 465.2 465.1 
313 3.49 x 10
3
 463.3 463.3 
323 7.16 x 10
3
 459.6 459.6 
333 1.47 x 10
4
 456.3 456.3 
 
 
Figure A11. Eyring Plot for 273 THF-d8 
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Table A12. Rotational Data for 273 in CD3NO2 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
Calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
248 3.2 337.1 336.9 
253 5.7 332.3 332.6 
263 15.2 323.5 323.4 
273 37.2 315.5 315.6 
278 52.1 311.8 311.4 
280 54.7 310.4 310.7 
282 62.9 309.0 309.0 
283 73.7 308.3 308.1 
284 76.5 307.6 307.7 
286 84.1 306.2 306.0 
288 93.4 304.9 304.9 
290 107 303.6 303.8 
292 139 302.3 302.1 
294 179 301.1 301.1 
298 233 298.6 298.9 
303 391 295.7 297.6 
313 591 290.2 290.2 
323 1.76 x 10
3
 285.1 285.1 
333 3.38 x 10
3
 280.4 280.3 
 
 
Figure A12. Eyring Plot for 273 CD3NO2 
 
y = -6287.7x + 20.905
R2 = 0.9912
-5
-4
-3
-2
-1
0
1
2
3
0.003 0.0035 0.004 0.0045
1/T
ln
 (
k
/T
)
 
Appendix A 
 
273 
 
Table A13. Rotational Data for 273 in DMF-d7 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
Calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
243 5.8 366.2 360.0 
253 11.4 358.1 358.4 
263 26.8 350.8 350.8 
273 52.1 344.2 344.0 
283 114 338.1 338.4 
298 339 330.0 330.1 
303 767 327.5 327.3 
305 825 326.5 326.5 
307 940 325.5 325.4 
309 1.10 x 10
3
 324.6 324.5 
311 1.24 x 10
3
 323.7 323.5 
313 1.44 x 10
3
 322.8 322.9 
315 1.80 x 10
3
 321.9 321.8 
317 2.17 x 10
3
 321.0 321.0 
319 2.49 x 10
3
 320.1 320.0 
321 2.88 x 10
3
 319.3 319.1 
323 3.21 x 10
3
 318.4 318.2 
333 6.30 x 10
3
 314.4 314.2 
343 1.21 x 10
4
 310.6 310.6 
353 1.26 x 10
4
 307.1 307.1 
 
 
Figure A13. Eyring Plot for 273 DMF-d7 
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Table A14. Rotational Data for 332 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
250 16.7 548.5 549.2 
261 40.5 522.8 522.3 
271 91.5 489.3 491.6 
281 172 460.1 459.6 
292 374 432.1 412.6 
311 1.62 x 10
3 
391.8 392.4 
321 3.12 x 10
3 
373.8 374.4 
331 5.76 x 10
3 
357.7 356.4 
341 1.19 x 10
4 
343.1 344.4 
350 2.11 x 10
4 
331.2 331.6 
 
 
Figure A14.  Eyring Plot for 332 in Toluene-d8 
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Table A15. Rotational Data for 274 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
230 11.0 506.6 508.5 
240 22.5 483.5 484.1 
250 60.0 463.2 461.6 
261 161 443.6 440.6 
271 365 427.7 426.1 
292 1.73 x 10
3 
399.5 399.6 
301 3.43 x 10
3 
389.1 388.6 
311 7.33 x 10
3 
378.6 379.6 
321 1.41 x 10
4 
369.0 369.6 
331 2.63 x 10
4 
360.1 359.9 
341 4.62 x 10
4 
352.0 350.9 
 
 
Figure A15. Eyring Plot for 274 in Toluene-d8 
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Table A16.  Rotational Data for 275 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
230 15.1 603.9 604.8 
240 35.4 584.2 583.8 
250 101 566.7 565.9 
261 280 549.4 549.9 
292 2.80 x 10
3 
510.0 510.0 
301 5.17 x 10
3 
500.5 500.0 
311 1.06 x 10
4 
490.8 490.0 
321 2.36 x 10
4 
481.9 481.7 
331 3.94 x 10
4 
473.6 473.4 
341 7.01 x 10
4 
466.0 467.1 
 
 
Figure A16.  Eyring Plot for 275 in Toluene-d8 
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Table A17.  Rotational Data for 305 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
220 8.0 110.9 111.2 
230 17.8 105.8 105.8 
240 42.8 101.3 101.4 
250 106 97.4 97.4 
271 432 90.4 90.4 
281 836 87.6 87.6 
292 1.80 x 10
3 
84.9 84.9 
301 3.03 x 10
3 
82.8 82.7 
311 5.58 x 10
3 
80.7 80.6 
 
 
Figure A17. Eyring Plot for 305 in d8-Toluene 
 
y = -4674.6x + 17.813
R2 = 0.9987
-4
-3
-2
-1
0
1
2
3
4
0.003 0.0035 0.004 0.0045 0.005
1/T
ln
 (
k
/T
)
 
 
Appendix A 
 
278 
 
Table A18.  Rotational Data for 306 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
341 6.0 600.5 599.3 
349 8.9 592.4 587.0 
359 14.6 582.9 576.6 
369 23.6 574.1 564.7 
379 38.9 565.9 553.5 
 
 
Figure A18. Eyring Plot for 306 in Toluene-d8 
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Table A19.  Rotational Data for 333 in Toluene-d8 
 
 
 
temp. 
(K) 
k1 + k-1 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
271 67.0 182.9 180.7 
281 136 175.5 175.5 
292 316 168.1 168.3 
301 656 162.7 162.7 
311 1.39 x 10
3 
157.3 157.1 
321 2.66 x 10
3
 152.3 152.4 
331 4.88 x 10
3 
147.9 148.0 
341 1.02 x 10
4 
143.7 143.7 
350 1.70 x 10
4 
140.3 140.2 
 
Upon cooling, two diastereomers were seen in a 2:1 ratio. 
Therefore, k1 = (1/3)(k1 + k-1), and k-1 = (2/3)(k1 + k-1) for each temperature. 
 
Figure A19.  Eyring Plot for 333 in Toluene-d8 
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Table A20. Rotational Data for 334 in d8-Toluene 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
193 50.0 743.4 743.4 
203 98.0 690.9 690.9 
213 251 646.5 646.5 
223 967 608.6 608.6 
233 2.12 x 10
3 
575.9 575.9 
243 6.53 x 10
3 
547.4 547.4 
253 1.41 x 10
4 
522.5 522.5 
263 3.89 x 10
4 
500.4 500.4 
273 6.08 x 10
4 
480.8 480.8 
283 8.27 x 10
4 
463.3 463.3 
 
Figure A20.  Eyring Plot for 334 in d8-Toluene 
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Table A21. Rotational Data for 335 in toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
183 62.4 702.8 702.7 
193 118 670.3 670.2 
203 306 642.3 642.3 
213 612 617.9 617.6 
223 1.18 x 10
3
 596.5 596.1 
233 2.56 x 10
3
 577.6 577.5 
243 5.08 x 10
3
 560.8 560.8 
253 1.07 x 10
4
 545.8 545.8 
263 2.06 x 10
4
 532.2 532.2 
273 3.60 x 10
4 
520.0 520.0 
283 5.48 x 10
4
 508.8 508.8 
298 6.70 x 10
4 
493.9 493.9 
303 7.80 x 10
4 
489.3 489.3 
313 1.00 x 10
5
 480.8 480.8 
323 1.71 x 10
5 
472.9 472.9 
 
Figure A21.  Eyring Plot for 335 in toluene-d8 
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Table A22. Rotational Data for 336 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
203 9.7 594.1 593.3 
213 27.8 569.4 567.8 
223 81.9 547.9 546.0 
233 188 529.0 527.2 
243 454 512.1 511.3 
253 874 497.1 496.1 
263 1.57 x 10
3
 483.6 483.2 
273 3.50 x 10
3 
471.5 471.3 
283 7.41 x 10
3 
460.4 460.3 
298 1.73 x 10
4 
445.7 445.6 
303 2.06 x 10
4
 441.2 441.2 
313 3.48 x 10
4 
432.8 432.8 
323 6.10 x 10
4
 425.0 425.0 
333 1.28 x 10
5 
417.8 417.8 
343 2.04 x 10
5 
411.2 411.2 
353 3.90 x 10
5
 405.0 405.0 
 
Figure A22.  Eyring Plot for 336 in Toluene-d8 
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Table A23. Rotational Data for 337 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
223 7.1 785.3 785.3 
233 15.4 760.4 760.4 
243 35.7 738.3 738.3 
253 102 718.6 718.6 
263 260 700.8 700.8 
273 602
 
684.7 684.7 
283 1.77 x 10
3 
670.0 670.0 
298 6.41 x 10
3 
650.4 650.4 
303 7.93 x 10
3
 644.4 644.4 
313 1.80 x 10
4 
633.2 633.2 
323 3.74 x 10
4
 622.8 622.8 
333 7.19 x 10
4 
613.2 613.2 
343 1.34 x 10
5 
604.3 604.3 
353 2.95 x 10
5
 596.1 596.1 
 
 
Figure A23.  Eyring Plot for 337 in Toluene-d8 
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Table A24. Rotational Data for 344 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
183 7.7 706.3 705.0 
193 12.5 672.7 673.8 
203 29.1 643.8 645.8 
213 63.4 618.1 617.1 
223 139 596.7 596.0 
233 325
 
577.3 576.6 
243 734
 
560.0 559.9 
253 1.49 x 10
3 
544.6 544.1 
263 3.16 x 10
3
 530.7 530.5 
273 6.02 x 10
3 
518.1 518.0 
283 1.10 x 10
4
 506.7 506.7 
298 2.57 x 10
4 
491.4 491.1 
303 3.09 x 10
4 
486.8 486.6 
313 4.50 x 10
4
 478.0 478.0 
323 7.00 x 10
4 
470.0 470.0 
333 1.45 x 10
5 
462.5 462.4 
343 1.87 X 10
5 
455.6 455.5 
 
 
Figure A24.  Eyring Plot for 344 in Toluene-d8 
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Table A25. Rotational Data for 339 in Toluene-d8 
 
 
 
temp. 
(K) 
k1 + k-1 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
213 69.1 620.6 620.7 
223 134 597.3 594.6 
233 312 576.8 575.1 
243 668 558.7 557.2 
253 1.34 x 10
3 
542.4 540.9 
263 2.70 x 10
3 
527.8 527.2 
273 4.74 x 10
3 
514.7 513.8 
283 8.16 x 10
3 
502.7 501.9 
298 2.00 x 10
4
 486.8 485.2 
303 2.96 x 10
4 
481.9 481.3 
313 4.37 x 10
4
 472.8 472.1 
323 6.20 x 10
4 
464.4 464.0 
333 8.60 x 10
4 
456.6 456.1 
343 1.07 x 10
5
 449.4 448.9 
353 1.57 x 10
5 
442.8 442.5 
363 1.93 x 10
5 
436.5 436.0 
Upon cooling, two diastereomers were seen in a 1:1 ratio. 
Therefore, k1 = (1/2)(k1 + k-1), and k-1 = (1/2)(k1 + k-1) for each temperature. 
 
Figure A25.  Eyring Plot for 339 in Toluene-d8 
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Table A26. Rotational Data for 343 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
183 22.8 590.7 590.2 
193 52.9 559.2 560.3 
203 117 532.1 531.6 
213 220 508.8 508.1 
223 630
 
488.4 487.7 
233 1.69 x 10
3 
470.5 470.0 
243 3.71 x 10
3 
454.7 454.1 
253 7.69 x 10
3 
440.5 439.9 
263 1.50 x 10
4
 427.9 427.4 
273 2.59 x 10
4 
416.5 416.2 
283 3.69 x 10
4
 406.1 405.5 
298 6.24 x 10
4 
392.4 392.1 
303 9.10 x 10
4 
388.2 388.0 
313 1.48 x 10
5
 380.3 380.0 
 
 
Figure A26.  Eyring Plot for 343 in Toluene-d8 
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Table A27. Rotational Data for 342 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
183 478 318.3 318.3 
193 1.32 x 10
3
 309.8 309.8 
203 2.74 x 10
3
 301.4 301.4 
213 5.46 x 10
3 
295.6 295.6 
223 1.15 x 10
4
 289.9 289.9 
233 2.35 x 10
4 
285.2 285.2 
 
 
Figure A27.  Eyring Plot for 342 in Toluene-d8 
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Table A28. Rotational Data for 341 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
253 4.0 681.3 681.3 
263 8.8 668.7 668.7 
273 28.9 657.3 657.3 
283 51.6 646.9 646.9 
298 161
 
632.8 632.8 
303 260
 
628.5 628.5 
313 494
 
620.4 620.4 
323 1.91 x 10
3 
612.8 612.8 
333 4.75 x 10
3
 605.8 605.8 
343 9.14 x 10
3 
599.3 599.3 
353 1.88 x 10
4
 593.2 593.2 
363 3.03 x 10
4 
587.5 587.5 
373 5.38 x 10
4 
582.2 582.2 
 
 
Figure A28.  Eyring Plot for 341 in Toluene-d8 
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Table A29. Rotational Data for 340 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
213 8.9 620.4 620.4 
223 21.6 602.0 602.0 
233 45.9 585.6 585.6 
243 100 571.0 571.0 
253 206
 
557.9 557.9 
263 417
 
546.0 546.0 
273 748
 
535.2 535.2 
283 2.31 x 10
3 
525.2 525.2 
298 7.38 x 10
3
 512.2 512.2 
303 9.99 x 10
3 
508.1 508.1 
313 1.77 x 10
4
 500.5 500.5 
323 2.83 x 10
4 
493.5 493.5 
333 4.61 x 10
4 
487.0 487.0 
343 7.45 x 10
4
 480.9 480.9 
353 1.28 x 10
5 
475.2 475.2 
363 1.99 x 10
5 
470.0 470.0 
 
 
Figure A29.  Eyring Plot for 340 in Toluene-d8 
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Table A30. Rotational Data for 363 in Toluene-d8 
 
 
 
temp. 
(K) 
k 
(s
-1
) 
calc. νa-νb 
(Hz) 
obs. νa-νb 
(Hz) 
298 0.7 985.9 979.6 
303 1.2 970.7 968.6 
313 1.8 942.5 943.6 
323 2.4 916.8 921.0 
333 4.3 893.3 898.4 
343 7.9 871.7 875.9 
353 15.0 851.9 852.7 
363 21.8 833.5 831.9 
373 42.8 816.5 810.5 
 
 
Figure A30.  Eyring Plot for 363 in Toluene-d8 
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Appendix B 
 
CHIRAL HPLC REPORTS 
 
360 N-Benzyl-N-(2,4-dimethylpent-2-en-3-yl)-acetamide 
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362 N-Benzyl-N-(2,6-dimethylcyclohexen-1-yl)-acetamide 
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364 N-Benzyl-N-(2-methyl-3,4-dihydronaphthalen-1-yl)-acetamide 
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361 N-Methyl-N-(2,4-dimethylpent-2-en-3-yl)-acetamide 
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Appendix C 
 
X-RAY CRYSTALLOGRAPHY DATA 
 
 
   
 
 
 
  
254 305 339 
364 372 
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 254 305 339 364 372 
Empirical C20H22BrNO3S C21H22BrNO C16H20BrNO C20H21NO C20H20BrNO 
FW 436.36 384.31 322.24 291.38 370.28 
Crystal Size 0.26 x 0.14  
x 0.12 
0.30 x 0.30 
x 0.20 
0.40 x 0.40 
x 0.25 
0.30 x 0.10  
x 0.10 
0.35 x 0.20  
x 0.15 
System Monoclinic Monoclinic Orthorhombic Orthorhombic Monoclinic 
Space group P2 (1)/c P2 (1)/c Pbca P2 (1) P2 (1)/n 
a (Å) 20.9783(10) 18.1071(3) 14.1009(3) 7.3684(3) 14.9163(3) 
b (Å) 7.8705(4) 6.0419(10) 12.1784(2) 9.7503(4) 7.5696(13) 
c (Å) 11.6620(5) 16.1361(2) 17.5284(4) 22.0856(9) 15.2555(2) 
α (deg)  90 90 90 90 90 
β (deg) 91.72 92.7860(10) 90 90 99.5960(16) 
γ (deg) 90 90 90 90 90 
V (Å
3
) 1924.64(16) 1763.22(5) 3010.10(11) 1586.74(11) 1698.39(5) 
Dcal (Mgm
-3
) 1.506 1.448 1.422 1.220 1.448 
μ (mm-1) 2.264 2.338 2.724 0.074 2.425 
F000 896 792 1328 624 760 
Total 
Reflections 
24210 15270 14040 8310 13615 
Independent 4389 4353 3691 3063 6820 
Rint 0.0718 0.0248 0.0287 0.0415 0.0218 
Data/Restraints/ 
Parameters 
4389/0/238 4353/0/219 3691/28/190 3063/0/201 6820/47/231 
R1, [I > 2σ(I)] 0.0606 0.0244 0.0368 0.0542 0.0366 
wR2 0.1547 0.0559 0.0948 0.1182 0.0839 
GoF on F
2
 1.023 0.955 1.038 0.941 0.900 
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